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Executive Summary 
 
Introduction. The European Integrated Project DRUID (Driving Under the Influence of 
Drugs, Alcohol and Medicines) is a part of the 6th Framework Program, the European 
Community Framework Program for Research, Technological Development and 
Demonstration. The objective of DRUID is to give scientific support to the EU transport 
policy by providing a solid basis to generate harmonised, EU-wide regulations for driving 
under the influence of alcohol, drugs and medicine. This study is a part of Work Package 
2, Epidemiology, of the DRUID project. The objective of the study is to assess the 
situation in Europe regarding the prevalence of alcohol and other psychoactive 
substances in drivers who have been injured/killed in traffic accidents. 
Part 1 of this report presents the general results of the hospital & killed driver studies. 
After a short introduction, the representativeness of the populations in the EU countries 
as well as the representativeness of hospitalised and killed driver samples are 
addressed. An overview of the non-response issues in the various countries is also 
included. Based on the toxicological findings, a general summary of the prevalence of 
drug use is given for the 9 participating countries. This is followed by a discussion and a 
conclusions part. 
Part 2 and 3 of this report include all the country reports. In this part more detailed 
information regarding study design, methods, representativeness of the sampling and 
results on a national level can be found. 
 
Material and Method. A cross-sectional survey was conducted to determine the 
prevalence of drugs in injured (sampled between October 2007 and May 2010) and killed 
(sampled between January 2006 and December 2009) drivers in 9 European countries. 
In order to be able to compare the 10 different studies (Finland performed an injured 
driver study and a killed driver study), a uniform design was developed for all participating 
countries (see Annex 1). Obligatory inclusion criteria were: Driver of a motorized vehicle, 
injured in an accident on a public road or in the direct vicinity of a public road, only 
primary admissions to the hospital (no referrals), because of traumatological reasons with 
a time interval between the accident and sampling of less than 3 hours and a injury 
severity being MAIS 2 or higher. Each country could decide upon additional national 
criteria. 
A total of 3570 seriously injured drivers and 1293 killed drivers were sampled in this 
study. For the general outcomes, among all subjects sampled, a selection was made to 
obtain relatively similar sub-populations of seriously injured (MAIS ≥2) and killed drivers. 
The analysis focuses on drivers of personal cars and vans. 
Drug dosage was conducted on blood samples. Extraction was based on liquid-liquid 
(LLE) or solid phase (SPE) extraction, chromatographic separation was performed by gas 
chromatography (GC) or liquid chromatography (LC): High Performance (HPLC) or Ultra 
Performance (UPLC). Detection was done by mass spectrometry (MS) or 
nitrogen/phosphorus detection (NPD). Commonly defined DRUID thresholds were used 
to define positivity (part 1, 2.2. toxicology). Prevalence data were also provided according 
to age and gender. 
 
Results 
In the injured drivers study, among car and van drivers (n= 2492), the highest number of 
subjects was sampled in Denmark (33.7%), followed by Italy (27.1%). Disregarding the 
Belgian data (classification of road type based on speed limit), 26.5% of drivers were 
sampled on urban roads, 29.2% on rural roads and 44.3% on unknown type of road. 
76.9% of the accidents occurred during daytime (50.9% on a weekday, 26% in 
weekends). More than 50% of the drivers were sampled in the first or fourth quarter. For 
Italy there was a higher proportion in the second quarter and a lower one in the fourth 
quarter compared to other countries. Males accounted for 69.9%, females for 29.5% 
(0.6% unknown). 79.7% of the study population was between 18 and 49 years old. The 
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use of safety belt was known for only 17.8% of the sampled drivers (Belgium and the 
Netherlands) and of these approximately 72% were using a safety belt. Overall 90.8% of 
the study population was driving a personal car and 5.8% a small van (3.4% unknown). 
32.3% was involved in a single-vehicle accident and 37.3% in a multi-vehicle collision 
(30.4% unknown). The most prevalent MAIS scores were 2 and 3. 
 
In the killed drivers study, among car and van drivers (n= 1118), the highest number of 
subjects was sampled in Finland (43.2%), followed by Portugal (25.5%). 63.5% of the 
population was sampled on rural roads, 10.1% on urban roads (26.4% unknown). 78% of 
the accidents occurred during daytime (53% on a weekday, 25% in weekends). The 
distribution by quarter of the year was equal between all countries, with the highest 
percentage in the third quarter. Males accounted for 83%. The highest proportion was 
found in the group 50 years and older. Overall 70.8% of the study population was driving 
a personal car. 30.9% was involved in a single-vehicle accident and 43.5% in a multi-
vehicle collision (25.6% unknown).  
 
Toxicological data were analysed according to two criteria.  
• Distribution of positive drivers among sampled subjects (mutually exclusive 
groups): a subject can be part of one group only, independently of the number of 
substances taken. 
• Prevalence of substance groups use among sampled drivers: data give an 
indication of how many people use the different substance groups among the 
sample population and the same subject may appear under several substance 
groups. 
 
The percentages of drivers positive for one or more substances (mutually exclusive) 
varied from around 28% up to 53% in the different countries, as shown in the table below. 
 
MUTUALLY EXCLUSIVE GROUPS - Percentage of drivers positive for the 
substance groups 
 Seriously injured drivers Killed drivers 
Toxicological 
finding 
BE 
(325
) 
DK 
(831)
FI 
(47) 
IT 
(676)
LT 
(385)
NL 
(186)
FI 
(459)
NO 
(165) 
PT 
(285) 
SE 
(141)
Negative 47.4 69.7 55.3 68.0 72.2 66.1 57.7 60.0 52.3 69.5 
Alcohol only 30.2 14.1 25.5 18.5 15.3 25.3 24.4 18.2 38.9 15.6 
Amphetamine only 0.9 1.0 0.0 0.0 0.3 1.1 0.7 1.2 0.0 2.1 
Benzoylecgonine 
only  0.0 0.0 0.0 0.7 0.3 1.1 0.0 0.0 0.0 0.0 
Cocaine  0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 0.0 
THCCOOH only  0.6 1.6 0.0 0.4 0.3 0.0 N.A. N.A. 1.1 0.0 
THC  1.5 0.6 2.1 1.6 0.3 0.5 0.0 1.8 0.0 0.7 
Illicit opiates only 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 
Benzodiazepines 
only 1.5 1.2 0.0 0.4 2.3 0.0 5.2 1.8 0.7 0.0 
Z-drugs only 0.9 0.5 2.1 0.0 0.0 0.5 1.7 1.2 0.0 2.8 
Medicinal opioids 
only 1.2 2.5 0.0 1.8 5.7 0.5 1.5 0.6 0.7 0.7 
Alcohol + drug 
combination 13.2 5.4 10.6 4.6 2.3 4.3 7.2 7.9 6.0 4.3 
Drug + drug 
combination 2.5 3.5 4.3 2.5 0.8 0.5 1.5 7.3 0.4 4.3 
Total  100 100 100 100 100 100 100 100 100 100 
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As expected, alcohol was the most common toxicological finding, both in the seriously 
injured and in killed drivers (range 17.7 - 42.5% and 19.0 - 44.9% respectively for the 
injured and killed drivers study). In the prevalence of use, among all seriously injured 
drivers, after alcohol, THC (range 0.5-7.6%) and benzodiazepines (range 0-10.2%) were 
the most common findings. In the killed drivers study, among all sampled subjects, the 
most prevalent substances after alcohol were benzodiazepines (range 1.4-13.3%), 
followed by amphetamine (range 0-7.4%) and THC (range 0-6.1%). These results are 
shown in the table below. 
To be able to give a better view on sporadic/single or chronic use of cannabis, a 
distinction between THC and THCCOOH was made. 
 
PREVALENCE OF USE OF SUBSTANCE GROUPS - Percentage of drivers positive  
 Positive seriously injured drivers Positive killed drivers 
 BE DK  FI  IT  LT  NL  FI  NO  PT  SE 
Alcohol (≥0.1g/L) 42.5 19.7 32.1 23.1 17.7 29.6 31.4 25.4 44.9 19.0 
Alcohol (≥0.5 g/L) 38.2 17.8 30.2 20.6 16.1 28.0 29.3 23.8 35.1 16.3 
Amphetamines 2.6 4.2 3.7 0.1 0.5 2.1 2.1 7.4 0.0 6.6 
Benzoylecgonine* 1.4 0.7 0.0 2.8 0.3 2.7 0.0 0.6 0.7 0.7 
Cocaine 2.3 0.6 0.0 2.7 0.3 2.1 0.0 0.0 0.7 0.7 
Cocaine and/or 
benzoylecgonine 
3.8 1.3 0.0 5.4 0.5 4.8 0.0 0.6 1.4 1.3 
THCCOOH** 2.3 5.3 0.0 1.3 0.3 1.1 N.A. N.A. 4.2 0.0 
THC 7.6 1.3 5.7 3.7 0.5 0.5 1.3 6.1 0.0 1.3 
THC and/or 
THCCOOH 
9.9 6.6 5.7 5.1 0.8 1.6 1.3 6.1 4.2 1.4 
Illicit opiates 0.6 0.5 0.0 2.1 0.3 0.0 0.0 0.0 0.0 0.0 
Benzodiazepines 7.3 6.7 10.2 0.7 3.6 0.0 13.3 9.7 1.8 3.9 
Z-drugs 1.7 1.2 3.8 0.0 0.0 0.5 3.0 4.4 0.0 3.2 
Medicinal opioids 3.3 4.2 4.0 3.7 7.8 0.5 2.1 1.7 2.1 4.1 
* Benzoylecgonine but negative for cocaine 
**THCCOOH but negative for THC 
 
Highlights 
Seriously injured drivers 
- The percentage of subjects testing positive for at least one psychoactive substance 
ranged between 28 and 53%. 
- Alcohol (cut-off = 0.1 g/L) was the most common finding with the highest percentage 
of positives found in Belgium (42.5%), where 50.6% of the male injured drivers tested 
positive. Among the positives, 90.5% had a blood alcohol concentration equal to or 
above 0.5 g/L. The mean and median values of ethanol were respectively 1.59 g/L 
and 1.60 g/L 
- The majority of drugs appeared to be used in combination with other psychoactive 
substances. 
- Among the illicit drugs, amphetamine use appeared to be more common in northern 
Europe, while cocaine use seemed to be more prevalent in southern Europe. No 
cases of cocaine/benzoylecgonine were recorded in Finland. 
- Approximately 9.9 % of the seriously injured drivers in Belgium tested positive for 
cannabis (THC and/or THCCOOH). 
- No positive findings for Z-drugs were recorded in Italy and Lithuania. 
- Lithuania had almost a double amount of positive subjects for medicinal opioids 
compared with the other countries in the study. 
 
Killed drivers 
- The percentage of subjects testing positive for at least one psychoactive substance 
ranged between 31 and 48%. 
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- Alcohol (cut-off = 0.1 g/L) was the most common finding with the highest percentage 
of positives found in Portugal (44.9%). Among the positives, 87.3% had a blood 
alcohol concentration equal to or above 0.5 g/L. The mean and median values of 
ethanol were respectively 1.61 g/L and 1.67 g/L. 
- In Portugal no subjects were found positive for the amphetamine group. 
- The majority of drugs appeared to be used in combination with other psychoactive 
substances. 
- No drivers tested positive for cocaine in Finland. 
- Subjects positive for THC (alone or in the presence of THCCOOH) were only found in 
males. 
- Norway had the highest percentage of positive findings for THC (6.1%). 
- In Portugal no subjects tested positive for Z-drugs. 
- Sweden had a double amount of subjects positive for medicinal opioids compared 
with the other three countries. 
 
Comparing the two Finnish datasets percentages in the seriously injured and in the killed 
drivers studies, similar findings were observed for most substance groups. 
 
Discussion.  
Non response. The non response in the six countries involved varies between 0% and 
8.5% for the surveys on injured drivers. The missing cases in the studies on killed drivers 
varied between 5.7% and 41%. 
Representativeness. Every country made several efforts to have a representative driver 
sample. These efforts resulted in a high participation rate in the injured driver surveys and 
in a maximum of 41% missing cases in the killed driver studies. Concerning the 
representativeness of the population in the EU countries: the Southern EU Member 
States are the best represented (54%), followed by the Northern Member States (29%) 
(due to the absence of the United Kingdom which alone accounts for 63% of the Northern 
Europe population). The Western Member States are only represented for 15% since 
large Member States like Germany and France, accounting together for 80% of Western 
Europe population, did not participate. Finally, the Eastern EU Member States are not 
represented in this study.  
Remarks. 
- The selection of countries was based on the institutes that participated in DRUID and 
based on their experience in organising hospital studies. During the negotiation progress, 
it was asked by the European Commission to also include southern and eastern 
European countries. Because of difficulties in organising previous similar studies, some 
countries decided not to participate in this DRUID-survey. Sweden and Hungary were at 
the beginning involved in the hospital study. Because of problems in cooperation with 
hospitals, these countries were allowed ot change their involvement. Instead of a hospital 
study, Sweden performed a killed driver study and Hungary a responsibility study on 
killed drivers. 
- In the killed drivers study the prevalence of cannabis use in Norway and Finland may 
have been underestimated due to the fact that samples were not analysed for 
THCCOOH. 
- A sample was considered positive for alcohol when the concentration was at or above 
the DRUID cut-off, which was set at 0.1 g/L. In most countries the legal cut-off for alcohol 
is 0.5 g/L. For the injured drivers study 9.5% of alcohol positive samples was found to 
have a concentration in the range 0.1-0.49 g/L. For the killed drivers study the percentage 
of positives in the same concentration range was 12.7. 
- Samples were considered positive if a substance was found at or above the set DRUID 
cut-offs. For this reason, the data give an estimate of the prevalence of substance groups 
among the sampled populations, which is likely to be conservative, because samples that 
tested positive but below the set cut-off were considered as negative. 
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Part 1 – Summary Report 
 
1 Introduction 
 
1.1 DRUID Project 
The European Integrated Project DRUID (Driving Under the Influence of Drugs, Alcohol 
and Medicines) is a part of the 6th Framework Program, the European Community 
Framework Program for Research, Technological Development and Demonstration. The 
DRUID project focuses on the improvement of road safety related to the problem of 
alcohol, drugs and medicines used or abused by drivers of vehicles in the road transport 
system. The objective of DRUID is to give scientific support to the EU transport policy by 
providing a solid basis to generate harmonised, EU-wide regulations for driving under the 
influence of alcohol, drugs and medicine. This study is a part of Work Package 2, 
Epidemiology, of the DRUID project. 
 
1.2 Work Package 2 – Epidemiology 
The objective of this work package is to assess the situation in Europe regarding the 
prevalence of alcohol and other psychoactive substances in drivers in traffic in general 
and in drivers who have been injured/killed in traffic accidents. Additionally, the 
characteristics of drivers who have been involved in accidents while impaired by alcohol 
or other psychoactive substances were explored. Furthermore relative risk estimates for 
traffic accident involvement of drivers impaired by alcohol and other psychoactive 
substances, who have been responsible for fatal accidents, were made. Finally 
differences in the patterns of psychoactive substance use between various EU countries 
were examined. The main purpose of the epidemiological studies was to determine the 
accident risk when driving under the influence of psychoactive substances, including 
alcohol (DUI). 
 
1.3 Task 2.2b 
This task studies drivers who have been injured and/or killed in traffic accidents. The 
prevalence of alcohol and/or various psychoactive substances among accident-involved 
drivers was assessed by means of two different populations (injured and killed drivers). 
The study was carried out in Belgium, Denmark, the Netherlands, Italy, Lithuania (injured 
drivers), Norway, Sweden, Portugal (killed drivers) and Finland (injured and killed 
drivers). For some countries samples from injured and/or killed drivers were collected in 
the same periods and geographical areas as for the roadside surveys (subtask 2.2a). 
Samples were either collected at hospitals, at the accident sites, or during legal 
autopsies. Toxicological analyses were carried out on a total of 4857 blood samples from 
injured and/or killed drivers collected in the 9 countries involved in subtask 2.2b. Samples 
were tested for the presence of the same substances analysed in the roadside surveys, 
and  the results serve as reference data for the relative risk estimation (odds ratio 
calculation) of alcohol and other psychoactive substances. 
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Table 1. Participating countries and number of samples 
Injured drivers Killed drivers 
 Samples  Samples 
Belgium 1078 Finland 652 
Denmark 856 Norway 193 
Finland 325 Portugal 290 
Italy 690 Sweden 158 
Lithuania 424   
Netherlands 197   
Total 3570  1293 
 
 
 
 
Figure 1. Participating countries 
All participating countries are members of the European Union (EU) except for Norway, 
which is associated with the European Union as a member of the European Economic 
Area (EEA). 
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2 Methods 
 
2.1 Driver sampling 
 
2.1.1 Description of the sampling method 
 
2.1.1.1 Injured drivers 
 
In general a blood sample was taken by hospital staff on arrival during the normal 
emergency procedure. At that stage the patient may not have been informed or asked 
permission, because unconscious. Informed consent was mandatory in some of the 
participating countries. If the patient refused to participate in the study, the blood sample 
was destroyed. If the patient took part in the study, a form including obligatory criteria 
(see annex 1) and additional data were filled in.  
 
The Belgian national database includes injured drivers who were admitted in one of the 
following hospitals: Ghent University Hospital, Regional Hospital of Namur, University 
Hospital Sart Tilman (Liège), Leuven University Hospital and Brussels University 
Hospital. These 5 hospitals were selected because they participated in a previous similar 
study (Belgium Toxicology and Trauma Study) in 1995. Samples were collected from 
drivers hospitalised between January 2008 and May 2010. Medical staff was in charge of 
filling in a patient form for each participant. Informed consent was mandatory. 
 
In Denmark the emergency room secretary controlled, on arrival by ambulance of the 
patient in one of the five selected hospitals, whether the patient was driver of a passenger 
car or a van. If this was the case, the emergency room secretary filled in a patient 
datasheet and the laboratory technician took besides the samples for treatment purposes 
an additional blood sample. Driver participation in the hospital study was, in principle, 
voluntary, without the need of an informed consent. 
 
The Finnish data were collected in southern Finland at two hospitals whose catchment 
areas covered the counties of Uusimaa and Itä-Uusimaa. Sample collection and 
interviews were carried out at the hospitals by nurses, who then sent the samples and 
interview forms to National Institute for Health and Welfare (THL). Patients included in the 
study were drivers of a motor vehicle or a bicycle and had a MAIS of 1 and above. To 
ensure efficient recruiting of patients and a high inclusion rate, all injured drivers over 18 
years old, even if only slightly injured, were asked to participate. Informed consent was 
mandatory. 
 
The Italian survey was carried out in close co-operation with the local hospitals. A 
selection of hospitals was made on the basis of willingness to cooperate, geographical 
distribution and influx of injured drivers. Only drivers that matched a number of well-
defined inclusion criteria were selected.  
 
In Lithuania a uniform protocol for hospital survey was used by the four participating 
hospitals in Vilnius, Kaunas, Klaipeda and Alytus. Responsible persons were appointed in 
each hospital. Blood samples were collected from injured drives and sent to the TMI 
Toxicology laboratory with the filled questionnaire.  
 
Hospitals in Enschede, Nijmegen and Tilburg participated in the study in the 
Netherlands. These hospitals collected accident and demographic data plus blood 
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samples from seriously injured drivers of passanger cars and vans who were admitted to 
the hospitals' Emergency Department. 
 
Table 2. Description of sampling method - Injured drivers 
Injured drivers 
Country Sample N Hospital + who collected 
Belgium Blood 5 hospitals; by appointed medical staff 
Denmark Blood 5 hospitals; by medical staff 
Finland Blood/oral fluid 2 hospitals; by medical staff 
Italy Blood/Urine 4 hospitals; by medical staff 
Lithuania Blood 4 hospitals; by appointed medical staff 
Netherlands Blood 3 hospitals; by medical staff 
 
 
2.1.1.2 Killed drivers 
 
In Finland the data concerning the accidents was collected from the Finnish Motor 
Insurers´ Centre (VALT). VALT is the agency which collects and holds information 
gathered by accident investigation teams in Finland. When toxicological analytical 
information for killed drivers could not be retrieved from the VALT archives the autopsy 
reports were requested from the Department of Forensic Medicine, Helsinki University, 
which performs forensic autopsies for the whole of Finland. In these instances the 
information for respective cases was then matched and collated to one database. 
 
In Norway data on persons injured or killed in road traffic accidents are submitted by the 
police to Statistics Norway on a regular basis. These data are entered into the Norwegian 
Road Accident Registry. Data on biological samples submitted for forensic analysis of 
alcohol or drugs at the Norwegian Institute of Public Health (NIPH) are recorded in the 
Forensic Toxicology Database at NIPH. In addition, analytical data from samples taken 
from legal autopsies from all regions of the country except Trøndelag in central Norway 
(which comprises two counties and 8.7% of the total population in Norway) are included 
in this database. A new dataset was generated by coupling these two databases, 
selecting drivers of passenger cars and vans who had been killed in road traffic accidents 
in Norway from January 2006 to December 2008.  
 
The cases included in the Portuguese study correspond to drivers victims of fatal road 
accidents on which autopsy was carried out in the Centre and South Branches of the 
Medico Legal Offices of the National Institute of Legal Medicine (INML, IP). As 
established by Law 45/2004, the National Institute of Legal Medicine is responsible for 
the medico-legal autopsies, which are mandatory in the cases of drivers killed in 
immediate fatal accidents. The cases selected for the present study were those classified 
as road accidents in which the driver was the victim and for which the toxicological 
analysis previously requested included alcohol, illicit drugs and medicinal drugs 
(benzodiazepines). Information about vehicle type could not be gathered but it is 
assumed that app. 95% of the sampled subjects were drivers of a passenger car or a 
van. 
 
All people killed in road traffic accidents in Sweden should undergo a post-mortem 
examination. In practice, about 90 per cent are examined. The Swedish sample includes 
drivers of personal cars and vans that were killed during the year 2008 and died within 24 
hours after the accident. The examination is carried out at the National Board of Forensic 
Medicine and, if possible, samples of blood, urine and sometimes other material are 
collected and sent to the department of Forensic Toxicology, which performs a 
toxicological analysis. The list of substances tested for is not standardised and may differ 
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between drivers. Additional analyses were therefore carried out in order to cover the 
DRUID substances.  
 
Table 3. Description of sampling method - Killed drivers 
Killed drivers 
Country Sample Organisation that collected samples 
Finland Blood VALT + Department of Forensic Medicine, Helsinki 
University 
Norway Blood  One database was created by Statistics Norway with: 
- Data on persons submitted by the police to Statistics 
Norway 
- Data on biological samples submitted to the Forensic 
Toxicology Database (NIPH1) 
Portugal Blood National Institute of Legal Medicine 
Sweden Blood/Urine2/Muscle 
tissue3 
National Board of Forensic Medicine. Analysis by the 
department of Forensic Toxicology. 
 
 
2.1.2 Representativeness of the population in the EU countries 
In 2008, when the collection for this study started, the European Union consisted of 27 
Member states with a total population of 497 million inhabitants (Source: Eurostat).  
 
According to the United Nations geoscheme, the region Europe can be devided in four 
geographical sub-regions, which do not imply any assumption regarding political or other 
affiliations of countries or territories. These sub-regions are commonly used for statistical 
purposes. 
 
Table 4. Coverage of the EU per sub region by the participating countries 
EU Member 
States per 
European sub 
region 
 
Number of 
inhabitants 
(million) 
Participation 
in the 
hospital 
study (X = 
yes) 
Representative-
ness per 
European sub 
region 
Northern Europe  29% 
 United Kingdom (UK)  60.9   
 Sweden (SE)  9.0 X  
 Denmark (DK)  5.4 X  
 Finland (FI)  5.3 X  
 Norway* (NO) 4.8 X  
 Ireland (IE)  4.3   
 Lituania (LT)  3.4 X  
 Latvia (LV)  2.3   
 Estonia (EE)  1.3   
 
Eastern Europe 0% 
 Poland (PL)  38.2   
                                                          
1 NIPH= Norwegian Institute of Public Health 
2 In some cases, screening results from urine haven been reported. This was only done when the screening 
gave a negative result and when there was not enough blood to conduct the analyses. 
3 Results from analyses on muscle tissue have also been reported in a few cases there was not enough blood to 
conduct the analyses 
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 Romania (RO)  21.6   
 Czech Republic (CZ)  10.3   
 Hungary (HU)  10.1   
 Bulgaria (BG)  7.7   
 Slovakia (SK)  5.4   
 
Southern Europe 54% 
 Italy (IT)  59.1 X  
 Spain (ES)  44.5   
 Greece (EL)  11.2   
 Portugal (PT)  10.6 X  
 Slovenia (SI)  2.0   
 Cyprus (CY)  0.8   
 Malta (MT)  0.4   
 
Western Europe 15% 
 Germany (DE)  82.3   
 France (FR)  63.4   
 The Netherlands (NL)  16.3 X  
 Belgium (BE)  10.6 X  
 Austria (AT)  8.3   
 Luxembourg (LU)  0.5   
Total  500.0   
* Norway is not a member of the EU. Norway is associated with the European Union as a 
member of the European Economic Area (EEA). 
 
Table 4 presents an overview of the EU Member States plus Norway and the 
geographical European sub-regions to which they belong. In this table the coverage of 
the participating countries is presented for the EU and for each geographical region that 
is covered by the EU Member States. Based on the population numbers it is shown that 
the Southern EU Member States are the best represented (54%). The Northern Member 
States together with Norway are represented for 29% due to the absence of the United 
Kingdom which accounts for 63% of the Northern EU Population. The Western Member 
States are only represented for 15% since large Member States like Germany and 
France, accounting together for 80% of the total Western EU population, did not 
participate. Finally, the Eastern EU Member States are not represented in this study. 
 
 
2.1.3 Representativeness of the hospitalised/killed driver samples 
 
2.1.3.1 Injured drivers 
 
For prevalence calculations, the Belgian data were grouped under the three 
administrative Belgian regions (Brussels, Flanders and Wallonia), so that they could be 
compared with the data collected during the roadside survey.4 Overall, only 3.2% of 
                                                          
4 Geographic distribution of roadside sessions was performed systematically. An equal number of sessions was 
scheduled in the catchment area of each hospital participating in DRUID task 2.2.b. For practical reasons, it was 
decided to include 9 police zones in each catchment area. These areas were defined based on information from 
the emergency services.  
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drivers were sampled in Brussels, while 81.3% were sampled in Flanders and 15.5% in 
Wallonia. This sampling distribution is significantly different from the one obtained in 
Flanders and Wallonia during the roadside surveys. The roadside figures are comparable 
with the distribution of vehicle kilometres in these regions (see D 2.2.3). 
 
The total number of seriously injured drivers for whom both a datasheet was received in 
DTU (Denmark) and a blood sample was received in UKBH was 856. Drivers below the 
age of 18 and drivers for whom the blood sample was taken three hours or more after the 
accident took place were excluded. A total of 840 drivers were included in the study.  
 
All Finnish hospital survey samples were collected in southern Finland at two hospitals 
whose catchment areas covered the counties of Uusimaa and Itä-Uusimaa. About 28% of 
the Finnish population lives within this area. According to national statistics, 8513 people 
were injured in traffic accidents in 2008 and of these 26% within the catchment areas. 
The overall participation rate was 82.9% (325 injured drivers consented from 392 
potential cases). The actual consent rate would increase to 91.5%, if it is considered that 
the number of potential participants decreases to 355 excluding those patients who did 
not refuse to take part in the study, but had to be excluded for other reasons (e.g. under 
18, transferred to another hospital before interview could be completed). 
 
The following specific districts were included in the Italian road side survey: Padova, 
Rovigo, Treviso, Venice, and Vicenza, accounting for more than 8% of the entire 
population in Italy and in 4 out of 5 districts could a hospital be selected for the hospital 
survey. The choice of these districts was based on the geographical distribution of 
population over the country. The four provinces cover all the geographical areas and 
reflect the Italian general topography. The social and economic structure of the region 
comprises agricultural, industrial and tourism activities thus representing a good model of 
the Italian socioeconomic configuration as well. Since it was stressed that the 
questionnaire was anonymous and all necessary efforts were made to guarantee the 
privacy of the patient and the confidentiality of the doctor-patient relation, non-response in 
collecting blood was reduced to zero. 
 
The four main hospitals of Lithuania (in Vilnius, Kaunas, Klaipeda and Alytus) were 
involved in the hospital study. These research areas of Lithuania were based on the 
geographical distribution of population over the country, accounting for 3,350 mln. 
inhabitants in total. The total number of injured drivers involved in Lithuanian hospital 
study was 424 drivers. During the hospital study there were no non-responses or 
refusals. The response rate was 100%. 
 
In the Netherlands the study area covered only the South and Eastern part of the 
Netherlands, but not the North and Western part. Based on the distribution of 
psychoactive substances in traffic in all regions, the expected bias was very small. 
 
2.1.3.2 Killed drivers 
 
The data presented in the Finnish Country Report is almost fully comprehensive for the 
three years 2006 to 2008. Therefore it can be assumed that these results are 
representative of the situation regarding killed drivers of motorised vehicles and bicycles 
in Finland.  
 
Norway was divided into three regions. About 53% of the cases were from south-east, 
25% from south-west, and 22% from middle/north. As comparison, in December 2008 
about 54% of all cars and vans were owned by drivers in south-east, 23% in south-west, 
and 23% in middle/north according to Statistics Norway (www.ssb.no). In the period 
2006-2008, a total of 328 drivers of cars and vans at the age of 18 years or older were 
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killed in road traffic accidents in Norway. Blood samples were submitted to NIPH for 
analysis of alcohol and drugs in 193 of those cases (59%); the data presented in the 
Norwegian report are based on those cases only. Blood samples were taken shortly after 
the accident from 100 drivers and during legal autopsy from 93 drivers. 
 
The Portuguese data include 79% of the total killed drivers autopsied in National Institute 
of Legal Medicine (INML), during the year 2009. The sampling distribution is different 
from the one obtained in the Road Side Survey and covers all Municipalities of the Centre 
and South regions, an area where about 71% of Portuguese population lives.  
 
During the study period, year 2008, 178 drivers of personal cars or vans were killed in 
road traffic accidents in Sweden and 170 (96%) of these did undergo a post-mortem 
examination, 11 cases were excluded because they died more than 24 hours after the 
accident. The final database for the study includes 158 cases for which patient data 
and/or toxicological data were available. The study area covers the whole of Sweden and 
the representativeness of the sample is very good since almost all killed drivers were 
included (ca 94%).  
 
 
2.1.4 Non-response problems 
Non response bias is often an issue in epidemiological studies. It often occurs if those 
who respond to the survey differ in the use of drugs from those who do not respond. The 
presence of non response bias is difficult to evaluate, but a comparison of data on age, 
gender, and time period between respondents and non responders could provide some 
information. In the DRUID prevalence studies non response varies not only between the 
two different studies (killed vs seriously injured drivers) but also between countries in the 
same study. 
 
The non response in the six countries varies between 0% and 8.5% for the surveys on 
the injured drivers. Missing cases varies between 5.7 and 41% for the studies on the 
killed drivers. 
 
In general two different types of reasons for the size of non-response can be given: non-
response as a result of the study design and non-response as a result of external factors. 
 
A first study design factor is the choice of body fluids to be collected. As in the injured 
drivers study the collection of blood/urine is part of a routine during emergency procedure 
by medical staff, this factor was likely to have a minimum influence on the response rate.  
 
A second factor relates to the voluntary character of the survey. In 3 of the 6 countries  
involved in the injured drivers study an informed consent had to be signed by the driver or 
a relative. The need for such a written informed consent can be expected to have a 
negative influence on the response rate. However looking at the data of Belgium, Finland 
and Italy, where informed consent was needed, non response was limited to a maximum 
of 8.5%. 
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Table 5. Study design and non-response – Injured drivers 
INJURED DRIVERS 
Country Sample Collection Mandatory Informed 
consent 
Non-
response 
percentage  
Missing 
Belgium Blood Hospital 
staff 
No Yes 5.4% 105 
cases  
Denmark Blood Hospital 
staff 
No5 No Unknown6  60 
cases  
Finland Blood/oral 
fluid 
Hospital 
staff 
No Yes 8.5 % No 
missing 
cases 
reported 
Italy Blood/Urine Hospital 
staff 
No Yes 0% No 
missing 
cases 
reported7
Lithuania Blood Hospital 
staff 
No No 0% No 
missing 
cases 
reported 
Netherlands Blood Hospital 
Staff 
No No Unknown8 No 
missing 
cases 
reported 
 
Besides study design factors, external factors have also an influence on the outcome of 
the survey. These factors cannot be included in the study design, and might result in 
missing cases.  
For example, in some countries the police was in charge for sending samples to the 
laboratory responsible for the analysis. When the police considered that the probability of 
finding alcohol or drugs was low, no samples were sent to the laboratory, resulting in a 
missing case. 
 
In the case of killed drivers, post-mortem examination is mandatory in Portugal, Finland 
and Sweden for all people killed in road traffic accidents. However, in practice less than 
100% of the cases are analysed. For this reason these three countries have a lower 
percentage of missing cases compared to Norway where sampling is not mandatory. 
 
Table 6 present an overview of the missing cases per country that performed a study on 
killed drivers. 
 
 
 
                                                          
5 Driver participation in the Danish study was in principle voluntary. However, the blood sample was taken on 
arrival during the normal procedure for blood samples, and the patient was not informed or asked. Because of 
the severity of injuries, some of the trauma patients were even unconscious at the sampling time. DTU prepared 
an information leaflet for the patients. It was however the decision of the hospital whether patients should 
receive information. In those hospitals were they did inform the patient, the patient could refuse to participate 
(non-response). 
6 No registration of the patients that refused is available 
7 Lack of accident data such as road type, accident type,.. is reported 
8 No information of non-respond(ers) could be retrieved from the hospitals 
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Table 6. External factors and refusals – Killed drivers 
KILLED DRIVERS 
Country Sample Collection  Mandatory Informed 
consent 
Non-
response 
percentag
e  
Missing 
Finland Blood VALT9 
Department of 
Forensic Medicine, 
Helsinki University 
Yes n.a n.a. 5.7% 
Norway Blood  Data on persons are 
submitted by the 
police to Statistics 
Norway 
Data on biological 
samples are 
submitted at the 
Forensic Toxicology 
Database (NIPH10) 
No n.a n.a. 41% 
Portugal Blood National Institute of 
Legal Medicine 
yes n.a n.a. 21% 
Sweden Blood/Urine
11/Muscle 
tissue12 
National Board of 
Forensic Medicine. 
Analysis by the 
department of 
Forensic Toxicology. 
yes n.a n.a. 6% 
na: not-applicable  
 
 
2.1.4.1 Injured drivers : problems encountered 
 
In Belgium 105 additional respondents had to be excluded from the database as no 
blood sample was available for toxicological analysis; they are reported as missing cases. 
For 67 people a patient form was filled in, but they refused to give a blood sample for 
toxicological analysis. For some other subjects, who refused to take part in the study, no 
form may have been filled in. Because of the low number of non-respondent forms, no 
statistical analysis was carried out and any comparison should be made cautiously. It is 
unlikely that the non-response had a significant effect on the distribution results of the 
present study, even if its size may have been underestimated to some extent for the 
reasons reported above. 
 
In Denmark, the total number of seriously injured drivers for whom both a datasheet was 
received in DTU and a blood sample was received in UKBH was 856. In about 60 cases 
either a blood sample analysis or a patient data sheet was missing. Reasons for this 
could be: the patient datasheet showed that the person did not meet the criteria for 
inclusion, the tube for the blood sample was broken so the sample could not be analysed, 
the blood sample was considered not relevant and discarded in the hospital or simply 
that, for a specific DRUID bar code, either blood sample was not taken or the patient 
                                                          
9 VALT= Finnish Motor Insurers’ Center 
10 NIPH= Norwegian Institute of Public Health 
11 In some cases, screening results from urine haven been reported. This was only done when the screening 
gave a negative result and when there was not enough blood to conduct the analyses. 
12 Results from analyses on muscle tissue have also been reported in a few cases there was nog enough blood 
to conduct the analyses 
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datasheet was not submitted to DTU. However, it is unlikely that this has influenced the 
distribution of drivers in the study population.  
 
The participation rate in the Finnish survey is more than 90%, no problems were 
reported. It is safe to assume that non-response does not have any confounding effect on 
the results. 
 
In Italy the collection of patient information other than age, gender and medication in the 
hospital prior to sampling was difficult and not achieved in most of the cases; accident 
information from the police could not be obtained. No confounding effect due to non-
responses in sampling injured drivers was observed.  
 
During the Lithuanian hospital study no patients refused to participate. The response 
rate was 100%. No problems were reported. 
 
No informed consent was needed to collect a blood sample from injured drivers in the 
Netherlands. Therefore, the risk of selection bias caused by this factor was non-existent. 
It is possible, however, that drug and alcohol intoxicated patients were less likely to be 
blood sampled than sober patients, e.g., because of aggressive behaviour or because of 
their entrance in the Emergency Departments during peak hours. Unfortunately, no 
information on this kind of non-response could be retrieved by the medical staff of the 
Emergency Departments. 
 
Table 7. Problems encountered-injured drivers 
INJURED DRIVERS 
Country Problems encountered 
Belgium No blood sample was available for toxicological analysis in 
some cases 
For some drivers a patient form was filled in, but they refused to 
give a blood sample for toxicological analysis 
Denmark Blood sample or patient sheet went missing 
Finland No problems reported 
Italy Accident information from the police could not be obtained 
Lithuania No problems reported 
Netherlands Drug and alcohol intoxicated patients were less likely to be 
blood sampled than sober patients 
 
 
2.1.4.2 Killed drivers : problems encountered 
 
In Finland analytical toxicology results were either partially or completely missing for only 
a relatively small number of cases (37). 
 
Norway received blood samples for analysis of alcohol and drugs from 59% of all drivers 
of cars and vans killed in Norway during the study period. It was expected that sampling 
was not performed if the police considered that the probability of finding alcohol or drugs 
was low, but other practical matters as economy and transportation over long distances 
to obtain an autopsy might also have contributed.  
 
In Portugal, the cases of drivers killed in immediate fatal accidents in which analysis was 
performed only for alcohol or only for alcohol  and illicit drugs were excluded from the 
study. This was done to permit a comparative analysis of the results obtained in other 
countries. Therefore the number of fatal road accidents that occurred in 2009 in Portugal 
is higher than the number of cases included in this study. 
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In Sweden additional analyses, besides the analyses performed by the National Board of 
Forensic Medicine, were carried out in order to cover the DRUID substances. This was 
possible in most cases but since the additional analyses were made afterwards, for a few 
drivers there was no blood sample left. Thus, there are missing values for some 
substances and drivers.  
 
Table 8. Problems encountered – killed drivers 
KILLED DRIVERS 
Country Problems encountered 
Finland No problems reported 
Norway No analysis was done for following reasons  
- Probability of finding alcohol or drugs was low 
- Practical matters such as economy  
- Transportation over long distances to obtain an autopsy 
Portugal If analysis was performed for only alcohol or only for alcohol 
and illicit drugs, the case was excluded from the study 
Sweden Lack of blood sample to do extra analysis 
Missing values for some substances or drivers 
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2.2 Toxicology 
2.2.1 Blood collection 
 
A. Body fluid collection 
It was decided to use whole blood or urine as matrix for the substance analyses. 
Table 9 shows which country used which matrix.  
 
Table 9. Body fluids used in DRUID WP 2 
Country Blood  Urine Oral fluid Muscle tissue 
Injured drivers 
Belgium X    
Denmark X    
Finland  X  X  
Italy X X   
Lithuania X    
Netherlands X    
Killed drivers 
Finland X    
Norway X    
Portugal X    
Sweden X X  X 
 
 
B. Method of blood collection:  
 
Summary: 
- 5-10 mL whole blood collection in vacuum tubes containing sodium fluoride and 
potassium oxalate 
- Transportation at 4°C (max 48 hours) 
- Storage in laboratory at -20°C. 
Sample collection for injured drivers study: 
All laboratories analysing blood samples within WP2 performed analysis on whole blood.  
Blood was most commonly obtained from the median cubital vein on the anterior forearm. 
It could be drawn by venipuncture with vacuum tubes (tubes that contain a vacuum that 
aspirates blood into the tube.). 
A tourniquet was placed on the arm where blood was to be collected. The vein to be used 
was palpated to determine its size, depth and direction. The skin was wiped with a 
disinfectant swab; an alcohol swab was not used due to possible contamination of the 
sample. The tourniquet was loosened or removed once blood started to enter the tube. A 
collection tube containing potassium oxalate and sodium fluoride (grey tops) were used. 
Blood collection tubes had to be filled completely to ensure that proper additive 
concentrations were maintained. The tubes were gently mixed by inverting 5 to 10 times 
immediately after collection to prevent coagulation. 
All appropriate documents had to be filled in using the same identification number as 
used to label the collection tubes. Labelling had to be unambiguous. 
If more than one container was taken from the same subject, these containers had to be 
identified with the same identification label, but the labels should specify how many 
containers were drawn from the same subject. 
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Storage and transportation  
Data on the stability of commonly used illicit drugs are scattered over various 
publications, and a uniform study design had not been applied. The stability of drugs in 
blood was reviewed by Levine and Smith in 1990 (Forensic Science Reviews, 2:147-157) 
and Skopp and Pötsch in 2002 (Rechtsmedizin, 12: 195-202, in German). Since stability 
of even the most labile compounds (especially cocaine) had to be ensured, transportation 
measures had to be strict. Enzymatic degradation was slowed down by the presence of 
preservatives in the tubes. Chemical hydrolysis was decreased by low temperature 
during transportation. Therefore the blood samples had be transported cooled down or 
frozen. 
 
Direct transportation of the samples to the laboratory was preferred. If this was 
impossible due to geographical reasons, samples could be shipped under specific 
conditions. Before shipping, national and international regulations had to be ascertained. 
Specimens had to be sent as diagnostic specimens and in two containers: the primary 
container had to be wrapped with Parafilm® or sealing tape around the lid, placed into a 
plastic bag or a screw cap container with enough absorbent material to absorb all of the 
fluid in the primary container, and be wrapped by a secondary container such as a 
cardboard box or mailing tube. This container had to prevent crushing of the specimen 
during transport. 
 
Dry ice had to be placed between the plastic bag and the outer shipping container. It had 
to be shipped in insulated outer packaging, and could not be shipped in airtight container. 
Useful information and appropriate shipping containers were available from most 
contractors. 
 
Upon arrival in the laboratory, samples had to be stored at -20°C. 
Since the maximum time for storage at 4°C (= time between sampling and freezing) was 
2 days, and transportation to the laboratory was not always easy to organise in some 
countries depending on the design of the studies (e.g. geographical situation, presence of 
dedicated personnel at the hospital,…) it was recommended to store samples frozen in 
the hospitals for e.g. one month and transport them to the laboratory in one shipment. 
During this transportation insulation and time were important, so that the samples were 
still frozen when they arrived at the laboratory since the consequences of multiple freeze-
thaw cycles for the recovery of drugs in blood samples were unknown.  
 
Sample collection for killed drivers study: 
In general in the killed drivers study toxicological analyses were performed either on a 
post-mortem blood sample, or, for those cases in which the driver did not die immediately 
at the scene of the accident, on a blood sample taken from the driver shortly after the 
accident, or at the moment of hospital admission. 
In the case of post-mortem samples, whenever possible, blood sample was taken from a 
peripheral site, typically the femoral vein, and collected in a glass or polyethylene test 
tube containing either sodium or potassium fluoride. 
Sample collection in the killed drivers study could not always be done by a standardized 
method. This happened for two main reasons:  
- post-mortem examination were carried out by institutions outside the DRUID-project.  
- depending on the severity of the injuries and on the preservation of the body, a 
peripheral blood sample was not always available. 
In the second case either the blood sample was collected not from a peripheral site 
and/or other specimens such as urine and muscle tissue were collected. 
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2.2.2 Toxicological analysis of blood and applied methods 
Table 10 shows the analytical methods used by the WP2-hospital study partners. 
Extraction was based on liquid-liquid (LLE) or solid phase (SPE) extraction, 
chromatographic separation was performed by gas chromatography (GC) or liquid 
chromatography (LC): High Performance (HPLC) or Ultra Performance (UPLC). Detection 
was done by mass spectrometry (MS) or nitrogen/phosphorus detection (NPD). 
 
Table 10. Analytical methods used in WP2 
Country Extraction Chromatography Detection 
Belgium 
Blood: 
 
SPE (LLE for THC) 
 
UPLC (GC for 
THC) 
 
MSMS (MS for 
THC) 
Denmark 
Blood:  
 
SPE (LLE for THC) 
 
UPLC 
 
MSMS 
Finland  
Blood: 
 
LLE,SPE 
 
GC 
 
MS 
Italy 
Blood/Urine: 
 
SPE +LLE (for THC) 
 
HPLC (GC for 
THC) 
 
MSMS (MS for 
THC) 
Lithuania 
Blood: 
 
LLE, SPE 
 
GC 
 
MS 
Norway 
Blood  
 
SPE or LLE or  
immobilised LLE or 
precipitation & evaporation 
 
GC or HPLC or 
UPLC 
 
MS or MSMS 
Portugal 
Blood:  
 
SPE 
 
GC 
LC 
 
MS 
MSMS 
Sweden 
Blood:  
 
LLE (Medications) 
LLE (THC and Amps) 
SPE (opiates, cocaine) 
 
GC 
 
 
 
 
NPD 
(Medications) 
MS (THC and 
Amps) 
MS (opiates, 
cocaine) 
The Netherlands 
Blood: 
 
PP 
 
UPLC 
 
MSMS 
 
 
2.2.3 DRUID core and extra substances, cut-offs 
A. Core substances 
The following list of core substances (analysed for in all countries that participated in the 
hospital and killed driver study) as well as analytical cut-off values for analyses of blood 
were decided upon based on discussions between all partners. These were carried out 
by means of email and personal communication and the final decision was made at the 
WP2 meeting in January 2007. 
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Table 11. Core substances analysed in WP2 
Substance Whole blood analytical cut-off (ng/mL) 
Ethanol 0.1 g/L 
6-acetylmorphine 10 
Alprazolam 10 
Amphetamine 20 
Benzoylecgonine 50 
Clonazepam 10 
Cocaine 10 
Codeine 10 
Diazepam 20 
Flunitrazepam 2 
Lorazepam 10 
MDA 20 
MDEA 20 
MDMA 20 
Methadone 10 
Methamphetamine 20 
Morphine 10 
Nordiazepam 20 
Oxazepam 50 
THC 1 
THCCOOH 5 
Zolpidem 20 
Zopiclone 10 
 
 
 
B. Extra substances  
Besides the core list, each country added a minimum of 3 extra substances for analysis, 
based on knowledge on distribution in the various countries and impairing effect on 
driving performance (e.g. based on pharmacological profile or previous studies). 
Analytical cut-off values for analyses of blood were decided upon based on discussions 
between partners who analysed the same extra substances. These were carried out by 
means of email and personal communication. The final list was made in February 2010. 
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Table 12. Extra substances analysed 
 FI LT DK BE PT NO NL IT SE  
Cut-off 
(ng/mL)
  THL TMI
DTU/ 
UKBH UGent
CPS-
NILM FHI SWOV/NFI 
TFA-
UNPD 
VTI/ 
RMV Total
Whole 
blood 
Carisoprodol 1     1   1 3 500 
Ketamine        1  2 20 
Buprenorphine 1  1 1    1  4 1 
Tramadol 1 1 1 1 1   1 1 7 50 
7-a-clonazepam  1 1 1 1 1 1 1 1 8 10 
Carbamazepine 1                 1 NA 
Olanzapine        1  1 10 
Bromazepam   1 1    1  3 20 
Meprobamate      1   1 2 2000 
Chlordiazepoxide   1       1 20 
7-a-flunitrazepam  1 1 1 1 1 1 1 1 8 2 
Midazolam 1      1   2 10 
Nitrazepam 1  1   1 1  1 6 10 
7-a-nitrazepam     1      1 1   1 4 10 
Temazepam 1      1   2 20 
Amitryptiline 1   1    1  3 10 
(Es)Citalopram 1   1      2 5 
Fluoxetine 1       1  2 10 
Mirtazapine 1   1      3 5 
Trazodone    1      1 10 
Venlafaxine               1   1 10 
Levomepromazine 1                 1 NA 
Norbuprenorphine 1       1  2 2 
11 OH-THC             1     1 1 
Number of extra substances 13 3 8 9 3 6 7 11 7   
 
 
2.2.4 Drugs administered after the accident 
The following medicinal drugs were possibly administered after the accident, before the 
(blood) sample was taken. These values were coded as -7. The concentration of these 
medicinal drugs was not taken into account for the calculation of prevalence. 
Table 13. Drugs administered after the accident 
Country Medicinal drugs administered after the accident 
Belgium Morphine (26 cases), tramadol (25 cases), diazepam (11 cases), 
lorazepam (1 case) 
Denmark 
 
Morphine (4 cases), methadone (2 cases), diazepam (1 case) 
Finland  Morphine (8 cases), tramadol (4 cases) 
Italy Morphine (15 cases) 
Lithuania Morphine (5 cases), Ketorolac (1case) 
Norway Morphine (1 case), Diazepam (6 cases) 
Sweden Morphine (6 cases) 
The Netherlands None 
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2.2.5 Proficiency tests 
The institute that conducted proficiency testing (PrT) for blood samples was Arvecon 
GmbH, Germany. 
Both qualitative and quantitative results were measured. 
Qualitative results were evaluated using sensitivity (and specificity), Quantitative results 
were evaluated using the standard deviation according to Horwitz (SDHOR). Z-scores were 
calculated using SDHOR.  
)log5,01(2 CVC −=  
 VC = variation coefficient (%) 
 C = analyte concentration (kg/L) 
 
 
A proficiency testing scheme was set up for the DRUID research project in which whole 
blood was analyzed by twelve laboratories. A common collection and analysis 
methodology was used: vacuum tubes containing sodium fluoride and potassium oxalate 
were used for collections and LC-MS/MS or GC-MS confirmation analysis of 25 
substances (26 in the second round) containing both licit and illicit drugs is performed on 
all samples. 
 
Four rounds of proficiency testing were organised between March 2008 and December 
2009.  
Whole blood samples were spiked with analytes and lyophilised at Arvecon. 
 
Laboratories were instructed to first store the vials at room temperature for 30 min. After 
reconstitution with exactly 5.0 ml bidistilled (demineralised) water, the specimen had to be 
swirled gently and stored for 15 minutes at room temperature. Before sampling, the vial 
had to be inverted gently to ensure homogeneity. It was strongly recommended to 
prepare the sample material for the analysis of cocaine and zopiclone on the day of 
reconstitution. 
 
Analytes were screened, identified and quantified using a mass spectroscopy-based 
technique. Samples were expected to be tested and electronically reported to Arvecon. 
Results were reported back to each participating lab anonymously, but with identification 
to the DRUID coordinator to allow the latter to make corrective actions. 
 
Qualitative results were evaluated using sensitivity. Sensitivity is defined as the number 
of analytes correctly reported positive divided by the total number of analytes spiked in 
the samples. 
 
In the first round of proficiency testing, most laboratories were still in the process of 
development and validation or had only recently completed this, and therefore lower 
scores were generally obtained. Both qualitative and quantitative performancey increased 
during the program. False negatives were mostly attributable to z-drugs and 
benzodiazepines. 
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2.3 Data analysis 
For calculating prevalence, substances of the same type were combined into following 
substance groups: alcohol, amphetamines, cocaine/1, cocaine/2, cannabis/1, cannabis/2, 
illicit opiates, benzodiazepines, Z-drugs, and medicinal opioids. 
 
Substance groups are aggregated into the following substance classes: alcohol, illicit 
drugs, medicinal drugs and following combinations: drug-alcohol and drug-drug. This last 
class is specified as a combination of different substance groups. For example: zolpidem 
+ cocaine will be considered a drug-drug combination but zolpidem + zopiclone will be 
considered a single use of z-drugs. 
  
Table 14. Substance classes, groups and the analytical findings 
Type No. Group Analytical findings 
Alcohol 512 alcohol ethanol 
Illicit 1 amphetamines amphetamine 
drugs    
methamphetamine or methamphetamine + 
amphetamine 
     MDMA or MDMA + MDA 
     MDEA or MDEA + MDA 
     MDA 
  2 cocaine/1 benzoylecgonine 
  4 cocaine/2 cocaine + benzoylecgonine or cocaine  
  8 cannabis/1 THCCOOH 
  16 cannabis/2 THC or THC+THCCOOH 
  
32 illicit opiates 6-acetylmorphine or 6-AM + codeine or 6-
AM + morphine or 6-AM + codeine + 
morphine or (morphine + codeine and 
morphine>= codeine) 
Medicinal 
64 benzodiazepines  Diazepam or 
diazepam + nordiazepam or diaz + oxaz or  
diaz + nordiaz + oxaz 
drugs    nordiaz or nordiaz + oxaz 
     oxazepam 
     lorazepam 
     alprazolam 
     
flunitrazepam or flunitrazepam + 7-
aminoflunitrazepam 
     
clonazepam or clonazepam + 7-
aminoclonazepam 
  128 Z-drugs zolpidem 
     zopiclone 
  256 medicinal opioids morphine 
    
codeine or (codeine + morphine and 
codeine> morphine) 
     methadone 
      tramadol 
Various   drug-alcohol   
combinations   drug-drug   
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In order to calculate frequencies to describe the distribution of drivers (by age groups, 
gender, road type, etc.) statistical analysis were carried out using the software package 
SPSS, version 15 (renamed in IBM SPSS Statistics). Confidence interval (95%) for 
difference in proportions were calculated to determine the significance of the differences. 
Whisker and Box plots were made with the software program MedCalc.Percentages of 
positive findings were calculated using Microsoft Office Excel 2007. 
 
2.4 Toxicological results - Data analysis 
 
For the analysis of the toxicological findings, drugs have been grouped according to their 
pharmacological characteristics (2.3 Data analysis: Table 14), and a sample was 
considered positive if at least one drug was found at or above the DRUID cut-offs (2.2.3 
DRUID core and extra substances, cut-offs: Tables 11-12). 
 
In this chapter, data are analysed according to two criteria. 
 
1) Prevalence of substance groups use among sampled drivers, calculated as 
 
Number of subjects positive for one specific substance group 
  ---------------------------------------------------------------------------------------------------------------------- 
 Number of subjects analysed for the presence of the same specific substance group 
 
In this first analysis the same subject may appear under several substance groups, as a 
result of poly-drug use. The data give an indication of how many people use the different 
substance groups among the sampled subpopulations. 
 
2) Distribution of positive drivers among sampled subjects, calculated as 
 
Number of subjects positive for one specific substance group 
 -------------------------------------------------------------------------- 
     Number of subjects analysed for all substance groups 
 
In this second analysis, substance groups become mutually exclusive. A subject can be 
part of one group only, independently of the number of substances taken. When this 
principle is applied, only one out of two cases can occur: either the driver tested positive, 
as a consequence of single/combined psychoactive substance use, or he/she did not. 
 
First data about prevalence of use are presented for the two studies separately (seriously 
injured drivers and killed drivers). Then distributions of positive drivers (Mutually exclusive 
groups) are presented for the seriously injured drivers study and for the killed drivers 
study. 
 
2.4.1 Missing values 
Toxicological analysis is sometimes incomplete for some of the drivers, in the sense that 
one subject may not have been screened for the presence of all drugs listed in the 
different substance groups. This can happen for two reasons: 
 
1. Insufficient blood sample to carry out all toxicological analyses 
2. Driver was given a specific drug in hospital before blood sampling (for example 
morphine for pain management). As a consequence, it is not anymore possible to 
establish if that specific drug was present in the blood sample before 
administration in hospital 
 
In the above cases, it is not always possible to include the driver in a specific substance 
group. For example, these two cases may occur: 
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A. Subject analysed for alcohol only and found positive. No other toxicological 
analysis performed. 
Prevalence of substance groups use: the subject is included in the alcohol 
prevalence calculation, but cannot be considered for the other substance groups, 
because it is not possible to establish if any of the other drugs was also present in 
the blood sample 
Distribution of positive drivers: the driver tested positive, but it is not possible to 
allocate the subject to the “alcohol-only” or “alcohol-drug” group, because the 
sample was analysed only for alcohol presence (substance group unknown) 
B. Subject analysed for all substance groups apart from alcohol. All negative 
findings. 
Prevalence of substance groups use: subject is included in all substance groups 
prevalence calculations, apart from alcohol because this value is missing 
Distribution of positive drivers: sample cannot be included, because the subject 
may have been positive for the presence of alcohol, but its presence/absence 
remains unknown 
 
As a consequence of incomplete toxicological analysis, the number of subjects included 
in prevalence calculations can vary. Also, as drugs have been aggregated into groups, 
one single substance may have a significant impact on the number of samples excluded. 
This is for example the case of “benzodiazepines” and “medicinal opioids” groups, that 
are most affected, both as a result of including different drugs in the same group and as a 
result of drug administration before blood sampling. 
 
The number of observations included in the calculation of each prevalence is reported at 
the beginning of the relative chapter. 
 
Some countries did not screen for one specific drug in a substance group. To reduce the 
number of samples rejected and to account for these major differences, some deviations 
from the substance groups described in Table 14 in chapter 2.3 (Data analysis) had to be 
applied. These are listed here. 
In both seriously injured and killed drivers studies. 
• All countries – Samples were not rejected if MDEA screening was not carried out. 
This was done after considering that none among all analysed samples in all 
countries was positive for this amphetamine. 
In the killed drivers study 
• Norway and Finland – No sample was screened for the presence of THCCOOH: 
samples were not rejected, however prevalence of THCCOOH (Cannabis 1) use 
cannot be calculated and association of alcohol or other drugs with THCCOOH 
cannot be detected.  
• Norway – No sample was screened for tramadol (this medication was not 
commonly prescribed in Norway during 2006-2008, when samples were 
collected): the “Medicinal opioids” group is reduced to “morphine, codeine, 
codeine+morphine (if codeine>morphine), methadone”  
• Norway – Not all samples were screened for the presence of lorazepam (this 
medication is not available for prescription in Norway): the “Benzodiazepines” 
group is reduced to “diazepam, nordiazepam, oxazepam, alprazolam, 
flunitrazepam, clonazepam and various combinations”.  
• Portugal – No sample was screened for zopiclone presence (this medication is 
not available for prescription in Portugal): the “Z-drug” group is reduced to: 
“zolpidem”.  
 
2.4.2 Interpretation of toxicological findings 
In the body cocaine and THC break down into benzoylecgonine and THCCOOH 
respectively. These two substances are not pharmacologically active. Although the active 
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substances may be still present in the brain, it is normally assumed that impairment 
cannot be demonstrated when benzoyleconine and/or THCCOOH are found alone in a 
blood sample, because it is not possible to establish unequivocally that the person was 
under the influence of cocaine and/or THC at the time the blood sample was taken. 
In the present study, substances of the same type have been aggregated into substance 
groups, with the group “Cocaine 1” and “Cannabis 1” including respectively 
benzoylecgonine only (without cocaine) and THCCOOH only (without THC). 
In the mutually exclusive groups (“Distribution of positive drivers”), substance groups in 
combination are aggregated into “alcohol-drug” or “drug-drug” classes. In this chapter, the 
combination of benzoylecgonine and/or THCCOOH with alcohol or another drug have 
been classified as “alcohol-drug” and “drug-drug” combinations respectively. 
 
Cases of opiates use have been classified as illicit when one of the following findings 
were present: “6-acetylmorphine” or “morphine + codeine and morphine>= codeine” or 
their combinations, according to the description in part 2.3 (Data analysis: Table 14). 
However, concentration of 6-acetylmorphine and/or codeine, when present, were taken 
into consideration even when below the DRUID cut-off. 
 
2.4.3 Prevalence of substance groups use among sampled drivers 
The data give an indication of how many people use a specific substance groups among 
the sampled subpopulations. 
 
In this analysis the same subject may appear under several substance groups, as a result 
of poly-drug use. Data are shown in the form of percentages in tables and graphs, and 
the prevalence is calculated as 
 
  Number of subjects found positive for one specific substance group 
 ------------------------------------------------------------------------------------------------------------------------ x 100 
Number of subjects screened for the presence of the same specific substance group 
 
 
In a first table the percentage of positive findings is reported for each substance group 
and for each country. In the corresponding bar graph, by means of different colours, a 
detail of the toxicological findings is given to distinguish subjects in which the substance 
group was found alone from those in which the substance group was found in 
combination. 
 
In a second table details are shown about the use of the substance group by age and 
gender. When possible, for subjects of known age and gender, the data are also shown 
in the form of a graph. 
 
Table 15 shows the number of subjects included in the “Prevalence of substance groups 
use” calculations for each country in the two studies. 
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Table 15. Number of subjects included in “Prevalence of substance groups use” 
 Seriously injured drivers Killed drivers 
Number of samples 
screened for specified 
substance group 
BE DK FI IT LT NL FI NO PT SE 
Alcohol 348 838 53 676 385 186 471 193 285 153
Amphetamines 346 837 54 676 385 187 466 176 285 152
Benzoylecgonine 
(=Cocaine/1) 346 837 49 676 385 187 466 171 285 152
Cocaine (=Cocaine/2) 346 837 53 676 385 187 466 179 285 152
THCCOOH (=Cannabis/1) 344 836 53 676 385 187 0 0 285 147
THC (=Cannabis/2) 344 836 53 676 385 187 466 179 285 152
Illicit opiates 346 837 53 676 385 187 466 179 285 152
Benzodiazepines 342 835 49 676 385 187 466 176 285 154
Z-drugs 346 837 53 676 385 187 466 182 285 154
Medicinal opioids 332 835 50 676 385 187 466 177 285 146
 
2.5 Distribution of positive drivers – Mutually exclusive groups 
 
This analysis is the one generally used to present data in the country reports. 
 
The data give an overview of the number of drivers who tested positive for at least one of 
the studied substances. 
 
Being the focus only on the presence/absence of a drug or combination of drugs, 
substance groups become mutually exclusive. This is because a subject can be part of 
one group only, independently of the number of substances taken: either the driver tested 
positive, as a consequence of single/combined psychoactive substance use, or he/she 
did not. 
 
Data are shown in the form of percentage in tables and graphs, and the distribution of 
positive drivers is calculated as: 
 
 
Number of subjects positive for one specific substance group 
 ------------------------------------------------------------------------------------------ x 100 
 Number of subjects screened (for all substance groups) 
 
When the toxicological analysis is incomplete and the exact substance group cannot be 
allocated, the sample is not included in the analysis. Once this first selection is made, 
prevalence calculation is always based on the same number of subjects. The number of 
samples included for each country in the “Distribution of positive drivers” calculations is 
shown in Table 16. 
Table 16. Number of subjects included in “Distribution of positive drivers” 
 Seriously injured drivers Killed drivers 
 BE DK FI IT LT NL FI NO PT SE 
 
Group of appurtenance 
known (“toxicological 
screening complete”) 
 
325 831 47 676 385 186 459 165 285 141
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Table 17 shows the total number of subject excluded from the “Distribution of positive 
drivers” calculations. Although some of these drivers tested positive, the substance group 
cannot be allocated, because of incomplete toxicological analysis. 
 
Table 17. Number of subjects excluded from “Distribution of positive drivers” 
 Seriously injured drivers Killed drivers 
 BE DK FI IT LT NL FI NO PT SE 
Toxicological screening 
incomplete and all negative 
findings 
13 6 6 0 2 1 19 21 0 13 
Positive toxicological finding, 
but substance group 
appurtenance unknown* 
10 3 1 0 0 0 5 7 0 3 
Total 23 9 7 0 2 1 24 28 0 16 
*Two possible cases: either “positive alcohol finding + missing analysis for drug groups” 
or “alcohol analysis missing + positive drug groups finding”. 
 
 
Distributions of positive drivers among different age and gender groups are reported, as 
well as distributions of positive drivers during different time periods (week/weekend, 
day/nights) and in different type of accident (single- and multiple-vehicle). 
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3 Results 
 
3.1 Introduction 
This chapter gives a general overview of substance distribution, and outlines similarities 
and differences between findings in seriously injured and/or killed drivers in the 9 
countries involved. Among all subjects sampled, a selection was made to obtain relatively 
similar subpopulations of seriously injured and killed drivers. The analysis focuses on the 
drivers of passenger cars and vans. 
 
Specific details about other type of drivers (of motorcycles, bicycles, lorries, etc.) can be 
found in the respective country reports, together with descriptions of different distributions 
(age, gender, time of accident, etc.) and toxicological findings. 
  
3.2 Inclusion criteria 
Guidelines for the study and the data collection, described in Annex 1, were used as a 
starting point to select the sub-populations. In particular, in the case of seriously injured 
drivers, subjects were selected on the basis of the following obligatory inclusion criteria: 
• Driver of a motorised vehicle (passenger car or van) 
• Time interval between accident and sampling less than 3 hours 
• Severity of injuries: MAIS (Maximum Abbreviated Injury Scale) 2 or higher, or 
drivers selected on the basis of national criteria that ensured severity of injuries in 
the range of MAIS score 2 or above 
 
Subjects aged below 18 and subjects not fulfilling the above criteria were also excluded. 
After considering the overall distribution of samples in the different databases from the 
participating countries, it was decided to include also subjects for whom one of the above 
variables was unknown. 
The criteria applied for the selection of the sub-populations analysed in this chapter were 
generally stricter than the ones applied in the single country reports. For this reason the 
number of subjects included are generally smaller than in the country reports. Table 18 
shows the number of samples left for each participating country after applying the listed 
selection criteria. 
 
Table 18. Seriously injured drivers study. Sub-populations sample selection 
Country Total 
number 
of 
subjects 
in the 
country 
database 
Cars & 
Vans or 
unknown 
Time 
between 
accident 
and 
sampling 
<3 hours 
or 
unknown 
MAIS ≥ 2 
or 
equivalent 
or 
unknown 
Age 18 
and 
above or 
unknown 
Number of 
subjects in 
the 
selected 
sub-
populations 
BE 1078 377 349 348 348 348
DK 856 856 844 844* 840 840
FIN 325 209 170 54 54 54
IT 690 690 682 682* 676 676
LT 424 389 388 387 387 387
NL 197 195 188 188 187 187
TOTAL 3570 2716 2621 2503 2492 2492
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* MAIS score was not available in Denmark and Italy and the two countries applied different inclusion criteria. In 
particular, in Denmark, inclusion criteria were based on Danish trauma score, while in Italy only subjects given a 
prognosis of 20 days or longer were included in the study. These criteria are considered to guarantee inclusion 
of patients with injury severity equivalent to MAIS score 2 or higher. 
 
“Time between accident and blood sampling” and “MAIS score” caused the most 
exclusions. The majority of car/van drivers sampled in Finland had a MAIS lower than 2 
and had to be excluded. 
The percentage of samples that cannot be included in the selected sub-populations, 
because they did not fulfil the inclusion criteria, ranged between 1.9% (Denmark) and 
74.2% (Finland). 
 
Table 19 shows the number of subjects included in the sub-populations from the killed 
drivers study. Drivers of car and vans, aged 18 and above, were selected together with 
subjects for which one of these variables was unknown. Time between accident and 
death was not considered. When recorded, the survival time ranged from 0 (immediate 
death) to just below 24 hours.  
Table 19. Killed drivers study. Sub-populations sample selection 
Country Total number of 
subjects in the 
country 
database 
Car & van 
drivers or 
unknown 
Age 18 and 
above or 
unknown 
Number of subjects in 
the selected sub-
populations 
FIN 652 483 483 483
NO 193 193 193 193
PT 290 290* 285 285
SE 158 158 157 157
TOTAL 1293 1124 1118 1118
 
*In Portugal information about type of vehicle could not be gathered, as data are stored in the police database, 
to which the Portuguese National Institute of Legal Medicine has no access. However, distribution of type of 
vehicles among killed drivers is expected to be similar to the one in the roadside survey, that showed a high 
prevalence of cars and a very low prevalence of other type of vehicles, with motorcycles and trucks accounting 
only for approximately 2% of the population. 
 
Samples collected in Finland and Norway fulfilled all inclusion criteria. In the Swedish 
database one subject was excluded being younger than 18 years. For the same reason 5 
subjects were excluded in the Portuguese database. 
 
General data about the selected subpopulations are described in this chapter separately 
first for the seriously injured drivers study and then for the killed drivers study. Discussion 
is done on two levels. First a description of the sampled subpopulations is presented, 
while in a second part the toxicological findings are reported. 
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3.3 Seriously injured drivers (C&V) - Description of the driver 
sample 
 
3.3.1 Distribution over the countries/regions 
 
Figure 2. Distribution of study population by country 
 
The highest number of injured drivers (C&V) was sampled in Denmark (33.7%), followed 
by Italy (27.1%).  
 
3.3.2 Distribution by road type 
Since in Belgium the classification urban-rural was not available, two categories were 
added for this country.  
39.1% of drivers were sampled on an unknown road type, with the highest numbers for 
Italy and The Netherlands because for those countries no data on road type was 
available.  
Disregarding the Belgian data for speed limit up to or above 90 km/h, 26.5% of drivers 
were sampled on urban roads, 29.2% on rural roads and 44.3% on unknown type of road. 
  
Table 20. Distribution by country and road type 
Country Type of 
road  Belgium Denmark Finland Italy Lithuania The 
Netherlands 
Total 
 Urban road 0 191 
(22.7%) 
13 
(24.1%) 
0 380 
(98.2%) 
0 584 
 Rural road 0 606 
(72.1%) 
33 
(61.1%) 
0 5 
(1.3%) 
0 644 
 Up to 90 
km/h 
208 
(59.8%) 
0 0 0 0 0 208 
 Above 90 
km/h 
81 
(23.3%) 
0 0 0 0 0 81 
Unknown 59 
(17.0%) 
43 
(5.1%) 
8 
(14.8%) 
676 
(100%) 
2 
(0.5%) 
187 
(100%) 
975 
Total 348 
(100%) 
840 
(100%) 
54 
(100%) 
676 
(100%) 
387 
(100%) 
187  
(100%) 
2492 
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By selecting only cases with urban, rural or unknown road type, significant differences 
were found between the countries (p<0.01). Both Denmark and Finland have more 
drivers injured on rural roads, this is in contrast to Lithuania, where there were more 
injured drivers on urban roads. The proportion of unknown road type was less in 
Lithuania and Denmark compared to Belgium and Finland. 
 
3.3.3 Distribution by day of the week and time of the day 
The time periods (see annex1) have been aggregated into Weekday (time periods 
1+2+3), Week night (time period 4), Weekend day (time periods 5+6+7) and Weekend 
night (time period 8). 
 
 
 
Figure 3. General distribution of the study population by time of the day and day of the week 
 
76.9% of the accidents occurred during daytime (50.9% on a weekday, 26% in 
weekends). 8.7% and 10.7% on week nights and weekend night accidents respectively. 
This trend was seen in all countries except for the Netherlands where week night 
accidents occurred more and weekend day accidents less. 
 
Table 21. Distribution by country and time of the week 
Country Time period  
Belgium Denmark Finland Italy Lithuania The 
Netherlands 
Total 
  Weekday 146(42.0%) 503(59.9%) 24(44.4%) 264(39.2%) 241(62.3%) 90(48.1%) 1268 
  Weeknight 45(12.9%) 39(4.6%) 5(9.3%) 71(10.5%) 11(2.8%) 46(24.6%) 217 
  Weekend 
day 
96(27.5%) 212(25.2%) 19(35.2%) 214(31.6%) 85(22.0%) 23(12.3%) 649 
  Weekend 
night 
52(14.9%) 68(8.1%) 6(11.1%) 89(13.2%) 24(6.2%) 28(15.0%) 267 
 unknown 9(2.6%) 18(2.1%) 0 38(5.6%) 26(6.7%) 0 91 
Total 348(100%) 840(100%) 54(100%) 676(100%) 387(100%) 187(100%) 2492 
 
Disregarding the unknown and the Finnish data, a significant difference was found 
between the countries (p<0.01). 
There are more weekday accidents in Denmark and Lithuania. For week- and weekend-
night accidents a lower proportion was found in these countries.  
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3.3.4 Distribution by quarter of the year 
 
 
Figure 4. General distribution of the study population by quarter of the year 
 
52.7% of the injured drivers were sampled in the first and fourth quarter of the year 
(26.2% and 26.5% respectively). The second quarter accounts for 22.8%, the third for 
24.3%. 
 
Table 22. Distribution by country and quarter of the year 
Country quarter 
Belgium Denmark Finland Italy Lithuania The 
Netherlands 
Total 
  First 86(24.7%) 265(31.5%) 7(13.0%) 129(19.1%) 114(16.9%) 53(28.3%) 654 
  Second 69(19.8%) 139(16.5%) 11(20.4%) 223(33.0%) 81(12.0%) 46(24.6%) 569 
  Third 88(25.3%) 156(18.6%) 23(42.6%) 224(33.1%) 79(11.7%) 36(19.3%) 606 
  Fourth 104(29.9%) 280(33.3%) 13(24.1%) 100(14.8%) 113(16.7%) 52(27.8%) 662 
 unknown 1(0.3%) 0 0 0 0 0 1 
Total 348(100%) 840(100%) 54(100%) 676(100%) 387(100%) 187(100%) 2492 
 
This figures might be misleading because of different sampling periods between the 
countries as shown in table 23. Taking this sampling periods into account, different 
proportions were calculated, shown in table 24 
 
Table 23. Distribution of sampling period by country 
Country Sampling period 
Belgium 24 January 2008 – 2 May 2010 
Denmark 1 October 2007 – 6 April 2010 
Finland 26 April 2008 – 28 April 2010 
Italy 25 February 2008 – 26 October 2009 
Lithuania 22 April 2008 – 20 March 2010 
The Netherlands 1 March 2008 – 30 April 2010 
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Table 24. Distribution by country and quarter of the year weighted for the sampling period 
accounting for one year 
Country Quarter 
Belgium Denmark Finland Italy Lithuania The 
Netherlands 
Total 
First 19.93% 26.95% 13.01% 23.41% 29.98% 26.33% 25.01% 
Second 18.74% 20.60% 20.07% 28.33% 22.61% 23.00% 23.41% 
Third 28.11% 23.88% 42.75% 28.45% 19.51% 20.96% 24.52% 
Fourth 33.22% 28.57% 24.16% 19.81% 27.90% 29.70% 26.15% 
 
Differences were seen in the second and fourth quarter. For Italy there was a higher 
proportion in the second quarter and a lower one in the fourth quarter compared to other 
countries. Finnish data are disregarded because of the low number of samples. 
 
 
3.3.5 Distribution by age and gender 
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Figure 5. General distribution of the study population by age and by gender 
 
Males accounted for 69.9%, females for 29.5%. 79.7% of the study population had an 
age between 18 and 49. 
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Figure 6. Histogram of the study population by age and gender 
 
Table 25. Distribution by country, age and gender. 
 
Significant differences were found for both gender and age groups (p<0.01) between the 
countries. There were more males in The Netherlands and Italy than in the other 
countries. For the age distribution, differences were found for the age group 18-24, which 
was less present in Belgium and Italy, and for the group 25-34, for which a higher 
proportion was seen in Italy, compared to the other countries. There were slightly more 
males in the age group 18-24, which could be attributed to the higher proportions in 
Country 
Gender   Age Belgium Denmark Finland Italy Lithuania 
The 
Netherlands Total 
 Male 18-24 53(21.8%) 188(34.4%) 14(32.6%) 100(19.2%) 67(28.0%) 50(33.3%) 472(27.1%)
  25-34 78(32.1%) 141(25.8%) 10(23.3%) 161(31.0%) 52(21.8%) 39(26.0%) 481(27.6%)
  35-49 56(23.0%) 127(23.2%) 9(20.9%) 149(28.7%) 66(27.6%) 35(23.3%) 442(25.4%)
  50+ 48(19.8%) 90(16.5%) 10(23.3%) 110(21.2%) 42(17.6%) 26(17.3%) 326(18.7%)
 unknown 8(3.3%) 1(0.2%) 0 0 12(5.0%) 0 21(1.2%)
  Total 243(100%) 547(100%) 43(100%) 520(100%) 239(100%) 150(100%) 1742
 Female 18-24 18(17.3%) 81(27.6%) 3(27.3%) 26(16.7%) 36(23.1%) 5(13.5%) 169(23.0%)
  25-34 28(26.9%) 63(21.5%) 1(9.1%) 47(30.1%) 42(26.9%) 12(32.4%) 193(26.2%)
  35-49 32(30.8%) 88(30.0%) 1(9.1%) 55(35.3%) 38(24.4%) 11(29.7%) 225(30.6%)
  50+ 22(21.2%) 56(19.1%) 6(54.5%) 28(17.9%) 15(9.6%) 9(24.3%) 136(18.5%)
 unknown 4(3.8%) 5(1.7%) 0 0 4(2.6%) 0 13(1.8%)
  Total 104(100%) 293(100%) 11(100%) 156(100%) 135(100%) 37(100%) 736
 Unknown 18-24 0    2(15.4%)  2(14.3%)
  25-34 0    2(15.4%)  2(14.3%)
  50+ 0    1(7.7%)  1(7.1%)
 unknown 1(100%)    8(61.5%)  9(64.3%)
  Total 1(100%)    13(100%)  14
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Denmark and The Netherlands. More females were present in the group 35-49 which was 
mostly seen in Denmark. 
 
 
3.3.6 Distribution by safety belt use 
Table 26. Distribution of safety belt use 
Country Safety belt 
use 
  
Belgium Denmark Finland Italy Lithuania The 
Netherlands 
Total 
Yes 215(61.8%) 0 0 0 0 106(56.7%) 321(12.9%) 
No 86(24.7%) 0 0 0 0 37(19.8%) 123(4.9%) 
 
  
Unknown 47(13.5%) 840(100%) 54(100%) 676(100%) 387(100%) 44(23.5%) 2048(82.2%) 
Total 348(100%) 840(100%) 54(100%) 676(100%) 387(100%) 187(100%) 2492 
 
In the injured drivers population, use of safety belt was unknown for 82.2% of the 
sampled drivers. This high percentage can be explained by the fact that only Belgium and 
the Netherlands gathered this type of information. If this is taken into consideration, out of 
the 535 drivers in Belgium and the Netherlands, 60% used a safety belt, 23% did not and 
for 17% data remained unknown. Since only Belgium and The Netherlands have data on 
the safety belt use, only these two countries were compared. A significant difference was 
found (p=0.011) due to the higher number of unknown in The Netherlands compared to 
Belgium. When only subjects for which safety belt use was known were taken into 
consideration, no difference found between the two countries (p= 0.553). 
 
 
3.3.7 Distribution by type of vehicle 
 
 
Figure 7. General distribution of the study population by vehicle type 
 
Overall 90.8% of the study population was driving a personal car and 5.8% a small van. 
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Table 27. Distribution by country and type of vehicle 
Country Type of 
vehicle  Belgium Denmark Finland Italy Lithuania The 
Netherlands 
Total 
Personal 
car 
324(93.1%) 789(93.9%) 51(94.4%) 577(85.4%) 346(89.4%) 176(94.1%) 2263 
Van 24(6.9%) 42(5.0%) 3(5.6%) 38(5.6%) 27(7.0%) 11(5.9%) 145 
 
  
Unknown 0 9(1.2%) 0 61(0.9%) 14(3.6%) 0 84 
Total 348(100%) 840(100%) 54(100%) 676(100%) 387(100%) 187(100%) 2492 
 
Disregarding the unknown and Finnish data (because of the low number of cases) no 
significant difference was found between the other five countries (p= 0.0583). 
 
 
3.3.8 Distribution by accident type 
 
Figure 8. General distribution of the study population by accident type 
Regarding the whole study population, 32.3% was involved in a single-vehicle accident 
and 37.3% in a multi-vehicle collision. For 30.4% accident data were unknown. This high 
percentage of unknown is due to the fact that Italy did not collect data on this variable. 
Taking only into consideration samples for which data about type of accident was known, 
out of the 1734 drivers, 46.4% and 53.6% were involved respectively in a single- and in a 
multi-vehicle accident. 
 
Table 28. Distribution of study population by type of accident 
Country Type of 
accident Belgium Denmark Finland Italy Lithuania The 
Netherlands 
Total 
Single 
vehicle 
158(45.4%) 411(48.9%) 25(46.3%) 0 110(28.4%) 101(54.0%) 805 
Multi 
vehicle 
165(47.4%) 415(49.4%) 26(48.1%) 0 263(68.0%) 60(32.1%) 929 
 
  
Unknown 25(7.2%) 14(1.7%) 3(5.6%) 676(100%) 14(3.6%) 26(14.0%) 758 
Total 348(100%) 840(100%) 54(100%) 676(100%) 387(100%) 187(100%) 2492 
 
Disregarding the unknown data, a significant difference was found (p<0.01). 
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There were more single-vehicle accidents in the Netherlands and more multi-vehicle 
accidents in Lithuania. 
 
 
3.3.9 Distribution by injury severity 
In Denmark and Italy, MAIS scores were not available, but drivers were selected on the 
basis of different criteria that ensured that the severity of injuries was in the range of 
MAIS score 2 or above. For these countries the variable code ‘equivalent’ was 
constructed. 
 
 
Figure 9. General distribution of the study population by severity of injuries 
60.8% of the population was sampled in Denmark and Italy. For this reason the code 
‘equivalent’ has the highest percentage, followed by MAIS 2 and unknown. 
 
Table 29. Distribution of study population by injury severity 
Country MAIS score 
Belgium Denmark Finland Italy Lithuania The 
Netherlands 
Total 
  2 208(59.8%) 0 30(55.6%) 0 136(35.1%) 91(48.7%) 465 
  3 97(27.9%) 0 21(38.9%) 0 12(3.1%) 66(35.3%) 196 
  4 20(5.7%) 0 2(3.7%) 0 4(1.0%) 16(8.6%) 42 
 5 12(3.4%) 0 0 0 1(0.3%) 13(7.0%) 26 
 6 0 0 0 0 1(0.3%) 0 1 
 Unknown 11(3.2%) 0 1(1.9%) 0 233(60.2%) 1(0.5%) 246 
 Equivalent 0 840(100%) 0 676(100%) 0 0 1516 
Total 348(100%) 840(100%) 54(100%) 676(100%) 387(100%) 187(100%) 2492 
 
Regarding the most prevalent MAIS scores (2 and 3) a significant difference was found 
(p< 0.01).The high number of unknown MAIS scores in Lithuania had the greatest 
influence on the unequal distribution. Because of the low number of samples per score, 
comparison with Finland was disregarded. Comparing Belgium and the Netherlands, 
there was an equal distribution for MAIS scores 3 to 5 and a higher proportion in Belgium 
for MAIS 2. 
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3.4 Killed drivers - Description of the driver sample  
 
3.4.1 Distribution by country 
 
 
Figure 10. Distribution of study population by country 
  
The highest number of killed drivers was sampled in Finland (43.2%), followed by 
Portugal (25.5%). 
  
 
3.4.2 Distribution by road type 
 
 
Figure 11. General distribution of the study population by road type 
63.5% of the population was sampled on rural roads, 10.1% on urban roads. The high 
number of unknown is due to the fact that Portugal was unable to gather data on road 
type. Disregarding Portugal, the proportion of unknown data decreased to 1.2%. Of the 
833 samples left, 13.5% and 85.2% were sampled respectively on urban and rural roads. 
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Table 30. Distribution by country and type of road 
Country Type of road  
Finland Norway Portugal Sweden 
Total 
  Urban road 64(13.3%) 26(13.5%) 0 23(14.6%) 113(10.1%) 
  Rural road 409(84.7%) 167(86.5%) 0 134(85.4%) 710(63.5%) 
 Unknown 10(2.1%) 0 285(100%) 0 295(26.4%) 
Total 483(100%) 193(100%) 285(100%) 157(100%) 1118 
 
By selecting only cases with urban or rural road type, no significant difference was found 
between the countries (p=0.933) 
 
 
3.4.3 Distribution by day of the week and time of the day 
The time periods (see annex1) have been aggregated into Weekday (time periods 
1+2+3), Weeknight (time period 4), Weekend day (time periods 5+6+7) and Weekend 
night (time period 8). 
 
 
Figure 12. General distribution of the study population by time of the day and day of the 
week 
 
78% of the accidents occurred during daytime (53% on a weekday, 25% in weekends). 
7.3% and 9.9% were the percentage of accidents occured respectively during week night 
and weekend night. 
 
Table 31. Distribution by country and time of the week 
Country Time period  
Finland Norway Portugal Sweden 
Total 
  Weekday 270(55.9%) 112(58.0%) 114(40.0%) 97(61.8%) 593(53.0%) 
  Weeknight 41(8.5%) 10(5.2%) 24(8.4%) 7(4.5%) 82(7.3%) 
 Weekend day 122(25.3%) 52(26.9%) 69(24.2%) 36(22.9%) 279(25.0%) 
 Weekend night 50(10.4%) 19(9.8%) 25(8.8%) 17(10.8%) 111(9.9%) 
 unknown 0 0 53(18.6%) 0 53(4.7%) 
Total 483(100%) 193(100%) 285(100%) 157(100%) 1118 
 
Disregarding the unknown data, no significant difference was found between the 
countries (p= 0.254). 
 DRUID 6th Framework Programme Deliverable D.2.2.5  
 Results - Killed drivers - Description of the driver sample 
Prevalence of alcohol and other psychoactive substances in injured and killed drivers. 
 
 Page 55 of 349 
3.4.4 Distribution by quarter of the year 
 
 
Figure 13. General distribution of the study population by quarter of the year 
 
The highest proportion was found for the third quarter (27%), followed by the fourth 
(26.6%). 46.4% of the population was sampled in the first half of the year. 
 
Table 32. Distribution by country and quarter of the year 
Country Time period  
Finland Norway Portugal Sweden 
Total 
  First 104(21.5%) 41(21.2%) 62(21.8%) 41(26.1%) 248(22.2%) 
  Second 120(24.8%) 44(22.8%) 69(24.2%) 38(24.2%) 271(24.2%) 
 Third 123(25.5%) 49(25.4%) 86(30.2%) 44(28.0%) 302(27.0%) 
 Fourth 136(28.2%) 59(30.6%) 68(23.9%) 34(21.7%) 297(26.6%) 
Total 483(100%) 193(100%) 285(100%) 157(100%) 1118 
 
The distribution by quarter of the year was equal between all countries, no significant 
difference was found (p = 0.628). 
This figures might be misleading because of different sampling periods between the 
countries as shown in table 33. Taking this sampling periods into account, similar 
proportions were calculated, (table 34) assuming no significant difference. 
 
Table 33. Distribution of sampling period by country 
Country Sampling period 
Finland 2 January 2006 – 29 December 2008 
Norway 2 January 2006 – 25 December 2008 
Portugal 5 December 2008– 19 December 2009 
Sweden 1 January 2008 – 31 December 2008 
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Table 34. Distribution by country and quarter of the year weighted for the sampling period 
accounting for one year 
Country Quarter 
Finland Norway Portugal Sweden 
First 21.49% 21.11% 22.51% 26.33% 
Second 24.79% 22.65% 25.05% 24.13% 
Third 25.41% 25.21% 31.22% 27.94% 
Fourth 28.30% 31.03% 21.23% 21.59% 
 
 
3.4.5 Distribution by age and gender 
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Figure 14. General distribution of study population of killed drivers by age and gender 
 
Males accounted for 83%. No unknown data for gender were found. As for age groups 
the highest proportion was found for the group 50+. 
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Figure 15. Histogram of the study population by age and gender 
 
Table 35. Distribution by country, age and gender 
 
Significant differences were found for both gender and age groups (p < 0.01). 
There were more males in Portugal compared to the other countries. For the age 
distribution, differences were found for the age group 18-24, which was less present in 
Portugal, this was in contrast to the age group 25-34. Subjects of the age group 50+ were 
more often found in Finland and Sweden than in the other countries. There were more 
males than females in the age group 18-24, which could be attributed to a higher 
proportion in Sweden. More females were found in the age group 35-49, because of a 
higher proportion in Finland. 
 
 
 
 
 
 
Country 
Gender   Age Finland Norway Portugal Sweden Total 
 Male 18-24 99(25.3%) 48(31.6%) 41(15.5%) 30(25.2%) 218(23.5%)
  25-34 64(16.3%) 29(19.1%) 65(24.5%) 14(11.8%) 172(18.5%)
  35-49 70(17.9%) 29(19.1%) 69(26.0%) 23(19.3%) 191(20.6%)
  50+ 159(40.6%) 46(30.3%) 83(31.3%) 52(43.7%) 340(36.6%)
 Unknown 0 0 7(2.6%) 0 7(0.8%)
   Total 392(100%) 152(100%) 265(100%) 119(100%) 928
 Female 18-24 16(17.6%) 8(19.5%) 4(20.0%) 4(10.5%) 32(16.8%)
  25-34 10(11.0%) 8(19.5%) 6(30.0%) 5(13.2%) 29(15.3%)
  35-49 32(35.2%) 13(31.7%) 8(40.0%) 12(31.6%) 65(34.2%)
  50+ 33(36.3%) 12(29.3%) 2(10.0%) 17(44.7%) 64(33.7%)
  Total 91(100%) 41(100%) 20 38(100%) 190
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3.4.6 Distribution by type of vehicle 
 
 
Figure 16. General distribution of study population by type of vehicle 
 
Overall 70.8% of the study population was driving a personal car. For 25.5% no data on 
vehicle type were available. This proportion is attributed to the missing data in Portugal, 
for which data about type of vehicle was not available. Disregarding the Portuguese data, 
95.1% of the sample was driving a personal car, 4.9% a small van. 
 
Table 36. Distribution by country and type of vehicle 
Country Type of vehicle 
Finland Norway Portugal Sweden 
Total 
  Personal car 462(95.7%) 183(94.8%) 0 147(93.6%) 792(70.8%) 
  Van 21(4.3%) 10(5.2%) 0 10(6.4%) 41(3.7%) 
 unknown 0 0 285(100%) 0 285(25.5%) 
Total 483(100%) 193(100%) 285(100%) 157(100%) 1118 
 
Disregarding the Portuguese data, no significant difference was found between the other 
countries. (p = 0.585) 
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3.4.7 Distribution by accident type 
 
 
Figure 17. General distribution of study population by type of accident 
Regarding the whole study population, 30.9% was involved in a single-vehicle accident 
and 43.5% in a multi-vehicle collision. For 25.6% the type of accident was unknown. This 
high percentage of unknown is due to the fact that in Portugal no data were available on 
this variable. Taking only into consideration the known data, of the 832 drivers, 41.6% 
and 58.4% were involved respectively in a single- and a multi-vehicle accident. 
 
Table 37. Distribution by country and type of accident 
Country Type of accident 
Finland Norway Portugal Sweden 
Total 
  Single vehicle 200(41.4%) 81(42.0%) 0 65(41.4%) 346(30.9%) 
  Multi vehicle 283(58.6%) 112(58.0%) 0 91(58.0%) 486(43.5%) 
 unknown 0 0 285(100%) 1(0.6%) 286(25.6%) 
Total 483(100%) 193(100%) 285(100%) 157(100%) 1118 
 
Disregarding the unknown data, there was an equal distribution between Finland, Norway 
and Sweden, as no significant difference was found (p = 0.991). 
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3.5 Prevalence of substance groups use among seriously 
injured drivers 
 
3.5.1 Seriously injured drivers – Prevalence of use – Alcohol ≥ 0.1 g/L 
Table 38. Prevalence of use – Alcohol 
SERIOUSLY 
INJURED DRIVERS BE (348) DK (838) FI (53) IT (676) LT (385) NL (186)
Percentage of 
subjects positive for 
alcohol 
42.5 19.7 32.1 23.1 17.7 29.6 
 
 
Figure 18. Prevalence of use – Alcohol: detail of toxicological findings 
 
As expected, alcohol (cut-off= 0.1 g/L) was the most common finding. In the 6 countries 
participating in the seriously injured drivers study, the percentage of positive drivers in 
which alcohol was found alone ranged between approximately 14 and 28. The 
percentage of drivers in which alcohol was found in combination with other substances 
ranged approximately between 2 and 13. In general more male than female tested 
positive for alcohol presence. This happens in all age groups. 
 
In males the percentage of positive shows a minimum of 19.3% (Lithuania) and a 
maximum of 50.6% (Belgium). The number of male subjects that tested positive for 
alcohol tend to have a peak in the age group 25-34 and then to decrease in the older age 
groups. This happens in all countries, apart from Belgium, where the highest percentage 
of positive male was found in the age group 18-24 followed by the age group 35-49. 
 
In the female groups, the distribution of positives shows a minimum of 5.5% in Denmark 
and a maximum of 24.0% in Belgium. Apart from Finland, for which the low number of 
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samples may explain the different pattern, with positive findings dropping from 66.7% in 
the age group 18-24 to 0% in the other age groups, the percentage of positive subjects 
tend to fluctuate across different age groups. The highest percentage of positives was 
found in the age group 18-24 in Italy, in the age groups 25-34 in Denmark and The 
Netherlands, and in the age group 35-49 in Belgium and Lithuania. 
 
In combination with drugs, alcohol was found mostly with THC and/or THCCOOH and 
with benzodiazepines. 
 
Table 39. Prevalence of use – Alcohol: detail on gender and age groups 
Prevalence of use - Percentage of subjects positive for ALCOHOL 
Among subjects of the same age group 
MALE 18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
male 
subjects 
Belgium 58.5 51.3 57.1 31.3 62.5 50.6 
Denmark 25.7 36.4 26.0 17.8 100.0 27.3 
Finland 35.7 50.0 33.3 22.2 N.A. 35.7 
Italy 24.0 31.1 24.2 18.2 N.A. 25.0 
Lithuania 22.7 21.2 18.2 11.9 25.0 19.3 
The 
Netherlands 32.0 51.3 26.5 23.1 N.A. 34.2 
Among subjects of the same age group 
FEMALE 
18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
female 
subjects 
Belgium 27.8 17.9 28.1 18.2 50.0 24.0 
Denmark 1.2 9.5 4.5 8.9 0.0 5.5 
Finland 66.7 0.0 0.0 0.0 N.A. 18.2 
Italy 19.2 19.1 14.5 14.3 N.A. 16.7 
Lithuania 22.2 12.2 23.7 0.0 0.0 16.4 
The 
Netherlands 0.0 16.7 9.1 11.1 N.A. 10.8 
Among subjects of the same age group UNKNOWN 
GENDER 18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
subjects of 
unknown 
gender 
Belgium N.A. N.A. N.A. N.A. 0.0 0.0 
Lithuania 0.0 0.0 N.A. 0.0 0.0 0.0 
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Figure 19. Prevalence of use – Alcohol: male drivers 
 
 
Figure 20. Prevalence of use – Alcohol: female drivers 
 
3.5.2 Seriously injured drivers- Prevalence of use - Alcohol (≥ 0.5 g/L) 
 
Table 40. Prevalence of use- alcohol (≥0.5g/L) 
SERIOUSLY INJURED 
DRIVERS BE (348) DK (838) FI (53) IT (676) LT (385) NL (186) 
Percentage of subjects 
tested positive for alcohol 38.2 17.8 30.2 20.6 16.1 28.0 
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Figure 21. Prevalence of uses – alcohol (≥0.5g/L) 
For alcohol (cut-off =  ≥ 0.5 g/L), the highest percentage of positive cases was recorded 
in Belgium followed by Finland and the Netherlands. 
The percentage of positive drivers in which alcohol (cut-off = ≥ 0.1 g/L) was found alone 
ranged between approximately 14 and 28. Using the cut-off ≥ 0.5 g/L, the percentage of 
positive drivers ranged between approximately 16 and 38.  
 
 
3.5.3 Seriously injured drivers – Prevalence of use – Amphetamines 
Table 41. Prevalence of use – Amphetamines 
SERIOUSLY 
INJURED DRIVERS BE (346) DK (837) FI (54) IT (676) LT (385) NL (187)
Percentage of 
subjects positive for 
amphetamines 
2.6 4.2 3.7 0.1 0.5 2.1 
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Figure 22. Prevalence of use – Amphetamines: detail of toxicological findings 
 
In the 6 countries participating in the seriously injured drivers study, the total percentage 
of drivers positive for amphetamines ranges between approximately 0.1 (Italy) to 4.2  
(Denmark). Except for The Netherlands, where the highest percentage of subjects was 
found in the female group, in the other countries more males than females tested positive 
for amphetamines. No positive cases were recorded in females in Denmark, Finland and 
Italy. 
 
In general amphetamines appear to be used in combination with other drugs, and in 
particular with benzodiazepines, alcohol, cannabis (as THC and/or THCCOOH) and 
cocaine (found as active parent drug or its metabolite benzoylecgonine), either combined 
singularly or together. 
 
The consumption tends to drop in the age group 50 and over. Only two positive cases 
were recorded in the older age group, one alone and one in combination with 
benzodiazepines. These were two male subjects, one in Belgium and one in Denmark, 
aged 52 and 54 respectively. The toxicological findings showed presence of 
amphetamine and methamphetamine, suggesting a possible therapeutic use of 
selegiline. This is a medication used in the treatment of early stages of Parkinson’s 
disease, depression and senile dementia that breaks down in the body in the two 
detected substances13. 
 
 
 
 
 
                                                          
13 Goodman and Gilman. The Pharmacological basis of therapeutics, 2001. Mc Graw Hill Companies. ISBN: 0-
07-112432-2. 
Baselt RC. Disposition of toxic drugs and chemicals in man. Biomedical publications Foster city, California, 2004 
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Table 42. Prevalence of use – Amphetamines: detail on gender and age groups 
Prevalence of use - Percentage of subjects positive for AMPHETAMINES 
Among subjects of the same age group 
MALE 18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
male 
subjects 
Belgium 1.9 5.1 3.6 2.1 0.0 3.3 
Denmark 5.4 10.7 2.4 1.1 0.0 5.3 
Finland 0.0 10.0 11.1 0.0 N.A. 4.7 
Italy 0.0 0.0 0.7 0.0 N.A. 0.2 
Lithuania 0.0 0.0 3.0 0.0 0.0 0.8 
The 
Netherlands 4.0 2.6 0.0 0.0 N.A. 2.0 
Among subjects of the same age group 
FEMALE 
18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
female 
subjects 
Belgium 5.6 0.0 0.0 0.0 0.0 1.0 
Denmark 3.7 3.2 1.1 0.0 0.0 2.0 
Finland 0.0 0.0 0.0 0.0 N.A. 0.0 
Italy 0.0 0.0 0.0 0.0 N.A. 0.0 
Lithuania 0.0 0.0 0.0 0.0 0.0 0.0 
The 
Netherlands 0.0 8.3 0.0 0.0 N.A. 2.7 
Among subjects of the same age group UNKNOWN 
GENDER 18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
subjects of 
unknown 
gender 
Belgium N.A N.A. N.A. N.A. 0.0 0.0 
Lithuania 0.0 0.0 N.A. 0.0 0.0 0.0 
 
 
Figure 23. Prevalence of use – Amphetamines: male drivers 
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Figure 24. Prevalence of use – Amphetamines: female drivers 
 
 
3.5.4 Seriously injured drivers – Prevalence of use – Benzoylecgonine 
Data about benzoylecgonine and cocaine are presented in separate tables and graphs, 
because of the substance groups classification. However, for a whole picture of the use 
of cocaine among the sampled subpopulations, the two sets of data should be considered 
together. 
Table 43. Prevalence of use – Benzoylecgonine  
SERIOUSLY 
INJURED DRIVERS BE (346) DK (837) FI (49) IT (676) LT (385) NL (187)
Percentage of 
subjects positive for 
benzoylecgonine (but 
negative for cocaine) 
1.4 0.7 0.0 2.8 0.3 2.7 
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Figure 25. Prevalence of use – Benzoylecgonine: detail of toxicological findings 
 
For benzoylecgonine (without the presence of cocaine), the highest percentage of 
positive cases was recorded in Italy followed by The Netherlands and Belgium. Use 
appears to be more common among males. Apart from Belgium, where the percentage of 
positives is spread through all age groups, in the other 5 countries percentage of 
positives for benzoylecgonine drop to zero in the age group 50 and over. 
 
Consumption is combined with alcohol or other drugs in the majority of cases, the 
association with alcohol, cannabis, illicit opiates, amphetamines and benzodiazepines, 
singularly or together, being the most common. 
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Table 44. Prevalence of use – Benzoylecgonine: detail on gender and age groups 
Prevalence of use - Percentage of subjects positive for BENZOYLECGONINE (without cocaine)
Among subjects of the same age group 
MALE 18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
male 
subjects 
Belgium 1.9 1.3 1.8 2.1 0.0 1.6 
Denmark 1.1 1.4 0.8 0.0 0.0 0.9 
Finland 0.0 0.0 0.0 0.0 N.A. 0.0 
Italy 5.0 5.0 3.4 0.0 N.A. 3.5 
Lithuania 0.0 1.9 0.0 0.0 0.0 0.4 
The 
Netherlands 2.0 5.1 5.7 0.0 N.A. 3.3 
Among subjects of the same age group 
FEMALE 
18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
female 
subjects 
Belgium 0.0 3.6 0.0 0.0 0.0 1.0 
Denmark 0.0 0.0 1.1 0.0 0.0 0.3 
Finland 0.0 0.0 0.0 0.0 N.A. 0.0 
Italy 0.0 2.1 0.0 0.0 N.A. 0.6 
Lithuania 0.0 0.0 0.0 0.0 0.0 0.0 
The 
Netherlands 0.0 0.0 0.0 0.0 N.A. 0.0 
Among subjects of the same age group UNKNOWN 
GENDER 18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
subjects of 
unknown 
gender 
Belgium N.A. N.A. N.A. N.A. 0.0 0.0 
Lithuania 0.0 0.0 N.A. 0.0 0.0 0.0 
 
 
 
Figure 26. Prevalence of use – Benzoylecgonine: male drivers 
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Figure 27. Prevalence of use – Benzoylecgonine: female drivers 
 
 
3.5.5 Seriously injured drivers – Prevalence of use – Cocaine 
Table 45. Prevalence of use – Cocaine  
SERIOUSLY 
INJURED DRIVERS BE (346) DK (837) FI (53) IT (676) LT (385) NL (187)
Percentage of 
subjects positive for 
cocaine 
2.3 0.6 0.0 2.7 0.3 2.1 
 
 
Figure 28. Prevalence of use – Cocaine: detail of toxicological findings 
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For cocaine (alone or in the presence of benzoylecgonine), as expected, the picture is 
similar to the one of benzoylecgonine. The highest percentage of positive cases was 
again recorded in Italy followed by Belgium and The Netherlands. Apart from The 
Netherlands, higher percentage of positive subjects were recorded among the male 
group, with no cases at all positive for cocaine in females in Belgium, Denmark, Finland 
and Lithuania. Apart from one positive case in Lithuania, in the other countries no cocaine 
was found in the age group 50 and over. 
 
As for benzoylecgonine, positive findings for cocaine are mostly associated with positive 
findings for alcohol, cannabis, amphetamines, benzodiazepines and illicit opiates, 
singularly or together. 
 
Table 46. Prevalence of use – Cocaine: detail on gender and age groups 
Prevalence of use - Percentage of subjects positive for COCAINE 
Among subjects of the same age group 
MALE 18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
male 
subjects 
Belgium 1.9 6.4 1.8 0.0 12.5 3.3 
Denmark 1.1 2.1 0.0 0.0 0.0 0.9 
Finland 0.0 0.0 0.0 0.0 N.A. 0.0 
Italy 2.0 3.1 6.7 0.0 N.A. 3.3 
Lithuania 0.0 0.0 0.0 2.4 0.0 0.4 
The 
Netherlands 2.0 5.1 0.0 0.0 N.A. 2.0 
Among subjects of the same age group 
FEMALE 18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
female 
subjects 
Belgium 0.0 0.0 0.0 0.0 0.0 0.0 
Denmark 0.0 0.0 0.0 0.0 0.0 0.0 
Finland 0.0 0.0 0.0 0.0 N.A. 0.0 
Italy 0.0 2.1 0.0 0.0 N.A. 0.6 
Lithuania 0.0 0.0 0.0 0.0 0.0 0.0 
The 
Netherlands 0.0 8.3 0.0 0.0 N.A. 2.7 
Among subjects of the same age group UNKNOWN 
GENDER 18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
subjects of 
unknown 
gender 
Belgium N.A. N.A. N.A. N.A. 0.0 0.0 
Lithuania 0.0 0.0 N.A. 0.0 0.0 0.0 
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Figure 29. Prevalence of use – Cocaine: male drivers 
 
Figure 30. Prevalence of use – Cocaine: female drivers 
 
 
3.5.6 Seriously injured drivers – Prevalence of use – Cocaine and/or 
benzoylecgonine 
When combined, data for cocaine and benzoylecgonine show the highest percentage of 
positive cases in Italy, followed by The Netherlands and Belgium. The number of 
positives is normally higher in the male group, in which again Italy has the biggest 
number of cases followed by The Netherlands and Belgium. No cases of 
cocaine/benzoyleconine were recorded in Finland, both in the male and female groups. In 
Lithuania no cases of cocaine/benzoylecgonine were recorded in the female group. The 
majority of subjects that tested positive for cocaine/benzoylecgonine tested positive also 
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for other substances, with the most common combinations being with alcohol, cannabis, 
illicit opiates, benzodiazepines and amphetamines. 
 
Table 47. Prevalence of use – Cocaine and/or benzoylecgonine 
SERIOUSLY 
INJURED DRIVERS 
BE 
(346) 
DK 
(837) FI (49) IT (676) LT (385) NL (187)
Percentage of 
subjects tested 
positive for cocaine 
and/or 
benzoylecgonine 
3.8 1.3 0.0 5.5 0.5 4.8 
 
 
 
Figure 31. Prevalence of use - Cocaine and/or benzoylecgonine 
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Table 48. Prevalence of use – Cocaine and/or Benzoylecgonine: detail on gender and age 
groups 
Prevalence of use - Percentage of drivers tested positive for COCAINE and/or 
BENZOYLECGONINE 
Among subjects of the same age group 
MALE 
18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
male 
subjects 
Belgium 3.8 7.7 3.6 2.1 12.5 4.9 
Denmark 2.2 3.6 0.8 0.0 0.0 1.8 
Finland 0.0 0.0 0.0 0.0 N.A. 0.0 
Italy 7.0 8.1 10.1 0.0 N.A. 6.7 
Lithuania 0.0 1.9 0.0 2.4 0.0 0.8 
The 
Netherlands 4.0 10.3 5.7 0.0 N.A. 5.3 
Among subjects of the same age group 
FEMALE 
18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
female 
subjects 
Belgium 0.0 3.6 0.0 0.0 0.0 1.0 
Denmark 0.0 0.0 1.1 0.0 0.0 0.3 
Finland 0.0 0.0 0.0 0.0 N.A. 0.0 
Italy 0.0 4.3 0.0 0.0 N.A. 1.3 
Lithuania 0.0 0.0 0.0 0.0 0.0 0.0 
The 
Netherlands 0.0 8.3 0.0 0.0 N.A. 2.7 
Among subjects of the same age group UNKNOWN 
GENDER 18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
subjects of 
unknown 
gender 
Belgium N.A. N.A. N.A. N.A. 0.0 0.0 
Lithuania 0.0 0.0 N.A. 0.0 0.0 0.0 
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Figure 32. Prevalence of use – Cocaine and/or Benzoylecgonine : Male drivers 
 
 
Figure 33. Prevalence of use – Cocaine and/or Benzoylecgonine : Female drivers 
 
3.5.7 Seriously injured drivers – Prevalence of use – THCCOOH 
 
Data about THCCOOH and THC are presented in separate tables and graphs, because 
of the substance group classification. However, for a whole picture of the use of cannabis 
among the sampled subpopulations, the two sets of data should be considered together, 
THCCOOH being the metabolite of THC in the body. 
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Table 49. Prevalence of use – THCCOOH 
SERIOUSLY 
INJURED DRIVERS BE (344) DK (836) FI (53) IT (676) LT (385) NL (187)
Percentage of 
subjects positive for 
THCCOOH (but 
negative for THC) 
2.3 5.3 0.0 1.3 0.3 1.1 
 
 
Figure 34. Prevalence of use – THCCOOH: detail of toxicological findings (combination with 
THC not included) 
 
For THCCOOH (without the presence of THC), the highest percentage of positive cases 
was recorded in Denmark, followed by Belgium and Italy. Denmark is the only country in 
which cases of THCCOOH only were recorded both in the male and the female groups, 
while in the other 5 countries no cases were recorded in the female group. The number of 
positive findings tend to decrease sharply in the age group 50 and over, reaching zero in 
all countries apart from Denmark and Belgium. 
 
Consumption is often combined, and THCCOOH is mostly found with alcohol, 
benzodiazepines and cocaine/benzoylecgonine. Several cases appear also in association 
with opioids, both of the medicinal and of the illicit group.  
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Table 50. Prevalence of use – THCCOOH: detail on gender and age groups 
Prevalence of use - Percentage of subjects positive for THCCOOH (without THC) 
Among subjects of the same age group 
MALE 18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
male 
subjects 
Belgium 1.9 6.4 0.0 4.3 0.0 3.3 
Denmark 7.5 7.9 8.7 1.1 0.0 6.8 
Finland 0.0 0.0 0.0 0.0 N.A. 0.0 
Italy 3.0 2.5 1.3 0.0 N.A. 1.7 
Lithuania 0.0 0.0 0.0 0.0 0.0 0.0 
The 
Netherlands 0.0 5.1 0.0 0.0 N.A. 1.3 
Among subjects of the same age group 
FEMALE 
18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
female 
subjects 
Belgium 0.0 0.0 0.0 0.0 0.0 0.0 
Denmark 1.3 4.8 3.4 0.0 0.0 2.4 
Finland 0.0 0.0 0.0 0.0 N.A 0.0 
Italy 0.0 0.0 0.0 0.0 N.A 0.0 
Lithuania 0.0 0.0 0.0 0.0 0.0 0.0 
The 
Netherlands 0.0 0.0 0.0 0.0 N.A 0.0 
Among subjects of the same age group UNKNOWN 
GENDER 18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
subjects of 
unknown 
gender 
Belgium N.A. N.A. N.A. N.A. 0.0 0.0 
Lithuania 0.0 0.0 N.A. 0.0 12.5 7.7 
 
 
 
Figure 35. Prevalence of use – THCCOOH: male drivers 
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Figure 36. Prevalence of use – THCCOOH: female drivers 
 
 
3.5.8 Seriously injured drivers – Prevalence of use – THC  
Table 51. Prevalence of use – THC 
SERIOUSLY 
INJURED DRIVERS BE (344) DK (836) FI (53) IT (676) LT (385) NL (187)
Percentage of 
subjects positive for 
THC 
7.6 1.3 5.7 3.7 0.5 0.5 
 
 
Figure 37. Prevalence of use – THC: detail of toxicological findings 
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The highest percentage of positive cases for THC (alone or in the presence THCCOOH) 
was recorded in Belgium, followed by Finland and Italy. In the male and female groups 
the percentage of positive findings seems to follow a different pattern in the 6 countries. 
Belgium has the highest number of positive cases for both the male and the female 
groups, with positive subjects mostly concentrated in the age groups 18-24 and 25-34. 
 
No positive cases for THC were recorded in females of Finland, Lithuania and The 
Netherlands. Once again the number of positive cases drops in the age group 50 and 
over, with no positive cases recorded. 
 
As in the case of THCCOOH, subjects positive for THC were often also positive for 
alcohol, cocaine/benzoylecgonine and benzodiazepines, either alone or in combination. 
 
Table 52. Prevalence of use – THC: detail on gender and age groups 
Prevalence of use - Percentage of subjects positive for THC 
Among subjects of the same age group 
MALE 18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
male 
subjects 
Belgium 17.3 16.7 1.8 0.0 12.5 10.0 
Denmark 2.7 0.0 3.9 0.0 0.0 1.8 
Finland 7.1 20.0 0.0 0.0 N.A. 7.1 
Italy 8.0 6.8 2.7 0.0 N.A. 4.4 
Lithuania 0.0 1.9 1.5 0.0 0.0 0.8 
The 
Netherlands 0.0 2.6 0.0 0.0 N.A. 0.7 
Among subjects of the same age group 
FEMALE 18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
female 
subjects 
Belgium 5.6 3.6 0.0 0.0 0.0 2.0 
Denmark 0.0 1.6 0.0 0.0 0.0 0.3 
Finland 0.0 0.0 0.0 0.0 N.A. 0.0 
Italy 0.0 2.1 1.8 0.0 N.A. 1.3 
Lithuania 0.0 0.0 0.0 0.0 0.0 0.0 
The 
Netherlands 0.0 0.0 0.0 0.0 N.A. 0.0 
Among subjects of the same age group UNKNOWN 
GENDER 18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
subjects of 
unknown 
gender 
Belgium N.A. N.A. N.A. N.A. 0.0 0.0 
Lithuania 0.0 0.0 N.A. 0.0 0.0 0.0 
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Figure 38. Prevalence of use – THC: male drivers 
 
 
Figure 39. Prevalence of use – THC: female drivers 
 
3.5.9 Seriously injured drivers – Prevalence of use – THC and/or THCCOOH 
When combined, data for THC and THCCOOH only show the highest percentage of 
positive cases in Belgium, followed by Denmark and Finland. This trend is confirmed in 
the male group, while in the female group positive cases are found only in Denmark, 
Belgium and Italy, with percentages decreasing in the same order. The majority of 
subjects that tested positive for THC and/or THCCOOH also tested positive for other 
substances, with the most common combinations being with alcohol, 
cocaine/benzoylecgonine and benzodiazepines. Combination with amphetamines is also 
present as well as with opioids, especially medicinal. All of these appear as single or 
multiple combinations. In the prevalence of use, among the whole subpopulation of 
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sampled drivers, subjects positive for THC and/or THCCOOH make the second largest 
group after the ones positive for alcohol. 
 
Table 53. Prevalence of use- THC and/or THCCOOH  
SERIOUSLY 
INJURED DRIVERS 
BE 
(344) 
DK 
(836) FI (53) IT (676) LT (385) NL (187)
Percentage of 
subjects tested 
positive for THC 
and/or THCCOOH 
9.9 6.6 5.7 5.0 0.8 1.6 
 
 
 
Figure 40. Prevalence of use – THC and/or THCCOOH 
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Table 54. Prevalence of use – THC and/or THCCOOH : detail gender and age groups 
Prevalence of use - Percentage of drivers tested positive for THC and/or THCCOOH 
Among subjects of the same age group 
MALE 
18-24 25-34 35-49 50 and over Age unknown 
Among all 
male 
subjects 
Belgium 19.2 23.1 1.8 4.3 12.5 13.3 
Denmark 10.2 7.9 12.6 1.1 0.0 8.6 
Finland 7.1 20.0 0.0 0.0 N.A. 7.1 
Italy 11.0 9.3 4.0 0.0 N.A. 6.2 
Lithuania 0.0 1.9 1.5 0.0 0.0 0.8 
The 
Netherlands 0.0 7.7 0.0 0.0 N.A. 2.0 
Among subjects of the same age group 
FEMALE 
18-24 25-34 35-49 50 and over Age unknown 
Among all 
female 
subjects 
Belgium 5.6 3.6 0.0 0.0 0.0 2.0 
Denmark 1.3 6.3 3.4 0.0 0.0 2.7 
Finland 0.0 0.0 0.0 0.0 N.A. 0.0 
Italy 0.0 2.1 1.8 0.0 N.A. 1.3 
Lithuania 0.0 0.0 0.0 0.0 0.0 0.0 
The 
Netherlands 0.0 0.0 0.0 0.0 N.A. 0.0 
Among subjects of the same age group UNKNOWN 
GENDER 18-24 25-34 35-49 50 and over Age unknown 
Among all 
subjects of 
unknown 
gender 
Belgium N.A. N.A. N.A. N.A. 0.0 0.0 
Lithuania 0.0 0.0 N.A. 0.0 12.5 7.7 
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Figure 41. Prevalence of use – THC and/or THCCOOH : Male drivers 
 
 
Figure 42. Prevalence of use – THC and/or THCCOOH : Female drivers 
 
3.5.10 Seriously injured drivers – Prevalence of use – Illicit opiates 
As already reported, in this chapter, concentrations of 6-acetylmorphine and codeine 
were considered even if below the set cut-offs, to allow classification of illicit opiates use 
more close to reality. For this reason, percentage found herein are likely to be higher than 
the ones reported in the country reports, with the exception of Italy, that used 
toxicological findings on urine samples to distinguish cases of illicit opiates use from the 
medicinal ones. 
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Table 55. Prevalence of use – Illicit opiates 
SERIOUSLY 
INJURED DRIVERS BE (346) DK (837) FI (53) IT (676) LT (385) NL (187)
Percentage of 
subjects positive for 
illicit opiates 
0.6 0.5 0.0 2.1 0.3 0.0 
 
 
Figure 43. Prevalence of use – Illicit opiates: detail of toxicological findings 
 
No cases of illicit opiates were detected in Finland and The Netherlands. In the other 
countries the highest percentage of subjects positive for illicit opiates was found in Italy, 
followed by Belgium, Denmark and Lithuania. Apart from one case registered in Italy, all 
subjects positive for illicit opiates were males. In general the age groups 24-34 and 35-49 
appear to be the bigger consumers of illicit opiates. 
Out of 21 cases detected, only 5 are not in combination with other drugs. The most 
common combinations are with cocaine/benzoylecgonine and THC/THCCOOH, followed 
by ethanol, benzodiazepines and medicinal opioids. 
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Table 56. Prevalence of use – Illicit opiates: detail on gender and age groups 
Prevalence of use - Percentage of subjects positive for ILLICIT OPIATES 
Among subjects of the same age group 
MALE 18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
male 
subjects 
Belgium 0.0 1.3 0.0 2.1 0.0 0.8 
Denmark 0.0 0.0 3.1 0.0 0.0 0.7 
Finland 0.0 0.0 0.0 0.0 N.A. 0.0 
Italy 2.0 3.7 3.4 0.0 N.A. 2.5 
Lithuania 0.0 1.9 0.0 0.0 0.0 0.4 
The 
Netherlands 0.0 0.0 0.0 0.0 N.A. 0.0 
Among subjects of the same age group 
FEMALE 
18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
female 
subjects 
Belgium 0.0 0.0 0.0 0.0 0.0 0.0 
Denmark 0.0 0.0 0.0 0.0 0.0 0.0 
Finland 0.0 0.0 0.0 0.0 N.A. 0.0 
Italy 0.0 2.1 0.0 0.0 N.A. 0.6 
Lithuania 0.0 0.0 0.0 0.0 0.0 0.0 
The 
Netherlands 0.0 0.0 0.0 0.0 N.A. 0.0 
Among subjects of the same age group UNKNOWN 
GENDER 18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
subjects of 
unknown 
gender 
Belgium N.A. N.A. N.A. N.A. 0.0 0.0 
Lithuania 0.0 0.0 N.A. 0.0 0.0 0.0 
 
 
Figure 44. Prevalence of use – Illicit opiates: male drivers 
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Figure 45. Prevalence of use – Illicit opiates: female drivers 
 
 
3.5.11 Seriously injured drivers – Prevalence of use – Benzodiazepines 
Table 57. Prevalence of use – Benzodiazepines 
SERIOUSLY 
INJURED DRIVERS BE (342) DK (835) FI (49) IT (676) LT (385) NL (187)
Percentage of 
subjects positive for 
benzodiazepines 
7.3 6.7 10.2 0.7 3.6 0.0 
 
 
Figure 46. Prevalence of use – Benzodiazepines: detail of toxicological findings 
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Finland, Belgium and Denmark had the highest percentage of subjects positive for 
benzodiazepines. The Netherlands is the only country in which no subject was found 
positive for benzodiazepines. With different patterns, consumption seems to be spread 
over both genders and all age groups. The vast majority of cases are in combination with 
alcohol, THC and/or THCCOOH, amphetamines and medicinal opioids. 
 
Although the number of Finnish samples selected for the this general part is very low,  
similar percentages of subjects positive for benzodiazepines were found both in the 
whole population of Finnish injured drivers (9.6%) and killed drivers (13.3%)  Statistically 
no difference is found between Belgium and Denmark.  
 
Table 58. Prevalence of use – Benzodiazepines: detail on gender and age groups 
Prevalence of use - Percentage of subjects positive for BENZODIAZEPINES 
Among subjects of the same age group 
MALE 18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
male 
subjects 
Belgium 1.9 1.3 14.5 6.4 37.5 6.7 
Denmark 5.9 10.7 7.1 6.7 0.0 7.6 
Finland 0.0 30.0 12.5 12.5 N.A. 12.8 
Italy 0.0 0.0 0.0 0.9 N.A. 0.2 
Lithuania 0.0 5.8 4.5 7.1 8.3 4.2 
The 
Netherlands 0.0 0.0 0.0 0.0 N.A. 0.0 
Among subjects of the same age group 
FEMALE 
18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
female 
subjects 
Belgium 5.6 0.0 13.8 13.6 25.0 8.9 
Denmark 2.5 6.3 4.6 7.1 20.0 5.1 
Finland 0.0 0.0 0.0 0.0 N.A. 0.0 
Italy 0.0 2.1 0.0 10.7 N.A. 2.6 
Lithuania 2.8 4.9 2.6 0.0 0.0 3.0 
The 
Netherlands 0.0 0.0 0.0 0.0 N.A. 0.0 
Among subjects of the same age group UNKNOWN 
GENDER 18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
subjects of 
unknown 
gender 
Belgium N.A. N.A. N.A. N.A. 0.0 0.0 
Lithuania 0.0 0.0 N.A. 0.0 0.0 0.0 
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Figure 47. Prevalence of use – Benzodiazepines: male drivers 
 
 
Figure 48. Prevalence of use – Benzodiazepines: female drivers 
 
3.5.12 Seriously injured drivers – Prevalence of use – Z-drugs 
Table 59. Prevalence of use – Z-drugs 
SERIOUSLY 
INJURED DRIVERS BE (346) DK (837) FI (53) IT (676) LT (385) NL (187)
Percentage of 
subjects positive for 
Z-drugs 
1.7 1.2 3.8 0.0 0.0 0.5 
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Figure 49. Prevalence of use – Z-drugs: detail of toxicological findings 
 
The highest percentage of subjects positive for Z-drugs was found in Finland followed by 
Belgium and Denmark, with a pattern similar to the one found for benzodiazepines. Only 
one case was recorded in The Netherlands, accounting for 0.5% of the sampled 
subpopulation, while no positive findings for Z-drugs were recorded in Italy and Lithuania. 
The use appears to be more common among older age groups, with no positive subjects 
in the age group 18-24. Approximately half of the cases are in combination, most 
commonly with benzodiazepines and alcohol. 
 
Table 60. Prevalence of use – Z-drugs: detail on gender and age groups 
Prevalence of use - Percentage of subjects positive for Z-DRUGS 
Among subjects of the same age group 
MALE 18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
male 
subjects 
Belgium 0.0 0.0 1.8 0.0 0.0 0.4 
Denmark 0.0 0.7 1.6 3.3 0.0 1.1 
Finland 0.0 10.0 0.0 11.1 N.A. 4.8 
Italy 0.0 0.0 0.0 0.0 N.A. 0.0 
Lithuania 0.0 0.0 0.0 0.0 0.0 0.0 
The 
Netherlands 0.0 0.0 0.0 3.8 N.A. 0.7 
Among subjects of the same age group 
FEMALE 18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
female 
subjects 
Belgium 0.0 0.0 10.0 0.0 50.0 4.9 
Denmark 0.0 1.6 0.0 5.4 0.0 1.4 
Finland 0.0 0.0 0.0 0.0 N.A. 0.0 
Italy 0.0 0.0 0.0 0.0 N.A. 0.0 
Lithuania 0.0 0.0 0.0 0.0 0.0 0.0 
The 
Netherlands 0.0 0.0 0.0 0.0 N.A. 0.0 
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Among subjects of the same age group 
UNKNOWN 
GENDER 18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
subjects of 
unknown 
gender 
Belgium N.A. N.A. N.A. N.A. 0.0 0.0 
Lithuania 0.0 0.0 N.A. 0.0 0.0 0.0 
 
 
 
Figure 50. Prevalence of use – Z-drugs: male drivers 
 
 
Figure 51. Prevalence of use – Z-drugs: female drivers 
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3.5.13 Seriously injured drivers – Prevalence of use – Medicinal opioids 
Table 61. Prevalence of use – Medicinal opioids 
SERIOUSLY 
INJURED DRIVERS BE (332) DK (835) FI (50) IT (676) LT (385) NL (187)
Percentage of 
subjects positive for 
medicinal opioids 
3.3 4.2 4.0 3.7 7.8 0.5 
 
 
Figure 52. Prevalence of use – Medicinal opioids: detail of toxicological findings 
The highest percentage of subjects positive for medicinal opioids was recorded in 
Lithuania. This is almost double when compared to the ones in the other countries, with 
the exception of The Netherlands, where only one case was recorded (0.5%). In general, 
subjects positive for medicinal opioids are present in both gender  and in all age groups. 
Approximately half the cases were found in combination, with alcohol, benzodiazepines 
and THC and/or THCCOOH being the most common findings. 
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Table 62. Prevalence of use – Medicinal opioids: detail on gender and age groups 
Prevalence of use - Percentage of drivers tested positive for MEDICINAL OPIOIDS 
Among subjects of the same age group 
MALE 18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
male 
subjects 
Belgium 2.0 6.7 0.0 2.2 12.5 3.4 
Denmark 0.5 2.1 7.2 6.7 0.0 3.5 
Finland 0.0 0.0 12.5 0.0 N.A. 2.6 
Italy 4.0 3.7 4.7 0.9 N.A. 3.5 
Lithuania 10.6 7.7 7.6 14.3 16.7 10.1 
The 
Netherlands 0.0 0.0 2.9 0.0 N.A. 0.7 
Among subjects of the same age group 
FEMALE 
18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
female 
subjects 
Belgium 0.0 3.8 6.9 0.0 0.0 3.1 
Denmark 0.0 7.9 8.0 5.4 20.0 5.5 
Finland 0.0 0.0 0.0 16.7 N.A. 9.1 
Italy 0.0 8.5 5.5 0.0 N.A. 4.5 
Lithuania 0.0 4.9 7.9 0.0 0.0 3.7 
The 
Netherlands 0.0 0.0 0.0 0.0 N.A. 0.0 
Among subjects of the same age group UNKNOWN 
GENDER 18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
subjects of 
unknown 
gender 
Belgium N.A. N.A. N.A. N.A. 0.0 0.0 
Lithuania 0.0 0.0 N.A. 0.0 12.5 7.7 
 
 
 
Figure 53. Prevalence of use – Medicinal opioids: male drivers 
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Figure 54. Prevalence of use – Medicinal opioids: female drivers 
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3.6 Prevalence of substance groups use among killed drivers 
 
3.6.1 Killed drivers – Prevalence of use – Alcohol ≥ 0.1 g/L 
Table 63. Prevalence of use – Alcohol 
KILLED DRIVERS FI (471) NO (193) PT (285) SE (153) 
Percentage of subjects 
positive for alcohol 31.4 25.4 44.9 19.0 
 
 
Figure 55. Prevalence of use – Alcohol: detail of toxicological findings 
 
In the killed drivers alcohol (cut-off= 0.1 g/L) was generally found in percentages relatively 
similar to the ones observed among seriously injured drivers. Portugal had the highest 
percentage of positive findings (approximately 45%). Finland had the second highest 
percentage with a prevalence of 31.4, relatively similar to the one recorded in the 
seriously injured drivers. 
 
More positive subjects were found in the male group compared to the females in all 
countries. Apart from Portugal, for which the trend appears to be opposite in the female 
group, the percentage of positive findings tends to drop in the older age group (50 and 
above). It has however to be noted that the number of female subjects was relatively low 
for all countries and a single positive subject in a single age group could lead to high 
percentage. 
 
When found in combination, alcohol is normally associated with benzodiazepines and/or 
THC/THCCOOH. 
 
It has to be noted that, due to post-mortem bacterial and fungal activity, alcohol may be 
both produced and consumed in a body, and the possibility that toxicological findings may 
have been partially affected by these phenomena cannot be completely excluded.  
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Table 64. Prevalence of use – Alcohol: detail on gender and age groups 
Prevalence of use - Percentage of subjects positive for ALCOHOL 
Among subjects of the same age group 
MALE 18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
male 
subjects 
Finland 51.0 45.3 42.0 15.3 N.A. 34.4 
Norway 37.5 34.5 34.5 13.0 N.A. 28.9 
Portugal 43.9 58.5 63.8 28.9 14.3 47.2 
Sweden 26.7 35.7 22.7 14.0 N.A. 21.6 
Among subjects of the same age group 
FEMALE 
18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
female 
subjects 
Finland 12.5 30.0 35.5 3.0 N.A. 18.9 
Norway 12.5 12.5 23.1 0.0 N.A. 12.2 
Portugal 0.0 16.7 12.5 50.0 N.A. 15.0 
Sweden 75.0 25.0 0.0 0.0 N.A. 10.8 
 
 
 
Figure 56. Prevalence of use – Alcohol: male drivers 
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Figure 57. Prevalence of use – Alcohol: female drivers 
 
3.6.2 Killed drivers – Prevalence of use – Alcohol (≥0.5 g/L) 
Table 65. Prevalence of use- alcohol (≥0.5 g/L) 
KILLED DRIVERS FI (471) NO (193) PT (285) SE (153) 
Percentage of subjects tested 
positive for alcohol 29.3 23.8 35.1 16.3 
 
 
 
Figure 58. Prevalence of use – alcohol (≥0.5 g/L) 
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In the four countries participating in the killed drivers study, the percentage of positive 
drivers in which alcohol (cut-off ≥0.5 g/L) was found ranged between approximately 16 
and 35. The percentage of drivers in which alcohol was found between 0.1 g/L-0.49 g/L 
ranged approximately between 1.5 and 10. Most positive drivers (alcohol ≥0.5 g/L) were 
found in Portugal (35.1%). 
 
3.6.3 Killed drivers – Prevalence of use – Amphetamines 
Table 66. Prevalence of use – Amphetamines 
KILLED DRIVERS FI (466) NO (176) PT (285) SE (152) 
Percentage of subjects 
positive for amphetamines 2.1 7.4 0.0 6.6 
 
 
Figure 59. Prevalence of use – Amphetamines: detail of toxicological findings 
In the killed drivers study subjects positive for the amphetamine group were found in all 
countries apart from Portugal. The highest percentage was found in Norway, which is 
also the only country that had one subject positive for amphetamines in the female group. 
In the male group the percentage of positive findings was relatively similar in Norway and 
Sweden. 
 
Four subjects in the age group 50 and over that tested positive for the amphetamine 
group, three being positive for amphetamine, alone or combined with methadone and 
alcohol respectively, and one being positive for methamphetamine only.  
 
In general amphetamines appear to be used with other drugs, being more often in 
combination with benzodiazepines and alcohol. 
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Table 67. Prevalence of use – Amphetamines: detail on gender and age groups 
Prevalence of use - Percentage of subjects positive for AMPHETAMINES 
Among subjects of the same age group 
MALE 18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
male 
subjects 
Finland 4.1 1.6 5.8 0.7 N.A. 2.7 
Norway 8.9 14.3 15.4 0.0 N.A. 8.5 
Portugal 0.0 0.0 0.0 0.0 0.0 0.0 
Sweden 6.9 21.4 8.7 6.0 N.A. 8.6 
Among subjects of the same age group 
FEMALE 
18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
female 
subjects 
Finland 0.0 0.0 0.0 0.0 N.A. 0.0 
Norway 0.0 0.0 8.3 0.0 N.A. 2.9 
Portugal 0.0 0.0 0.0 0.0 N.A. 0.0 
Sweden 0.0 0.0 0.0 0.0 N.A. 0.0 
 
 
 
Figure 60. Prevalence of use – Amphetamines: male drivers 
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Figure 61. Prevalence of use – Amphetamines: female drivers 
 
3.6.4 Killed drivers – Prevalence of use – Benzoylecgonine 
As for the seriously injured drivers, data about benzoylecgonine and cocaine are 
presented in separate tables and graphs, because of the substance groups classification. 
However, as already mentioned, for a whole picture of the use of cocaine among the 
sampled sub-populations, the two sets of data should be considered together. 
 
Table 68. Prevalence of use – Benzoylecgonine  
KILLED DRIVERS FI (466) NO (171) PT (285) SE (152) 
Percentage of subjects 
positive for benzoylecgonine 
(but negative for cocaine) 
0.0 0.6 0.7 0.7 
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Figure 62. Prevalence of use – Benzoylecgonine: detail of toxicological findings 
 
The number of cases positive for benzoylecgonine (without the presence of cocaine) is 
relatively low in the killed drivers subpopulations, with no positive findings in Finland. In 
the other three countries a total of four drivers tested positive for benzoylecgonine, with 
only one positive subject found both in Norway and Sweden and two in Portugal. All were 
males and part of either the age group 25-34 or 35-49. 
 
Benzoylecgonine is always found in combination with other psychoactive substances, 
and in particular with alcohol in three cases and with amphetamines in one case. 
 
Table 69. Prevalence of use – Benzoylecgonine: detail on gender and age groups 
Prevalence of use - Percentage of drivers tested positive for BENZOYLECGONINE (without 
cocaine) 
Among subjects of the same age group 
MALE 18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
male 
subjects 
Finland 0.0 0.0 0.0 0.0 N.A. 0.0 
Norway 0.0 3.4 0.0 0.0 N.A. 0.7 
Portugal 0.0 1.5 1.4 0.0 0.0 0.8 
Sweden 0.0 7.1 0.0 0.0 N.A. 0.9 
Among subjects of the same age group 
FEMALE 
18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
female 
subjects 
Finland 0.0 0.0 0.0 0.0 N.A. 0.0 
Norway 0.0 0.0 0.0 0.0 N.A. 0.0 
Portugal 0.0 0.0 0.0 0.0 N.A. 0.0 
Sweden 0.0 0.0 0.0 0.0 N.A. 0.0 
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Figure 63. Prevalence of use – Benzoylecgonine: male drivers 
 
3.6.5 Killed drivers – Prevalence of use – Cocaine 
Table 70. Prevalence of use – Cocaine 
KILLED DRIVERS FI (466) NO (179) PT (285) SE (152) 
Percentage of subjects 
positive for cocaine 0.0 0.0 0.7 0.7 
 
 
Figure 64. Prevalence of use – Cocaine: detail of toxicological findings 
 
The number of positive findings for cocaine (alone or in the presence of benzoylecgonine) 
in the killed drivers subpopulations is small as in the case of benzoylecgonine. No driver 
tested positive for cocaine in Finland and Norway. Of the 3 positive subjects, two were 
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found in Portugal and one in Sweden. All were male, one being of the age group 18-24 
and two of the age group 25-34. 
 
As for benzoylecgonine, all findings for cocaine are in association, and all in association 
with alcohol. 
 
Table 71. Prevalence of use – Cocaine: detail on gender and age groups 
Prevalence of use - Percentage of drivers tested positive for COCAINE 
Among subjects of the same age group 
MALE 18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
male 
subjects 
Finland 0.0 0.0 0.0 0.0 N.A. 0.0 
Norway 0.0 0.0 0.0 0.0 N.A. 0.0 
Portugal 2.4 1.5 0.0 0.0 0.0 0.8 
Sweden 0.0 7.1 0.0 0.0 N.A. 0.9 
Among subjects of the same age group 
FEMALE 
18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
female 
subjects 
Finland 0.0 0.0 0.0 0.0 N.A. 0.0 
Norway 0.0 0.0 0.0 0.0 N.A. 0.0 
Portugal 0.0 0.0 0.0 0.0 N.A. 0.0 
Sweden 0.0 0.0 0.0 0.0 N.A. 0.0 
 
 
 
Figure 65. Prevalence of use – Cocaine: male drivers 
 
3.6.6 Killed drivers – Prevalence of use – Cocaine and/or benzoylecgonine 
When combined, data for cocaine and benzoylecgonine in the killed driver study show the 
highest percentage of positive cases in Portugal and Sweden. Only male subjects were 
found positive for cocaine and/or benzoylecgonine. As in the seriously injured drivers 
study, also in the killed drivers study no cases of cocaine/benzoyleconine were recorded 
in Finland. 
All subjects positive for cocaine and/or benzoylecgonine tested positive also for another 
substance group, ethanol being the most commonly associated finding. 
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Table 72. Prevalence of use – Cocaine and/or benzoylecgonine 
KILLED DRIVERS FI (466) NO (171) PT (285) SE (152) 
Percentage of subjects 
tested positive for cocaine 
and/or benzoylecgonine 
0.0 0.6 1.4 1.3 
 
 
Figure 66. Prevalence of use – Cocaine and/or benzoylecgonine 
 
Table 73. Prevalence of use – Cocaine and/or Benzoylecgonine : detail on gender and age 
groups 
Prevalence of use - Percentage of drivers tested positive for COCAINE and/or 
Benzoylecgonine 
Among subjects of the same age group 
MALE 
18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
male 
subjects 
Finland 0.0 0.0 0.0 0.0 N.A. 0.0 
Norway 0.0 3.4 0.0 0.0 N.A. 0.7 
Portugal 2.4 3.1 1.4 0.0 0.0 1.5 
Sweden 0.0 14.3 0.0 0.0 N.A. 1.7 
Among subjects of the same age group 
FEMALE 
18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
female 
subjects 
Finland 0.0 0.0 0.0 0.0 N.A. 0.0 
Norway 0.0 0.0 0.0 0.0 N.A. 0.0 
Portugal 0.0 0.0 0.0 0.0 N.A. 0.0 
Sweden 0.0 0.0 0.0 0.0 N.A. 0.0 
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Figure 67. Prevalence of use – Cocaine and/or Benzoylecgonine : Male drivers 
 
 
3.6.7 Killed drivers – Prevalence of use – THCCOOH 
As already reported for the seriously injured drivers study, data about THCCOOH and 
THC are presented in separate tables and graphs, because of the substance groups 
classification. However, for a whole picture of the use of cannabis among the sampled 
subpopulations, the two sets of data should be considered together, being THCCOOH 
the break down product of THC in the body. 
 
As Finland and Norway did not analyse for the presence of THCCOOH, prevalence of 
cannabis use in this countries might have been underestimated. 
 
Table 74. Prevalence of use – THCCOOH 
KILLED DRIVERS FI (0) NO (0) PT (285) SE (147) 
Percentage of subjects 
positive for THCCOOH (but 
negative for THC) 
N.A. N.A. 4.2 0.0 
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Figure 68. Prevalence of use – THCCOOH: detail of toxicological findings 
 
Subjects positive for THCCOOH (without the presence of THC) were found in Portugal 
only. All positive drivers were found in the male group, with percentages that decrease as 
age increases. More than three quarters of the subjects tested positive also for another 
psychoactive substance, alcohol being the most common associated finding. 
 
Table 75. Prevalence of use – THCCOOH: detail on gender and age groups 
Prevalence of use - Percentage of drivers tested positive for THCCOOH (without THC)
Among subjects of the same age group 
MALE 18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
male 
subjects 
Finland N.A. N.A. N.A. N.A. N.A. N.A. 
Norway N.A. N.A. N.A. N.A. N.A. N.A. 
Portugal 9.8 7.7 2.9 1.2 0.0 4.5 
Sweden 0.0 0.0 0.0 0.0 N.A. 0.0 
Among subjects of the same age group 
FEMALE 18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
female 
subjects 
Finland N.A. N.A. N.A. N.A. N.A. N.A. 
Norway N.A. N.A. N.A. N.A. N.A. N.A. 
Portugal 0.0 0.0 0.0 0.0 N.A. 0.0 
Sweden 0.0 0.0 0.0 0.0 N.A. 0.0 
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Figure 69. Prevalence of use – THCCOOH: male drivers 
 
3.6.8 Killed drivers – Prevalence of use – THC 
Table 76. Prevalence of use – THC 
KILLED DRIVERS FI (466) NO (179) PT (285) SE (152) 
Percentage of subjects 
positive for THC 1.3 6.1 0.0 1.3 
 
 
Figure 70. Prevalence of use – THC: detail of toxicological findings 
Subjects positive for THC (alone or in the presence of THCCOOH) were found only in the 
male groups and only in the first three age groups up to 49 years. While there were no 
positive findings in Portugal, the highest percentage of positive cases was found in 
Norway. Sweden and Finland show a similar percentage (1.3% on the whole population).  
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In the majority of cases subjects positive for THC tested also positive for other 
psychoactive substances, alcohol, benzodiazepines and amphetamines being the most 
common associated findings. 
 
Table 77. Prevalence of use – THC: detail on gender and age groups 
Prevalence of use - Percentage of drivers tested positive for THC 
Among subjects of the same age group 
MALE 18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
male 
subjects 
Finland 1.0 1.6 5.8 0.0 N.A. 1.6 
Norway 11.1 13.8 8.0 0.0 N.A. 7.7 
Portugal 0.0 0.0 0.0 0.0 0.0 0.0 
Sweden 3.4 0.0 4.3 0.0 N.A. 1.7 
Among subjects of the same age group 
FEMALE 18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
female 
subjects 
Finland 0.0 0.0 0.0 0.0 N.A. 0.0 
Norway 0.0 0.0 0.0 0.0 N.A. 0.0 
Portugal 0.0 0.0 0.0 0.0 N.A. 0.0 
Sweden 0.0 0.0 0.0 0.0 N.A. 0.0 
 
 
 
Figure 71. Prevalence of use – THC: male drivers 
 
 
3.6.9 Killed drivers – Prevalence of use – THC and/or THCCOOH 
In the killed drivers study, data on the prevalence of use of cannabis are partial for 
Finland and Norway, the samples not having been analysed for the presence of 
THCCOOH. 
 
In general, however, Norway had the highest percentage of positive findings. In all four 
countries THC and/or THCCOOH were detected only in the male group, with only one 
case, positive for THCCOOH only, in the age group 50 and above, recorded in Portugal. 
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Cannabis use appears to be more often in combination with other psychoactive 
substances, with alcohol and benzodiazepines being the most commonly associated 
findings. 
Table 78. Prevalence of use - THC and/or THCCOOH 
KILLED DRIVERS FI (466) NO (179) PT (285) SE (147) 
Percentage of subjects 
tested positive for THC 
and/or THCCOOH 
1.3 6.1 4.2 1.4 
 
 
Figure 72. Prevalence of use - THC and/or THCCOOH 
 
Table 79. Prevalence of use – THC and/or THCCOOH : detail gender and age groups 
Prevalence of use - Percentage of drivers tested positive for THC and/or THCCOOH
Among subjects of the same age group 
MALE 
18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
male 
subjects 
Finland 1.0 1.6 5.8 0.0 N.A. 1.6 
Norway 11.1 13.8 8.0 0.0 N.A. 7.7 
Portugal 9.8 7.7 2.9 1.2 0.0 4.5 
Sweden 3.7 0.0 4.5 0.0 N.A. 1.8 
Among subjects of the same age group 
FEMALE 
18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
female 
subjects 
Finland 0.0 0.0 0.0 0.0 N.A. 0.0 
Norway 0.0 0.0 0.0 0.0 N.A. 0.0 
Portugal 0.0 0.0 0.0 0.0 N.A. 0.0 
Sweden 0.0 0.0 0.0 0.0 N.A. 0.0 
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Figure 73. Prevalence of use – THC and/or THCCOOH : Male drivers 
 
3.6.10 Killed drivers – Prevalence of use – Illicit opiates 
Table 80. Prevalence of use – Illicit opiates 
KILLED DRIVERS FI (466) NO (179) PT (285) SE (152) 
Percentage of subjects 
positive for illicit opiates 0.0 0.0 0.0 0.0 
 
No cases of illicit opiates use were recorded in the killed drivers subpopulations of the 
four countries participating in the study. 
 
 
3.6.11 Killed drivers – Prevalence of use – Benzodiazepines 
Table 81. Prevalence of use – Benzodiazepines 
KILLED DRIVERS FI (466) NO (176) PT (285) SE (154) 
Percentage of subjects 
positive for benzodiazepines 13.3 9.7 1.8 3.9 
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Figure 74. Prevalence of use – Benzodiazepines: detail of toxicological findings 
 
As in the seriously injured drivers study, among the subpopulations of killed drivers, 
Finland had the highest percentage of subjects positive for benzodiazepines, followed by 
Norway and Sweden. In Portugal only 1.8% of the sampled subpopulation tested positive 
for benzodiazepines. In the male group the highest percentage of positive findings were 
recorded in the age groups 25-34 and 35-49. In Portugal and Sweden no subject tested 
positive for benzodiazepines in the female group. In Finland and Norway the highest 
percentage of female positive for benzodiazepines were recorded in the age group 50 
and over.  
 
It has however to be noted that, because of the low number of female subjects (17%) the 
results should be interpreted cautiously .  
 
Benzodiazepines are more often found in association with other psychoactive substances 
than alone, the most common associated findings being alcohol, amphetamines, THC 
and/or THCCOOH and Z-drugs. 
 
Table 82. Prevalence of use – Benzodiazepines: detail on gender and age groups 
Prevalence of use - Percentage of drivers tested positive for BENZODIAZEPINES 
Among subjects of the same age group 
MALE 18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
male 
subjects 
Finland 3.1 21.9 23.2 11.6 N.A. 13.3 
Norway 4.5 23.1 19.2 2.4 N.A. 10.1 
Portugal 0.0 3.1 2.9 1.2 0.0 1.9 
Sweden 3.3 14.3 4.3 3.9 N.A. 5.1 
Among subjects of the same age group 
FEMALE 18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
female 
subjects 
Finland 12.5 0.0 15.6 16.1 N.A. 13.5 
Norway 12.5 0.0 0.0 20.0 N.A. 7.9 
Portugal 0.0 0.0 0.0 0.0 N.A. 0.0 
Sweden 0.0 0.0 0.0 0.0 N.A. 0.0 
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Figure 75. Prevalence of use – Benzodiazepines: male drivers 
 
 
Figure 76. Prevalence of use – Benzodiazepines: female drivers 
 
3.6.12 Killed drivers – Prevalence of use – Z-drugs 
Table 83. Prevalence of use – Z-drugs 
KILLED DRIVERS FI (466) NO (182) PT (285) SE (154) 
Percentage of subjects 
positive for Z-drugs 3.0 4.4 0.0 3.2 
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Figure 77. Prevalence of use – Z-drugs: detail of toxicological findings 
 
The highest percentage of subjects positive for Z-drugs was found in Norway, followed by 
Sweden and Finland. No subject tested positive in Portugal. Percentage of positives 
appeared to be generally higher in the older age groups (35-49 and 50 and above). In 
approximately half of the cases Z-drugs were found in combination with other 
substances, benzodiazepines and alcohol being the most commonly associated findings. 
 
Table 84. Prevalence of use – Z-drugs: detail on gender and age groups 
Prevalence of use - Percentage of drivers tested positive for Z-DRUGS 
Among subjects of the same age group 
MALE 18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
male 
subjects 
Finland 1.0 1.6 1.4 7.5 N.A. 3.7 
Norway 0.0 0.0 7.4 6.8 N.A. 3.5 
Portugal 0.0 0.0 0.0 0.0 0.0 0.0 
Sweden 0.0 0.0 4.3 5.9 N.A. 3.4 
Among subjects of the same age group 
FEMALE 
18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
female 
subjects 
Finland 0.0 0.0 0.0 0.0 N.A. 0.0 
Norway 12.5 0.0 0.0 20.0 N.A. 7.9 
Portugal 0.0 0.0 0.0 0.0 N.A. 0.0 
Sweden 0.0 0.0 9.1 0.0 N.A. 2.8 
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Figure 78. Prevalence of use – Z-drugs: male drivers 
 
 
Figure 79. Prevalence of use – Z-drugs: female drivers 
 
3.6.13 Killed drivers – Prevalence of use – Medicinal opioids 
Table 85. Prevalence of use – Medicinal opioids 
KILLED DRIVERS FI (466) NO (177) PT (252) SE (146) 
Percentage of subjects 
positive for medicinal opioids 2.1 1.7 2.1 4.1 
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Figure 80. Prevalence of use – Medicinal opioids: detail of toxicological findings 
 
The highest percentage of subjects positive for medicinal opioids was recorded in 
Sweden. This is approximately double of when compared to the ones recorded in the 
other countries. With different patterns in the 4 countries, subjects positive for medicinal 
opioids were present in both gender and in all age groups, with higher percentages in the 
male group aged 50 and over. Apart from Finland, where the majority of the cases of 
medicinal opioids appeared alone, in the other three countries medicinal opioids 
appeared in higher percentage in combination with other psychoactive substances, 
benzodiazepines and alcohol being the most commonly associated findings. 
 
Table 86. Prevalence of use – Medicinal opioids: detail on gender and age groups 
Prevalence of use - Percentage of drivers tested positive for MEDICINAL OPIOIDS 
Among subjects of the same age group 
MALE 18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
male 
subjects 
Finland 1.0 0.0 4.3 3.4 N.A. 2.4 
Norway 0.0 0.0 0.0 2.4 N.A. 0.7 
Portugal 0.0 6.2 1.4 1.2 0.0 2.3 
Sweden 0.0 7.7 0.0 8.3 N.A. 4.5 
Among subjects of the same age group 
FEMALE 18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
female 
subjects 
Finland 0.0 0.0 0.0 3.2 N.A. 1.1 
Norway 12.5 0.0 8.3 0.0 N.A. 5.4 
Portugal 0.0 0.0 0.0 0.0 N.A. 0.0 
Sweden 0.0 25.0 0.0 0.0 N.A. 2.9 
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Figure 81. Prevalence of use – Medicinal opioids: male drivers 
 
 
Figure 82. Prevalence of use – Medicinal opioids: female drivers 
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3.7 Seriously injured drivers – Distribution of positive drivers – 
Mutually exclusive groups 
 
3.7.1 Distribution of positive drivers 
Table 87. Seriously injured drivers – Distribution of positive drivers 
MUTUALLY EXCLUSIVE GROUPS 
Toxicological finding BE DK FI IT LT NL 
Negative 47.4 69.7 55.3 68.0 72.2 66.1 
Positive 52.6 30.3 44.7 32.0 27.8 33.9 
 
In the mutually exclusive groups, the highest percentage of positive drivers was found in 
Belgium, followed by Finland. In the other four countries participating in the seriously 
injured drivers study, the percentage of positive drivers is approximately in the range of 
30%, Lithuania being the country with the lowest percentage (27.8). In Belgium, more 
than half of the drivers were positive. 
 
3.7.2 Distribution of positive drivers by age and gender 
The distribution by gender and age showed a higher percentage of positive drivers 
among the male group in all six countries. This happened almost in all age groups, with 
the exception of Finland, for which a higher percentage of positive subjects was present 
in the female group aged 18-24 compared to the same male group, and Lithuania, for 
which a slightly higher percentage of positive drivers was found in the female group aged 
35-49 compared to the same male group. 
 
The male group aged 25-34 was the one with the highest percentage of drivers testing 
positive for alcohol or drugs. This was the case of all the countries apart from Lithuania, 
where the highest percentage of positive male drivers was found in the age group 50 and 
above. With the exception of Lithuania, the percentage of positive drivers tend to 
decrease with increasing age in the age groups 35-49 and 50 and over. 
In the female groups, the percentage of subjects positive for one of the mutually exclusive 
groups tended to fluctuate more across different age groups and in different countries. In 
Finland, female subjects testing positive for one of the mutually exclusive groups were 
found only in the age group 18-24. 
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Table 88. Seriously injured drivers – Distribution of positive drivers by age and gender 
Mutually exclusive group - Percentage of positive drivers 
Among subjects of the same age group 
MALE 18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
male 
subjects 
Belgium 61.2 66.2 60.0 40.9 75.0 59.3 
Denmark 33.5 47.1 39.2 31.5 100.0 38.1 
Finland 50.0 60.0 57.1 37.5 N.A. 51.4 
Italy 38.0 42.2 34.9 19.1 N.A. 34.4 
Lithuania 33.3 32.7 28.8 35.7 33.3 32.4 
The 
Netherlands 32.0 59.0 35.3 26.9 N.A. 38.9 
Among subjects of the same age group 
FEMALE 
18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
female 
subjects 
Belgium 35.3 26.9 48.1 30.0 75.0 37.2 
Denmark 6.3 23.8 14.9 19.6 40.0 15.8 
Finland 66.7 0.0 0.0 0.0 N.A. 20.0 
Italy 19.2 34.0 18.2 21.4 N.A. 23.7 
Lithuania 25.0 19.5 28.9 0.0 0.0 20.9 
The 
Netherlands 0.0 25.0 9.1 11.1 N.A. 13.5 
Among subjects of the same age group UNKNOWN 
GENDER 18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
subjects of 
unknown 
gender 
Belgium N.A. N.A. N.A. N.A. 0.0 0.0 
Lithuania 0.0 0.0 N.A. 0.0 25.0 15.4 
 
 
 
Figure 83. Mutually exclusive groups – Percentage of positive drivers: male 
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Figure 84. Mutually exclusive groups – Percentage of positive drivers: female 
 
3.7.3 Distribution of positive drivers by substance groups 
 
Table 89. Seriously injured drivers – Distribution of positive drivers by substance groups 
MUTUALLY EXCLUSIVE GROUPS - Distribution of drivers by substance groups 
Toxicological finding BE DK FI IT LT NL 
Negative 47.4 69.7 55.3 68.0 72.2 66.1 
Alcohol only 30.2 14.1 25.5 18.5 15.3 25.3 
Amphetamine only 0.9 1.0 0.0 0.0 0.3 1.1 
Benzoylecgonine only (Cocaine/1) 0.0 0.0 0.0 0.7 0.3 1.1 
Cocaine (Cocaine/2) 0.0 0.0 0.0 0.6 0.3 0.0 
THCCOOH only (Cannabis/1) 0.6 1.6 0.0 0.4 0.3 0.0 
THC (Cannabis/2) 1.5 0.6 2.1 1.6 0.3 0.5 
Illicit opiates only 0.0 0.0 0.0 0.7 0.0 0.0 
Benzodiazepines only 1.5 1.2 0.0 0.4 2.3 0.0 
Z-drugs only 0.9 0.5 2.1 0.0 0.0 0.5 
Medicinal opioids only 1.2 2.5 0.0 1.8 5.7 0.5 
Alcohol + drug combination 13.2 5.4 10.6 4.6 2.3 4.3 
Drug + drug combination 2.5 3.5 4.3 2.5 0.8 0.5 
Total  100.0 100.0 100.0 100.0 100.0 100.0 
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Figure 85. Seriously injured drivers – Distribution of positive drivers by substance groups 
 
In the distribution of positive drivers by substance groups, subjects testing positive for 
“alcohol only” represent the largest group across all six countries. The group of subjects 
testing positive for an “alcohol-drug” combination is the second most represented in all 
countries apart from Lithuania, where a higher percentage of subjects is found in the 
“medicinal opioids” group. The group “drug-drug” represent either the third (Belgium, 
Denmark, Finland, Italy) or the fourth (Lithuania, The Netherlands) biggest group for 
percentage of positive subjects. 
 
3.7.4 Distribution of positive drivers by amount of different substance groups 
taken 
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Figure 86. Seriously injured drivers - General distribution by number of drug groups taken 
In general of the drivers tested positive for one or more substances, 75.7% used a single 
drug and 17.8% tested positive for 2 substance groups. In this distribution ‘drug group’ is 
defined as the  substance groups classified in table 14 (2.3 data analysis) with cases 
positive for alcohol also categorized as a drug-positive. 
 
Table 90. Seriously injured drivers – Distribution by country of number of different drug 
groups taken  
Country Drug 
groups Belgium Denmark Finland Italy Lithuania The 
Netherland
s 
1  120(69.8%) 178 (70.6%) 14 (66.7%) 168 (77.8%) 95 (88.8%) 54 (85.7%) 
2  40 (23.3%) 43 (17.1%) 6 (28.6%) 40 (18.5%) 11 (10.3%) 8 (1.3%) 
3 10 (5.8%) 21 (8.3%) 1 (4.8%) 8 (3.7%) 1 (0.9%) 1 (1.6%) 
4 2 (1.2%) 9 (3.6%) 0 0 0 0 
5 0  1 (0.4%) 0 0 0 0 
Total 172(100%) 252 (100%) 21 (100%) 216(100%) 107 (100%) 63(100%) 
 
Only one Danish person was found to have taken a combination of 5 substances. 
Combinations up to 3 different substance groups are seen in all countries involved in the 
seriously injured driver study. Only Belgium and Denmark had subjects tested positive for 
4 different substance groups. 
Because of the low number in some of the variables, a chi-square test could only be 
calculated for the first two categories, and disregarding the Finnish data. A significant 
difference was found between the countries for these substance group combinations 
(p=0.03). The single drug use was found in a higher percentage in Lithuania and the 
Netherlands, resulting also in a lower percentage of substance group combinations in 
these countries.  
 
 
3.7.5 Distribution of substance groups by gender and age 
 
Detailed distribution of substance groups by gender and age for each single country can 
be found in annex in the form of tables. Main findings have been summarised here below. 
Only for the “alcohol only”, “alcohol-drug” and “drug-drug” groups data are presented 
herein in the form of table and/or graphs, which show the pattern of positive subjects in 
the male and female drivers by age groups. 
 
The distribution of drivers positive for alcohol only shows a higher percentage among 
the male group in all countries. This happens for all age categories with the exception of 
Finland where the female group aged 18-24 shows a higher percentage of positive 
drivers compared to the one found in the same male age group. This is probably due to 
the small numbers of drivers included in the female group. 
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Table 91. Seriously injured drivers – Distribution of positive drivers – Alcohol only 
Mutually exclusive group – Percentage of drivers positive for ALCOHOL ONLY  
Among subjects of the same age group 
MALE 18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
male 
subjects 
Belgium 32.7 37.8 41.8 27.3 12.5 34.6 
Denmark 17.8 24.3 19.2 14.6 100.0 19.4 
Finland 41.7 10.0 42.9 12.5 N.A. 27.0 
Italy 21.0 23.0 17.4 17.3 N.A. 19.8 
Lithuania 22.7 17.3 13.6 11.9 16.7 16.8 
The 
Netherlands 26.0 41.0 26.5 23.1 N.A. 29.5 
Among subjects of the same age group 
FEMALE 
18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
female 
subjects 
Belgium 17.6 19.2 22.2 15.0 25.0 19.1 
Denmark 1.3 7.9 2.3 7.1 0.0 4.1 
Finland 66.7 0.0 0.0 0.0 N.A. 20.0 
Italy 19.2 14.9 12.7 10.7 N.A. 14.1 
Lithuania 22.2 9.8 18.4 0.0 0.0 14.2 
The 
Netherlands 0.0 8.3 9.1 11.1 N.A. 8.1 
Among subjects of the same age group UNKNOWN 
GENDER 18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
subjects of 
unknown 
gender 
Belgium N.A. N.A. N.A. N.A. 0.0 0.0 
Lithuania 0.0 0.0 N.A. 0.0 0.0 0.0 
 
Few subjects tested positive for amphetamines only. In the male subgroup the highest 
percentage of positive findings was in Denmark (1.3%) followed by Belgium, The 
Netherlands and Lithuania (0.4%). In the female group positive subjects wer found in The 
Netherlands (2.7%), Belgium and Denmark (0.3%) only. No positive findings in both 
gender groups were recorded in Finland and Italy (Table 114, annex 2). 
Among males, the highest prevalence for the benzoylecgonine only group was found in 
the Netherlands (1.3%), while no positive findings were recorded in Belgium, Denmark 
and Finland. For the female group only Italy had positive findings (0.6%). (Table 115,  
annex 2) 
Regarding the distribution of the cocaine only group no positive drivers were found in the 
female subgroup. For the male group “cocaine only” was found in Italy in the age group 
25-34 (0.6%) and 35-49 (2.0) and in Lithuania in the age group 50 and over (2.4%). The 
highest prevalence among all male subjects was found in Italy (0.8%) (Table 116, annex 
2). 
Positive findings for THCCOOH only in the male group and in all age group were found 
in Denmark (2.0%) and Belgium (0.9%). In the female group positive cases for  
THCCOOH  were found only in Denmark (0.7%). (Table 117, annex 2). 
For the THC only (with or without THCCOOH) group there were positive cases in the 
male group in all countries with the highest prevalence found in Finland (2.7%) followed 
by Italy (1.9%) and Belgium (1.7%). All countries had positive findings. In the female 
group positive cases were only recorded in Belgium (1.1%), in Italy (0.6%) and Denmark 
(0.3%). There were no positive findings for Finland, Lithuania and The Netherlands in the 
female group (Table 118,  annex 2). 
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Only Italy had drivers that tested positive for illicit opiates only, with 0.8% of positive 
cases among male and 0.6% among female. (Table 119 in annex 2). 
For the benzodiazepines only group, the highest percentage in the male group was 
found in Lithuania (2.5%). Belgium and Denmark were the only two other countries in 
which male subjects tested positive for benzodiazepines only (0.9% in both countries).  In 
the female subpopulations cases positives for benzodiazepines only were recorded in 
four countries: Belgium (3.2%), Lithuania (2.2%), Italy (1.9%) and Denmark (1.7%). 
(Table 120, annex 2). 
For the Z-drug only group positive male subjects were found only in Finland (2.7%), the 
Netherlands (0.7%) and Denmark (0.7%), while in the female group there were positive 
findings only in Belgium (3.2%) and Denmark (0.7%). (Table 121, annex 2). 
Apart from Finland, all countries had positive findings for medicinal opioids only in the 
male group. The highest prevalence was recorded in Lithuania (7.6%). Finland and The 
Netherlands had no positive findings for medicinal opioids only in the female group. In the 
other countries the percentage of positives in the female group ranged from 3.4 in 
Denmark to 2.1 in Belgium. (Table 122, annex 2). 
Among all male subjects Belgium had the highest prevalence of drivers positive for 
alcohol-drug combination (16.1%), followed by Finland (13.5%). Also among all female 
subjects Belgium had the highest prevalence of drivers positive for alcohol-drug 
combination (6.4%), followed by Italy (2.6%).  
Table 92. Seriously injured drivers – Distribution of positive drivers – Alcohol-Drug 
combinations 
Mutually exclusive group - Percentage of drivers positive for ALCOHOL-DRUG 
combination 
Among subjects of the same age group 
MALE 18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
male 
subjects 
Belgium 24.5 14.9 14.5 4.5 50.0 16.1 
Denmark 7.0 12.1 6.4 3.4 0.0 7.6 
Finland 0.0 40.0 0.0 12.5 N.A. 13.5 
Italy 3.0 8.1 6.7 0.9 N.A. 5.2 
Lithuania 0.0 3.8 4.5 0.0 8.3 2.5 
The 
Netherlands 6.0 10.3 0.0 0.0 N.A. 4.7 
Among subjects of the same age group 
FEMALE 
18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
female 
subjects 
Belgium 5.9 0.0 11.1 5.0 25.0 6.4 
Denmark 0.0 1.6 2.3 1.8 0.0 1.4 
Finland 0.0 0.0 0.0 0.0 N.A. 0.0 
Italy 0.0 4.3 1.8 3.6 N.A. 2.6 
Lithuania 0.0 2.4 5.3 0.0 0.0 2.2 
The 
Netherlands 0.0 8.3 0.0 0.0 N.A. 2.7 
Among subjects of the same age group UNKNOWN 
GENDER 18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
subjects of 
unknown 
gender 
Belgium N.A. N.A. N.A. N.A. 0.0 0.0 
Lithuania 0.0 0.0 N.A. 0.0 0.0 0.0 
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Figure 87. Mutually exclusive groups – Alcohol-drug combination: male drivers 
 
 
Figure 88. Mutually exclusive groups – Alcohol-drug combination: female drivers 
All countries had drivers testing positive for drug-drug combinations. Finland had the 
highest percentage of drivers positive for drug-drug combinations in the male group 
(5.4% among all males). The Netherlands had the lowest percentage (1.3% among all 
male subjects).  
In the female group only Belgium and Denmark had positive findings for drug-drug 
combinations. The highest prevalence for both countries was found in the age group 25-
34, with a prevalence of 3.8% in Belgium and 4.8% in Denmark. 
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Table 93. Seriously injured drivers – Distribution of positive drivers – Drug-Drug 
combinations 
Mutually exclusive group - Percentage of drivers positive for DRUG-DRUG 
combination 
Among subjects of the same age group 
MALE 18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
male 
subjects 
Belgium 0.0 6.8 1.8 2.3 0.0 3.0 
Denmark 2.7 4.3 6.4 1.1 0.0 3.7 
Finland 0.0 10.0 14.3 0.0 N.A. 5.4 
Italy 6.0 3.7 3.4 0.0 N.A. 3.3 
Lithuania 0.0 1.9 1.5 0.0 8.3 1.3 
The 
Netherlands 0.0 2.6 0.0 0.0 N.A. 0.7 
Among subjects of the same age group 
FEMALE 
18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
female 
subjects 
Belgium 0.0 3.8 0.0 0.0 0.0 1.1 
Denmark 2.5 4.8 2.3 3.6 0.0 3.1 
Finland 0.0 0.0 0.0 0.0 N.A. 0.0 
Italy 0.0 0.0 0.0 0.0 N.A. 0.0 
Lithuania 0.0 0.0 0.0 0.0 0.0 0.0 
The 
Netherlands 0.0 0.0 0.0 0.0 N.A. 0.0 
Among subjects of the same age group UNKNOWN 
GENDER 18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
subjects of 
unknown 
gender 
Belgium N.A. N.A. N.A. N.A. 0.0 0.0 
Lithuania 0.0 0.0 N.A. 0.0 0.0 0.0 
 
 
 
Figure 89. Mutually exclusive groups – Drug-drug combination: male drivers 
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Figure 90. Mutually exclusive groups – Drug-drug combination: female drivers 
 
 
3.7.6 Distribution of positive drivers during DRUID time periods aggregated into 
weekday, weeknight, weekend day and weekend night  
 
Table 94. Seriously injured drivers – Distribution of positive drivers during day/night and 
week/weekends 
Percentage of positive drivers on subjects involved in accidents during the same 
time period 
  Week day Week night Weekend day Weekend night 
Belgium 35.1 65.9 61.1 73.5 
Denmark 24.6 59.5 32.9 52.9 
Finland 15.8 80.0 57.9 75.0 
Italy 20.1 60.6 32.2 48.3 
Lithuania 26.4 18.2 24.7 50.0 
The Netherlands 18.9 41.3 45.5 60.7 
 
Apart from Lithuania, where the lowest percentage of positive subjects was found during 
week nights, in all other countries the lowest percentages of positive drivers was found in 
subjects involved in accidents occurred in a week day. In all countries the peak of positive 
drivers was found at nighttimes, either during the week or during the weekend. In general 
no statistical difference was found between week and weekend nights. 
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Figure 91. Mutually exclusive groups – Percentage of positive drivers during week/weekend 
day/night 
 
3.7.7 Distribution of positive drivers in single-vehicle and multi-vehicle accidents 
 
Figure 92. Mutually exclusive groups – Percentage of positive drivers in single-vehicle and 
multi-vehicle accidents 
Data about type of accident could not be recorded in Italy that therefore does not appear 
in the graph showing the percentage of positive drivers in single- and in multi-vehicle 
accidents. In all the other five countries, the percentage of drivers testing positive for one 
of the mutually exclusive groups is always higher in single-vehicle accidents than in multi-
vehicle accidents, with a ratio of at least 1.5 to 1. 
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Table 95. Injured drivers – Distribution of type of accident by substance group 
Type of accident Substance groups 
  single- vehicle multi-vehicle 
Total 
  negative 424(54.2%) 700(76.9%) 1124 
  amphetamines only 7(0.9%) 6(0.7%) 13 
  benzoylecgonine only 2(0.3%) 1(0.1%) 3 
 THCCOOH only 5(0.6%) 10(1.1%) 15 
  THC only 8(1.0%) 5(0.5%) 13 
  benzodiazepines only 8(1.0%) 16(1.8%) 24 
  z-drugs only 3(0.4%) 4(0.4%) 7 
  medicinal opioids only 16(2.0%) 31(3.4%) 47 
  alcohol only 217(27.7%) 85(9.3%) 302 
  alcohol-drug 27(3.4%) 14(1.5%) 41 
  drug-drug 66(8.4%) 38(4.2%) 104 
Total 783(100%) 910(100%) 1693 
 
More negatives were found in multi-vehicle accidents. Alcohol (alone or in combination), 
THC, benzoylecgonine and drug-drug combination were found more in single vehicle 
accidents. Benzodiazepines, medicinal opioids and THCCOOH were found more in multi-
vehicle collisions. 
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3.8 Killed drivers – Distribution of positive drivers – Mutually 
exclusive groups 
 
3.8.1 Distribution of positive drivers 
Table 96. Killed drivers – Distribution of positive drivers 
MUTUALLY EXCLUSIVE GROUPS - Percentage of negative and positive drivers 
Toxicological finding FI NO PT SE 
Negative 57.7 60.0 52.3 69.5 
Positive 42.3 40.0 47.7 30.5 
 
In the killed driver study the highest percentage of positive drivers was found in Portugal, 
where a bigger proportion of sampled drivers tested positive for alcohol, both in the 
prevalence of use and in the mutually exclusive groups. Finland is the second country for 
drivers testing positive with a percentage relatively similar to the one recorded in the 
seriously injured drivers study (44.7%). The lowest percentage of positive drivers was 
found in Sweden. 
 
3.8.2 Distribution of positive drivers by age and gender 
As in the seriously injured drivers study, also in the killed drivers study the distribution by 
gender and age shows a higher percentage of positive drivers among the male group in 
all countries. This happens in all the first three age groups, up to 49 years, with the 
exception of Sweden, where the female group aged 18-24 shows a higher percentage of 
positive drivers compared to the one found in the same male age group. This is probably 
due to the small number of drivers included in the female group, in which 3 out of 4 
subjects are positive for one of the mutually exclusive groups. 
In the male group, in all countries, subjects aged 50 and over show the smallest 
percentage of positive drivers. 
Once again, in the female groups percentage of positive subjects for one of the mutually 
exclusive groups tends to fluctuate more across different age groups and different 
countries, most likely as a consequence of the very small number of subjects included in 
each group. 
 
Table 97. Killed drivers – Distribution of positive drivers by age and gender 
Mutually exclusive group - Percentage of positive drivers 
Among subjects of the same age group 
MALE 18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
male 
subjects 
Finland 54.6 51.6 54.4 32.4 N.A. 45.6 
Norway 41.5 61.5 57.7 18.9 N.A. 42.3 
Portugal 46.3 66.2 63.8 31.3 14.3 50.2 
Sweden 32.1 61.5 38.1 28.9 N.A. 35.5 
Among subjects of the same age group 
FEMALE 
18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
female 
subjects 
Finland 18.8 30.0 45.2 16.1 N.A. 28.4 
Norway 37.5 12.5 33.3 42.9 N.A. 31.4 
Portugal 0.0 16.7 12.5 50.0 N.A. 15.0 
Sweden 75.0 25.0 10.0 0.0 N.A. 14.7 
 
 DRUID 6th Framework Programme Deliverable D.2.2.5  
 Results - Killed drivers – Distribution of positive drivers – Mutually 
exclusive groups 
Prevalence of alcohol and other psychoactive substances in injured and killed drivers. 
 
 Page 128 of 349 
 
 
Figure 93. Mutually exclusive groups – Percentage of positive drivers: male 
 
 
Figure 94. Mutually exclusive groups – Percentage of positive drivers: female 
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3.8.3 Distribution of positive drivers by substance groups 
Table 98. Killed drivers – Distribution of positive drivers by substance groups 
MUTUALLY EXCLUSIVE GROUPS - Distribution of drivers by substance groups 
Toxicological finding FI NO PT SE 
Negative 57.7 60.0 52.3 69.5 
Alcohol only 24.4 18.2 38.9 15.6 
Amphetamine only 0.7 1.2 0.0 2.1 
Benzoylecgonine only  0.0 0.0 0.0 0.0 
Cocaine  0.0 0.0 0.0 0.0 
THCCOOH only N.A. N.A. 1.1 0.0 
THC  0.0 1.8 0.0 0.7 
Illicit opiates only 0.0 0.0 0.0 0.0 
Benzodiazepines only 5.2 1.8 0.7 0.0 
Z-drugs only 1.7 1.2 0.0 2.8 
Medicinal opioids only 1.5 0.6 0.7 0.7 
Alcohol + drug combination 7.2 7.9 6.0 4.3 
Drug + drug combination 1.5 7.3 0.4 4.3 
Total  100.0 100.0 100.0 100.0 
 
 
 
Figure 95. Killed drivers – Distribution of positive drivers by substance groups 
 
Also in the killed driver study, in the distribution of positive drivers by substance groups, 
subjects who tested positive for “alcohol only” represent the largest group across all 
countries. For all countries the second most prevalent substance group is the one of 
“alcohol-drug combination”. In Sweden the same percentage was found for subjects 
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testing positive for the “alcohol-drug combination” and for the “drug-drug combination”. 
Different patterns were then found in the different countries for the other mutually 
exclusive groups, “benzodiazepines only”, “drug-drug combination”, “THCCOOH only” 
and “Amphetamines” being the third biggest groups in Finland, Norway, Portugal and 
Sweden respectively. 
 
 
 
3.8.4 Distribution of positive drivers by amount of different substance groups 
taken 
 
Figure 96. Killed drivers - General distribution by number of drug groups taken 
In general of the drivers tested positive for one or more substances, 78.7% used a single 
drug and 18.4% tested positive for 2 substance groups. In this distribution ‘drug group’ is 
defined as the  substance groups classified in table 14 (2.3 data analysis) with cases 
positive for alcohol also categorized as a drug-positive. 
 
Table 99. Killed drivers – Distribution by country of number of different drug groups taken  
Country Drug 
groups Finland Norway Portugal Sweden 
1  154 (79.4%) 42 (63.6%) 101 (87.8%) 32 (74.4%) 
2  34 (17.5%) 21 (31.8%) 13 (11.3%) 9 (20.9%) 
3 4 (2.1%) 3 (4.5%) 1 (0.9%) 2 (4.7%) 
4 2 (1.0%) 0  0 0 
Total 194 (100%) 66 (100%) 115 (100%) 43 (100%) 
 
Only two Finnish person was found to have taken a combination of 4 substances. 
Combinations up to 3 different substance groups are seen in all countries involved in the 
killed driver study.  
Because of the low number in some of the variables, a chi-square test could only be 
calculated for the first two categories. A significant difference was found between the 
countries for these substance group combinations (p=0.005). The single drug use was 
found in a lower percentage in Norway, resulting also in a higher percentage of 
substance group combinations in this country.  
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3.8.5 Distribution of substance groups by gender and age 
Detailed distribution of substance groups by gender and age for each single country can 
be found in annex in the form of tables. Main findings have been summarised here below. 
Only for the “alcohol only”, “alcohol-drug” and “drug-drug” groups data are presented 
herein in the form of table and/or graphs, which show the pattern of positive subjects in 
the male and female drivers by age groups. 
 
The highest prevalence of alcohol among all male and female subjects was found in 
Portugal (40.8% and 15.0% in the male and female group resp.), followed by Finland 
(26.3% and 14.8% in the male and female group resp). In Portugal 56.5% of the male 
subgroup aged 35-49 tested positive for alcohol only. In Finland 47.4% of the male 
drivers in the age group 18-24 was positive for alcohol only. 
In Portugal 50% of the female subgroup aged 50 and over tested positive for alcohol only. 
However the female group in Portugal was very small amoung all age categories, and 
percentage should be considered very carefully. In Finland approximately 30% of the 
female subjects aged between 25 and 49 were find positive for alcohol only. 
 
Table 100. Killed drivers – Distribution of positive drivers – Alcohol only 
Mutually exclusive group - Percentage of drivers positive for ALCOHOL ONLY  
Among subjects of the same age group 
MALE 18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
male 
subjects 
Finland 47.4 29.7 26.5 11.3 N.A. 26.7 
Norway 19.5 23.1 30.8 10.8 N.A. 20.0 
Portugal 34.1 47.7 56.5 27.7 14.3 40.8 
Sweden 21.4 23.1 19.0 13.3 N.A. 17.8 
Among subjects of the same age group 
FEMALE 18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
female 
subjects 
Finland 6.3 30.0 29.0 0.0 N.A. 14.8 
Norway 0.0 12.5 25.0 0.0 N.A. 11.4 
Portugal 0.0 16.7 12.5 50.0 N.A. 15.0 
Sweden 75.0 0.0 0.0 0.0 N.A. 8.8 
 
While no positive findings were recorded in Portugal, the highest prevalence of 
amphetamines only in the male group was find in Sweden (2.8%), followed by Norway 
(1.5%) and Finland (0.8%). None of the drivers in the female group tested positive for 
amphetamine only. (Table 123, annex 3) 
No positive cases of benzoylecgonine only and cocaine only were recorded in the 
subpopulations of the four countries participating in the killed driver study. (Table 124-
125, annex 3) 
Finland and Norway did not screen the samples for THCCOOH, therefore no data are 
available for this substance in these two countries. Positive findings for THCCOOH only 
were recorded only in Portugal and only in the male group (1.1%). (Table 126, annex 3) 
 Norway and Sweden were the only two countries with drivers testing positive for THC 
only (with or without THCCOOH). All were in the male group, with the highest prevalence 
found in Norway (2.3%). Positives were only in to the first two age groups. (Table 127, 
annex 3) 
 For the benzodiazepines only group, no positive findings were recorded in Sweden in 
both gender groups and in Portugal in the female group. The highest percentage of 
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positive subjects were detected in Finland both in the male (4.6%) and in the female 
(8.0%) subpopulations. (Table 129, annex 3) 
No cases of Z-drugs only were found in Portugal. In the other countries the highest 
percentage was found in Sweden in the male group (2.8%) followed by Finland (2.2%). 
Female subjects positive for Z-drugs only were recorded in Norway and Sweden (both 
2.9%). (Table 130, annex 3) 
In the male subgroup the highest prevalence of medicinal opioids only was found in 
Finland (1.9%), followed by Sweden (1.9%) and Portugal (0.8%), while no positive 
findings were recorded in Norway. In contrast among all female subjects, positive cases 
were recorded only in Norway (2.9%). (Table 131, annex 3) 
Subjects positive for alcohol-drug combinations were found in  all countries in the male 
subgroups. The highest prevalence was found in Norway (9.2%), followed by Finland 
(7.8%). While in Portugal no female subjects tested positive for a alcohol-drug 
combination in the other countries prevalence ranged from 2.9% (Norway and Sweden) 
to 4.5% (Finland).  
 
Table 101. Killed drivers – Distribution of positive drivers – Alcohol-Drug combinations 
Mutually exclusive group - Percentage of drivers positive for ALCOHOL-DRUG 
combination 
Among subjects of the same age group 
MALE 18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
male 
subjects 
Finland 3.1 15.6 16.2 3.5 N.A. 7.8 
Norway 17.1 15.4 0.0 2.7 N.A. 9.2 
Portugal 9.8 10.8 7.2 1.2 0.0 6.4 
Sweden 3.6 15.4 4.8 2.2 N.A. 4.7 
Among subjects of the same age group 
FEMALE 
18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
female 
subjects 
Finland 6.3 0.0 6.5 3.2 N.A. 4.5 
Norway 12.5 0.0 0.0 0.0 N.A. 2.9 
Portugal 0.0 0.0 0.0 0.0 N.A. 0.0 
Sweden 0.0 25.0 0.0 0.0 N.A. 2.9 
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Figure 97. Mutually exclusive groups – Alcohol-drug combination: male drivers 
 
 
Figure 98. Mutually exclusive groups – Drug-drug combination: female drivers 
Drug-drug combinations were recorded in all countries in the male group and only in 
Finland and Norway in the female group. These subjects accounted for a percentage of 
positives ranging between 0.4 (Portugal) and 7.7 (Norway) in the male group, and 
between 1.1 (Finland) and 5.7 (Norway) among the female subpopulations. 
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Table 102. Killed drivers – Distribution of positive drivers – Drug-Drug combinations 
Mutually exclusive group - Percentage of drivers positive for DRUG-DRUG 
combination 
Among subjects of the same age group 
MALE 18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
male 
subjects 
Finland 0.0 1.6 4.4 1.4 N.A. 1.6 
Norway 0.0 15.4 19.2 2.7 N.A. 7.7 
Portugal 0.0 1.5 0.0 0.0 0.0 0.4 
Sweden 0.0 15.4 4.8 6.7 N.A. 5.6 
Among subjects of the same age group 
FEMALE 18-24 25-34 35-49 50 and over 
Age 
unknown 
Among all 
female 
subjects 
Finland 0.0 0.0 0.0 3.2 N.A. 1.1 
Norway 0.0 0.0 8.3 14.3 N.A. 5.7 
Portugal 0.0 0.0 0.0 0.0 N.A. 0.0 
Sweden 0.0 0.0 0.0 0.0 N.A. 0.0 
 
 
Figure 99. Mutually exclusive groups – Drug-drug combination: male drivers 
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Figure 100. Mutually exclusive groups – Drug-drug combination: female drivers 
 
3.8.6 Distribution of positive drivers during DRUID time periods aggregated into 
weekday, weeknight, weekend day and weekend night 
Table 103. Killed drivers – Distribution of positive drivers during day/night week/weekends 
Percentage of positive drivers on subjects involved in accidents during the same 
time period 
  Week day Week night Weekend day Weekend night 
Finland 30.4 67.5 43.7 78.0 
Norway 28.4 66.7 39.5 88.9 
Portugal 31.6 70.8 52.2 80.0 
Sweden 23.3 85.7 24.2 60.0 
 
Also in the killed drivers study the lowest percentage of positive drivers were found in 
accidents that occurred during weekdays. The highest percentages of positive drivers 
were found in night time accidents. No significant difference was found regarding the 
distribution of positive findings in week vs weekend nights (p=0.562).The percentage of 
drivers, involved in a day accident, testing positive for one of the mutually exclusive 
groups appeared to be generally lower in Sweden than in the other countries.  
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Figure 101. Mutually exclusive groups – Percentage of positive drivers during week/weekend 
day/night 
 
3.8.7 Distribution of positive drivers in single-vehicle and multi-vehicle accidents 
 
 
Figure 102. Mutually exclusive groups – Percentage of positive drivers in single-vehicle and 
multiple-vehicle accident 
Data about type of accident could not be recorded in Portugal that therefore does not 
appear in the graph. In all the other three countries, the percentage of drivers testing 
positive for one of the mutually exclusive groups was always higher in single-vehicle 
accidents than in multi-vehicle accidents, with a ratio of at least 1.8 to 1.  
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Table 104. Killed drivers - Distribution of type accident by substance group 
Type of accident Substance groups 
  single vehicle multi vehicle 
Total 
  negative 138(39.9%) 323(66.5%) 461 
  amphetamines only 4(1.2%) 4(0.8%) 8 
  THC only 1(0.3%) 3(0.6%) 4 
  benzodiazepines only 7(2.0%) 20(4.1%) 27 
  z-drugs only 5(1.4%) 9(1.9%) 14 
  medicinal opioids only 4(1.2%) 5(1.0%) 9 
  alcohol only 109(31.5%) 55(11.3%) 164 
  drug-drug 10(2.9%) 15(3.1%) 25 
  alcohol-drug 38(11.0%) 14(2.9%) 52 
Total 346(100%) 486(100%) 833 
 
More negatives were found in multi-vehicle accidents. Alcohol (alone or in combination) 
was found more in single vehicle accidents. THC, benzodiazepines and z-drugs were 
more found in multi-vehicle collisions. Amphetamines, medicinal opioids, and drug-drug 
combinations are equally distributed.  
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3.9 Distribution of concentrations 
 
3.9.1 Distribution of core substances and Tramadol 
Distribution of concentrations are reported for core substances and tramadol, that has 
been included in the “medicinal opioids” substance group (2.3 Data analysis: Table 14). 
Data are based on all recorded values in the six countries participating in the seriously 
injured drivers study and in the four countries participating in the killed drivers study. 
Data from the seriously injured drivers study and the killed drivers study are shown 
separately in two different tables. 
 
In both tables, the number of samples screened for each listed substance is reported in 
the third column. Minimum, maximum, median and mean concentrations are reported for 
each detected substance. In each table two sets of data are presented. 
Under “Concentrations at or above the DRUID cut-off”, the number of samples that tested 
positive at or above the DRUID cut-off is reported. Based on this first group of samples, 
minimum, maximum, median and mean concentrations are presented. 
Under “All recorded concentrations”, the total number of samples for which a 
concentration was recorded is reported, including the ones with value below the DRUID 
cut-offs. Based on this second group of findings minimum, median and mean 
concentrations are reported. 
 
Table 105. Seriously injured drivers – Distribution of concentrations for core substances and 
tramadol 
SERIOUSLY INJURED DRIVERS 
Concentrations at or above 
DRUID cut-off  
All recorded 
concentrations Substance 
DRUID 
cut-off 
(ng/mL) 
Number 
of 
samples 
screened Pos Min. Max. Median Mean Pos Min. Median Mean
Ethanol 0.1 g/L 2486 609 0.10 4.20 1.60 1.59 615 0.06 1.59 1.57 
6-acetylmorphine 10  2484 1 12.4 12.4 12.4 12.4 8 0.6 3.2 4.2 
Alprazolam 10  2484 6 18.5 128 44.5 52.3 20 1.0 8.2 19.2 
Amphetamine 20  2485 45 20.0 1095 102 215 61 1.0 49.3 160 
Benzoylecgonine 50  2480 71 51.6 1500 254 338 108 0.5 138 228 
Clonazepam 10  2484 30 11.2 174 40.2 45.8 33 2.3 37.8 41.9 
Cocaine 10 2484 36 10.0 400 35.5 59.5 67 0.5 11.6 34.2 
Codeine 10 2484 18 10.0 66.9 20.5 27.1 37 0.5 8.7 15.2 
Diazepam 20  2480 41 20.0 1747 112 234 62 0.7 45.7 158 
Flunitrazepam 2  2480 4 5.9 12.1 8.0 8.5 7 1.1 5.9 5.5 
Lorazepam 10  2483 13 12.0 114 25.6 37.7 21 0.5 17.4 24.0 
MDA 20  2485 1 43.4 43.4 43.4 43.4 5 6.0 13.6 18.1 
MDEA 20  2485 0 N.A. N.A. N.A. N.A. 0 N.A N.A. N.A. 
MDMA 20  2485 5 29.3 436 93.9 199 7 3.8 47.6 144 
Methadone 10  2483 29 13.0 581 72.0 140 31 1.6 65.0 131 
Methamphetamine 20  2485 11 22.2 240 125 112 17 2.0 27.6 74.6 
Morphine 10  2470 58 11.0 898 31.5 65.3 77 0.5 24.0 50.0 
Nordiazepam 20  2481 46 27.9 854 138 223 73 1.1 54.3 143 
Oxazepam 50  2483 14 55.2 1486 174 303 47 1.0 12.7 96.7 
THC 1  2481 68 1.0 19.7 2.3 3.0 94 0.2 1.5 2.3 
THCCOOH 5  2482 121 5.0 351 23.7 40.0 145 1.0 15.0 33.8 
Tramadol 50  2480 33 55.7 5098 300 596 51 1.0 121 392 
Zolpidem 20  2484 11 31.6 1161 131 238 14 6.9 75.0 190 
Zopiclone 10  2484 8 12.0 422 59.6 103 14 0.5 15.8 61.4 
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Table 106. Killed drivers – Distribution of concentrations for core substances and tramadol 
KILLED DRIVERS 
Concentrations at or above DRUID 
cut-off  
All recorded 
concentrations Substance 
DRUID 
cut-off 
(ng/mL) 
Number 
of 
samples 
screened Pos Min. Max. Median Mean
Pos
 Min. Median Mean
Ethanol 0.1 g/L 1102 354 0.10 3.70 1.67 1.61 383 0.01 1.60 1.49 
6-acetylmorphine 10  1072 0 N.A. N.A. N.A. N.A. 0 N.A. N.A. N.A. 
Alprazolam 10  1087 15 12.7 100 30.0 44.8 17 8.2 30.0 40.6 
Amphetamine 20  1083 28 20.3 120000 420 5151 30 6.8 406 4808 
Benzoylecgonine 50  1074 7 73.0 1613 277 483 7 73.0 277 483 
Clonazepam 10  1087 4 10.7 60.9 16.4 26.1 6 2.5 11.0 18.3 
Cocaine 10  1082 3 35.0 68.0 50.5 51.2 4 9.1 42.8 40.7 
Codeine 10  1082 6 20.0 731 40.0 156 7 9.3 40.0 135 
Diazepam 20  1081 47 20.0 1200 200 257 50 4.4 151 242 
Flunitrazepam 2  1087 0 N.A. N.A. N.A. N.A. 4 0.3 0.9 0.9 
Lorazepam 10  1062 4 10.0 20.0 20.0 17.5 5 4.4 20.0 14.9 
MDA 20  1077 1 273 273 273 273 2 16.1 145 145 
MDEA 20  1046 0 N.A. N.A. N.A. N.A. 0 N.A. N.A. N.A. 
MDMA 20  1083 4 300 1511 317 611 4 300 317 611 
Methadone 10  1087 1 12310 1231 1231 1231 1 1231 1231 1231 
Methamphetamine 20  1083 11 40.0 2939 411 803 12 11.9 372 737 
Morphine 10  1075 12 11.8 345 53.5 82.3 16 0.7 34.0 62.1 
Nordiazepam 20  1087 54 20.0 1600 100 238 57 10.8 100 226 
Oxazepam 50  1087 25 50.0 2400 300 482 38 1.5 100 325 
THC 1  1082 19 1.1 20.5 3.4 5.2 29 0.3 2.2 3.6 
THCCOOH 5  430 11* 6.0 95.0 12.0 25.7 11* 6.0 12.0 25.7 
Tramadol 50  905 9 146 2966 605 758 9 146 605 758 
Zolpidem 20  1087 6 90.0 708 250 311 6 90.0 250 311 
Zopiclone 10  802 22 10.9 800 60.0 134 23 3.5 60.0 128 
* 11 samples tested positive for THCCOOH, however for one of them exact concentration was not reported, as 
the value was above the calibration curve. Maximum, median and mean concentrations are therefore based on 
10 values 
 
Concentrations recorded in this study are not from controlled administration of drugs, 
and, therefore, they represent the result of different consumption patterns. For example, 
MDA and oxazepam are drugs themselves, but they are also breakdown products in the 
body of MDMA and diazepam/nordiazepam respectively. Codeine can be found as a 
consequence of therapeutic use, but also as breakdown product of acetylcodeine, an 
impurity present in street heroin. Also, depending on time between accident and blood 
sampling, the concentration of certain drugs may have decreased significantly due to 
their short halflife in the body and normal metabolism. For these reasons, for some of the 
listed drugs, minimum, maximum, median and mean concentrations obtained from the 
data gathered could be the results of concentrations derived both from therapeutic/illicit 
use and from metabolism. 
  
For the seriously injured drivers study, when all recorded concentrations are considered, 
median and mean are found to be above the DRUID cut-off for almost all substances. For 
alprazolam, codeine, MDA and oxazepam the median concentration is found to be lower 
than the set cut-offs. Among all detected core substances for which a concentration was 
measured, 6-acetymorphine is the only one for which both median and mean 
concentrations are found to be below the DRUID cut-off. 6-acetylmorphine is the first 
break down product of heroin in the body that lasts very shortly, being rapidly converted 
into morphine. This, with the fact that 6-acetylmorphine may break down after blood 
sampling, is likely to explain the low concentrations detected.  
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The same cut-offs have been applied in the seriously injured drivers study and in the 
killed drivers study, however data for the killed drivers study are presented separately as 
concentrations of drugs may change after death. This can be due to bacterial and fungal 
activity that, for example, can either produce or consume alcohol as well as degrade 
other substances, or to drugs being released after death into the blood from tissues, such 
as the liver, where they were accumulated during life, due to a phenomenon known as 
“post-mortem redistribution”. The site of sampling may also determine significant 
differences in observed concentrations, with a blood sample taken from the heart 
normally containing higher drug concentrations than a blood sample taken from a 
peripheral site, such as the femoral vein. 
In general, in the killed drivers study, median and mean concentrations obtained 
considering all recorded values are above the DRUID cut-off for all substances apart from 
flunitrazepam. This benzodiazepine is known to degrade rapidly in post-mortem samples, 
a fact that is likely to explain the very low concentrations detected.  
 
Although in all countries hospital staff was asked to record any drug administered before 
blood sampling on the patient form, there is the possibility that in some cases this 
procedure was not followed. This possibility is raised when looking at concentrations 
measured that, for some drugs and in some cases, appear to be relatively high to result 
from normal therapeutic use. This is for example the case of morphine and tramadol. For 
morphine, according to the scientific literature, concentrations in the range of 20 ng/mL 
are considered sufficient for pain management in cancer patients, and concentrations in 
the range of 300 ng/mL, in non-tolerant subjects, are associated with loss of 
consciousness requiring assisted ventilation. For tramadol, in a previous study on drug-
impaired driving, the average concentration was found to be around 500 ng/mL14. 
While high concentrations recorded in the killed drivers study may be explained by post-
mortem redistribution or a sample havin been taken not from a peripheral site, some of 
the high concentrations recorded in the seriously injured drivers study appear more likely 
to be in the range of those found during emergency treatment than in normal pain 
management. This observation leads to the possibility that, in a few cases, the 
administration of drugs prior to blood sampling may have not been recorded on the 
patient form.  
 
 
                                                          
14 Baselt RC. Disposition of toxic drugs and chemicals in man. Biomedical publications Foster city, California, 
2004 
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3.9.2 Concentrations of drugs found alone and in combination 
Table 107. Distribution of concentrations for core substances and tramadol 
  Injured Drivers Killed Drivers 
Concentrations at or above DRUID 
cut-off 
Concentrations at or above DRUID 
cut-off 
Substance 
DRUID 
cut-off 
(ng/mL) Pos Min. Max. Median Mean Pos 
 
Min. 
 
Max 
 
Median Mean
Ethanol only 0.1 g/L 458 0.10 4.20 1.60 1.60 285 0.10 3.70 1.68 1.62 
Ethanol 
combination 0.1 g/L 151 0.10 3.31 1.60 1.56 69 0.12 3.15 1.60 1.57 
6-acetylmorphine 
combination  10  1 12.4 12.4 12.4 12.4 0 N.A. N.A. N.A. N.A. 
Alprazolam only 10  2 18.5 19.5 19.0 19.0 4 18.5 100 31.0 45.1 
Alprazolam 
combination 10  4 35.0 128 56.3 69.0 11 12.7 100 30.0 44.7 
Amphetamine only 20  7 23.9 328 208 167 6 35.3 120000 445 20338
Amphetamine 
combination 20  38 20.0 1095 101 223 23 20.3 4931 430 1012 
Benzoylecgonine 
only 50  8 52.0 570 189 218 0 N.A. N.A. N.A. N.A. 
Benzoylecgonine 
combination 50  63 51.6 1500 257 353 7 73.0 1613 277 483.7 
Clonazepam only 10  4 26.0 74.9 56.5 53.5 0 N.A. N.A. N.A. N.A. 
Clonazepam 
combination 10  26 11.2 474 38.5 44.6 4 10.7 60.9 16.4 26.1 
Cocaine only or in 
combination with 
benzoylecgonine 
10  5 20.0 400 170 170 0 N.A. N.A. N.A. N.A. 
Cocaine 
combination, other  10  31 10.0 208 33.0 41.6 3 35.0 68.0 50.5 51.2 
Codeine only 10  6 10.6 54.3 33.1 33.6 4 20.0 70.0 40.0 42.5 
Codeine 
combination 10  12 10.0 66.9 16.5 23.9 2 36.1 731 383 383 
Diazepam only 20  7 20.0 277 30.0 71.9 3 30.0 50.0 30.0 36.7 
Diazepam 
combination 20  34 23.2 1747 132 268 44 20.0 1200 200 272 
Flunitrazepam 
only 2  1 5.9 5.9 5.9 5.9 0 N.A. N.A. N.A. N.A. 
Flunitrazepam 
combination 2  3 6.1 12.1 9.9 9.4 0 N.A. N.A. N.A. N.A. 
Lorazepam only 10  5 12.0 41.2 23.0 26.3 2 20.0 20.0 20.0 20.0 
Lorazepam 
combination 10  8 17.3 114 32.3 44.8 4 10.0 20.0 20.0 17.5 
MDA combination 20  1 43.4 43.4 43.4 43.4 1 273 273 273 273 
MDMA only 20  1 29.3 29.3 29.3 29.3 1 314 314 314 314 
MDMA 
combination 20  4 47.6 436 241 241 3 300 1511 320 710 
Methadone only 10  8 13.0 177 49.5 70.3 0 N.A. N.A. N.A. N.A. 
Methadone 
combination 10  21 26.0 581 91.0 167 1 1231 1231 1231 1231 
Methamphetamine 
only or in 
combination with 
amphetamine 
20  4 22.2 240 133 132 2 40.0 2939 1489 1489 
Methamphetamine 
combination, other 20  7 26.2 177 125 100 9 148 1658 411 650 
Morphine only 10  26 11.0 103 27.0 37.0 4 34.0 128 60.5 70 
Morphine 
combination 10  32 12.3 898 42.5 88.2 8 11.8 345 45.0 88 
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Nordiazepam only 20  2 42.0 76 59.0 59.0 4 40.0 90.0 51.5 58 
Nordiazepam 
combination 20  44 27.9 854 142 231 50 20.0 1600 100 253 
Oxazepam only 50  1 164 164 164 164 8 50.0 2400 359 624 
Oxazepam 
combination 50  13 55.2 148 176 314 17 70.0 1600 289 414 
THC only or in 
combination with 
THCCOOH 
1  24 1.0 19.7 2.2 3.7 4 2.2 20.5 6.9 9.1 
THC combination 1  44 1.0 8.0 2.3 2.6 15 1.1 10.9 3.1 4.2 
THCCOOH only 5  19 5.0 112.5 24.5 35.3 3* 16.0 82.0 49.0 49.0 
THCCOOH 
combination 5  100 5.0 351 21.7 40.8 9 6.0 95.0 10.0 20.6 
Tramadol only 50  24 55.7 5098 243 651 3 146 607 200 317 
Tramadol 
combination 50  9 63.8 1012 414 450 6 300 2966 652 978 
Zolpidem only 20  6 31.6 436 94.3 157 3 90.0 708 300 366 
Zolpidem 
combination 20  5 79.1 1161 131 336 3 100 471 200 257 
Zopiclone only 10  3 19.6 82.2 22.5 41.4 12 10.9 419 53.0 92.8 
Zopiclone 
combination 10  5 12.0 422 111 141 10 19.1 800 100 183 
*11 samples tested positive for THCCOOH, however for one of them the exact concentration was not reported, 
as the value was above the calibration curve. Maximum, median and mean concentrations are therefore based 
on 10 values. 
 
The concentration ranges of ethanol found alone or in combination with other drugs were 
similar. This happened in both the seriously injured and killed drivers study. 
In the injured drivers study, for the majority of substances, the concentration range was 
wider when the drug was found in combination compared to when the drug was found 
alone. Exceptions were found for metamphetamine, THC and tramadol, for which the 
concentration range was smaller when the drug was combined with other psychoactive 
substances. 
Also in the killed driver study, for the majority of substances (when leaving out the 
outliers), the concentration range was wider when drugs were found in combination with 
other psychoactive substances. This trend was not shown by certain substances, and in 
particular in the case of alprazolam (equal when alone and in association), 
metamphetamine, oxazepam, THC and zolpidem (wider concentration range when found 
alone compared to when found in combination) 
 
3.9.3 Distribution of the alcohol concentrations 
In general 24.4% of the injured drivers population was positive for alcohol. Of these 609 
subjects, 9.5% had a BAC between 0.1g/L (= DRUID cut-off) and 0.5 g/L (= legal cut-off 
in most countries involved) and 65.7% had a BAC ≥ 1.3 g/L.  
Among all subjects testing positive for alcohol the highest percentage of drivers with a 
BAC between 0.1 and 0.5 g/L was found in Italy (10.9%) followed by Belgium (10.1%) 
and Denmark (9.7%). Among the same sample the highest percentage of subjects with a 
BAC ≥ 1.3 g/L was found in Finland (76.5%), followed by Lithuania (70.6%) and Belgium 
(68.2%).  
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Table 108. Injured drivers- Distribution of positive alcohol findings by BAC-group 
 BAC group Frequency Percent 
 0.1 ≤ BAC < 0.5 g/L 58 9.5
0.5 ≤ BAC < 0.8 g/L 48 7.9
0.8 ≤ BAC <1.3 g/L 103 16.9
BAC ≥ 1.3 g/L 400 65.7
Total 609 100.0
 
 
Figure 103. Injured drivers - Distribution of positive alcohol findings by BAC-group (in g/L) 
and by country 
 
In general 31.7% of the killed driver population was positive for alcohol. Of these 354 
subjects, 12.7% had a BAC between 0.1g/L (= DRUID cut-off) and 0.5 g/L (= legal cut-off 
in most countries involved). 70.6% of the killed drivers testing positive for alcohol had a 
BAC > 1.3 g/L.  
In the killed driver study, among all subjects testing positive for alcohol the highest 
percentage of drivers with a BAC between 0.1 and 0.5 g/L was found in Portugal (21.9%) 
followed by Sweden (13.8%). Among the same sample the highest percentage of 
subjects with a BAC ≥ 1.3 g/L was found in Finland (83.8%), followed by Norway (71.4%).  
  
Table 109. Killed drivers- Distribution of positive alcohol findings by BAC-group 
 BAC group Frequency Percent 
0.1 ≤ BAC < 0.5 g/L 45 12.7
0.5 ≤ BAC < 0.8 g/L 26 7.3
0.8 ≤ BAC <1.3 g/L 33 9.3
BAC ≥ 1.3 g/L 250 70.6
Total 354 100.0
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Figure 104. Killed drivers- Distribution of positive alcohol findings by BAC-group (in g/L) and 
by country 
 
 
3.9.4 Comparison of the concentrations in injured and killed driver population 
Comparison between concentrations found in injured and killed drives should be made 
very carefully. This is because, as already mentioned, in post-mortem samples 
concentrations of drugs not only depend on site of blood sampling (with higher 
concentrations often found in heart blood compared to periferal blood), but can also 
increase or decrease after death, due to post-mortem changes. Also, in the case of those 
drivers who did not die immediately at the scene of the accident and the blood sample 
was collected only during the post-mortem examination, drugs may have been partially or 
completely eliminated during the survival time, which extended up to 24 hours for some 
subjects.  
 
In general, when considering the different number of subjects included in the two studies 
(with a ratio of aproximately 2:1 between injured and killed drivers), the number of 
subjects testing positive was relatively similar in the two studies only for alcohol, 
amphetamine and zolpidem. For the other substances, for which at least 5 positive 
findings at or above the DRUID cut-off were recorded, the number of positive was in 
general higher in the seriously injured drivers population than in the killed drivers 
population. This happened for all substances apart from alprazolam, diazepam, 
nordiazepam, oxazepam, methamphetamine and zopiclone, for which the number of 
positive findings was higher in the killed drivers study. 
 
When looking at median and mean concentrations, differences could be noticed between 
the concentrations recorded in the two studies. These are likely to be the consequence 
both of the different number of cases recorded in the two studies and of the phenomena 
that may lead to drugs concentration changes (for example: post-mortem redistribution 
for amphetamine and methamphetamine, with higher concentrations in the killed drives 
population), as already explained above. 
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Table 110. Comparison concentrations in injured and killed driver population 
 Injured drivers Killed drivers 
Concentrations at or above DRUID cut-
off  
Concentrations at or above DRUID cut-
off Substance 
Pos Min. Max. Median Mean Pos  Min. Max. Median Mean 
Ethanol 609 0.10 4.20 1.60 1.59 354 0.10 3.70 1.67 1.61 
6-acetylmorphine 1 12.4 12.4 12.4 12.4 0 N.A. N.A. N.A. N.A. 
Alprazolam 6 18.5 128 44.5 52.3 15 12.7 100 30 44.8 
Amphetamine 45 20 1095 102 215 28 20.3 120000 420 5151 
Benzoylecgonine 71 51.6 1500 254 338 7 73 1613 277 483 
Clonazepam 30 11.2 174 40.2 45.8 4 10.7 60.9 16.4 26.1 
Cocaine 36 10 400 35.5 59.5 3 35 68 50.5 51.2 
Codeine 18 10 66.9 20.5 27.1 6 20 731 40 156 
Diazepam 41 20 1747 112 234 47 20 1200 200 257 
Flunitrazepam 4 5.9 12.1 8 8.5 0 N.A. N.A. N.A. N.A. 
Lorazepam 13 12 114 25.6 37.7 4 10 20 20 17.5 
MDA 1 43.4 43.4 43.4 43.4 1 273 273 273 273 
MDEA 0 N.A. N.A. N.A. N.A. 0 N.A. N.A. N.A. N.A. 
MDMA 5 29.3 436 93.9 199 4 300 1511 317 611 
Methadone 29 13 581 72 140 1 1231 1231 1231 1231 
Methamphetamine 11 22.2 240 125 112 11 40 2939 411 803 
Morphine 58 11 898 31.5 65.3 12 11.8 345 53.5 82.3 
Nordiazepam 46 27.9 854 138 223 54 20 1600 100 238 
Oxazepam 14 55.2 1486 174 303 25 50 2400 300 482 
THC 76 1 19.7 2.1 2.9 19 1.1 20.5 3.4 5.2 
THCCOOH 121 5 351 23.7 40 11* 6 95 12 25.7 
Tramadol 33 55.7 5098 300 596 9 146 2966 605 758 
Zolpidem 11 31.6 1161 131 238 6 90 708 250 311 
Zopiclone 8 12.0 422 59.6 103 22 10.9 800 60.0 134 
 
3.9.5 Comparison of concentrations between countries 
 
3.9.5.1 Introduction 
 
Box and whisker plots were drawn for substances for which there were at least 20 cases 
above the DRUID cut-off. This way, differences in the concentration range can be 
compared between the countries involved in respectively the seriously injured drivers 
study and the killed drivers study. 
The box in these box and whisker plots represents those cases between the 75th and 25th 
percentile (Q3-Q1), whilst the line that bisects the box is the median concentration of the 
cases. The whiskers that protrude from the box extend to 1.5 times ‘Q3-Q1’ or, if no case 
has a value in that range, to the minimum or maximum values. If the data are distributed 
normally, approximately 95% of the cases are expected to lie between the whiskers. 
Outliers, denoted by a point, are defined as cases that do not fall within the whiskers. 
Extreme outliers are denoted by squares and represent cases that have values more 
than three times ‘Q3-Q1’ beyond the limits of the box. It should be remembered that the 
scale for concentration in the box and whisker plots in this report is in most cases linear, 
but for some substances the scale is logarithmic base 10. This scale was used in order to 
facilitate viewing cases with high concentrations whilst not unduly compressing the plot. 
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3.9.5.2 Injured drivers 
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Figure 105. Seriously injured drivers – Distribution concentrations Ethanol 
The box plots overlap, which means there was no clear distinction in the distribution of 
concentrations between the countries. 
The widest spread was seen in Italy, with the maximum concentration of 4.20 g/L 
integrated in the whisker. In Belgium the highest concentration (approximately 4g/L) was 
seen as an outlier. The median values are very similar among the studied countries. 
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Figure 106. Seriously injured drivers – Distribution concentrations Amphetamine 
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No driver tested positive for amphetamines in Italy. Since the number of positives in 
Finland, Lithuania and The Netherlands was very low, no comparison with these 
countries was made. 
The box plots for Belgium and Denmark overlap, which means there is no clear 
distinction in the concentration distribution. The median concentration although is higher 
in Belgium than in Denmark. 
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Figure 107. Seriously Injured drivers – Distribution concentrations Benzoylecgonine 
Since the number of positives in Lithuania was very low, no clear comparison could be 
made with this country. For the other countries the box and whisker plots overlap, 
meaning an equal distribution. 
The median concentration in Denmark and The Netherlands is comparable. The median 
concentration in Belgium was higher. 
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Clonazepam 
 
180
160
140
120
100
80
60
40
20
0
Country
C
lo
na
ze
pa
m
 >
 1
0 
ng
/m
l
BE DK FI LT
 
Figure 108. Seriously injured drivers – Distribution concentrations Clonazepam 
Since the low number of positives in Belgium, Finland and Lithuania, no comparison for 
the distribution of clonazepam concentrations could be made. In Denmark 75% of 
samples testing positive for clonazepam at or above the DRUID cut-off had a 
concentration below 70 ng/mL. 
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Figure 109. Seriously injured drivers – Distribution concentrations Cocaine 
Due to the low number of positives in Lithuania, no comparison with this country could be 
made. The box an whisker plots for the other countries overlap with Italy, which means 
there is no clear distinction in concentration distribution. However in this country there is a 
wide spread for concentration. Among the other countries, concentration range of cocaine 
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in Belgium and the Netherlands overlap partially, however due to the lower number of 
positives, a clear comparison could not be made.  
In general median concentration did not appear to be comparable, however in Denmark 
the lowes value was found. 
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Figure 110. Seriously injured drivers – Distribution concentrations Codeine 
Due to the very low number of positives in Belgium and Lithuania, no conclusions were 
made for these countries. The plots for Denmark and Italy were almost completely 
separated. Disregarding the lowest outlier for Denmark, a distinction can be made 
between these two countries: the concentration range in Denmark is higher. 
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Diazepam 
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Figure 111. Seriously injured drivers – Distribution concentrations Diazepam 
For diazepam the box and whisker plots overlap, indicating that there is no clear 
distinction in concentration distribution. The maximum concentration was found in 
Denmark, while  the lowest median concentration was found in Lithuania. 
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Figure 112. Seriously injured drivers- Distribution concentrations Methadone 
The boxes are almost completely separated between Denmark, Italy and Belgium, 
indicating a different distribution of concentration of methadone. Denmark has the mostly 
spread range of concentration. 
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Morphine 
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Figure 113. Seriously injured drivers – Distribution concentrations Morphine 
Since the number of positives in The Netherlands was very low, no conclusion on that 
country could be made. All other plots overlap, which means that the distribution of 
concentration was equal in these countries. The median concentration was higher in 
Denmark and comparable between Belgium and Italy. 
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Figure 114. Seriously injured drivers – Distribution concentrations Nordiazepam 
Since the number of positives in Finland an Italy was very low, no comparison with these 
countries could be made. The plots for Belgium and Denmark overlap. The distribution of 
concentrations in Lithuania were generally lower. 
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Figure 115. Seriously injured drivers – Distribution concentrations THC 
Among all subjects testing positive for THC, only two had a concentration higher than 10 
ng/ml. No comparison with Finland, Lithuania and The Netherlands could be made due to 
the low number of positives. The plots for the other countries overlap, which means that 
no clear distinction can be made in concentration ranges.  
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Figure 116. Seriously injured drivers – Distribution concentrations THCCOOH 
No comparison with Finland, Lithuania and The Netherlands could be made due to the 
low number of positives. For the other plots the median is different. The highest median 
concentration was found in Denmark, the lowest in Italy. Since the plots overlap, 
distribution of concentration was found comparable. In Italy 3 outliers were defined. Only 
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few subjects had a THCCOOH > 75 ng/mL, which is considered to be a criterion of 
chronic use in Germany. 
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Figure 117. Seriously injured drivers – Distribution concentrations Tramadol 
Due to the low number of positives in Belgium and Finland, no comparison could be 
made with these countries. 
The plots for Denmark and Lithuania overlap, meaning a similar distribution of 
concentration in these countries. The median concentration in Denmark was lower 
compared to Lithuania. 
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3.9.5.3 Killed drivers 
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Figure 118. Killed drivers- Distribution concentrations Ethanol  
Note: FIN= Finland; N= Norway; P=Portugal; S= Sweden 
 
For ethanol the highest maximum concentration (3.70 g/L) was found in Finland as well 
as the highest median concentration; the lowest in Portugal. The median concentration 
for ethanol was similar in Norway and Sweden, however the inter-quartile range was 
wider in Sweden compared to the one of Norway.  
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Figure 119. Killed drivers – Distribution concentrations Amphetamine 
Note: FIN= Finland; N= Norway; P=Portugal; S= Sweden 
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The highest concentrations for amphetamine was found in Finland, the lowest in Norway. 
In Sweden the concentrations were more equally spread in comparison to Finland and 
Norway. The mean concentration of Norway was much lower than those in Finland and 
Sweden (below 100 ng/mL). There was an overlap between the boxplots which means 
there was no clear distinction in the distribution of concentrations between the countries. 
 
 
Diazepam 
 
1200
1000
800
600
400
200
0
Country
D
ia
ze
pa
m
 >
 2
0 
ng
/m
l
FIN N P S
 
Figure 120. Killed drivers – Distribution concentrations Diazepam 
Note: FIN= Finland; N= Norway; P=Portugal; S= Sweden 
 
Due to the low number of positives in Portugal and Sweden, no comparison could be 
made with thes countries. Finland had the higher number of observations and the widest 
spread of concentrations of diazepam including the maximum value recorded (1200 
ng/ml). The median concentrations were similar for Finland and Norway. 
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Figure 121. Killed drivers – Distribution concentrations Nordiazepam 
Note: FIN= Finland; N= Norway; P=Portugal; S= Sweden 
 
Due to the low number of positives observed for nordiazepam in Portugal (4) and Sweden 
(3), no conclusion can be drawn. For Finland and the Netherlands the boxes were 
overlapping, meaning no clear distinction in distribution of concentration. The highest 
concentrations of nordiazepam was found in Finland. In Norway the median 
concentration of nordiazepam was higher than in Finland.  
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Figure 122. Killed drivers – Distribution concentrations Oxazepam  
Note: FIN= Finland; N= Norway; P=Portugal; S= Sweden 
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There were no positive cases for oxazepam in Portugal and only one in Sweden. The 
boxes for Finland and Norway overlap, however the number of observations in Finland 
was higher probably leading to  much more spread concentration values. The median 
concentrations were relatively similar in Finland and Norway.  
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Figure 123. Killed drivers – Distribution concentrations THC 
Note: FIN= Finland; N= Norway; P=Portugal; S= Sweden 
 
Only two cases positive for THC were observed in Sweden, not allowing to make any 
comparison with this country. The widest spread of concentration was found in Norway. 
The boxes are overlapping, indicating similar concentrations in the two countries. 
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4 Discussion 
 
In the present study, data about subjects injured or killed in road traffic accidents during 
the years 2006-2010 were collected across nine European countries. Information 
gathered included data relative to the driver, the time and type of accident and the 
toxicological findings in a blood sample, collected from the driver after the accident, and 
analysed for a representative group of psychoactive substances that may affect the ability 
to drive. This result chapter analysed data relative only to drivers of cars and vans. 
 
Data about seriously injured drivers were collected in Belgium, Denmark, Finland, Italy, 
Lithuania and The Netherlands, during different time frames between October 2007 and 
April 2010. 
Data about killed drivers were collected in Finland, Norway, Portugal and Sweden, 
between January 2006 and December 2009, with different collection periods in the four 
participating countries. 
 
The non response in the six countries varies between 0% and 8.5% for the surveys on 
the injured drivers. For the studies on killed drivers the missing cases varied between 5.7 
- 41%. In Norway the police was in charge for sending samples to the laboratory 
responsible for analysis. When the police considered that the probability of finding alcohol 
or drugs was low, no samples were sent to the laboratory. This procedure can be an 
explanation for the high percentage of missing cases. 
 
Concerning the representativeness of the population in the EU countries and the 
representativeness of the hospitalised and killed driver sample. The Southern EU 
Member States are the best represented (54%), followed by the Northern Member States 
(29%). Every country made several efforts to have a representative driver sample, 
resulting in a high participation rate in the injured driver surveys and in a low number of 
missing cases in most of the countries involved in the killed driver study. 
 
When grouping the samples by quarter of the year, in the seriously injured drivers study, 
the percentages of samples collected during the first and the fourth quarters appeared to 
be more represented. The significant difference recorded may be due to the fact that 
collection campaigns in the six participating countries started and ended at different 
times, not covering exactly the same time frames. On the whole sub-population in the 
killed drivers study, more samples appeared to have been collected during the third and 
fourth quarter of the year, however no significant difference was found in the sample 
distribution across the four quarters of the year in the four participating countries. 
 
In both studies, the distribution of sampling along the week time periods showed that the 
percentage of accidents recorded during daytime was higher than the one recorded 
during nighttime, with more than half of the accidents occurring during a weekday and 
approximately one quarter during a weekend day. In both studies and all countries, 
except for The Netherlands, the percentage of accidents decreased in the order 
weekdays, weekend days, weekend nights and weeknights (in The Netherlands: 
weekday, weeknights, weekend nights and weekend days). While in the seriously injured 
drivers study significant differences were found in the sample size collected during the 
different aggregated time periods, no significant difference was found in the sample size 
collected in the killed driver study. 
 
In both studies significant differences were found between both gender and age groups. 
In general, the prevalence in males was higher than in females, with a percentage ratio 
approximately 70/30 in the seriously injured drivers and 83/17 in the killed drivers. 
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The age group distribution was different in the two studies, with the age group 50 and 
above accounting for approximately 19% of the sample in the injured drivers study and 
approximately 36% of the sample in the killed drivers study. 
In men, the two first age groups, 18-24 and 25-34, accounted for approximately 55% of 
the sample in the injured drivers study, and for approximately 42% of the sample in the 
killed drivers study. For the same two female age groups, the distribution was 
approximately equal to 49% in the seriously injured drivers study and to 32% in the killed 
drivers study. 
 
In both studies, among accidents for which type was recorded, the percentage of multi-
vehicle was higher than single-vehicle accidents, being the ratio approximately 54/46 in 
the seriously injured drivers study, and 58/42 in the killed drivers study. 
 
Findings from the toxicological analysis have been presented in two sets of data, one 
giving an overview of the number of drivers using the different substance groups 
(prevalence of use) and in mutually exclusive groups. It has to be noted that in both 
analyses a sample was considered positive if a substance was found at or above the set 
DRUID cut-offs. For this reason, the data give an estimate of the prevalence of substance 
groups among the sampled population, which is likely to be conservative, because 
samples tested positive below the set cut-off were considered as negative.  
 
As expected, alcohol was the most common toxicological finding, both in the seriously 
injured and in killed drivers. The highest percentages were recorded for alcohol in both 
sets of data: prevalence of use and mutually exclusive groups. Alcohol was the only 
substance among the ones tested for that appeared more often alone than in 
combinations. When alcohol was combined with other drugs, benzodiazepines and 
cannabis, in the form of THC and/or THCCOOH, were the most common associated 
findings. This happened in both studies, even if in the killed drivers study the prevalence 
of cannabis use may have been further underestimated due to the fact that Norway and 
Finland did not analyse for the presence of THCCOOH. 
 
In the prevalence of use, among all seriously injured drivers, after alcohol, cannabis, 
detected as THC and/or THCCOOH, and benzodiazepines were the most common 
findings. Use of these psychoactive substances appeared in both gender and all age 
groups. 
 
In the killed drivers study, among all sampled subjects, the most prevalent substances 
after alcohol were benzodiazepines, followed by amphetamine and cannabis. The total 
number of findings for amphetamine (33 at or above DRUID cut-offs) was slightly higher 
than the one for cannabis (29), however, as already mentioned, the use of cannabis may 
have been underestimated in the killed drivers study because THCCOOH was not 
measured in two countries. It has to be noted that out of the four participating countries in 
the killed driver study three, Finland, Norway and Sweden, are part of the Scandinavian 
area where the use of amphetamines is generally higher than in the southern European 
countries.  
 
Belgium, Denmark and Finland had the highest percentage of subjects positive for 
cannabis among the seriously injured drivers, while in the killed drivers study the highest 
percentages were found in Norway and Portugal. Although still present, in general, use of 
cannabis appeared to decrease in the age group 50 and above. 
 
Benzodiazepines use was present in both gender and all age groups, with higher 
percentage of positive findings recorded in Finland, Belgium and Denmark, in the 
seriously injured drivers study, and in Finland, Norway and Sweden, in the killed drivers 
study. The diffusion of this substance group among both gender and all age groups may 
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be explained by the various therapeutic uses, different benzodiazepines being 
prescribed, among others, for the treatment of anxiety disorder, sleeping disorders and 
epilepsy. 
 
In the prevalence of use, the other substance groups appeared with more different 
patterns in the participating countries. 
 
Among the illicit drugs, amphetamine use appeared to be more common in northern 
Europe, with the highest percentages of positive findings recorded in Denmark, followed 
by Finland, Belgium and The Netherlands in the seriously injured drivers study. In the 
killed drivers study, the highest percentages of amphetamines use were recorded in 
Norway and Sweden. Cocaine use seemed to be more prevalent in the southern Europe, 
with Italy and Portugal having the highest percentages of subjects testing positive for 
cocaine and/or benzoylecgonine in the seriously injured and killed drivers study 
respectively. Finland was the only country in which no case of cocaine use was recorded, 
both in the seriously injured and in the killed drivers study. Cases of illicit opiates use 
were recorded only in the seriously injured drivers study and only in Belgium, Denmark, 
Italy and Lithuania. In general the use of these three groups of illicit drugs tended to 
decrease, if not disappear, in the older age group (50 and above). Use of cocaine and 
amphetamines appeared somehow more common in the youngest age groups, up to 34 
years, while illicit opiates use seemed more common in the age groups 25-34 and 35-49. 
 
Use of Z-drugs appeared to be more common in northern Europe, with the highest 
percentages of cases recorded in Finland, followed by Belgium and Denmark in the 
seriously injured drivers study, and in Norway followed by Sweden and Finland in the 
killed drivers study. Use of these medications was recorded in both genders, and 
apparently more frequent in the older age groups starting from 35 years. 
 
In the prevalence of use the medicinal opioids group appeared to be relatively equally 
distributed in both genders and all ages. In the seriously injured drivers the highest 
percentage of positive subjects was found in Lithuania, with 7.8% of the cases testing 
positive for at least one medicinal opioid. In the other countries involved in the seriously 
injured drivers study, percentages of prevalence of use for medicinal opioids ranged from 
4.2 in Denmark to 0.5 in the Netherlands. In the killed drivers study the highest 
percentage of positive findings for medicinal opioids was found in Sweden at 4.1%, with 
the other countries recording percentages around approximately 2%. 
 
Apart from alcohol, all other substance groups appeared more often in combination with 
other drugs or alcohol than alone, in percentages that may vary from approximately 50% 
up to 100% of the cases, for different substance groups and in different countries. 
 
In the mutually exclusive groups, percentages of positive drivers varied from around 28% 
up to 53% in the different countries. Both, highest and lowest percentages of positive 
drivers, were recorded in the seriously injured drivers study, with Belgium having 52.6% 
positive drivers among the sampled population and Lithuania 27.8%. In the killed drivers 
study, the highest percentage was found in Portugal, with 47.7% of drivers testing 
positive for at least one of the mutually exclusive groups. The lowest percentage was 
found in Sweden, with 30.5% of positive drivers. 
 
 “Alcohol alone” and “alcohol-drug” combinations represented the most common groups 
in the mutually exclusive groups in both studies and all countries apart from Lithuania, 
where the second most common group was the one of “medicinal opioids”. In the killed 
drivers study, for Sweden the same percentage of positive drivers was recorded in both, 
the “alcohol-drug” combination group and the “drug-drug” combination group. The 
distribution of mutually exclusive groups was then less homogeneous in different 
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countries and in the two studies. However for Belgium, Denmark, Finland and Italy, in the 
seriously injured drivers study, and for Norway, in the killed drivers study, the “drug-drug” 
combination group was the third for percentage of drivers included. 
 
In general more positives were found among males than females. In both studies, in the 
male group, the group aged 25-34 was the one that had the highest percentage of 
positive subjects. This happened in all countries apart from Lithuania, in the seriously 
injured drivers, where the age group 50 and over presented a higher percentage of 
positives, and in Finland, in killed drivers, where the age group 18-24 was the one 
recording the highest percentage of positive subjects. In the female group distribution of 
positives was somehow less regular and, in both studies, the highest percentages were 
found in different age groups.  
 
As for time periods, in both studies, higher percentage of positives were normally found 
among drivers involved in accidents occurred at night time, either during the week or the 
weekend, compared to percentages of positive drivers found among subjects involved in 
accidents during daytime. Lithuania was the only country in which the lowest percentage 
of positive drivers was found during week nights.  
 
Although, as reported, the percentage of drivers involved in multiple-vehicle accidents 
was higher than the one involved in single-vehicle accident, percentage of positive 
subjects was higher in single-vehicle accident in both studies, with a ratio of at least 1.5:1 
in the seriously injured drivers, and 1.8:1 in killed drives. In most cases the ratio is > 2. 
 
In the seriously injured drivers study, the distribution of concentrations, when all recorded 
values were considered,  showed that median and mean were above the DRUID cut-off 
for almost all substances. In the killed drivers study, median and mean concentrations 
obtained considering all recorded values were above the DRUID cut-off for all substances 
apart from flunitrazepam. 
 
Regarding the distribution of alcohol concentration, 24.4% of the injured drivers 
population was positive for alcohol. 65.7% of them had a BAC ≥ 1.3 g/L. In the killed 
drivers population 31.7% was positive for alcohol. 70.6% of them had a BAC ≥ 1.3 g/L.  
 
 
Comparing the DRUID-results with data from previous studies conducted on injured 
drivers (see table 111), the following conclusions could be drawn: 
- DRUID alcohol prevalence was higher than in the Australian study and lower than the 
percentages found in the United States or South-Africa. 
- More positive findings for the combination alcohol-drug were found than in the 
Australian study. On the other hand DRUID-prevalence for this substance group was 
lower than found in the American study of 2005. 
- The percentage of amphetamine positives within DRUID was higher. This could be 
explained by the inclusion of Northern European countries that have a higher prevalence 
of use, which was supported by the fact of a similar percentage of amphetamine positive 
findings in the Danish study (2005). 
- The prevalence of cocaine was much lower than in the United States. 
- The percentage of drivers positive for cannabis was lower in DRUID except for the 
Danish and Dutch studies conducted in 2005. 
- The prevalence of benzodiazepines was lower than in one of the American and both 
French studies. 
- Opiate use is quite similar, except for two of the American studies where higher 
percentages were seen. 
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Comparing the DRUID-results with data from previous studies conducted on killed drivers 
(see table 112), the following conclusions could be drawn: 
- DRUID alcohol prevalence was lower than in the American, Italian and Spanish studies. 
It has to be noted that Italy and Spain were not involved in the DRUID study. 
- The prevalence of drug use was lower except for the study conducted in Hong Kong 
- More positive findings for the combination alcohol-drug were found than in the studies in 
Hong Kong and Sweden. On the other hand DRUID prevalence for this substance group 
was lower than found in the American, Italian, Canadian and Australian studies. 
- The percentage of amphetamine positives within DRUID was lower except for the 
Spanish, Italian and Canadian studies.This confirmes the lesser amphetamine use in 
Southern Europe  
-  The prevalence of cocaine was lower than in the other studies. This could be explained 
by the fact that only one Southern European country was involved in the DRUID study 
amongst four Northern countries, where the use of cocaine is known to be lower. This 
conclusion could be supported by the fact of a similar prevalence found in the Swedish 
study in 2005. 
- The percentage for positive findings for cannabis is lower in DRUID except for the 
studies conducted in Spain and Hong Kong 
- The prevalence of benzodiazepines was higher except for the Canadian study where a 
similar percentage was found. 
 
 
Perspectives/Recommendations 
- It is recommended (if there is enough funding) to include more countries and hospitals 
to get a better European overview. 
- It can be recommended to collect saliva samples in hospital studies to be able to make 
better comparisons with saliva samples collected in road side surveys, were it is known to 
be more difficult to collect blood samples (see D2.2.3). It was performed in Finland and 
this shows that it is feasible. However, when requested to take saliva samples from 
seriously injured drivers, hospitals in Denmark refused. 
- Guidelines and legislation regarding ethical issues in studies with human subjects can 
hamper the survey. The need of a written informed consent makes the patient less 
inclined to participate.  
- This study emphasised the importance of the chosen study design and protocols.  For 
example in the killed drivers study the collaboration with police forces was needed to get 
essential information. A recommendation for future research is to establish a good 
communication and collaboration with all partners involved in the survey. The working 
group on alcohol, drugs, medicines and driving of DG Move has recommended that in all 
EU member states, all killed drivers have a toxicology screening. This is performed in the 
Scandinavian countries, but not elsewhere. In the Netherlands this is impossible, 
because of the fear that insurance companies would misuse the results to refuse 
reimbursement. 
- The study showed how difficult it is to collect samples from injured drivers in hospitals, 
as collecting study samples is not the priority of emergency personnel. The importance of 
staff specifically assigned to the study in the hospitals was underlined. It was seen that 
hospitals who had such a key person collected more samples and that this contact 
person was essential for a good follow-up.  
- One of the inclusion criteria applied was that the injury severity had to be MAIS 2 or 
higher.  When analysing the data it became clear that a lot of injured drivers in different 
countries had a lower injury severity.  In future research it should be considered to 
include also MAIS 1, because there are fewer seriously injured drivers expected than in 
the past. 
-In this study it was chosen to use LCMSMS or GCMS for the analysis of blood. This 
restricted the amount of substances to be searched for, e.g. not all benzodiazepines were 
analysed for. Future studies should consider using more broad-spectrum methods such 
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as immunoassays for some drug classes like benzodiazepines. The emergence of new 
designer drugs like mephedrone, piperazines, spice, etc. brings new challenges.  
- Attention should be paid to the collection of data of patients that refused to participate 
and patients that were missed. This is needed in order to be able to examine refusal rates 
and to see whether they introduce bias. 
-Attention should also be paid to the recording of drugs administered prior to sampling 
and to the interval between time of accident/time of death and the time the sample is 
taken. These were not reported in all cases in our study, and some manual corrections 
were necessary. 
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Table 111. Prevalence of drugs, medicines and/or alcohol in seriously injured drivers (percentage)15 
 Country 
 Australia Denmark France Netherlands South Africa United States BE, 
DK, FI, 
IT, LT, 
NL 
Study Longo et al. 
(2000a) 
Bernhoft 
et al. 
(2005) 
Kintz 
et al. 
(2000) 
Mura 
et al. 
(2003) 
Assum et al. 
(2005) 
Sukhai 
(2004) 
Soderstrom 
et al. 
(2001) 
Lowenstein 
and Koziol-
McLain 
(2001) 
Walsh 
et al. 
(2005) 
DRUID 
2010 
 
Year(s) 1995-1996 2002-
2004 
1999 2000-
2001 
2000-2004 1999-2001 1994-1996 1995-1996 2003 2007-
2010 
Sample size 2 500 330 198 900 184 / 748 (A) 414 108 2450 
        500 (D)    
Sample blood blood 
and/or 
blood blood blood or 
urine 
/ blood urine blood 
(A) 
blood 
   saliva       urine 
(D) 
 
Remarks     weighted 
results 
     
Alcohol  detected 11.0  13.6   45.2 30.0  30.6 24.4 
≥ 0.1 ‰          24.4 
> 0.2 ‰     18.6 (*)      
> 0.4 ‰        13.8   
≥ 0.5 ‰ 10.3    17.4 (*)     22.1 
> 0.8 ‰ 9.2    15.2 (*)      
Drugs      34.1   50.9 15.2 
Drugs + alcohol  1.4     19.5   15.7 5.8 
≥ 0.1 ‰          5.8 
> 0.2 ‰ 1.2    10.4      
                                                          
15 Source: Raes E, Van den Neste T, Verstraete A, EMCDDA Insights: Drug use, impaired driving and traffic accidents: Table A2 p135 
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≥ 0.5 ‰ 1.0   3.8 8.9     5.3 
> 0.8 ‰     8.4      
Drug +  drug          2.4 
MDEA 0.04         0.0 
Amphetamine 0.2  0.7   0.0 0.7 0.9 1.6 
MDMA        0.2 
MDA  
0.5 
      0.0 
Methamphetamine 0.7 
1.5 
      5.6 0.4 
Cocaine  0.6 0.5 0.1   18.7 3.6 10.2 2.9 
Cannabis 7.1 3.3 9.6 10.0 3.4 (*)  9.6 16.9 26.9 5.3 
Benzodiazepines 1.8 3.0 6.1 14.0 3.6 (*)   1.2 11.1 4.3 
Opiates   1.8  2.7   23.7 1.5 10.2  
  morphine         1.5 
  heroin   0.5  
0.5 (*) 
    0.9 
  codeine   1.5  1.0 (*)     0.3 
Methadone        0.2 5.6 1.1 
Tramadol          1.3 
Barbiturates        1.0 3.7  
Norephedrine   0.5        
Antidepressants    1.8       
Propoxyphene        1.5   
(*): only this substance present, no combinations / A: alcohol / D: drugs  
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Table 112. Prevalence of drugs, medicines and/or alcohol in killed drivers (percentage)16 
 Country 
 
 Australi
a 
Canada France Hong 
Kong 
Italy Spain Sweden UK US FI,NO, 
PO, SE 
Study Drummer 
et al 
(2005) 
Brault et 
al (2004)
Mura et 
al 
(2006) 
Cheng et al 
(2005) 
Sironi 
et al 
(1999)
Vignali 
et al 
(2001) 
del Rio et 
al (2002)
Lopez-
Rivadulla 
and Cruz 
(2000) 
Holmgren 
et al 
(2005) 
Assum et 
al (2005) 
Logan 
and 
Schwilke 
(2004-
05) 
DRUID 
2010 
Year 1990-
1999 
1999-
2002 
2003-
2004 
1996-2000 1986-
1996 
1997-
1999 
1991-
2000 
1996-
1998 
2000-2002 1998-
2002 
2001-
2002 
2007-
2010 
Sample size 3398 855 2003 197 129 119 5745 33 855 22 370 1050 
Sample blood blood 
and 
urine 
blood blood (A), 
blood and 
urine (D) 
blood 
(A),  
blood 
and 
urine 
(D) 
blood blood blood 
and urine
blood and 
urine 
blood blood 
and 
serum 
blood 
>0.5 ‰: 
29.1 
33.5  >0.5‰: 
24.9 
55.8 47.9 43.8 58.9 >0.2‰: 
22.2 
36.4 44.0 32.8 Alcohol  
 >0.8‰: 
28.5 
  >0.1‰: 
48.1 
 >0.8‰: 
32.0  
   ≥0.5‰: 
28.6 
Drugs 26.7 24.7 6.1 21.9 15.6 
      Illicit  8.8 8.1  
      Medicinal  4.7 19.4  
Drugs + alcohol  9.7 11.7  2.5 
 
16.0 5.6 7.0 >0.2‰: 4.9  17.0 6.6 
                                                          
16 Source: Raes E, Van den Neste T, Verstraete A, EMCDDA Insights: Drug use, impaired driving and traffic accidents: Table A3 p136-7 
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    >0.5‰:  2.0
       ≥5‰: 5.9 
Drug + drug            2.5 
Amphetamine 4.1 0.4 3.1 0.0 1.2 5.2 4.6 4.9 1.6 
Methamphetamine  1.5 0.8 1.0 
MDMA  1.5 0.0 0.6 0.9 0.4 
MDA   0.8  0.0 
Cocaine  4.7 3.0 4.7 8.4 5.2 0.5 3.5 0.7 
Cannabis 13.5 13.1 28.9 2.0 4.7 8.4 2.2 3.9 12.7 2.9 
Benzodiazepines 4.1 9.2  1.0 3.9  5.9 3.4  7.6 Diazepa
m: 4.6
4.1 8.4 
Opiates  4.9 1.3 1.9     3.4 3.2   4.6 1.6 1.7 
Methadone  3.9 0.8  0.1 0.1 
 A: alcohol / D: drugs    
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Annex 1 Guidelines for the study and the data 
collection17  
 
The study population was achieved by ‘multistage sampling’. First a selection of hospitals 
was made. Secondly, only patients that match a number of well-defined inclusion criteria 
were selected. 
 
Selection of hospitals 
Different criteria were considered for the selection of the hospitals. 
• willingness to cooperate 
• geographical distribution. This is especially important when roadside surveys 
were organised in the hospital catchment areas in order to increase 
representativeness of the roadside survey. 
• Influx of injured drivers. A small amount of large hospitals was preferred over a 
large number of small hospitals (with better geographical distribution) because 
the data collection was easier to control. 
Once a first selection of hospitals was made, it was recommended to perform pilot tests 
in each hospital over a limited period of time (e.g. 2 weeks). The number of incoming 
injured drivers was recorded including information concerning the inclusion criteria. These 
data could be extrapolated to the expected duration of the study to see if the desired 
sample size could be obtained. If necessary, the number of hospitals could then be 
adjusted. 
Each partner had to check if approval of the ethical committee of the hospitals and 
informed consent of the patients was necessary. 
 
Hospital personnel 
It was advised to have dedicated personnel present in each hospital, eg a local 
supervisor (MD) and a local coordinator (nurse). A researcher would regularly visit all 
hospitals to check for problems and made changes if necessary. 
Each hospital received a detailed manual explaining all aspects of the study (e.g. 
inclusion criteria, data to be gathered and correct interpretation of all forms). 
 
Inclusion criteria 
It was necessary to define precise inclusion criteria for the subjects. To increase 
homogeneity across Europe, it was preferred that these were the same in all countries. 
However, due to practical and legal issues, national differences might have been 
necessary. Therefore two lists of criteria were made: a first list of inclusion criteria that all 
countries needed to comply with and an additional list of criteria on which countries could 
decide for themselves. 
 
Recommendations 
 
Deviations from these inclusion criteria had to be substantiated and approved by the Task 
and WP leader 
Obligatory inclusion criteria: 
• Driver of a motorised vehicle 
• Injured in accident on a public road or in the direct vicinity of a public road 
                                                          
17 Source: D2.1.2: Working paper “uniform design and protocols for carrying out case-control studies” 
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• Only primary admissions, not patients transferred from other hospitals 
• Admissions because of traumatological reasons 
• Time interval between accident and sampling had to be less than 3 hours 
• Severity of injuries: MAIS (Maximum Abbreviated Injury Scale) 2 or higher 
National inclusion criteria (each country decided whether to apply these criteria): 
• Inclusion of injured bicycle riders 
• Age. It was suggested to include only drivers older than 18, since informed 
consent was easier to obtain 
• Inclusion of drivers killed on the spot. In most countries this was not possible due 
to practical or legal reasons 
• Inclusion of foreign drivers. This was recommended since the study investigated 
the driving population within a country an not only the native driving population 
• Inclusion of professional drivers 
Minimum data to be gathered 
The data that could be obtained were limited because of the low accessibility of the 
patients (e.g. short stay in hospital, unconsciousness, deceased in hospital,…) and 
practical concerns from the hospital staff.  
Therefore it was advised to collect only a limited number of data which had to be 
standardised across Europe. The minimum data to be gathered could be divided into 
three groups: 
• Toxicological information: the substances and analytical cut-offs have been 
standardised across Europe 
• Patient information 
- Identification number (for labeling of samples and recorded data) 
- Age 
- Gender 
- Time + date of sampling 
- Medication/fluids administered prior to blood sampling 
- Severity of injuries: MAIS 
• Accident data 
- Time + date 
- Type of vehicle 
- Single vehicle accident: yes/no 
- Driver’s license: yes/yes, but suspended/no 
- Professional use of vehicle: yes/no (only if professional drivers were 
included) 
If possible, more information was gathered in each country, e.g. the degree of damage to 
the vehicle. 
 
Collection of patient information 
The questioning of the patient was preferably done face-to-face. If this was impossible 
(e.g. patient remains unconscious), partial information could be gathered from other 
sources (e.g. medical record). It was stressed that the questionnaire should be 
anonymous. Consequently, non-response could be reduced to a minimum. 
When patients refused to cooperate with the study, the reason had to be recorded. 
Proxy-informants were allowed to give certain information, if patients were unable to 
answer. 
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Protection of patient information 
All necessary procedures were applied to guarantee the privacy of the patient and the 
confidentiality of the doctor-patient relation: 
• All information was gathered under supervision of an MD 
• No references about the inclusion of a patient in the study could be made in the 
medical files of the patient 
• The blood samples gathered for this study were treated in a separate procedure 
and could never be used for clinical or forensic purposes. 
• The toxicological analysis and data processing were done anonymously. All 
forms and samples were given a unique and anonymous code, of which only the 
local coordinator had the key. An additional coding was performed in the centre 
where all data are centralised; the files containing the decoding keys had to be 
password-protected. 
• The results of the analysis could not be given to anyone outside the laboratory 
and the responsible partner for data processing. 
 
Collecting of accident information 
Collection of accident information would in some countries require cooperation between 
the police and researchers. This was not always easy since the principles of police work 
were different from those of the research. Since the terms of the cooperation depended 
on the local situation, each partner had to check with the police how this had to be 
organised. Points of particular interest were reliable collection of data and guaranteeing 
the anonymity of the patients included in the study. 
 
Time frame 
Both traffic accidents and the prevalence of psychoactive substances may vary by time. 
Consequently, the roadside surveys had to cover all year, all week and all day. Since the 
same logic applied to the hospital study, the time frame for collection of samples in both 
studies had to be the same. 
Week and weekend – day and night was defined in the following 8 time intervals of the 
week to ensure comparability: 
 
Table 113. DRUID-time periods 
Weekdays Weekend 
1. Monday to Friday 04:00 to 09:59 5. Saturday and Sunday 04:00 to 09:59 
2. Monday to Friday 10:00 to 15:59  6. Saturday and Sunday 10:00 to 15:59 
3. Monday to Thursday 16:00 to 21:59 7. Friday to Sunday 16:00 to 21:59 
4. Monday to Thursday 22:00 to 03:59 8. Friday to Sunday 22:00 to 03:59 
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Annex 2 Seriously injured drivers- Distribution of 
positive drivers- Mutually exclusive groups 
Table 114. Seriously injured drivers – Distribution of positive drivers – Amphetamines only 
Mutually exclusive group - Percentage of drivers positive for AMPHETAMINES ONLY  
Among subjects of the same age group 
MALE 
18-24 25-34 35-49 50 and over Age unknown 
Among all male 
subjects 
Belgium 0.0 0.0 1.8 2.3 0.0 0.9 
Denmark 1.1 3.6 0.0 0.0 0.0 1.3 
Finland 0.0 0.0 0.0 0.0 N.A. 0.0 
Italy 0.0 0.0 0.0 0.0 N.A. 0.0 
Lithuania 0.0 0.0 1.5 0.0 0.0 0.4 
The Netherlands 0.0 2.6 0.0 0.0 N.A. 0.7 
Among subjects of the same age group 
FEMALE 
18-24 25-34 35-49 50 and over Age unknown 
Among all 
female subjects 
Belgium 5.9 0.0 0.0 0.0 0.0 1.1 
Denmark 1.3 0.0 0.0 0.0 0.0 0.3 
Finland 0.0 0.0 0.0 0.0 N.A. 0.0 
Italy 0.0 0.0 0.0 0.0 N.A. 0.0 
Lithuania 0.0 0.0 0.0 0.0 0.0 0.0 
The Netherlands 0.0 8.3 0.0 0.0 N.A. 2.7 
Among subjects of the same age group UNKNOWN 
GENDER 18-24 25-34 35-49 50 and over Age unknown 
Among all 
subjects of 
unknown gender
Belgium N.A N.A. N.A. N.A. 0.0 0.0 
Lithuania 0.0 0.0 N.A. 0.0 0.0 0.0 
 
Table 115. Seriously injured drivers – Distribution of positive drivers – Benzoylecgonine 
only  
Mutually exclusive group - Percentage of drivers positive for BENZOYLECGONINE ONLY  
Among subjects of the same age group 
MALE 
18-24 25-34 35-49 50 and over Age unknown 
Among all male 
subjects 
Belgium 0.0 0.0 0.0 0.0 0.0 0.0 
Denmark 0.0 0.0 0.0 0.0 0.0 0.0 
Finland 0.0 0.0 0.0 0.0 N.A. 0.0 
Italy 1.0 0.6 1.3 0.0 N.A. 0.8 
Lithuania 0.0 1.9 0.0 0.0 0.0 0.4 
The Netherlands 0.0 0.0 5.9 0.0 N.A. 1.3 
Among subjects of the same age group 
FEMALE 
18-24 25-34 35-49 50 and over Age unknown 
Among all 
female subjects 
Belgium 0.0 0.0 0.0 0.0 0.0 0.0 
Denmark 0.0 0.0 0.0 0.0 0.0 0.0 
Finland 0.0 0.0 0.0 0.0 N.A. 0.0 
Italy 0.0 2.1 0.0 0.0 N.A. 0.6 
Lithuania 0.0 0.0 0.0 0.0 0.0 0.0 
The Netherlands 0.0 0.0 0.0 0.0 N.A. 0.0 
Among subjects of the same age group UNKNOWN 
GENDER 18-24 25-34 35-49 50 and over Age unknown 
Among all 
subjects of 
unknown gender
Belgium N.A. N.A. N.A. N.A. 0.0 0.0 
Lithuania 0.0 0.0 N.A. 0.0 0.0 0.0 
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Table 116. Seriously injured drivers – Distribution of positive drivers – Cocaine only 
Mutually exclusive group - Percentage of positive for COCAINE ONLY  
Among subjects of the same age group 
MALE 
18-24 25-34 35-49 50 and over Age unknown 
Among all male 
subjects 
Belgium 0.0 0.0 0.0 0.0 0.0 0.0 
Denmark 0.0 0.0 0.0 0.0 0.0 0.0 
Finland 0.0 0.0 0.0 0.0 N.A. 0.0 
Italy 0.0 0.6 2.0 0.0 N.A. 0.8 
Lithuania 0.0 0.0 0.0 2.4 0.0 0.4 
The Netherlands 0.0 0.0 0.0 0.0 N.A. 0.0 
Among subjects of the same age group 
FEMALE 
18-24 25-34 35-49 50 and over Age unknown 
Among all 
female subjects 
Belgium 0.0 0.0 0.0 0.0 0.0 0.0 
Denmark 0.0 0.0 0.0 0.0 0.0 0.0 
Finland 0.0 0.0 0.0 0.0 N.A. 0.0 
Italy 0.0 0.0 0.0 0.0 N.A. 0.0 
Lithuania 0.0 0.0 0.0 0.0 0.0 0.0 
The Netherlands 0.0 0.0 0.0 0.0 N.A. 0.0 
Among subjects of the same age group UNKNOWN 
GENDER 18-24 25-34 35-49 50 and over Age unknown 
Among all 
subjects of 
unknown gender
Belgium N.A. N.A. N.A. N.A. 0.0 0.0 
Lithuania 0.0 0.0 N.A. 0.0 0.0 0.0 
 
Table 117. Seriously injured drivers – Distribution of positive drivers – THCCOOH only  
Mutually exclusive group - Percentage of drivers positive for THCCOOH ONLY 
Among subjects of the same age group 
MALE 
18-24 25-34 35-49 50 and over Age unknown 
Among all male 
subjects 
Belgium 0.0 2.7 0.0 0.0 0.0 0.9 
Denmark 2.2 2.1 2.4 1.1 0.0 2.0 
Finland 0.0 0.0 0.0 0.0 N.A. 0.0 
Italy 2.0 0.6 0.0 0.0 N.A. 0.6 
Lithuania 0.0 0.0 0.0 0.0 0.0 0.0 
The Netherlands 0.0 0.0 0.0 0.0 N.A. 0.0 
Among subjects of the same age group 
FEMALE 
18-24 25-34 35-49 50 and over Age unknown 
Among all 
female subjects 
Belgium 0.0 0.0 0.0 0.0 0.0 0.0 
Denmark 0.0 1.6 1.1 0.0 0.0 0.7 
Finland 0.0 0.0 0.0 0.0 N.A 0.0 
Italy 0.0 0.0 0.0 0.0 N.A 0.0 
Lithuania 0.0 0.0 0.0 0.0 0.0 0.0 
The Netherlands 0.0 0.0 0.0 0.0 N.A 0.0 
Among subjects of the same age group UNKNOWN 
GENDER 18-24 25-34 35-49 50 and over Age unknown 
Among all 
subjects of 
unknown gender
Belgium N.A. N.A. N.A. N.A. 0.0 0.0 
Lithuania 0.0 0.0 N.A. 0.0 12.5 7.7 
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Table 118. Seriously injured drivers – Distribution of positive drivers – THC only  
Mutually exclusive group - Percentage of drivers positive for THC ONLY 
Among subjects of the same age group 
MALE 
18-24 25-34 35-49 50 and over Age unknown 
Among all male 
subjects 
Belgium 4.1 2.7 0.0 0.0 0.0 1.7 
Denmark 1.6 0.0 0.8 0.0 0.0 0.7 
Finland 8.3 0.0 0.0 0.0 N.A. 2.7 
Italy 4.0 3.1 0.7 0.0 N.A. 1.9 
Lithuania 0.0 0.0 1.5 0.0 0.0 0.4 
The Netherlands 0.0 2.6 0.0 0.0 N.A. 0.7 
Among subjects of the same age group 
FEMALE 
18-24 25-34 35-49 50 and over Age unknown 
Among all 
female subjects 
Belgium 5.9 0.0 0.0 0.0 0.0 1.1 
Denmark 0.0 1.6 0.0 0.0 0.0 0.3 
Finland 0.0 0.0 0.0 0.0 N.A. 0.0 
Italy 0.0 2.1 0.0 0.0 N.A. 0.6 
Lithuania 0.0 0.0 0.0 0.0 0.0 0.0 
The Netherlands 0.0 0.0 0.0 0.0 N.A. 0.0 
Among subjects of the same age group UNKNOWN 
GENDER 18-24 25-34 35-49 50 and over Age unknown 
Among all 
subjects of 
unknown gender
Belgium N.A. N.A. N.A. N.A. 0.0 0.0 
Lithuania 0.0 0.0 N.A. 0.0 0.0 0.0 
 
Table 119. Seriously injured drivers – Distribution of positive drivers – Illicit opiates only 
Mutually exclusive group - Percentage of drivers positive for ILLICIT OPIATES ONLY 
Among subjects of the same age group 
MALE 
18-24 25-34 35-49 50 and over Age unknown 
Among all male 
subjects 
Belgium 0.0 0.0 0.0 0.0 0.0 0.0 
Denmark 0.0 0.0 0.0 0.0 0.0 0.0 
Finland 0.0 0.0 0.0 0.0 N.A. 0.0 
Italy 0.0 1.2 1.3 0.0 N.A. 0.8 
Lithuania 0.0 0.0 0.0 0.0 0.0 0.0 
The Netherlands 0.0 0.0 0.0 0.0 N.A. 0.0 
Among subjects of the same age group 
FEMALE 
18-24 25-34 35-49 50 and over Age unknown 
Among all 
female subjects 
Belgium 0.0 0.0 0.0 0.0 0.0 0.0 
Denmark 0.0 0.0 0.0 0.0 0.0 0.0 
Finland 0.0 0.0 0.0 0.0 N.A. 0.0 
Italy 0.0 2.1 0.0 0.0 N.A. 0.6 
Lithuania 0.0 0.0 0.0 0.0 0.0 0.0 
The Netherlands 0.0 0.0 0.0 0.0 N.A. 0.0 
Among subjects of the same age group UNKNOWN 
GENDER 18-24 25-34 35-49 50 and over Age unknown 
Among all 
subjects of 
unknown gender
Belgium N.A. N.A. N.A. N.A. 0.0 0.0 
Lithuania 0.0 0.0 N.A. 0.0 0.0 0.0 
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Table 120. Seriously injured drivers – Distribution of positive drivers – Benzodiazepines only 
Mutually exclusive group - Percentage of drivers positive for BENZODIAZEPINES ONLY 
Among subjects of the same age group 
MALE 
18-24 25-34 35-49 50 and over Age unknown 
Among all male 
subjects 
Belgium 0.0 0.0 0.0 4.5 0.0 0.9 
Denmark 0.5 0.0 0.8 3.4 0.0 0.9 
Finland 0.0 0.0 0.0 0.0 N.A. 0.0 
Italy 0.0 0.0 0.0 0.0 N.A. 0.0 
Lithuania 0.0 3.8 1.5 7.1 0.0 2.5 
The Netherlands 0.0 0.0 0.0 0.0 N.A. 0.0 
Among subjects of the same age group 
FEMALE 
18-24 25-34 35-49 50 and over Age unknown 
Among all 
female subjects 
Belgium 0.0 0.0 3.7 10.0 0.0 3.2 
Denmark 1.3 1.6 1.1 1.8 20.0 1.7 
Finland 0.0 0.0 0.0 0.0 N.A. 0.0 
Italy 0.0 2.1 0.0 7.1 N.A. 1.9 
Lithuania 2.8 4.9 0.0 0.0 0.0 2.2 
The Netherlands 0.0 0.0 0.0 0.0 N.A. 0.0 
Among subjects of the same age group UNKNOWN 
GENDER 18-24 25-34 35-49 50 and over Age unknown 
Among all 
subjects of 
unknown gender
Belgium N.A. N.A. N.A. N.A. 0.0 0.0 
Lithuania 0.0 0.0 N.A. 0.0 0.0 0.0 
 
Table 121. Seriously injured drivers – Distribution of positive drivers – Z-drugs only 
Mutually exclusive group - Percentage of drivers positive for Z-DRUGS ONLY 
Among subjects of the same age group 
MALE 
18-24 25-34 35-49 50 and over Age unknown 
Among all male 
subjects 
Belgium 0.0 0.0 0.0 0.0 0.0 0.0 
Denmark 0.0 0.0 0.0 2.2 0.0 0.4 
Finland 0.0 0.0 0.0 12.5 N.A. 2.7 
Italy 0.0 0.0 0.0 0.0 N.A. 0.0 
Lithuania 0.0 0.0 0.0 0.0 0.0 0.0 
The Netherlands 0.0 0.0 0.0 3.8 N.A. 0.7 
Among subjects of the same age group 
FEMALE 
18-24 25-34 35-49 50 and over Age unknown 
Among all 
female subjects 
Belgium 0.0 0.0 7.4 0.0 25.0 3.2 
Denmark 0.0 1.6 0.0 1.8 0.0 0.7 
Finland 0.0 0.0 0.0 0.0 N.A. 0.0 
Italy 0.0 0.0 0.0 0.0 N.A. 0.0 
Lithuania 0.0 0.0 0.0 0.0 0.0 0.0 
The Netherlands 0.0 0.0 0.0 0.0 N.A. 0.0 
Among subjects of the same age group UNKNOWN 
GENDER 18-24 25-34 35-49 50 and over Age unknown 
Among all 
subjects of 
unknown gender
Belgium N.A. N.A. N.A. N.A. 0.0 0.0 
Lithuania 0.0 0.0 N.A. 0.0 0.0 0.0 
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Table 122. Seriously injured drivers – Distribution of positive drivers – Medicinal opioids 
only 
Mutually exclusive group - Percentage of drivers positive for MEDICINAL OPIOIDS ONLY 
Among subjects of the same age group 
MALE 
18-24 25-34 35-49 50 and over Age unknown 
Among all male 
subjects 
Belgium 0.0 1.4 0.0 0.0 12.5 0.9 
Denmark 0.5 0.7 3.2 5.6 0.0 2.0 
Finland 0.0 0.0 0.0 0.0 N.A. 0.0 
Italy 1.0 1.2 2.0 0.9 N.A. 1.3 
Lithuania 10.6 3.8 4.5 14.3 0.0 7.6 
The Netherlands 0.0 0.0 2.9 0.0 N.A. 0.7 
Among subjects of the same age group 
FEMALE 
18-24 25-34 35-49 50 and over Age unknown 
Among all 
female subjects 
Belgium 0.0 3.8 3.7 0.0 0.0 2.1 
Denmark 0.0 3.2 5.7 3.6 20.0 3.4 
Finland 0.0 0.0 0.0 0.0 N.A. 0.0 
Italy 0.0 6.4 3.6 0.0 N.A. 3.2 
Lithuania 0.0 2.4 5.3 0.0 0.0 2.2 
The Netherland 0.0 0.0 0.0 0.0 N.A. 0.0 
Among subjects of the same age group UNKNOWN 
GENDER 18-24 25-34 35-49 50 and over Age unknown 
Among all 
subjects of 
unknown gender
Belgium N.A. N.A. N.A. N.A. 0.0 0.0 
Lithuania 0.0 0.0 N.A. 0.0 12.5 7.7 
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Annex 3 Killed drivers – Distribution of positive 
drivers – Mutually exclusive groups  
 
 
Table 123. Killed drivers – Distribution of positive drivers – Amphetamine only 
Mutually exclusive group - Percentage of drivers positive for AMPHETAMINES ONLY  
Among subjects of the same age group 
MALE 
18-24 25-34 35-49 50 and over Age unknown 
Among all male 
subjects 
Finland 2.1 0.0 0.0 0.7 N.A. 0.8 
Norway 2.4 0.0 3.8 0.0 N.A. 1.5 
Portugal 0.0 0.0 0.0 0.0 0.0 0.0 
Sweden 3.6 7.7 4.8 0.0 N.A. 2.8 
Among subjects of the same age group 
FEMALE 
18-24 25-34 35-49 50 and over Age unknown 
Among all 
female subjects 
Finland 0.0 0.0 0.0 0.0 N.A. 0.0 
Norway 0.0 0.0 0.0 0.0 N.A. 0.0 
Portugal 0.0 0.0 0.0 0.0 N.A. 0.0 
Sweden 0.0 0.0 0.0 0.0 N.A. 0.0 
 
Table 124. Killed drivers – Distribution of positive drivers – Benzoylecgonine only  
Mutually exclusive group - Percentage of drivers positive for BENZOYLECGONINE ONLY  
Among subjects of the same age group 
MALE 
18-24 25-34 35-49 50 and over Age unknown 
Among all male 
subjects 
Finland 0.0 0.0 0.0 0.0 N.A. 0.0 
Norway 0.0 0.0 0.0 0.0 N.A. 0.0 
Portugal 0.0 0.0 0.0 0.0 0.0 0.0 
Sweden 0.0 0.0 0.0 0.0 N.A. 0.0 
Among subjects of the same age group 
FEMALE 
18-24 25-34 35-49 50 and over Age unknown 
Among all 
female subjects 
Finland 0.0 0.0 0.0 0.0 N.A. 0.0 
Norway 0.0 0.0 0.0 0.0 N.A. 0.0 
Portugal 0.0 0.0 0.0 0.0 N.A. 0.0 
Sweden 0.0 0.0 0.0 0.0 N.A. 0.0 
 
Table 125. Killed drivers – Distribution of positive drivers – Cocaine only  
Mutually exclusive group - Percentage of drivers positive for COCAINE ONLY  
Among subjects of the same age group 
MALE 
18-24 25-34 35-49 50 and over Age unknown 
Among all male 
subjects 
Finland 0.0 0.0 0.0 0.0 N.A. 0.0 
Norway 0.0 0.0 0.0 0.0 N.A. 0.0 
Portugal 0.0 0.0 0.0 0.0 0.0 0.0 
Sweden 0.0 0.0 0.0 0.0 N.A. 0.0 
Among subjects of the same age group 
FEMALE 
18-24 25-34 35-49 50 and over Age unknown 
Among all 
female subjects 
Finland 0.0 0.0 0.0 0.0 N.A. 0.0 
Norway 0.0 0.0 0.0 0.0 N.A. 0.0 
Portugal 0.0 0.0 0.0 0.0 N.A. 0.0 
Sweden 0.0 0.0 0.0 0.0 N.A. 0.0 
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Table 126. Killed drivers – Distribution of positive drivers – THCCOOH only  
Mutually exclusive group - Percentage of drivers positive for THCCOOH ONLY 
Among subjects of the same age group 
MALE 
18-24 25-34 35-49 50 and over Age unknown 
Among all male 
subjects 
Portugal 2.4 3.1 0.0 0.0 0.0 1.1 
Sweden 0.0 0.0 0.0 0.0 N.A. 0.0 
Among subjects of the same age group 
FEMALE 
18-24 25-34 35-49 50 and over Age unknown 
Among all 
female subjects 
Portugal 0.0 0.0 0.0 0.0 N.A. 0.0 
Sweden 0.0 0.0 0.0 0.0 N.A. 0.0 
 
Table 127. Killed drivers – Distribution of positive drivers – THC only 
Mutually exclusive group - Percentage of drivers positive for THC ONLY 
Among subjects of the same age group 
MALE 
18-24 25-34 35-49 50 and over Age unknown 
Among all male 
subjects 
Finland 0.0 0.0 0.0 0.0 N.A. 0.0 
Norway 2.4 7.7 0.0 0.0 N.A. 2.3 
Portugal 0.0 0.0 0.0 0.0 0.0 0.0 
Sweden 3.6 0.0 0.0 0.0 N.A. 0.9 
Among subjects of the same age group 
FEMALE 
18-24 25-34 35-49 50 and over Age unknown 
Among all 
female subjects 
Finland 0.0 0.0 0.0 0.0 N.A. 0.0 
Norway 0.0 0.0 0.0 0.0 N.A. 0.0 
Portugal 0.0 0.0 0.0 0.0 N.A. 0.0 
Sweden 0.0 0.0 0.0 0.0 N.A. 0.0 
 
Table 128. Killed drivers – Distribution of positive drivers – Illicit opiates only 
Mutually exclusive group - Percentage of drivers positive for ILLICIT OPIATES ONLY 
Among subjects of the same age group 
MALE 
18-24 25-34 35-49 50 and over Age unknown 
Among all male 
subjects 
Finland 0.0 0.0 0.0 0.0 N.A. 0.0 
Norway 0.0 0.0 0.0 0.0 N.A. 0.0 
Portugal 0.0 0.0 0.0 0.0 0.0 0.0 
Sweden 0.0 0.0 0.0 0.0 N.A. 0.0 
Among subjects of the same age group 
FEMALE 
18-24 25-34 35-49 50 and over Age unknown 
Among all 
female subjects 
Finland 0.0 0.0 0.0 0.0 N.A. 0.0 
Norway 0.0 0.0 0.0 0.0 N.A. 0.0 
Portugal 0.0 0.0 0.0 0.0 N.A. 0.0 
Sweden 0.0 0.0 0.0 0.0 N.A. 0.0 
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Table 129. Killed drivers – Distribution of positive drivers – Benzodiazepines only 
Mutually exclusive group - Percentage of drivers positive for BENZODIAZEPINES ONLY 
Among subjects of the same age group 
MALE 
18-24 25-34 35-49 50 and over Age unknown 
Among all male 
subjects 
Finland 0.0 4.7 5.9 7.0 N.A. 4.6 
Norway 0.0 0.0 0.0 2.7 N.A. 0.8 
Portugal 0.0 1.5 0.0 1.2 0.0 0.8 
Sweden 0.0 0.0 0.0 0.0 N.A. 0.0 
Among subjects of the same age group 
FEMALE 
18-24 25-34 35-49 50 and over Age unknown 
Among all 
female subjects 
Finland 6.3 0.0 9.7 9.7 N.A. 8.0 
Norway 12.5 0.0 0.0 14.3 N.A. 5.7 
Portugal 0.0 0.0 0.0 0.0 N.A. 0.0 
Sweden 0.0 0.0 0.0 0.0 N.A. 0.0 
 
Table 130. Killed drivers – Distribution of positive drivers – Z-drugs only 
Mutually exclusive group - Percentage of drivers positive for Z-DRUGS ONLY 
Among subjects of the same age group 
MALE 
18-24 25-34 35-49 50 and over Age unknown 
Among all male 
subjects 
Finland 1.0 0.0 0.0 4.9 N.A. 2.2 
Norway 0.0 0.0 3.8 0.0 N.A. 0.8 
Portugal 0.0 0.0 0.0 0.0 0.0 0.0 
Sweden 0.0 0.0 4.8 4.4 N.A. 2.8 
Among subjects of the same age group 
FEMALE 
18-24 25-34 35-49 50 and over Age unknown 
Among all 
female subjects 
Finland 0.0 0.0 0.0 0.0 N.A. 0.0 
Norway 0.0 0.0 0.0 14.3 N.A. 2.9 
Portugal 0.0 0.0 0.0 0.0 N.A. 0.0 
Sweden 0.0 0.0 10.0 0.0 N.A. 2.9 
 
Table 131. Killed drivers – Distribution of positive drivers – Medicinal opioids only 
Mutually exclusive group - Percentage of positive for MEDICINAL OPIOIDS ONLY 
Among subjects of the same age group 
MALE 
18-24 25-34 35-49 50 and over Age unknown 
Among all male 
subjects 
Finland 1.0 0.0 1.5 3.5 N.A. 1.9 
Norway 0.0 0.0 0.0 0.0 N.A. 0.0 
Portugal 0.0 1.5 0.0 1.2 0.0 0.8 
Sweden 0.0 0.0 0.0 2.2 N.A. 0.9 
Among subjects of the same age group 
FEMALE 
18-24 25-34 35-49 50 and over Age unknown 
Among all 
female subjects 
Finland 0.0 0.0 0.0 0.0 N.A. 0.0 
Norway 12.5 0.0 0.0 0.0 N.A. 2.9 
Portugal 0.0 0.0 0.0 0.0 N.A. 0.0 
Sweden 0.0 0.0 0.0 0.0 N.A. 0.0 
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Part 2 – Country Reports from hospital 
studies 
 
 
1 Country Report Belgium  
 
Authors 
Trudy Van der Linden, Sara-Ann Legrand, Cristina Isalberti, Alain Verstraete 
Ghent University, Belgium. 
 
1.1 Description of the hospitalised driver sample 
1.1.1 Introduction: description of main deviations and justifications/reasons 
The Belgian national database includes injured drivers who were admitted in one of the 
following hospitals: Ghent University Hospital, Regional Hospital of Namur, University 
Hospital Sart Tilman (Liège), Leuven University Hospital and Brussels University 
Hospital. These 5 hospitals were selected because they participated in a previous similar 
study (Belgium Toxicology and Trauma Study) in 1995. The roadside study was adapted 
to the catchment areas of these hospitals. Samples were collected from patients 
hospitalised between January 2008 and May 2010.  
 
Medical staff was in charge of filling in a patient form for each participant. One person 
among the staff members of the accident and emergency department was responsible for 
the study (see Annex 1 of the summary report). The patient form included the ‘minimum 
required data’ and optional data. (see annex 2) 
 
The following optional information were not recorded: 
- Nationality 
- Driver license  
- Clinical signs of impairment 
 
As in Belgium no distinction is made between urban and rural road type, classification 
was made according to speed limit. Roads were grouped into two categories: ‘other 
roads’ (speed limit ≤ 90 km/h) and ‘highway’ (speed limit >90 km/h). 
 
For type of vehicle 7 categories were included: personal car, van, truck/bus, motorcycle, 
bicycle, moped and other vehicles. 
 
For the factor ‘safety belt’ the value ‘not applicable’, coded as a zero, was added in the 
database because of the inclusion of two-wheel vehicles. 
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1.1.2 Geographical distribution of hospitalised drivers over the country/region 
 
Figure 1. Geographical distribution of drivers over the country 
 
For prevalence calculations, data were grouped under the three administrative Belgian 
regions (Brussels, Flanders and Wallonia), so that they could be compared with the data 
collected during the roadside survey.18  
 
Overall, only 3.2% of our injured population was sampled in Brussels, while 81.3% were 
sampled in Flanders and 15.5% in Wallonia (Table 1). This sampling distribution is 
significantly different from the one obtained in Flanders and Wallonia during the roadside 
surveys. The roadside figures are comparable with the distribution of vehicle kilometres in 
these regions (see D 2.2.3). 
 
Table 1. Distribution of drivers by region 
 Distribution of injured drivers Distribution of drivers in the 
roadside survey 
Region  
Brussels 
Flanders 
Wallonia 
   
 Total  
 
35 (3.2%) 
876 (81.3%) 
167 (15.5%) 
 
1078 
 
3.7% 
57.1% 
39.2% 
 
2957 
 
1.1.3 Distribution of drivers by hospital  
A total of 1078 blood samples from injured drivers were collected and delivered to the 
laboratory with the corresponding patient form. Of the 1078 respondents, 40.8% were 
sampled in Ghent University Hospital, 40.4% in Leuven University Hospital, 3.2% in 
Brussels University Hospital, 15% in the Regional Hospital of Namur and only 0.5% in 
University Hospital Sart Tilman (Liège) (Table 2). 
 
                                                          
18 Geographic distribution of roadside sessions was performed systematically. An equal number of sessions was 
scheduled in the catchment area of each hospital participating in DRUID task 2.2.b. For practical reasons, it was 
decided to include 9 police zones in each catchment area. These areas were defined based on information from 
the emergency services.  
 
 DRUID 6th Framework Programme Deliverable D.2.2.5  
Part 2 – Country Reports from hospital studies - Country Report Belgium 
Prevalence of alcohol and other psychoactive substances in injured and killed drivers. 
 
 Page 182 of 349 
Table 2. Geographical distribution of drivers by hospital 
Distribution of injured drivers Hospital 
 n % 
 Ghent 
 Leuven 
 Brussel 
 Namur 
 Sart Tilman (Liège) 
Total 
440 
436 
35 
162 
5 
1078 
40.8% 
40.4% 
3.2% 
15.0% 
0.5% 
 
 
1.1.4 Distribution of drivers by road type 
Table 3. Distribution of drivers by road type 
Distribution of injured drivers Road type 
 n % 
Other roads (≤ 90 km/h) 
Highway (> 90 km/h) 
Unknown 
Total  
797 
118  
163  
1078 
73.9% 
10.9% 
15.1% 
 
 
The road type classification in this report differs from the one in the international 
description. 73.9% of the injured drivers were involved in an accident on ‘other roads’, 
while only 10.9% was involved in a ‘highway’ accident. For 163 injured drivers (15.1%) 
the site of the accident was unknown (Table 3). 
 
1.1.5 Distribution of drivers by day of the week and time of the day 
Table 4. Distribution of drivers by day of the week and time of the day 
Distribution of injured drivers Time period 
 n % 
1 
2 
3 
4 
5 
6 
7 
8 
Unknown 
 
Total 
160 
217 
186 
76 
60 
136 
138 
88 
17 
 
1078 
14.8% 
20.1% 
17.3% 
7.1% 
5.6% 
12.6% 
12.8% 
8.2% 
1.6% 
 
1 = Week 04:00-9:59  5 = Weekend 04:00-9:59 
2 = Week 10:00-15:59  6 = Weekend 10:00-15:59 
3 = Week 16:00-21:59  7 = Weekend 16:00-21:59 
4 = Week 22:00-3:59  8 = Weekend 22:00-3:59 
 
Most of the injured drivers were admitted during the week, between 10:00 and 15:59 
(20.1%). Approximately half of the sample (52.2%) was involved in a weekday accident 
between 04:00 and 21:59 (time periods 1-3). The second biggest group (31%) was from 
weekend day accidents (time periods 5-7). Drivers injured during week nights (time 
period 4) accounted for 7.1% of the sample, while those injured during weekend nights 
(time period 8) accounted for 8.2%.  
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For the calculation of the results reported below, time periods were aggregated into day 
(time periods 1-3 and 5-7), night (time periods 4&8), week (time periods 1-4) and 
weekend (time periods 5-8).  
 
0.0%
10.0%
20.0%
30.0%
40.0%
50.0%
60.0%
70.0%
80.0%
90.0%
Day‐Night Week‐Weekend Unknown
83.2% 59.3% 1.6%
15.3% 39.2%
Distribution by day‐night and week‐weekend
 
Figure 2. Distribution of drivers by day vs night and week vs weekend 
 
1.1.6 Distribution of drivers by season 
Table 5. Distribution of drivers by season 
Distribution of injured drivers Distribution of traffic 
accidents19 
Quarter of the 
year 
n % % 
weighted 
for 
sampling 
period 
n % 
First 
Second 
Third 
Fourth 
Unknown 
Total  
230 
265 
335 
245 
3 
1078 
21.3% 
24.6% 
31.1% 
22.7% 
0.3% 
 
17.2% 
23.2% 
34.5% 
25.2% 
2207 
2932 
3188 
3061 
 
11388 
19.4% 
27.8% 
28.0% 
26.8% 
 
 
Taking into account the sampling period being from 24/1/2008 to 2/5/2010, no equal 
amount of quarters of the year was obtained. Adjusted percentage was calculated by 
weighing for the sampling period (see table 5) 
Most accidents occurred in the third quarter of the year (34.5%). Distribution of drivers in 
the other seasons was quite similar, with 17.2% of respondents sampled in the first 
quarter of the year, 23.2% in the second and 25.2% in the fourth. However, when 
calculating the confidence intervals, a slight significant difference was found for the 
second and third of the year between the data collected in this study and the distribution 
of traffic accidents in 2006 2. 
 
                                                          
19 Studie van de uitwendige oorzaken in de minimale klinische gegevens (2010). Figures from 2006 
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Figure 3. Distribution of injured drivers by quarter of the year (weighted DRUID percentage) 
 
1.1.7 Distribution of drivers by injury severity 
Table 6. Distribution of drivers by injury severity 
Distribution of injured drivers Injury severity (MAIS) 
 n % 
  1 
  2 
  3 
  4 
  5 
  Unknown 
 Total  
2 
734 
248 
41 
31 
22 
1078 
0.2% 
68.1% 
23.0% 
3.8% 
2.9% 
2.0% 
 
 
91.1% of the drivers had a MAIS score of 2 or 3 (68.1% and 23.0% respectively). 3.8% 
had a MAIS score of 4, and 2.9% had a MAIS score of 5. For 0.2% of the sample the 
MAIS score was rated as 1, while for 22 subjects (2%) the MAIS score was not recorded. 
 
1.1.8 Distribution of drivers by age and gender 
Table 7. Distribution of drivers by age and gender 
Gender 
male female unknown 
Total  Age 
groups 
n % n % n % n % 
 unknown 16 2.0% 4 1.5% 1 100.0% 21 1.9% 
 17 years 4 0.5% 0 0% 0 0% 4 0.4% 
  18-24 153 18.9% 50 18.7% 0 0% 203 18.8% 
  25-34 175 21.6% 51 19.0% 0 0% 226 21.0% 
  35-49 236 29.2% 71 26.5% 0 0% 307 28.5% 
  50+ 225 27.8% 92 34.3% 0 0% 317 29.4% 
Total 809 268 1 1078 
 
75% (809) of injured drivers were male and 24.9% (268) female (Table 7). 49.5% of the 
sample belonged to the age groups 25-34 (21.0%) and 35-49 (28.5%). The group aged 
50 and over included 317 subjects (29.4%).  
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Figure 4. Age and gender distribution of injured drivers 
 
1.1.9 Distribution of drivers by safety belt use 
Table 8. Distribution of drivers by safety belt use 
Distribution of drivers Safety belt use 
 n % 
   Yes 
   No 
   Not applicable 
   Unknown 
  Total  
244 
100 
679 
55 
1078 
22.6% 
9.3% 
63.0% 
5.1% 
 
 
Data about safety belt use are shown in Table 8. It has to be noted that, at the time of the 
accident, 63.0% of the respondents were driving vehicles that were not fitted with a safety 
belt, such as motorcycles, bicycles or mopeds. If this is taken into consideration, out of 
399 subjects involved in a road traffic accident while driving a vehicle fitted with safety 
belts (personal cars, vans, bus and trucks), 61.2% were using a seat belt while 25.1% 
were not. Use of safety belt was unknown in 13.8%.  
 
 
Figure 5. Safety belt use in vehicles fitted with safety belts 
 DRUID 6th Framework Programme Deliverable D.2.2.5  
Part 2 – Country Reports from hospital studies - Country Report Belgium 
Prevalence of alcohol and other psychoactive substances in injured and killed drivers. 
 
 Page 186 of 349 
 
1.1.10 Distribution of drivers by type of vehicle 
Table 9. Distribution of drivers by type of vehicle 
Distribution of drivers Type of vehicle 
n % 
   Personal car 
   Van 
   Motorcycle 
   Moped 
   Bicycle 
   Bus/truck > 3500kg 
   Other vehicles 
  Total  
353 
24 
159 
96 
413 
22 
11 
1078 
32.7% 
2.2% 
14.7% 
8.9% 
38.3% 
2.0% 
1.0% 
 
 
Of the 1078 subjects included in the study, approximately 35% were driving either a 
personal car or a van at the time of the accident.  
 
 
1.1.11 Distribution of drivers by accident type 
Table 10. Distribution of drivers by accident type 
Distribution of drivers Accident type 
n % 
Single-vehicle accident 
Multi-part accident 
Unknown 
Total  
500 
517 
61 
1078 
46.4% 
48.0% 
5.6% 
 
 
46.4% (500) of the sampled drivers had a single-vehicle accident, while 48% (517) was 
involved in a multi-part accident. 
Multi-part accidents are defined as accidents involving more than one moving part in the 
traffic. The distribution of counterparts is given in Figure 6. 
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Figure 6. Distribution of counterparts in the multipart accident group (N=517) 
 
If the accident type were divided into single-vehicle (involving only one vehicle) and multi-
vehicle (involving two or more vehicles), 22 accidents, with either a pedestrian or an 
animal as the counterpart, would be classified as single-vehicle accidents and the 
distribution would change slightly as showed in Table 11. For the results described below, 
accidents have been grouped into single-vehicle and multi-vehicle. 
 
Table 11. Distribution of drivers by single-vehicle and multi-vehicle type 
Distribution of drivers Accident type 
n % 
   Single-vehicle accident 
   Multi-vehicle accident 
   Unknown 
  Total  
522 
495  
61  
1078 
48.4% 
45.9% 
5.7% 
 
 
1.2 Methods: data collection and analysis 
 
1.2.1 Ethical approval 
The protocol was submitted to the ethics committee of Ghent University Hospital. 
Approval was obtained on 19/11/2008. (Belgian registration number B67020072944) 
 
1.2.2 Setup of the sampling (specimen collection, site of sampling) 
The data collection took place in the emergency departments of the selected hospitals 
(see section 1.1.1). A flow chart on the data collection procedure and a thesaurus for the 
medical personnel were prepared.(see annex 1 and 2 of the Belgian report). 
Blood samples were taken using a 5 mL glass collection tube containing potassium 
oxalate and sodium fluoride. 
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Samples were stored in freezers at the hospitals. Shipments (under cooled conditions) to 
the laboratory of the Department of Clinical chemistry, microbiology and immunology of 
Ghent University were done on regular basis. 
 
1.2.3 Toxicological analysis of body fluids 
Toxicological analyses were performed in the laboratory of the Department of Clinical 
chemistry, microbiology and immunology of Ghent University. 
The following methods were used for the toxicological analysis of the whole blood 
samples: 
- enzymatic method for ethanol analysis 
- solid phase extraction followed by UPLC-MS/MS analysis for all substances 
except cannabinoids 
- ELISA screening (qualitative) for cannabinoids 
- liquid-liquid extraction followed by GC-MS analysis for samples that gave positive 
result at the ELISA screening for cannabinoids. 
Detailed information on the toxicological analyses can be found in annex 1 
A list of applied DRUID cut-offs can be found in the summary report. 
 
1.2.4 Method of BAC quantification 
Blood alcohol concentration, in g/L, was determined in whole blood samples using an 
enzymatic method (alcohol dehydrogenase). 
 
1.2.5 Other collected data 
Hospital staff was asked to record the following information on the patient datasheet: 
 
Patient information 
- Identification number (for labelling of samples and recorded data) 
- Age and gender 
- Time and date of sampling 
- Medication/Fluids administered prior to blood sampling 
- Severity of injuries (according to MAIS trauma scales) 
 
Accident information 
- Time and date of the accident 
- Time of ambulance arrival 
- Place of accident for road type classification (highway or other roads)  
- Type of vehicle of the injured driver (passenger car, van, truck/lorry, motorcycle, 
moped, bicycle, unknown, others: e.g. quad) 
- Type of other vehicle/part involved in the accident (personal car, van, truck/lorry, 
motorcycle, moped, pedestrian, animal, bicycle, fixed object: e.g. wall, unknown 
and other) 
- Condition of the road (dry, wet, dirty, snow, ice, unknown, other) 
- Use of safety belt (yes, no, not applicable, unknown) 
- Weather conditions (dry, rain, fog, snow, hail, unknown, other) 
- Maximum speed (<30, 40-50, 60-90, >100 km/h, unknown) 
- Highest education degree of the patient (primary school, low secondary school, 
high secondary school, university college type (2-3 years), college-long type 
(4years), university) 
- Outcome for the patient (discharge, hospitalised, deceased)  
 
1.2.6 Statistical analysis 
In order to calculate frequencies to describe the distribution of drivers (by age groups, 
gender, road type, etc.) statistical analysis were carried out using the software package 
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SPSS, version 15 (renamed in PASW). Confidence intervals (95%) for difference in 
proportions were calculated to determine the significance of the differences. 
 
1.3 Non- response and missing cases 
105 additional respondents had to be excluded from the database as no blood sample 
was available for toxicological analysis.  
For 67 people a patient form was filled in, but they refused to give a blood sample for 
toxicological analysis. The figures below (non-response) are based on these 67 subjects. 
For some other subjects, who refused to take part in the study, no form may have been 
filled in. Since correct non-response data is only available for the hospitals in Ghent and 
Leuven, statistical analysis was carried out only for those hospitals. Because of the low 
number of non-respondent forms any comparison should be made cautiously. Also, the 
size of non-response may have been underestimated to some extent based on the fact of 
the low number of samples in 2 hospitals (Brussels and Liège). 
 
1.3.1 Size and nature of non-response 
Following tables were calculated on refusals (n= 65) and respondents (=876) in the 
hospitals of Ghent and Leuven.  
 
1.3.1.1 Age and Gender 
Table 12. Non-response distribution by gender  
Refusals Respondents Total  Gender 
n % n % n % 
Male 38 63.3% 646 73.7% 684 73.1% 
Female 22 36.7% 230 26.3% 252 26.9% 
Total 60  876  936  
Note: 5 refusers had unknown gender and were left out this calculation 
 
73.7% (684) of the respondents were male and 26.3% (230) female. 63.3% of the drivers 
who refused to participate in the research were male and 36.7% female. No statistically 
significant difference was found between both response groups (p= 0.079). 
 
Table 13. Non-response distribution by age 
Refusals Respondents Total  Age groups 
n % n % n % 
18-24 18 28.1% 167 19.1% 185 19.7% 
 25-34 12 18.8% 187 21.4% 199 21.2% 
 35-49 17 26.6% 242 27.7% 259 27.6% 
 50 or older 17 26.6% 279 31.9% 296 31.5% 
Total 64  875  939  
Note: 1 refusal and 1 respondent had unknown age and were left out this calculation 
 
53.2% of the drivers who refused to participate in the DRUID-research belonged to the 
two age groups 35-49 and 50 or older. 59.6% of the drivers who took part in the study 
could be placed in the age group 35-49 (27.7%) and the age group 50 or older (31.9%). 
No significant statistical difference was found between both response groups (p= 0.358). 
 
1.3.1.2 Type of vehicle 
Since the frequencies of some vehicle types were too low, non response calculations 
were only made on the three most frequently used types of vehicle (n>5 in refusals): 
personal car, motorbike and bicycle.  
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Table 14. Non-response distribution by type of vehicle (personal car, motorbike and bicycle) 
Refusals Respondents Total Type of vehicle 
n % n % n % 
 Personal car 21 37.5% 247 32.8% 268 33.1% 
 Motorbike 7 12.5% 120 15.9% 127 15.7% 
 Bicycle 28 50% 386 51.3% 414 51.2% 
Total 56  753  809  
Note: Following numbers were excluded: for refusals: 3 unknown, 1 van, 3 mopeds, 2 
other; for respondents: 21 vans, 79 mopeds, 19 bus/trucks, 4 other 
 
51.3% of the respondents rode a bicycle, 50% of the refusals were cyclists. No significant 
statistical difference was found between both response groups (p= 0.685). 
 
1.3.1.3 Distribution of drivers by time period 
 
Table 15. Non-response distribution by time period 
Refusals Participants Total Time periods 
n % n % n % 
1:Monday to Friday, 04:00 to 09:59 9 15.0% 123 14.1% 132 14.1% 
 2:Monday to Friday, 10:00 to 15:59 10 16.7% 188 21.5% 198 21.2% 
 3:Monday to Thursday, 16:00 to 21:59 16 26.7% 155 17.7% 171 18.3% 
 4:Monday to Thursday, 22:00 to 03:59 5 8.3% 63 7.2% 68 7.3% 
5: Saturday and Sunday, 04:00 to 09:59 6 10.0% 45 5.1% 51 5.5% 
 6:Saturday and Sunday, 10:00 to 15:59 2 3.3% 116 13.3% 118 12.6% 
 7:Friday to Sunday, 16:00 to 21:59 8 13.3% 114 13.0% 122 13.0% 
 8:Friday to Sunday, 22:00 to 03:59 4 6.7% 71 8.1% 75 8.0% 
Total 60  875  935  
Note: 5 refusals and 1 participant had unknown time category and were left out this 
calculation. 
 
Most of the refusals and of the participants were sampled on weekdays between 10:00-
21:59 (refusal: 43.4%; participant: 39.2%) and weekend days in the time frame 16:00-
21:59 (refusal: 13.3%; participant: 13.0%). 
When leaving out time period 6 and 8, because of the lower number of refusals (n<5), no 
significant statistical difference was found (p= 0.52). By calculating confidence intervals 
for the difference in proportions, a significant difference was found for time period 6. Time 
period 8 was equally distributed between both response groups.  
 
 
1.3.2 Effects of non-response 
It is unlikely that the non-response had a significant effect on the distribution of results of 
the present study, even if its size may have been underestimated to some extent for the 
reasons reported above. 
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1.4 Results 
 
1.4.1 Substance group distribution + substance classes (alcohol, illicit and 
medicinal drugs) 
 
1.4.1.1  General distribution of substance classes and groups 
 
Table 16. Distribution of substance classes (mutually exclusive groups) 
Substance class Number of cases Percentage 
 None 679 63.0 
  Alcohol only 219 20.3 
  Illicit drugs only 53 4.9 
  Medicinal drugs only 59 5.5 
  Alcohol + illicit drugs 30 2.8 
  Alcohol + medicinal drugs 27 2.5 
  Illicit + medicinal drugs 4 0.4 
  Alcohol + illicit + medicinal 
drugs 
7 0.6 
  Total 1078 100.0 
 
Table 17. Distribution of substance groups 
Type Group Number of 
cases 
Percentage 
None 679 63.0 
Alcohol Alcohol 219 20.3 
Illicit Drugs Amphetamines 5 0.5 
 Benzoylecgonine only 3 0.3 
 Cocaine (+ 
benzoylecgonine) 
1 0.1 
 THCCOOH only 11 1.0 
 THC (+THCCOOH) 27 2.5 
 Illicit opiates 0 0 
Medicinal drugs Benzodiazepines 27 2.5 
 Z-drugs 4 0.4 
 Opiates and opioids 25 2.3 
Various 
combinations 
Drug-alcohol 64 5.9 
 Drug-drug 13 1.2 
Total 1078 
 
37% of drivers were found positive for one or more (il)licit substances. The highest 
prevalence was found for alcohol only (20.3%). 5.5% of the sampled subjects were 
positive for medicinal drugs only: benzodiazepines (2.5%) and medicinal opioids (2.3%) 
being the most common drugs detected. 4.9% of patients had used an illicit drug only 
with the highest prevalence for THC (2.5%). The most common combinations found were 
benzodiazepines + alcohol (1.9%) and THC + alcohol (1.5%). 
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Figure 7. Distribution of drugs alone and combined 
 
In figure 7 the total distribution of all substance groups are shown, taking into account 
both the drug alone or in combination. In 26.2% of the samples alcohol was found, 
cannabis in 7.2%. The other groups have a higher prevalence for the combinations 
compared to the prevalence of the substance alone, except for medicinal opioids. A 
reason for this might be that administration of drugs prior to blood sampling may have not 
been recorded on the patient form. 
 
 
Figure 8. Distribution of positive alcohol findings by BAC-group (in g/l) 
In general 26.2% of the injured drivers was found positive for alcohol. Of these 283 
subjects, 12% had a BAC between 0.1 g/l (= DRUID cut-off) and 0.5 g/l (=the legal cut-off 
in Belgium) and 63.6% had a BAC at or above 1.3 g/l. 
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1.4.1.2 Detailed substance group distribution by region 
 
Table 18. Distribution of substance groups by region 
Type Group Brussels Flanders Wallonia 
 n % n % n % 
None 24 68.6% 581 66.3% 74 44.3%
Alcohol Alcohol 6 17.1% 165 18.8% 48 28.7%
Illicit Drugs Amphetamines 0 0% 5 0.6% 0 0% 
 Benzoylecgonine 
only 
1 2.9% 2 0.2% 0 0% 
 Cocaine (+BE) 0 0% 1 0.1% 0 0% 
 THCCOOH only 0 0% 9 1.0% 2 1.2% 
 THC (+THCCOOH) 2 5.7% 19 2.2% 6 3.6% 
 Illicit opiates 0 0% 0 0% 0 0% 
Medicinal drugs Benzodiazepines 0 0% 22 2.5% 5 3.0% 
 Z-drugs 0 0% 3 0.3% 1 0.6% 
 Opiates and opioids 0 0% 20 2.3% 5 3.0% 
Various 
combinations 
Drug-alcohol 2 5.7% 41 4.4% 21 12.6%
 Drug-drug 0 0% 8 0.8% 5 3.0% 
Total 35 876 167 
 
Taking into account the lower sampling in Brussels and Wallonia, the prevalence of 
positive drivers was found equal in Brussels and Flanders, but higher in Wallonia. In 
Brussels 31.4% of the sampled drivers were positive for one or more substances, in 
Flanders 33.7% and in Wallonia 55.7%.  
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Table 19. Detailed substance group distribution by regions: Brussels, Flanders and Wallonia 
Region Substances 
  Brussels Flanders Wallonia 
Total 
 None 24(68.6%) 581(66.3%) 74 (44.3%) 679 (63.0%) 
  Amphetamines only 0  5 (0.6%) 0 5 (0.5%) 
  Benzoylecgonine only 1 (2.9%) 2 (0.2%) 0 3 (0.3%) 
  Cocaine only 0 1 (0.1%) 0  1 (0.1%) 
  THCCOOH only 0 9 (1.0%) 2 (1.2%) 11 (1.0%) 
  THC only 2 (5.7%) 19 (2.2%) 6 (3.6%) 27 (2.5%) 
  Amphetamine + THC 0 1 (0.1%) 1 (0.6%)  2 (0.2%) 
  Benzoylecgonine +THC 0 1 (0.1%) 1 (0.6%) 2 (0.2%) 
  Amphetamine + benzoylecgonine + THC 0 1 (0.1%) 0 1 (0.1%) 
  Amphetamine + cocaine + THC 0 1 (0.1%) 0 1 (0.1%) 
  Benzodiazepines 0 22 (2.5%) 5 (3.0%) 27 (2.5%) 
  Amphetamine + THC + Benzodiazepine 0 1 (0.1%) 0 1 (0.1%) 
  Z-drugs 0 3 (0.3%) 1 (0.6%) 4 (0.4%) 
  Benzodiazepines +Z-drugs 0 0 1 (0.6%) 1 (0.1%) 
  Medicinal opioids 0 20 (2.3%) 5 (3.0%) 25 (2.3%) 
  Benzoylecgonine + medicinal opioids 0 0 1 (0.6%) 1 (0.1%) 
  THC + medicinal opioids 0 1 (0.1%) 1 (0.6%) 2 (0.2%) 
  Benzodiazepines + medicinal opioids 0 1 (0.1%) 0 1 (0.1%) 
  Z-drugs + medicinal opioids 0 1 (0.1%) 0 1 (0.1%) 
  Alcohol only 6 (17.1%) 165 (18.8%) 48  
(28.7%) 
219 (20.3%) 
  Amphetamines + alcohol 0 1 (0.1%) 0 1 (0.1%) 
  Benzoylecgonine + alcohol 0 0 1 (0.6%) 1 (0.1%) 
  Cocaine + alcohol 0 1 (0.1%) 1 (0.6%) 2 (0.2%) 
  Amphetamines + cocaine + alcohol 0 1 (0.1%) 0 1 (0.1%) 
  THCCOOH + alcohol 0 4 (0.5%) 1 5 (0.2%) 
 Benzoylecgonine + THCCOOH + alcohol 0 1 (0.1%) 0 1 (0.1%) 
 Cocaine + THCCOOH + alcohol 0 0 1 (0.6%) 1 (0.1%) 
  THC + alcohol 2 (5.7%) 11 (1.3%) 3 (1.8%) 16(1.5%) 
  Cocaine + THC + alcohol 0 2 (0.2%) 0 2 (0.2%) 
  Benzodiazepines + alcohol 0 10 (1.1%) 10 (6.0%) 20 (1.9%) 
  Cocaine + Benzodiazepines + alcohol 0 1 (0.1%) 0 1 (0.1%) 
  THC + benzo + alcohol 0 1 (0.1%) 1 (0.6%) 2 (0.2%) 
  Amphetamines + THC + benzo + alcohol 0 1 (0.1%) 0 1 (0.1%) 
  Z-drug + alcohol 0 2 (0.2%) 0 2 (0.2%) 
  Benzo + z-drug + alcohol 0 1 (0.1%) 2 (1.2%) 3 (0.3%) 
  Medicinal opioids + alcohol 0 1 (0.1%) 1 (0.6%) 2 (0.2%) 
  Amphetamines + medicinal opioids + 
alcohol 
0 1 (0.1%) 0 1 (0.1%) 
  THCCOOH + medicinal opioids + alcohol 0 2 (0.2%) 0 2 (0.2%) 
Total 35 (100.0%) 876 (99.5%) 167 
(100.0%) 
1078 (100%) 
 
The higher percentage for benzoylecgonine in Brussels does not result in a higher 
prevalence for that region, because of the low number of sampling in Brussels compared 
to Flanders, there is no significant difference between the two proportions. 
 
 DRUID 6th Framework Programme Deliverable D.2.2.5  
Part 2 – Country Reports from hospital studies - Country Report Belgium 
Prevalence of alcohol and other psychoactive substances in injured and killed drivers. 
 
 Page 195 of 349 
1.4.2 Distribution of substance groups by DRUID time periods aggregated into 
day vs. night, week vs. WE 
 
For this distribution, time period remained unknown in 17 cases (1.7%). 
 
Table 20. Distribution of substance groups by Day vs Night 
Type Group Day Night Unknown 
  n % n % n % 
None 615 68.5% 57 34.8% 7 41.2% 
Alcohol Alcohol 127 14.2% 86 52.4% 6 35.3% 
Illicit Drugs Amphetamines 4 0.4% 1 0.6% 0 0% 
 Benzoylecgonine 
only  
3 0.3% 0 0% 0 0% 
 Cocaine (+BE) 1 0.1% 0 0% 0 0% 
 THCCOOH only 11 1.2% 0 0% 0 0% 
 THC 
(+THCCOOH) 
26 2.9% 1 0.6% 0 0% 
 Illicit opiates 0 0% 0 0% 0 0% 
Medicinal 
drugs 
Benzodiazepines 25 2.8% 0 0% 2 11.8% 
 Z-drugs 1 0.1% 2 1.2% 1 5.9% 
 Opiates & opioids 24 2.7% 1 0.6% 0 0% 
Various 
combinations 
Drug-alcohol 49 5.5% 14 8.5% 1 5.9% 
 Drug-drug 11 1.2% 2 1.2% 0 0% 
Total 897 164 17 
 
Toxicological results showed a higher prevalence of positive drivers in the night-time 
group mainly due to alcohol. Cannabis and medicinal opioids were found more during 
daytime, while alcohol alone was more prevalent during nights. Benzodiazepines were 
only found during daytime. In general different drug-alcohol and drug-drug combinations 
were equal during day and night. 
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Table 21. Detailed substance groups distribution by Day vs Night 
Substances Day Night 
 None 615 (68.6%) 57 (34.8%) 
  Amphetamines only 4 (0.4%) 1 (0.6%) 
  Benzoylecgonine only 3 (0.3%) 0 
  Cocaine only 1 (0.1%) 0 
  THCCOOH only 11 (1.2%) 0 
  THC only 26 (2.9%) 1 (0.6%) 
  Amphetamine + THC 2 (0.2%) 0 
  Benzoylecgonine +THC 1 (0.1%) 1 (0.6%) 
  Amphetamine + benzoylecgonine + THC 1 (0.1%) 0 
  Amphetamine + cocaine + THC 1 (0.1%) 0 
  Benzodiazepines 25 (2.8%) 0 
  Amphetamine + THC + Benzodiazepine 0 1 (0.6%) 
  Z-drugs 1 (0.1%) 2 (1.2%) 
  Benzodiazepines +Z-drugs 1 (0.1%) 0 
  Medicinal opioids 24 (2.7%) 1 (0.6%) 
  Benzoylecgonine + medicinal opioids 1 (0.1%) 0 
  THC + medicinal opioids 2 (0.2%) 0 
  Benzodiazepines + medicinal opioids 1 (0.1%) 0 
  Z-drugs + medicinal opioids 1 (0.1%) 0 
  Alcohol only 127 (14.2%) 86 (52.4%) 
  Amphetamines + alcohol 0 1 (0.6%) 
  Benzoylecgonine + alcohol 1 (0.1%) 0 
  Cocaine + alcohol 1 (0.1%) 1 (0.6%) 
  Amphetamines + cocaine + alcohol 1 (0.1%) 0 
  THCCOOH + alcohol 5 (0.6%) 0 
 Benzoylecgonine + THCCOOH + alcohol 1 (0.1%) 0 
 Cocaine + THCCOOH + alcohol 1 (0.1%) 0 
  THC + alcohol 9 (1.0%) 7 (4.3%) 
  Cocaine + THC + alcohol 2 (0.2%) 0 
  Benzodiazepines + alcohol 16 (1.8%) 4 (2.4%) 
  Cocaine + Benzodiazepines + alcohol 1 (0.1%) 0 
  THC + benzo + alcohol 1 (0.1%) 0 
  Amphetamines + THC + benzo + alcohol 1 (0.1%) 0 
  Z-drug + alcohol 2 (0.2%) 0 
  Benzo + z-drug + alcohol 3 (0.3%) 0 
  Medicinal opioids + alcohol 1 (0.1%) 1 (0.6%) 
  Amphetamines + medicinal opioids + alcohol 1 (0.1%) 0 
  THCCOOH + medicinal opioids + alcohol 2 (0.2%) 0 
Total 897 (99.5%) 164 (99.9%) 
 
A deeper insight into the different drug-alcohol combinations shows that the association 
THC + alcohol was more prevalent during night, while the combination benzodiazepines 
+ alcohol had a similar distribution during day and night. 
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Table 22. Distribution of substance groups by week vs. weekend 
Type Group Week Weekend Unknown 
 n % n % n % 
None 442 69.2% 230 54.2% 7 41.2% 
Alcohol Alcohol 95 14.8% 118 28.0% 6 35.3% 
Illicit Drugs Amphetamines 4 0.6% 1 0.2% 0 0% 
 Benzoylecgonine 
only 
2 0.3% 1 0.2% 0 0% 
 Cocaine (+BE) 0 0% 1 0.2% 0 0% 
 THCCOOH only 6 0.9% 5 1.2% 0 0% 
 THC 
(+THCCOOH) 
23 3.6% 4 0.9% 0 0% 
 Illicit opiates 0 0% 0 0% 0 0% 
Medicinal 
drugs 
Benzodiazepines 17 2.7% 8 1.9% 2 11.8% 
 Z-drugs 3 0.5% 0 0% 1 5.9% 
 Opiates and 
opioids 
14 2.2% 11 2.6% 0 0% 
Various 
combinations 
Drug-alcohol 26 4.1% 37 8.8% 1 5.9% 
 Drug-drug 7 1.1% 6 1.4% 0 0% 
Total 639 422 17 
 
Apart from benzodiazepines, medicinal opioids and drug-drug combinations, which were 
equally distributed, the prevalence of other substances was significantly different between 
week and weekend. In general more positive drivers were found during weekends. 
Alcohol alone and combinations drug-alcohol were both more prevalent during weekend, 
with an increase of approximately twofold. Cannabis was present especially during 
weeks. 
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Table 23. Detailed substance group distribution by week vs weekend 
Substances week weekend 
 None 441 (69.0%) 229 (54.3%) 
  Amphetamines only 4 (0.6%) 1 (0.2%) 
  Benzoylecgonine only 2 (0.3%) 1 (0.2%) 
  Cocaine only 0 1 (0.2%) 
  THCCOOH only 6 (0.9%) 5 (1.2%) 
  THC only 23 (3.6%) 4 (0.9%) 
  Amphetamine + THC 1 (0.2%) 1 (0.2%) 
  Benzoylecgonine +THC 1 (0.2%) 1 (0.2%) 
  Amphetamine + benzoylecgonine + THC 0 1 (0.2%) 
  Amphetamine + cocaine + THC 1 (0.2%) 0 
  Benzodiazepines 17 (2.6%) 8 (1.9%) 
  Amphetamine + THC + Benzodiazepine 0 1 (0.2%) 
  Z-drugs 3 (0.5%) 0 
  Benzodiazepines +Z-drugs 1 (0.2%) 0 
  Medicinal opioids 14 (2.2%) 11 (2.6%) 
  Benzoylecgonine + medicinal opioids 0 1 (0.2%) 
  THC + medicinal opioids 2 (0.3%) 0 
  Benzodiazepines + medicinal opioids 1 (0.2%) 0 
  Z-drugs + medicinal opioids 0 1 (0.2%) 
  Alcohol only 95 (14.9%) 118 (28.0%) 
  Amphetamines + alcohol 1 (0.2%) 0 
  Benzoylecgonine + alcohol 0 1 (0.2%) 
  Cocaine + alcohol 1 (0.2%) 1 (0.2%) 
  Amphetamines + cocaine + alcohol 0 1 (0.2%) 
  THCCOOH + alcohol 1 (0.2%) 4 (0.9%) 
 Benzoylecgonine + THCCOOH + alcohol 0 1 (0.2%) 
 Cocaine + THCCOOH + alcohol 1 (0.2%) 0 
  THC + alcohol 5 (0.8%) 11 (2.6%) 
  Cocaine + THC + alcohol 0 2 (0.5%) 
  Benzodiazepines + alcohol 11 (1.7%) 9 (2.1%) 
  Cocaine + Benzodiazepines + alcohol 1 (0.2%) 0 
  THC + benzo + alcohol 1 (0.2%) 0 
  Amphetamines + THC + benzo + alcohol 1 (0.2%) 0 
  Z-drug + alcohol 1 (0.2%) 1 (0.2%) 
  Benzo + z-drug + alcohol 1 (0.2%) 2 (0.5%) 
  Medicinal opioids + alcohol 0 2 (0.5%) 
  Amphetamines + medicinal opioids + alcohol 1 (0.2%) 0 
  THCCOOH + medicinal opioids + alcohol 0 2 (0.5%) 
Total 639 (100.5%) 422 (99.5%) 
 
For the combination alcohol + cannabis a significant difference between week and 
weekend was found, with a higher prevalence at weekends. The combination 
benzodiazepine and alcohol was not significantly different during the 7 days of the week.  
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1.4.3 Distribution of substance groups by gender and age 
Table 24. Distribution of substance groups age and gender 
Age groups Total 
 
Gender  Substances 
unknown 17y 18-24 25-34 35-49 50+  
Un-
known 
None 1 
(100%) 
     1 (100%) 
  
Total 
1 
(100%) 
     1 (100%) 
Male None 8 
(44.4%) 
2 (100%) 71 
(46.4%) 
90 
(51.4%) 
145 
(61.4%) 
166 
(73.8%) 
482 
(59.6%) 
  Alcohol 2 
(11.1%) 
0 44 
(28.8%) 
48 
(27.4%) 
60 
(25.4%) 
34 
(15.1%) 
188 
(23.2%) 
  Amphetamine
s 
0 0 0 1 
(0.6%) 
1 (0.4%) 2 (0.9%) 4 (0.5%) 
  Benzoylecgoni
ne only 
0 0 2 
(1.3%) 
0 1 (0.4%) 0 3 (0.4%) 
  Cocaine (+BE) 0 0 0 1 
(0.6%) 
0 0 1 (0.1%) 
  THCCOOH 
only 
0 0 2 
(1.3%) 
5 
(2.9%) 
2 (0.8%) 1 (0.4%) 10(1.2%) 
  THC 
(+THCCOOH) 
1 
(5.6%) 
0 13 
(8.5%) 
5 
(2.9%) 
4 (1.7%) 0 23 (2.1%) 
  Benzodiazepi
ne 
0 0 1 
(0.7%) 
0 7 (3.0%) 9 (4.0%) 17 (2.1%) 
  Medicinal 
opioids 
2 
(11.1%) 
0 3 
(2.0%) 
3 
(1.7%) 
4 (1.7%) 4 (1.8%) 16 (2.0%) 
  Drug-alcohol 5 
(27.8%) 
0 16 
(10.5%) 
16 
(9.1%) 
10 (4.2%) 8 (3.6%) 55 (6.8%) 
  Drug-drug 0 0 1 
(0.7%) 
6 
(3.4%) 
2 (0.8%) 1 (0.4%) 10(1.2%) 
  
Total 
18 (100%) 2 (100%) 153 
(100%) 
175 
(100%) 
236 
(99.8%) 
225 
(99.9%) 
809 
(99.8%) 
Female None 1 
(25.0%) 
 37 
(74.0%) 
39 
(76.5%) 
51 
(71.8%) 
68 
(73.9%) 
196 
(73.1%) 
  Alcohol 1 
(25.0%) 
 5 
(10.0%) 
8 
(15.7%) 
10 
(14.1%) 
7 (7.6%) 31 
(11.6%) 
  Amphetamine
s 
0  1 (2.0%) 0 0 0 1 (0.4%) 
 THCCOOH 
only 
0  1 (2.0%)    1 (0.4%) 
  THC 
(+THCCOOH) 
0  4 (8.0%) 0 0 0 4(1.5%) 
  Benzodiazepi
nes 
0  0 0 2 (2.8%) 8 (8.7%) 10 (3.7%) 
  Z-drugs 1 
(25.0%) 
 0 0 2 (2.8%) 1 (1.1%) 4 (1.5%) 
  Medicinal 
opioids 
0  1 
(2.0%) 
1 
(2.0%) 
2 (2.8%) 5 (5.4%) 9 (3.4%) 
  Drug-alcohol 1 
(25.0%) 
 1 
(2.0%) 
2 
(3.9%) 
4 (5.6%) 1 (1.1%) 9 (3.4%) 
  Drug-drug 0  0 1 
(2.0%) 
0 2 (2.2%) 3 (1.1%) 
  
Total 
4 (100%)  50 
(100%) 
51 
(100%) 
71 
(100%) 
92 
(100%) 
268 
(100%) 
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Table 25. Detailed substance group distribution by age and gender 
Age groups   
Gender 
  
 Substances unknown 18-24 25-34 35-49 50+ 17y Total 
Male 
None 8 
(44.0%) 
71(46.4%) 90 
(51.4%) 
145 
(61.4%) 
166 
(73.8%) 
2 
(100.0%) 
482 
(59.6%) 
Amphetamines only 0 0 1 
(0.6%) 
1 
(0.4%) 
2 (0.9%) 0 4 (0.5%) 
Benzoylecgonine only 0 2 
(1.3%) 
0 1 
(0.4%) 
0 0 3 (0.4%) 
Cocaine only 0 0 1 
(0.6%) 
0 0 0 1 (0.1%) 
THCCOOH only 0 2 
(1.3%) 
5 
(2.9%) 
2 (0.8%) 1 (0.4%) 0 10 
(1.2%) 
THC only 1 
(5.6%) 
13 (8.5%) 9 
(2.9%) 
4 
(1.7%) 
0 0 23 
(2.8%) 
Amphetamine + THC 0 1 (0.7%) 1 (0.6%) 0 0 0 2 (0.2%) 
Benzoylecgonine +THC 0 0 0 1 
(0.4%) 
0 0 1 (0.1%) 
Amphetamine + 
benzoylecgonine + THC 
0 0 1 
(0.6%) 
0 0 0 1 (0.1%) 
Amphetamine + cocaine + THC 0 0 1 
(0.6%) 
0 0 0 1 (0.1%) 
Benzodiazepines 0 1 
(0.7%) 
0 7 
(3.0%) 
9 (4.0%) 0 17 
(2.1%) 
Amphetamine + THC + 
Benzodiazepine 
0 0 1 
(0.6%) 
0 0 0 1 (0.1%) 
Benzodiazepines +Z-drugs 0 0 0 1 
(0.4%) 
0 0 1 (0.1%) 
Medicinal opioids 2 
(11.1%) 
3 
(2.0%) 
3 
(1.7%) 
4 
(1.7%) 
4 (1.8%) 0 16 
(2.0%) 
Benzoylecgonine + medicinal 
opioids 
0 0 0 0 1 (0.4%) 0 1 (0.1%) 
THC + medicinal opioids 0 0 2 
(1.1%) 
0 0 0 2 (0.2%) 
Alcohol only 2 
(11.1%) 
44 
(28.8%) 
48 
(27.4%) 
60 
(25.4%) 
34 
(15.1%) 
0 188 
(23.2%) 
Amphetamines + alcohol 0 1 
(0.7%) 
0 0 0 0 1 (0.1%) 
Benzoylecgonine + alcohol 0 1 
(0.7%) 
0 0 0 0 1 (0.1%) 
Cocaine + alcohol 1 
(5.6%) 
0 1 
(0.6%) 
0 0 0 2 (0.2%) 
Amphetamines + cocaine + 
alcohol 
0 0 1 
(0.6%) 
0 0 0 1 (0.1%) 
THCCOOH + alcohol 0 2 (1.3%) 2 
(1.1%) 
0 1 (0.4%) 0 5 (0.6%) 
Benzoylecgonine + THCCOOH 
+ alcohol 
 0 0 1 (0.4%) 0 0 1 (0.1%) 
Cocaine + THCCOOH + alcohol  0 1 (0.6%) 0 0 0 1 (0.1%) 
THC + alcohol 0 8 (5.2%) 8 
(4.6%) 
0 0  0 16 
(2.0%) 
Cocaine + THC + alcohol 0 1 
(0.7%) 
1 
(0.6%) 
0 0 0 2 (0.2%) 
Benzodiazepines + alcohol 2 
(11.1%) 
1 
(0.7%) 
0 7 
(3.0%) 
5 (2.2%) 0 15 
(1.9%) 
Cocaine + Benzodiazepines + 
alcohol 
0 0 0 1 
(0.4%) 
0 0 1 (0.1%) 
THC + benzo + alcohol 1 
(5.6%) 
0 1 
(0.6%) 
0 0 0 2 (0.2%) 
Amphetamines + THC + benzo 
+ alcohol 
0 0 0 1 
(0.4%) 
0 0 1 (0.1%) 
Z-drug + alcohol 0 0 0 0 1 (0.4%) 0 1 (0.1%) 
Benzo + z-drug + alcohol 1 
(5.6%) 
0 0 0 0 0 1 (0.1%) 
Medicinal opioids + alcohol 0 1 
(0.7%) 
0 0 1 (0.4%) 0 2 (0.2%) 
THCCOOH + medicinal opioids 
+ alcohol 
0 1 
(0.7%) 
1 
(0.6%) 
0 0 0 2 (0.2%) 
Total 18  153  175  236 225 2  809  
Female 
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None 1 
(25.0%) 
37 
(74.0%) 
39 
(76.5%) 
51 
(71.8%) 
68 
(73.9%) 
 196 
(73.1%) 
Amphetamines only 0 1 
(2.0%) 
0 0 0  1 (0.4%) 
THCCOOH only 0 1 (2.0%) 0 0 0  1 (0.4%) 
THC only 0 4 (8.0%) 0 0 0  4 (1.5%) 
Benzoylecgonine +THC 0 0 1 
(2.0%) 
0 0  1 (0.4%) 
Benzodiazepines 0 0 0 2 
(2.8%) 
8 (8.7%)  10 
(3.7%) 
Z-drugs 1 
(25.0%) 
0 0 2 
(2.8%) 
1 (1.1%)  4 (1.5%) 
Medicinal opioids 0 1 
(2.0%) 
1 (2.0%) 2 
(2.8%) 
5 (5.4%)  9 (3.4%) 
Benzodiazepines + medicinal 
opioids 
0 0 0 0 1 (1.1%)  1 (0.4%) 
Z-drugs + medicinal opioids 0 0 0 0 1 (1.1%)  1 (0.4%) 
Alcohol only 1 
(25.0%) 
5 (10.0%) 8 
(15.7%) 
10 
(14.1%) 
7 (7.6%)  31 
(11.6%) 
Benzodiazepines + alcohol 0 1 
(2.0%) 
1 
(2.0%) 
2 
(2.8%) 
1 (1.1%)  5 (1.9%) 
Z-drug + alcohol 0 0 0 1 
(1.4%) 
0  1 (0.4%) 
Benzo + z-drug + alcohol 1 
(25.0%) 
0 0 1 
(1.4%) 
0  2 (0.7%) 
Amphetamines + medicinal 
opioids + alcohol 
0 0 1 
(2.0%) 
0 0  1 (0.4%) 
Total 4  50  51 71  92   268  
Note: One subject was not included in the above table as data about age and gender 
were not recorded 
 
The distribution by gender showed to be unequal, with a significantly higher number of 
male drivers positive for one or more drugs. A significant difference was found for 
cannabis, alcohol and drug-alcohol combinations. Z-drugs were only found in female 
drivers, while cocaine only in male drivers. 
As for age groups distribution, THC was most prevalent in the male groups 18-24 and 25-
34. In females, THC was only found in the age group 18-24. Benzodiazepines were most 
found in drivers aged over 35. Medicinal opioids were equally distributed over all age 
categories. In female drivers alcohol was equally distributed over all age groups, whereas 
in male drivers there was a decrease with age. Combinations drug-alcohol in the male 
population were most found in subjects aged between 18 and 34 years, while for female 
drivers the distribution was equal over all ages. 
 
The combination THC-alcohol was only found in male drivers, with the highest prevalence 
in the age groups 18-24 and 25-34. Alcohol and benzodiazepines were equally 
distributed over gender and age. 
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1.4.4 Distribution of substance groups by single- vehicle accidents vs. multi-
vehicle accidents 
Table 26. Distribution of substance groups by accident type 
Type Group Single-Vehicle Multi-Vehicle unknown 
  n % n % n % 
None 298 57.2% 360 72.7% 20 32.8%
Alcohol Alcohol 136 26.1% 55 11.1% 28 45.9%
Illicit Drugs Amphetamines 3 0.6% 1 0.2% 1 1.6% 
 Benzoylecgonine 
only 
0 0% 3 0.6% 0 0% 
 Cocaine (+BE) 1 0.2% 0 0% 0 0% 
 THCCOOH only 3 0.6% 7 1.4% 1 1.6% 
 THC 
(+THCCOOH) 
13 2.5% 12 2.4% 2 3.3% 
 Illicit opiates 0 0% 0 0% 0 0% 
Medicinal 
drugs 
Benzodiazepines 11 2.1% 13 2.6% 3 4.9% 
 Z-drugs 0 0% 2 0.4% 2 3.3% 
 Opiates and 
opioids 
10 2.0% 14 2.8% 1 1.6% 
Various 
combinations 
Drug-alcohol 37 7.1% 25 5.1% 2 3.3% 
 Drug-drug 9 1.7% 3 0.6% 1 1.6% 
Total  522 495 61 
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Table 27. Detailed substance group distribution by accident type 
Substances single-vehicle multi-vehicle 
 None 299 (57.3%) 360 (72.7%) 
  Amphetamines only 3 (0.6%) 1 (0.2%) 
  Benzoylecgonine only 0 3 (0.6%) 
  Cocaine only 1 (0.2%) 0 
  THCCOOH only 3(0.6%) 7 (1.4%) 
  THC only 13 (2.5%) 12 (2.4%) 
  Amphetamine + THC 1 (0.2%) 1 (0.2%) 
  Benzoylecgonine +THC 1 (0.2%) 1 (0.2%) 
  Amphetamine + benzoylecgonine + THC 1 (0.2%) 0 
  Amphetamine + cocaine + THC 1 (0.2%) 0 
  Benzodiazepines 11 (2.1%) 13 (2.6%) 
  Amphetamine + THC + Benzodiazepine 0 0 
  Z-drugs 0 2 (0.4%) 
  Benzodiazepines +Z-drugs 1 (0.2%) 0 
  Medicinal opioids 10 (1.9%) 14 (2.8%) 
  Benzoylecgonine + medicinal opioids 0 1 (0.2%) 
  THC + medicinal opioids 2 (0.4%) 0 
  Benzodiazepines + medicinal opioids 1 (0.2%) 0 
  Z-drugs + medicinal opioids 1 (0.2%) 0 
  Alcohol only 136 (26.1%) 55 (11.1%) 
  Amphetamines + alcohol 1 (0.2%) 0 
  Benzoylecgonine + alcohol 1 (0.2%) 0 
  Cocaine + alcohol 2 (0.4%) 0 
  Amphetamines + cocaine + alcohol 1 (0.2%) 0 
  THCCOOH + alcohol 3 (0.6%) 2 (0.4%) 
 Benzoylecgonine + THCCOOH + alcohol 1 (0.2%) 0 
 Cocaine + THCCOOH + alcohol 1 (0.2%) 0 
  THC + alcohol 7 (1.3%) 7 (1.4%) 
  Cocaine + THC + alcohol 1 (0.2%) 1 (0.2%) 
  Benzodiazepines + alcohol 9 (1.7%) 11 (2.2%) 
  Cocaine + Benzodiazepines + alcohol 1 (0.2%) 0 
  THC + benzo + alcohol 1 (0.2%) 1 (0.2%) 
  Amphetamines + THC + benzo + alcohol 0 1 (0.2%) 
  Z-drug + alcohol 1 (0.2%) 1 (0.2%) 
  Benzo + z-drug + alcohol 2 (0.4%) 1 (0.2%) 
  Medicinal opioids + alcohol 2 (0.4%) 0 
  Amphetamines + medicinal opioids + alcohol 1 (0.2%) 0 
  THCCOOH + medicinal opioids + alcohol 2 (0.4%) 0 
Total 522 (100.1%) 495 (99.8%) 
 
Except for alcohol, for which prevalence was more than double in single-vehicle 
compared to multi-vehicle accidents, no statistically significant difference was found in the 
distribution of the other drugs and their combinations. 
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1.4.5 Distribution of substance groups by type of vehicle 
 
Table 28. Distribution of substance groups by vehicle type 
Substan
ce group 
Personal 
car 
Van Motor-
cycle 
Moped Bicycle Bust/ 
truck 
Other 
 n % n % n % n % n % n % n % 
None 17
1 
48.4 15 62.5 11
0 
69.2 47 49.0 31
1 
75.3 20 90.9 5 45.5
Alcohol 10
9 
30.9 4 16.7 24 15.1 20 20.8 58 14.0 0 0 3 27.3
Amphe-
tamines 
3 0.8 0 0 1 0.6 0 0 1 0.2 0 0 0 0 
Benzoyle
c-gonine 
only 
0 0 0 0 2 1.3 1 1.0 0 0 0 0 0 0 
Cocaine 
(+BE) 
0 0 0 0 0 0 0 0 1 0.2 0 0 0 0 
THCCOO
H only 
3 0.8 0 0 3 1.9 5 5.2 0 0 0 0 0 0 
THC 
(+THCC
OOH) 
6 1.7 0 0 6 3.8 8 8.3 6 1.5 0 0 1 9.1 
Illicit 
opiates 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Benzodia
-zepines 
5 1.4 0 0 3 1.9 6 6.3 12 2.9 1 4.5 0 0 
Z-drugs 3 0.8 0 0 0 0 0 0 1 0.2 0 0 0 0 
Opiates 
and 
opioids 
7 2.0 0 0 5 3.1 1 1.0 12 2.9 0 0 0 0 
Drug-
alcohol 
40 11.3 3 12.5 5 3.1 6 6.3 9 2.2 0 0 1 9.1 
Drug-
drug 
6 1.7 2 8.3 0 0 2 2.1 2 0.5 0 0 1 9.1 
 353 24 159 96 413 22 11 
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Figure 9. Distribution of substance groups by vehicle type 
 
Alcohol was found more in drivers of a personal car compared to other vehicle types. 
Cannabis was equally distributed, except for vans, with zero positive cases, and moped, 
which had a slightly higher prevalence. No significant differences were found for 
benzodiazepines and medicinal opioids. The combination drug-alcohol was found more in 
personal car drivers than in drivers of other vehicle types. 
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Table 29. Detailed substance group distribution by type of vehicle 
Vehicle type Substances 
 personal 
car 
van motorcycle moped bicycle bus/truck other 
None 171 
(48.4%) 
15 
(62.5%) 
110 (67.9%) 47 
(49.0%) 
311 
(75.3%) 
20 (90.9%) 5 (45.5%) 
Amphetamines only 3 (0.8%) 0 1(0.6%) 0 1 (0.2%) 0 0 
Benzoylecgonine only 0 0 2(1.3%) 1(1.0%) 0 0 0 
Cocaine only 0 0 0 0 1 (0.2%) 0 0 
THCCOOH only 3 (0.8%) 0 3(1.9%) 5(5.2%) 0 0 0 
THC only 6 (1.7%) 0 6 (3.8%) 8(8.3%) 6 (1.5%) 0 1 (9.1%) 
Amphetamine + THC 0 0 0 0 1 (0.2%) 0 1 (9.1%) 
Benzoylecgonine +THC 1 (0.3%) 0 0 1(1.0%) 0 0 0 
Amphetamine + 
benzoylecgonine + THC 
1 (0.3%) 0 0 0 0 0 0 
Amphetamine + cocaine + 
THC 
0 1 (4.2%) 0 0 0 0 0 
Benzodiazepines 5 (1.4%) 0 3 (1.9%) 6(6.3%) 12 
(3.0%) 
1 (4.5%) 0 
Amphetamine + THC + 
Benzo 
0 1 (4.2%) 0 0 0 0 0 
Z-drugs 3 (0.8%) 0 0 0 1 (0.2%) 0 0 
Benzodiazepines +Z-drugs 1 (0.3%) 0 0 0 0 0 0 
Medicinal opioids 7 (2.0%) 0 5 (3.1%) 1 (1.0%) 12 
(3.0%) 
0 0 
Benzoylecgonine + 
medicinal opioids 
1 (0.3%) 0 0 0 0 0 0 
THC + medicinal opioids 2 (0.6%) 0 0 0 0 0 0 
Benzodiazepines + 
medicinal opioids 
0 0 0 1 (1.0%) 0 0 0 
Z-drugs + medicinal opioids 0 0 0 0 1 (0.2%) 0 0 
Alcohol only 109 
(30.9%) 
4 (16.7%) 24 (15.1%) 20 
(20.8%) 
58 
(14.0%) 
1 (4.5%) 3 (27.3%) 
Amphetamines + alcohol 1 (0.3%) 0 0 0 0 0 0 
Benzoylecgonine + alcohol 1 (0.3%) 0 0 0 0 0 0 
Cocaine + alcohol 2 (0.6%) 0 0 0 0 0 0 
Amphetamines + cocaine + 
alcohol 
0 1 (4.2%) 0 0 0 0 0 
THCCOOH + alcohol 3 (0.8%) 0 1 (0.6%) 1 (1.0%) 0 0 0 
Benzoylecgonine + 
THCCOOH + alcohol 
1 (0.3%) 0 0 0 0 0 0 
Cocaine + THCCOOH + 
alcohol 
1 (0.3%) 0 0 0 0 0 0 
THC + alcohol 11(3.1%) 0 1 (0.6%) 3 (3.1%) 1 (0.2%) 0 0 
Cocaine + THC + alcohol 1 (0.3%) 1 (4.2%) 0 0 0 0 0 
Benzodiazepines + alcohol 13 (3.7%) 0 2 (1.3%) 1 (1.0%) 4 (1.0%) 0 0 
Cocaine + Benzodiazepines 
+ alcohol 
1 (0.3%) 0 0 0 0 0 0 
THC + benzo + alcohol 1 (0.3%) 0 0 0 1 (0.2%) 0 0 
Amphetamines + THC + 
benzo + alcohol 
1 (0.3%) 0 0 0 0 0 0 
Z-drug + alcohol 0 0 0 1 (1.0%) 1 (0.2%) 0 0 
Benzo + z-drug + alcohol 2 (0.6%) 0 0 0 0 0 1 (9.1%) 
Medicinal opioids + alcohol 0 1 (4.2%) 0 0 1 (0.2%) 0 0 
Amphetamines + medicinal 
opioids + alcohol 
0 0 1 (0.6%) 0 0 0 0 
THCCOOH + medicinal 
opioids + alcohol 
1 (0.3%) 0 0 0 1 (0.2%) 0 0 
Total 353 
(100.2%) 
24 
(100.2%) 
159 
(100.0%) 
96 
(99.7%) 
413 
(99.8%) 
22 
(100.0%) 
11 
(100.1%) 
 
 
The prevalence for THC combined with alcohol was significantly higher in personal car 
drivers than in motorcycle or bicycle riders. The distributions for this combination were 
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equal for the two-wheel vehicle drivers. The distribution of the combination 
benzodiazepines + alcohol was lower in bicycle riders. 
 
 
1.4.6 Distribution of additional substances 
Beside the core substances, additional substances were analysed. A list of the additional 
analytes can be found in the summary report, under the method part.  
The number of positive cases for the additional substances is shown in table 30. 
Positive cases for tramadol, 7-aminoclonazepam and 7-aminoflunitrazepam, 3 analytes of 
the additional substances list, were incorporated in the result calculations of the core 
substances, under the groups opiates and opioids (tramadol) and benzodiazepines (7-
aminoclonazepam and 7-aminoflunitrazepam). 
 
Table 30. Number of positive cases for additional substances 
Substance Number of cases 
Amitriptyline  2 
Bromazepam  6 
Buprenorphine  0 
Citalopram  35 
Mirtazapine  7 
11-OH-THC  49 
Trazodone  18 
Total 117 
 
In total 117 cases were found positive for additional substances. Hydroxy-THC and 
citalopram represented the major additional findings. 
 
Table 31. Distribution of additional substances by region 
Region  
Brussels Flanders Wallonia 
Positive for additional substances 4 (11.4%) 86(9.8%) 27 (16.2%) 
Total injured drivers 35 (100%) 876 (100%) 167 (100%) 
 
There was no significant difference in prevalence of additional substances between 
Brussels and Flanders nor between Brussels and Wallonia. A slight difference was found 
between Flanders and Wallonia. 
 
Table 32. Distribution of additional substances by Day vs Night 
Day vs. night  
unknown Day Night 
Positive for additional substances 3 (17.6%) 95(10.6%) 19 (11.6%) 
Total injured drivers 17 (100%) 897 (100%) 164 (100%) 
 
No significant difference was found in the distribution of additional substances both 
between day and night (Table 32) and between week and weekend (Table 33). A 
possible explanation is that, apart form 11-OH-THC, all extra substances are medicinal 
drugs, likely to be taken on a regular basis.  
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Table 33. Distribution of additional substances by Week vs Weekend 
Week vs. weekend  
unknown week weekend 
Positive for additional substances 3 (17.6%) 69 (10.8%) 45 (10.6%) 
Total injured drivers 17 (100.0%) 639 (100.0%) 422 (100.0%) 
 
Table 34. Distribution of additional substances by age and gender 
Age groups Gender 
  unknown 17y 18-24 25-34 35-49 50+ Total 
Male positive 
for additional 
substance 
5 (31.3%) 1 
(25.0%
) 
22 
(14.4%) 
22 
(12.6%) 
19 
(8.1%) 
12 
(5.3%) 
81 
(10.0%) 
Total injured 
males 
16 
(100%) 
4 
(100%)
153 
(100%) 
175 
(100%) 
236 
(100%) 
225 
(100%) 
809 
(100%) 
Female 
positive for 
additional 
substance 
1 (25.0%) 0 4 (8.0%) 6 
(11.8%) 
8 
(11.3%) 
17 
(18.5%) 
36 
(13.4%) 
Total injured 
females 
4 (100%) 0 50 
(100%) 
51 
(100%) 
71 
(100%) 
92 
(100%) 
268 
(100%) 
 
There was no significant difference in distribution of additional substances between male 
and female drivers. Within the male subpopulation additional substances were found less 
often over 34 years (age groups 35-49 and 50+).  
For females distribution of additional substances was found equal over the 4 different age 
groups. 
 
Table 35. Distribution of additional substances by accident type 
Accident type  
unknown single-vehicle multi-vehicle
Positive for additional substances 7 (11.5%) 56 (10.7%) 54 (10.9%) 
Total injured drivers 61 (100.0%) 522 (100.0%) 495 (100.0%)
 
As for accident type, distribution of additional substances was equal between single and 
multi-vehicle crash. 
 
 
 DRUID 6th Framework Programme Deliverable D.2.2.5  
Part 2 – Country Reports from hospital studies - Country Report Belgium 
Prevalence of alcohol and other psychoactive substances in injured and killed drivers. 
 
 Page 209 of 349 
1.4.7 Distribution of substance concentrations 
Distribution of concentrations is reported in the tables below for DRUID core substances 
and for additional substances separately. 
 
Core substances 
 
Table 36. Concentration distribution of core substances (above DRUID cut-off) 
Concentration range 
(ng/mL) 
Substance Number 
of cases 
Min Max 
Median 
(ng/mL) 
Mean 
(ng/mL) 
Ethanol 283 0.10 g/L 4.29 g/L 1.59 g/L 1.58 g/L 
Morphine  12 10.5 104.9 17.7 35.6 
Amphetamine  13 21.9 1327.6 300.2 377.9 
MDMA  2 389.1 436.4 412.8 412.8 
MDA  1 43.4 43.4   
Cocaine  9 13.3 54.5 37.5 34.5 
THC  57 1.0 14.2 2.5 2.9 
Diazepam  19 20.1 373.9 131.4 154.4 
Alprazolam  5 10.4 42.9 13.5 22.3 
Clonazepam  3 13.5 18.8 14.3 15.5 
Benzoylecgonine  18 54.5 1252.1 309.7 367.5 
Codeine  4 13.8 78.8 23.9 35.1 
6-acetylmorphine  0     
Metamphetamine  0     
Methadone  5 17.2 53.1 45.9 42.3 
Oxazepam  5 55.2 227.0 73.6 101.7 
Nordiazepam  25 27.9 500.0 141.9 162.0 
Zolpidem  10 22.9 436.0 88.6 135.4 
MDEA  0     
THC-COOH  74 5.5 87.4 17.1 23.1 
Lorazepam  19 12.0 268.9 30.3 47.4 
Flunitrazepam  1 5.9 5.9   
Zopiclone  1 10.5 10.5   
7-a-clonazepam  6 21.4 65.4 29.5 37.4 
7-a-flunitrazepam  1 33.6 33.6   
Tramadol  18 56.2 6048.9 273.7 1062.6 
 
Additional substances 
 
Table 37. Concentration distribution of additional substances (above DRUID cut-off) 
Concentration range 
(ng/mL) 
Substances Number 
of cases 
Min Max 
Median 
(ng/mL) 
Mean 
(ng/mL) 
Amitriptyline  2 15.9 53.4 34.7 34.7 
Bromazepam  6 35.0 140.6 82.6 84.8 
Buprenorphine  0     
Citalopram  35 6.1 459.6 41.8 65.8 
Mirtazapine  7 6.9 39.3 32.8 26.8 
11-OH-THC  49 1.0 31.7 2.0 2.8 
Trazodone  18 22.1 190.7 57.5 69.9 
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Maximum concentrations for some pain management drugs, such as tramadol and 
morphine, appeared to be relatively high to result from normal therapeutic use. In a 
previous study on drug-impaired driving20, the average concentration for tramadol was 
found to be around 500 ng/mL. Also, according to the scientific literature, concentrations 
of morphine in the range of 20 ng/mL are normally considered sufficient for pain 
management in cancer patients. The maximum concentrations found in this study for 
tramadol and morphine appear more likely to be in the range of those found during 
emergency treatment than in normal pain management. This observation leads to the 
possibility that, in a few cases, the administration of drugs prior to blood sampling may 
have not been recorded on the patient form.  
 
1.5 Discussion of results 
1.5.1 Representativeness 
The study area covers most of Belgium. Samples for this hospital study were collected in 
the same regions where the sample collection for the roadside survey took place (D 
2.2.3.). But with a low number of samples that was collected in Liège and Brussels. 
National data from 2006 were available on the distribution of injured drivers by quarter of 
the year (see 1.1.6). A slight difference could be noticed between the data sets collected 
in 2006 in the third and fourth quarters of the year and those collected in the present 
study in the same time frames.  
Since the response rate was high, it is safe to assume that non-response did not 
influence the representativeness of the sample.  
In the present study, bicycle riders constituted a high portion of the sampled population. 
This may have had an influence on the general outcomes of the toxicological findings, as 
the percentage of negative cases was the highest among this subpopulation. 
 
1.5.2 Effects of non-response 
Even if its size may have been underestimated to some extent for the reasons reported 
above, it is unlikely that the non-response had a significant effect on the distribution of the 
results of the present study. 
 
1.5.3 Highlights  
Alcohol was the most prevalent substance among injured drivers in Belgium, with a 
percentage of 26.2. Almost 23% of alcohol positive cases were positive for a drug-alcohol 
combination. Cases positive for alcohol only were more common in male drivers, with 
prevalence decreasing as age increased. The second most prevalent group was the one 
positive for cannabis only (3.5%), with positive cases more common in the male 
subpopulation aged 18-34. The combination alcohol-cannabis was not found in the 
female population.  
In general the number of positive drivers was higher during night-time. Alcohol alone and 
in combination with cannabis was found more during nights (with a prevalence 3.6 times 
higher than in daytime accidents). Accidents involving drivers positive for cannabis only 
occurred more often during daytime. In general, analyses revealed more positive cases 
during weekends than during weekdays, with an occurrence of alcohol that was almost 
double during weekends compared to weekdays.  
When comparing accident type, drivers involved in single-vehicle accidents were found 
positive for one or more substances 1.6 times more often than drivers involved in 
multiple-vehicle crashes. 
                                                          
20 Baselt RC. Disposition of toxic drugs and chemicals in man. Biomedical publications Foster city, California, 
2004 
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Big differences among vehicle types were observed. Alcohol was most prevalent among 
drivers of personal cars, while the percentage of subjects testing positive for THC was the 
highest in the subpopulation of moped drivers 
 
1.5.4 Comparison to other studies 
A study similar to the one presented in this report was carried out in Belgium between 
January 1995 and June 1996, under the name of Belgian Toxicology and Trauma Study 
(BTTS). BTTS collected data about drivers of motor vehicles and bicycles, aged more 
than 14 years, involved in traffic accidents that led at least to 24 hour hospitalisation. In 
the BTTS toxicological analyses were performed on blood and urine samples taken from 
injured drivers conveyed to the same 5 hospitals selected in the present project. 
When comparing the findings of the present study to the ones of the BTTS, no significant 
difference can be found in gender distributions. Regarding time period distribution, the 
percentage of accidents recorded during weekdays is lower in the DRUID-project. As for 
vehicle type, cars, vans and motorcycles are more represented in the BTTS, with a higher 
prevalence of multiple-vehicle accidents, while a higher proportion of bicycles, mopeds 
and trucks are recorded in the present study. Use of seat belt appears to have stayed 
equal. 
In the toxicological analyses, alcohol remains the most common finding. The percentage 
of BAC above 0.5 g/L decreases from 28% in the BTTS to the present 23%, but is linked 
to an increased prevalence among younger people (the higher prevalence shift from age 
groups 35-39 and 50-54 to age groups 25-34 and 35-49). THC use is consistent in the 
two studies. Cocaine prevalence appears to be higher in the DRUID sample compared to 
the BTTS findings, while amphetamines, benzodiazepines and medicinal opioids 
incidence decrease. A limitation of the BTTS is the screening and confirmation of illicit 
drugs in urine instead of blood. It is possible that a certain number of drivers was found 
positive because they had taken drugs several days before the accident. Comparison 
with blood results in DRUID should therefore be made cautiously. 
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1.8 Annex 1 : Flow chart 
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1.9 Annex 2 : Patient Form 
 
Registration forms are available in Dutch and French. This annex only includes a 
translation to English. The registration form can be printed on 1 recto-verso sheet. The 
upper part (which includes a Patient Identification Number) has to be removed before 
sending the forms to the DRUID researchers. 
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1.10 Annex 3 :Toxicological analysis of blood samples  
 
1.10.1 Extraction 
1.10.1.1 Whole blood – cannabinoids 
Internal standard (25ng/mL) was added to 1000µL of blood, together with 100µL H2O, 
50µL methanol and 100µL acetic acid 10%. 
5.5 mL hexane/ethyl acetate (90/10) was added. After 30 min rolling and centrifugation 
(3000 rpm, 5 min) the organic phase was removed, transferred to a silanised tube and 
evaporated under nitrogen at 56°C. The dry residue was resuspended in 200µL 
TMAH/DMSO (100mg Trimethylammoniumhydroxide in 1.9 mL Dimethylsulfoxide + 0.1 
mL H2O). After 5 min incubation (ambient temperature) 50µL methyliodide was added. 
After 1h incubation (ambient temperature) 200µL HCl 0.1N was added to stop the 
derivatisation reaction. After 5 min incubation 2 mL iso-octane was added, the samples 
were rolled for 10 min and centrifuged for 5 min. The organic phase was removed, 
evaporated under nitrogen at 56°C, reconstituted in 30µL ethyl acetate and transferred 
into a vial for analysis with GC-MS. 
 
1.10.1.2 Whole blood – other substances 
Whole blood samples were extracted using solid phase extraction (SPE). Internal 
standard (20 ng/mL) was added to 500 µL of blood which was diluted using 2.5 mL 
ammonium acetate (0.05M, pH 4.1)/methanol (80:20). After centrifugation, this mixture 
was loaded on Bond Elut Plexa PCX cartridges (3 mL, 60mg) (Varian, Sint-Katelijne-
Waver, Belgium) previously conditioned with 2 mL of methanol and 2 mL of H2O. 
Cartridges were washed consecutively with 2 mL H2O and 4 mL methanol/H2O (1:1). 
Cartridges were dried under vacuum and analytes were eluted using 4.5 mL acetonitrile 
with 2% ammonia. Samples were evaporate at room temperature, reconstituted in 100 µL 
methanol/ H2O (1:1) and transferred into a vial for analysis with UPLC-MS/MS. 
 
 
1.10.2 UPLC-MS/MS parameters 
Separation and detection were performed using an ultra-performance liquid 
chromatography tandem mass spectrometer (UPLC-MS/MS).  
Chromatographic separation was performed on an AcquityTM ultra performance liquid 
chromatograph (Waters, Zellik, Belgium). The system was equipped with an Acquity 
UPLC BEH C18 column (1.7µm, 2.1 x 100 mm) and a Vanguard BEH C18 pre-column 
(1.7µm, 2.1 x 5 mm). A gradient elution of water with 2mM ammonium bicarbonate pH 9.3 
(A) and methanol (B) was used. The column oven was heated to 60°C. Injection was 
performed using partial loop using needle overfill mode. Ten µL were injected for whole 
blood samples. Both the ratio between aqueous and organic solvent and total flow-rate 
were changed over time. Total run-time including re-equilibration was 7 min. (figure 9) 
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Figure 9. Mobile phase gradient used for UPLC 
 
Detection was performed using a Waters Quattro Premier XE tandem mass 
spectrometer. The general source parameters used are given in Table 1. 
 
Table 1. General parameters used for mass spectrometry 
ES+ Source Capillary Voltage 0.8 kV 
 Extractor Voltage 4 V 
 RF Lens 0 V 
 Source Temperature 140 °C 
 Desolvation Temperature 450 °C 
 Desolvation Gas Flow 1000 L/h 
 Cone Gas Flow 50 L/h 
Analyser Collision Gas Flow 0.15 mL/min 
 
To determine component-dependent mass spectrometric parameters, all analytes were 
infused separately. Retention time windows were defined as the retention time ± 0.15 min 
for all analytes except amphetamines (± 0.35 min). For each analyte, the maximum dwell 
times were chosen at which a minimum of twelve data points per peak was obtained for 
all analytes. MRM transitions, collision energies, cone voltages, retention times and dwell 
times are shown in Table 2. 
 
Table 2. MRM transitions, dwell times, cone voltage, collision energy and retention times for 
all standards and internal standards 
Substance Q 1 Q 3 Dwell 
time 
(msec)
Cone 
(V) 
Collision 
Energy 
(eV) 
Retention 
time 
(min) 
6-acetylmorphine 328.12 152.08 35 47 61 3.61 
6-acetylmorphine-D3 331.10 164.90 35 45 37 3.58 
7-amino-clonazepam 286.08 222.05 35 41 25 2.79 
7-amino-clonazepam-D4 290.02 226.00 35 39 27 2.78 
7-amino-flunitrazepam 284.14 226.86 35 39 25 2.96 
7-amino-flunitrazepam-D7 291.11 230.30 35 39 27 2.94 
Alprazolam 309.01 204.94 25 49 39 4.34 
Amitriptyline 278.14 233.07 25 33 17 5.33 
Amitriptyline-D3 281.10 233.00 25 33 17 5.33 
Amphetamine 136.07 119.05 35 15 9 3.43 
Amphetamine-D5 141.01 92.90 35 17 27 3.37 
Benzoylecgonine 290.14 168.00 35 33 19 2.64 
Benzoylecgonine-D3 293.10 171.00 35 33 19 2.63 
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Bromazepam 316.03 181.96 30 41 29 3.91 
Buprenorphine 468.26 55.27 25 55 49 5.51 
Buprenorphine-D4 472.23 83.00 25 63 53 5.50 
Citalopram 325.11 262.10 25 37 25 4.79 
Clonazepam 316.08 269.96 30 45 25 4.02 
Cocaine 304.11 182.1 15 31 19 4.66 
Cocaine-D3 307.10 185.00 15 31 19 4.64 
Codeine 300.14 165.01 30 41 43 3.84 
Codeine-D3 303.10 215.00 30 45 25 3.83 
Diazepam 285.08 222.02 25 43 27 4.71 
Diazepam-D5 290.08 227.00 25 43 27 4.69 
Flunitrazepam 314.08 268.09 30 41 25 4.09 
Lorazepam 321.02 229.03 40 29 29 4.30 
MDA 180.02 105.03 35 15 21 3.28 
MDA-D5 185.01 110.00 35 17 21 3.23 
MDEA 208.10 162.97 30 23 13 3.79 
MDEA-D5 213.07 162.90 30 21 13 3.69 
MDMA 194.10 162.95 35 21 13 3.43 
MDMA-D5 199.10 135.20 35 21 21 3.34 
Methadone 310.27 265.13 25 31 15 5.30 
Methadone-D3 313.21 268.10 25 29 15 5.29 
Methamphetamine 149.96 90.95 30 21 17 3.61 
Methamphetamine-D5 155.00 120.90 30 19 11 3.55 
Mirtazapine 266.10 195.00 25 37 25 4.83 
Morphine 286.11 152.10 35 45 53 3.10 
Morphine-D3 289.08 164.90 35 43 37 3.10 
Nordiazepam 271.02 208.03 25 41 25 4.58 
Oxazepam 287.05 241.01 40 33 25 4.31 
THC 315.18 193.05 60 31 21 5.44 
THC-d3 318.13 196.00 20 31 25 5.44 
Tramadol 264.18 58.18 25 27 15 4.59 
Tramadol-13C-D3 268.14 58.20 25 25 15 4.58 
Trazodone 372.08 176.0 25 43 23 4.86 
Zolpidem 308.21 235.10 40 43 35 4.30 
Zolpidem-D6 314.18 263.10 40 53 27 4.28 
Zopiclone 389.03 244.92 30 17 17 3.94 
 
1.10.3 GC-MS parameters 
Detection of THC, 11-OH-THC and THCCOOH, was performed on an Agilent 6890 N gas 
chromatograph with split injection and a quadrupole mass spectrometer (Agilent 5973). 
Analytes were separated on a GC capillary column (Agilent 127-100ADB1, 5m x 
0.10mm), in constant flow mode with an initial flow of 0.4ml/min. 
The components are identified/quantified using qualifier ions in combination with their 
retention time (Table 3). 
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Table 3. Retention time, target ion, qualifier ions and dwell time for GC-MS of cannabinnoids 
in blood 
Substance Retention 
Time 
Target ion Qualifier ions Dwell time 
THC 2.97 328 313, 285 50 
THC.D3 2.97 331 316, 288 50 
11-OH-THC 3.25 313 / 10 
11-OH-THC.D3 3.25 316 / 10 
THCCOOH 3.47 357 313, 372 10 
THCCOOH.D3 3.47 360 316, 375 10 
 
1.10.4 Validation 
 
1.10.4.1 LC-MS/MS 
 
Whole blood was collected from drug-free volunteers in the same containers as used in 
the hospital study. 
 
Selectivity was tested by injecting ten blank samples from different sources to check for 
interfering signals. No interfering signals were observed. 
Nine calibration points were used: 0, 0.5, 1, 5, 10, 20, 50, 100 and 200 ng/mL; best fitting 
regression model and weighting factors were determined based on 5 replicate injections 
of each concentration level. 
 
Accuracy and precision at DRUID cut-off were determined based on 6 injections at the 
DRUID cut-off concentration. Since the CV on the response of these injections is below 
15%, the LLOQ (lower limit of quantification) of the method is below the DRUID cut-off for 
all analytes. 
 
To measure absolute and relative matrix effects, blood samples were collected from 10 
different volunteers. Five replicates were used. Absolute matrix effect was defined as the 
ratio between peak areas of samples spiked after extraction compared to injections of 
spiked mobile phase. To determine if the absolute matrix effect has an influence on 
quantification of analytes, the relative matrix effect was defined as described by 
Matuszewski21: calibration lines were prepared in whole blood from five different 
volunteers. Slopes from the standard lines were determined. It is recommended that the 
CV of these slopes does not exceed 3-4% in order to conclude that the method is not 
affected by relative matrix effects. This value was lower than 2% for all analytes for which 
a deuterated internal standard was used. The analytes without deuterated internal 
standards were more affected by relative matrix effects, but were below 4% in all cases 
except for citalopram, which is significantly more affected by matrix effects. However, 
when this method was developed, deuterated citalopram was not available to be used as 
internal standard. 
 
All validation parameters are described in table 5  
 
Legend for table 5: 
 
                                                          
21 Matuszewski et al. J Chromatogr B Analyt Technol Biomed Life Sci 2006 ; 830(2) :293-300 
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* extraction yield at medium concentration (20 ng/mL) 
§ inaccuracy and imprecision at DRUID cut-off 
£ absolute matrix effect determined at 100 ng/mL 
$ CV of slopes of standard lines from five different sources  
 
 
1.10.4.2 GC-MS22 
 
Whole blood was collected from drug-free volunteers in a Venoject 5mL container (ref 
VT-050SFX), the same as used during the hospital study.  
 
Selectivity was tested by injecting five blank samples from different subjects to check for 
interfering signals. For four samples no interfering signals were observed, one sample 
showed a signal for THCCOOH that was below the DRUID cut-off. 
 
Accuracy and precision were determined based on 14 injections at low concentrations 
(THC and OH-THC: 1.5 ng/mL and THCCOOH 7.5 ng/mL) and 14 injections at high 
concentrations (THC and OH-THC: 8 ng/mL and THCCOOH 40 ng/mL). At low 
concentration inaccuracy was below 5% for all compounds, at high concentration 
inaccuracy was below 15% for THC and OH-THC and below 17% for THCCOOH. 
Imprecision was below 6% for all compounds at low and high concentration. 
 
Extraction efficiency for each analyte was determined at low (n=4) and high (n=4) 
concentrations (THC and OH-THC 1.5 and 8 ng/mL respectively; THCCOOH 7.5 and 40 
ng/mL). Relative recovery was assessed by adding internal standard (IS) working solution 
to one set of spiked samples before extraction and to the second set after extraction but 
prior to evaporation. Samples were derivatised and analysed. The relative extraction 
efficiency was calculated by comparing the peak area ratios of analyte to internal 
standard for each compound in the first set with the appropriate peak area ratios in the 
second. Recovery was 50% or higher for all compounds. 
 
The validation parameters are described in table 4. 
 
Table 4. Validation parameters for GC-MS confirmation method 
 Intra assay (n=9) Inter assay (n=14)  
Analyte  Nominal 
concentration 
(ng/mL) 
Mean 
(ng/mL) 
Inaccuracy 
% 
Imprecision 
% 
Mean 
(ng/mL) 
Inaccuracy 
% 
Imprecision 
% 
Recovery 
± SD (%) 
THC 1.5 1.50 0.2 4.32 1.54 4.2 5.61 52.59 ± 
6.74 
 8 7.90 11 2.26 7.89 -11 2.77 53.12 ± 
9.74 
OHTHC 1.5 1.54 4.2 3.83 1.53 3.2 3.17 51.11 ± 
1.10 
 8 7.95 -9.6 0.95 7.90 -12 1.74 62.08 ± 
5.79 
THCCOOH 7.5 7.45 -4.5 1.12 7.45 -4.6 1.73 58.45 ± 
                                                          
22 Steinmeyer S, Bregel D, Warth S, Kraemer T, Moeller MR. Improved and validated method for the 
determination of delta-9-tetrahydrocannabinol (THC), 11-hydorxy-THC and 11-nor-9-carboxy-THC in serum, 
and in human liver microsomal preparations using gas chromatography-mass spectrometry. Journal of 
Chromatography B 2002; 772: 239-248. 
Gustafson RA, Moolchan ET, Barnes A, Levine B, Huestis MA. Validated method for the simultaneous 
determination of delta9-tetrahydrocannabinol (THC), 11-hydorxy-THC and 11-nor-9-carboxy-THC in human 
plasma using solid phase extraction and gas chromatography-mass spectrometry with positive chemical 
ionisation. Journal of Chromatography B 2003; 798: 145-154. 
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5.63 
 40 39.97 -16.9 1.77 39.83 -16 1.97 49.67 ± 
2.27 
 
 
Table 5. Validation parameters for UPLC-MS/MS confirmation method 
 Whole blood 
 R2 Extract
ion 
yield* 
(%) 
Inaccuracy
§ (%) 
Imprecision
§ (%) 
Absolut
e matrix 
effect 
(%)£ 
Relativ
e 
matrix 
effect$ 
(CV) 
6-acetylmorphine 0.991 81.8 -8.4 8.2 -42.0 1.9 
7-amino-
clonazepam 
0.995 49.7 6.4 2.8 -24.7 1.0 
7-amino-
flunitrazepam 
0.995 56.5 -10.5 4.4 -41.2 0.9 
Alprazolam 0.990 72.5 0.8 3.7 -23.2 0.9 
Amitriptyline 0.997 54.7 6.6 2.5 -26.2 1.2 
Amphetamine 0.994 20.0 -4.9 8.3 -16.1 1.3 
Benzoylecgonine 0.997 22.0 3.2 2.3 -14.0 1.3 
Bromazepam 0.994 78.4 2.9 8.4 -18.9 1.8 
Buprenorphine 0.995 41.7 -8.6 10.2 -34.0 1.3 
Citalopram 0.993 73.7 0.8 5.9 -37.6 5.5 
Clonazepam 0.992 67.2 -10.3 2.2 -47.7 1.7 
Cocaine 0.998 77.2 4.1 2.4 -6.4 1.8 
Codeine 0.996 80.0 1.6 3.6 -48.9 1.7 
Diazepam 0.996 67.0 -9.9 2.0 -34.6 1.7 
Flunitrazepam 0.990 70.2 -4.1 2.4 -31.2 1.9 
Lorazepam 0.982 51.9 14.0 3.5 -24.7 2.0 
MDA 0.991 79.6 -7.8 8.6 -39.3 1.6 
MDEA 0.995 72.2 -3.6 3.7 +37.9 1.2 
MDMA 0.986 56.3 -5.1 7.2 -35.3 1.8 
Methadone 0.990 56.6 -0.3 2.7 -3.9 1.4 
Methamphetamine 0.994 5.3 -1.0 3.7 -11.8 2.2 
Mirtazapine 0.997 63.9 9.5 6.1 -13.1 3.0 
Morphine 0.988 59.0 -5.0 7.2 -23.1 1.6 
Nordiazepam 0.997 71.5 10.0 2.4 -21.5 1.3 
Oxazepam 0.992 69.2 5.9 4.7 -26.5 2.1 
THC NA NA NA NA NA NA 
Tramadol 0.997 82.7 5.7 2.7 +7.5 1.5 
Trazodone 0.997 96.7 -14.9 4.7 -39.8 2.3 
Zolpidem 0.995 84.7 -2.2 2.0 -3.1 0.9 
Zopiclone 0.990 84.2 10.2 3.7 -33.0 3.4 
 
1.10.5 Ethanol analyses 
Ethanol was quantified using the Ethanol Gen.2 enzymatic method on a Roche Cobas 
Integra 400 system. 
 
Whole blood samples were first precipitated using trichloroacetic acid.  
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1.10.6 ELISA method 
Cannabinoids were analysed using Elisa One Step Cannabis (IDS, Cat No. TH-96-CE-U. 
The kit contains an enzyme conjugate (horseradish peroxidase), an enzyme diluent 
(containing a pharmaceutical stabiliser in PBS buffer), a washing solution (containing 
Tween-20 in a PBS buffer; which is diluted 1:10 before use), a substrate (containing 
3,3’,5,5’-Tetramethylbenzidine) and a stop solution (3N H2SO4) 
 
20µL of the whole blood samples were deposited into a well each. Per plate 4 control 
samples were added with concentration of 0, 0.5, 1 and 5 ng/mL.  
 
100µL of the diluted enzyme were added to the wells. After the plate was incubated at 
ambient temperature for 30 min, the plate was turned over to empty the wells. 300µL of 
washing solution were added and the plate was turned over. After this, a washing step 
was performed 3 times, 150µL of substrate were added to each well, and the plate was 
incubated at ambient temperature for 15 min. 150µL stop solution were added. The 
optical density of each well was read using a micro-plate reader (Behring BEP3 Elisa 
processor) with a measurement filter of 450 nm (reference filter of 650 nm). 
 
When the optical density value was lower or equal to the positive control of 5ng/mL, 
confirmation analysis was performed with the GC-MS method on the corresponding blood 
sample. 
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2 Country Report Denmark  
 
Authors 
Hospital study information: Inger Marie Bernhoft, Tove Hels and Kira Janstrup, 
Technical University of Denmark, Department of Transport.  
Toxicological analyses: Kirsten Wiese Simonsen and Anni Steentoft, University of 
Copenhagen.  
 
 
 
2.1 Description of the hospitalised driver study population 
 
2.1.1 Introduction  
The hospital study in Denmark fully complies with the general guidelines mentioned in 
Annex 1 of the Summary Report. The main survey was carried out in the period 1 
October 2007 – 31 March 2010 in five selected hospitals. The personnel in the hospitals 
were in charge of the inclusion of patients in the study.  
 
Only drivers of passenger cars and vans were included in the study and only drivers who 
fulfilled the Danish criterion of being a “trauma-patient”. Two or more points on the Danish 
trauma scale indicates that the patient will be treated as a trauma patient and that 
laboratory technicians will take blood samples from the patient as part of the treatment. 
The Danish trauma scales differ from the international accident injury scale, but it is 
assumed that 2 points equals MAIS=2. 
 
On arrival of the patient, the emergency room secretary controlled, whether the patient 
fulfilled the inclusion criteria for DRUID: 
- Driver of passenger cars and small vans up to 3500 kg (driving licence category 
B), who was brought to the hospital after a road traffic accident 
- Injured in traffic accident on public road 
- Minimum age: 18 years 
- Only primary admissions 
- Admission because of traumatological reasons (based on the Danish trauma 
score) 
- Time interval between admission and sampling is less than 3 hours 
- Severity of injuries: Trauma score of the hospital 
 
If this was the case, the emergency room secretary filled in a patient datasheet and the 
laboratory technician took besides the samples for treatment purposes an additional 
blood sample. The blood collection device and the patient datasheet carried the same 
DRUID ID-bar code. Ethanol swabs were not used for cleaning. The blood samples were 
stored in the deep freezer at -20o C until they were picked up by the project courier on a 
regular basis and transported on ice to the DRUID partner University of Copenhagen for 
further storage and analysis. After completion in the hospital, each patient datasheet was 
mailed separately to DTU by the emergency room secretary. 
 
DTU prepared an information leaflet for the patients. However it was the decision of the 
hospital whether patients should receive the information. Driver participation in the 
hospital study was, in principle, voluntary. However, the blood sample was taken on 
arrival during the normal procedure for blood samples, and the patient was not informed 
or asked permission. Because of the severity of injuries, some of the trauma patients 
were even unconscious at the sampling time. 
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There is no information on the number of cases that the hospitals missed because of time 
pressure or for some other reason did not include in the study sample. However, for 
about 60 patients, either patient information or blood sample was missing, so this number 
of missing cases is considered a minimum. 
  
Reasons for missing samples could be: the patient datasheet showed that the person did 
not meet the criteria for inclusion, the tube for the blood sample was broken so the 
sample could not be analysed, the blood sample was considered not relevant and 
discarded in the hospital or simply that, for a specific DRUID bar code, either blood 
sample was not taken or the patient datasheet was not submitted to DTU.  
 
The total number of seriously injured drivers for whom both a datasheet was received in 
DTU and a blood sample was received in UKBH was 856. Four drivers were below the 
age of 18. These drivers were excluded from the study population that comprises in total 
852 drivers.  
 
 
2.1.2 Geographic distribution of drivers over the country  
Five hospitals participated in the survey: 
− Region 1: Aalborg and Viborg 
− Region 2: Kolding, Vejle and Odense. 
 
No hospitals from region 3 took part in the study 
 
 
Figure 1. Map of Denmark showing the hospitals in two regions 
2 
3 
1 
Odense 
Kolding 
Vejle 
Viborg 
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2.1.3 Distribution of hospitalised drivers 
Seriously injured drivers were brought to the hospital from road accidents. Although the 
hospital catchment areas with regard to population size do not differ much between 
region 1 and 2, table 1 shows that two thirds of the injured drivers were brought to one of 
the three hospitals in region 2.  
 
Table 1. Distribution by region, N=852 
Region Number Percentage 
4501 
Aalborg and Viborg 
269 31.6% 
4502 
Vejle, Kolding and Odense 
583 68.4% 
 
Although the hospitals informed DTU about the size of their catchment areas before the 
study started, it turned out that victims from road traffic accidents that took place outside 
the catchment areas of Kolding and Odense hospital were also brought to these 
hospitals. 
 
 
2.1.4 Distribution by type of road 
Based on information about the accident place, in most cases it was possible to 
determine whether the accident took place on an urban or rural road. As shown in table 
2, most of the accidents of the seriously injured drivers took place on rural roads. For 5% 
of the drivers, the road type was not known.  
 
Table 2. Distribution of drivers by road type, N=852 
Road type Number of drivers Percentage of drivers  
Urban roads 194 22.8% 
Rural roads 615 72.2% 
Unknown 43 5.0% 
 
2.1.5 Distribution by type of vehicle 
The hospitals were asked to record whether the vehicle was a passenger car or a van. As 
shown in table 3, the majority of vehicles were passenger cars.  
 
Table 3. Distribution of drivers by road type, N=852 
Vehicle type Number of drivers Percentage of drivers  
Passenger cars 801 94.0% 
Vans 42 4.9% 
Unknown 9 1.1% 
 
 
2.1.6 Distribution by type of accident 
The hospitals were asked to record whether the accident was a single vehicle accident or 
a multiple vehicle accident. As shown in table 4, there was an equal distribution  
between single and multiple vehicle accidents  
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Table 4. Distribution of single and multiple vehicle accidents, N=852 
Accident type Number of drivers Percentage of drivers  
Single vehicle 419 49.2% 
Multiple vehicle 419 49.2% 
Unknown 14 1.6% 
 
 
2.1.7 Distribution of drivers by season  
Based on the accident date, the drivers have been grouped by season. As the inclusion 
period started on 1 October 2007 (1 December 2007 for Aalborg hospital) and ended on 
31 March 2010, quarter 1 and 4 cover three years and quarter 2 and 3 only two years. 
Table 5 shows the mean distribution within each quarter of the year. The lowest number 
of seriously injured drivers was included in quarter 2 and the highest number in quarter 4. 
 
Table 5. Distribution of drivers by quarter of the year, N=852 
Season of the 
year 
Number of drivers Mean number of 
drivers per year 
Mean percentage of 
drivers  
Quarter 1 
January-March 
265 88 26.3% 
Quarter 2 
April-June 
140 70 20.9% 
Quarter 3 
July-September 
163 82 24.5% 
Quarter 4 
October-December 
284 95 28.3% 
 
 
2.1.8 Distribution of drivers by day of the week and time of the day  
The day and time of the accidents were grouped into type of day (week day – weekend 
day) and time of day (day: 4-10, 10-16 and 16-22, night: 22-04), according to the 8 
DRUID time periods, as described in Annex 1 of the summary report. As shown in table 
6, the majority of the accidents took place during week days, followed by weekend days.  
 
Table 6. Distribution of drivers by time and day of the week (DRUID time periods) , N=852 
DRUID time period Number of drivers Percentage of drivers  
Week day (1-3) 510 59.9% 
Week nights (4) 40 4.7% 
Weekend days (5-7) 215 25.2% 
Weekend nights (8) 69 8.1% 
Unknown 18 2.1% 
 
 
2.1.9 Distribution of drivers by gender and age  
The distribution by age and gender is shown in table 7. The percentages of seriously 
injured males and females differ slightly, with an underrepresentation of young females 
aged 18-24 and 25-34 and consequently an overrepresentation of females aged 35 and 
above. 
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Table 7. Distribution by gender and age (18-24; 25-34; 35-49 and 50+), N=852 
Age group Number of 
males 
Percentage of 
males 
Number of 
females 
Percentage of 
females 
18-24 193 34.5% 81 27.7% 
25-34 144 25.8% 63 21.5% 
35-49 129 23.1% 88 30.0% 
50+ 92 16.4% 56 19.1% 
Unknown 1 0.2% 5 1.7% 
Total 559 65.6% 293 34.4% 
 
 
2.2 Methods: Data collection and analysis 
 
2.2.1 Ethical approval  
No ethical approval was needed in Denmark. After having been informed about the 
project, the Ethical Committee answered that “the project is not encompassed by the law 
on Ethical Committees and consideration regarding bio-medical research projects. 
Therefore, the project should not be announced to the ethical Committee”. Hence, no 
informed consent was requested. 
 
2.2.2 Specimen collection  
5-10 mL whole blood was collected in vacuum tubes containing sodium fluoride and 
potassium oxalate. For wiping the skin before taking the sample, no alcohol swabs were 
used. Instead a disinfectant swab with chlorhexidine was used. The vacuum tubes, 
provided with the ID bar code, were gently mixed 5-10 times immediately after collection 
to prevent coagulation. The tubes were stored in plastic containers before they were 
stored in the deep freezer in the laboratory of the hospital. 
 
2.2.3 Tocicological analysis  
All drugs except ∆-9-tetrahydrocannabinol 
To analyse the blood samples for the European DRUID project an ultra performance 
liquid chromatography tandem mass spectrometry (UPLC-MS/MS) method was 
developed and validated for detection of 29 medicine and illicit drugs. The drugs detected 
were the DRUID core drugs: morphine, 6-acetylmorphine, codeine, amphetamine, 
methamphetamine, MDA, MDMA, MDEA, methadone, cocaine, benzoylecgonine, 
zolpidem, diazepam, nordiazepam, clonazepam, flunitrazepam, , oxazepam, alprazolam, 
lorazepam, zopiclone, and THC-COOH as well as the following extra drugs: tramadol, 
buprenorphine, nitrazepam, 7-aminonitrazepam, 7-aminoclonazepam, 7-
aminoflunitrazepam, bromazepam and chlordiazepoxide. 
 
Solid phase extraction was performed with a Gilson ASPEC XL4 system equipped with 
Bond Elut Certify SPE sample cartridges. Whole blood samples (200 mg) diluted with 5 
ml of ammonium acetate/methanol (v/v, 90:10) buffer were applied to the columns and 
eluted with 3 ml of acetonitrile containing 0.5% (v/v) aqueous ammonia. Target drugs 
were quantified using a Waters ACQUITY UPLC system coupled to a Waters Quattro 
Premier XE triple quadrupole (ESI+, MRM mode). The column used for the 
chromatography was a 100 mm × 2.1 mm, 1.8 µm Acquity UPLC HSS T3 C18, which was 
maintained at a column temperature of 35°C and a constant flow rate of 0.4 mL/min. The 
mobile phase was composed of solvents A (2 mmol/L ammonium acetate, pH 6.2) and B 
(100% methanol). A chromatographic gradient program was run for 15 min. The injection 
volume was 10 µL. 
 DRUID 6th Framework Programme Deliverable D.2.2.5  
Part 2 – Country Reports from hospital studies - Country Report Denmark 
Prevalence of alcohol and other psychoactive substances in injured and killed drivers. 
 
 Page 227 of 349 
 
Extraction recoveries were 20%–93% for all analytes (table 8). Lower limits of 
quantification (LloQ) was 1.0 µg/L for all analytes; measuring range: 1.0-100 µg/L except 
morphine and THC-COOH. LloQ for morphine was 10 µg/L; measuring range: 10-100 
µg/L. LloQ for THC-COOH was 5 µg/L; measuring range: 5-100 µg/L. Minor to moderate 
matrix effect was seen but no major ion suppression or enhancement was observed. 
Total imprecision (CV) of the method was 3-30%. 
Table 8. Extraction recovery for the drugs 
Analyte Extraction 
Recovery 
(%) 
(n=6) 
THC 35 
THC-COOH 20 
Buprenorphine 54 
7-AMN 47 
7-AMC 40 
7-AMF 44 
Bromazepam 35 
Zopiclone 81 
Nitrazepam 49 
Oxazepam 61 
Clonazepam 66 
Lorazepam  70 
Chlordiazepoxide  93 
Alprazolam 87 
Flunitrazepam 77 
Nordiazepam 83 
Diazepam 86 
Zolpidem 85 
Methadone 79 
Tramadol 81 
6-Acetylmorphine 54 
Benzoylecgonine 34 
Codeine 62 
Cocaine 88 
Morphine 20 
Amphetamine 50 
Methamphetamine 53 
MDA 73 
MDMA 49 
MDEA 70 
 
∆-9-Tetrahydrocannabinol 
Whole blood samples (200 mg) were spiked with internal standard (THC-D3) and 
extracted with pentane. After centrifugation, the organic phase was evaporated at room 
temperature under a stream of nitrogen and redissolved in 200 µL mobile phase. 
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The analyses were performed on an Acquity UPLC-Quattro Premier XE Tandem MS/MS 
system (Waters). The separation column was a Waters Acquity 2.1 x 50 mm, 1.7 micron. 
The solvent consists of 2 mM ammonium acetate pH 6.2:methanol (9:1) (isocratic). Run 
time was 3 min. 
 
Extraction recovery was 35%. Lower limit of quantification (LloQ) was 0.2 µg/L; 
measuring range: 0.2-50 µg/L. Matrix effect and ion suppression/enhancement were not 
seen. Total imprecision was 7-17%. 
 
2.2.4 Method of BAC quantification  
100 µL sample volume (whole blood) was sampled 2 times and analyzed on 2 different 
Restek columns, length: 30 m and I.D. 0.25 mm. 2-butanol was used as internal standard 
for the analysis on Restek column-1 and 2-methyl-2-propanol used as internal standard 
for Restek column-2. The chromatography was done isothermically at 30 0C. Carrier gas 
was nitrogen 5.0 . Cut off was 0.1 g/L.  
 
2.2.5 Information about the drivers 
The hospitals were asked to record the following information on the patient datasheet: 
Patient information 
− Identification number (for labeling of samples and recorded data) 
− Age and gender 
− Time and date of sampling 
− Medication/Fluids administered prior to blood sampling 
− Severity of injuries (according to Danish trauma scales) 
Accident information 
− Time and date of the accident 
− Place of accident for decision on road type (urban and rural)  
− Type of accident (single vehicle or multi vehicle)  
− Type of vehicle (passenger car or van) 
 
Based on the information about the time of the accident and the time of blood sampling, 
drivers whose blood sample was taken more than three hours after the accident were 
excluded from the study. 12 drivers have been excluded from the study population 
because of this. These drivers are excluded from the study population in the further 
analyses. The remaining study population includes 840 seriously injured drivers.  
 
2.3  Non-response/refusals 
In those hospitals where it was decided to provide the patients with the information 
leaflet, patients could refuse participation. A few patient datasheets were returned with 
this information. But no registration of the patients that refused is available. Nor is any 
information on drivers that filled in the inclusion criteria, but for some reason, e.g. time 
pressure, were not included in the study. However, it is unlikely that this has influenced 
the distribution of drivers in the study population.  
 
2.4 Results  
Based on the toxicological analyses of the core substances and various information 
regarding the patients and the accidents, a number of cross tabulations are shown. The 
results have been processed by means of SAS computing programmes. The core 
substances have been grouped into substance groups according to the information in 
Annex 1 of the summary report. It should however be noted that although tramadol is 
considered an extra substance, samples that were positive for tramadol are included in 
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the substance group medicinal opioids. All substance concentrations are above the 
DRUID cut-off and each positive concentration is only recorded one time in the 
percentages of positive samples. Samples that are positive for more than one substance 
are recorded either in the group alcohol-drugs or in the group drug-drug. The 
percentages are thus mutually exclusive. 
 
The distribution of substance groups by time of the day and day of the week is shown in 
table 9. Alcohol alone was found in 15.36% of the study population, with a considerably 
higher prevalence in weekends compared to the working days. The most prevalent drug 
is medicinal opioids (2.50%), of which the prevalence was considerably higher during 
weekdays compared to weekends. Combinations of alcohol and drugs or multiple drugs 
were found in 7.03% of the study population, with a higher prevalence of alcohol in 
combination with drugs in weekends whereas the highest prevalence of multiple drugs 
was found in working days. Amphetamine is only found in working days. Finally medicinal 
opioids are more prevalent during the week than in the weekend. 
 
Table 9. Distribution of substance groups by day of the week (percentages), N=840 
 Week (period 1-4) 
(N=542) 
Weekend (period 5-8)
(N=280) 
Unknown 
(N=18) 
In total
(N=840) 
Alcohol 10.70 24.64 11.11 15.36 
Amphetamines 1.66 0 0 1.07 
Benzoylecgonine 0 0 0 0 
Cocaine 0 0.18 0 0.12 
THCCOOH 1.85 1.43 0 1.67 
THC 0.74 0.36 0 0.60 
Illicit opiates 0.18 0 0 0.12 
Benzodiazepines 1.66 1.43 0 1.55 
Z-drugs 0.55 0.36 0 0.48 
Medicinal opioids 2.95 1.79 0 2.50 
Alcohol-drugs 3.51 6.07 0 4.29 
Multiple drugs 3.14 2.14 0 2.74 
Total 26.94 38.40 11.11 30.50 
 
Table 10 shows the distribution by time of the day and day of the week. In total, more 
than half of the seriously injured drivers were positive for one of the substance groups. 
The highest prevalence of alcohol positive samples is found in weekend nights, followed 
by week nights whereas the highest prevalence of alcohol in combination with drugs is 
found in week nights, followed by weekend nights, whereas a higher prevalence of 
combined alcohol and drug positive samples were found in the study population from 
accidents that took place during the week nights that the weekend nights.  
 
Besides alcohol and alcohol in combination with drugs that are the most prevalent 
substance groups both in week nights and weekend nights, week nights are 
characterised by a high prevalence of amphetamines, cocaine and THCCOOH, whereas 
weekend nights are characterised by a high prevalence of benzodiazepines. Medicinal 
opioids were prevailing in week days.  
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Table 10. Distribution of substance groups by time of the day and day of the week 
(percentages), N=840 
 Week 
days 
(N=503) 
Week 
nights 
(N=39) 
Weekend 
days 
(N=212) 
Weekend 
nights 
(N=68) 
Unknown 
 
(N=18) 
In total
 
(N=840)
Alcohol 9.15 30.77 20.75 36.75 11.11 15.36 
Amphetamines 1.39 5.13 0 0 0 1.07 
Benzoylecgonine 0 0 0 0 0 0 
Cocaine 0 2.56 0 0 0 0.12 
THCCOOH 1.39 7.69 1.89 0 0 1.67 
THC 0.80 0 0.47 0 0 0.60 
Illicit opiates 0.20 0 0 0 0 0.12 
Benzodiazepines 1.79 0 0.94 2.94 0 1.55 
Z-drugs 0.60 0 0.47 0 0 0.48 
Medicinal 
opioids 
3.18 0 1.89 1.47 0 2.50 
Alcohol-drugs 2.78 12.82 4.72 10.29 0 4.29 
Multiple drugs 3.38 0 2.36 1.47 0 2.74 
Total 24.86 58.97 33.49 52.89 11.11 30.50 
 
 
547 men and 293 women were included in the final study population. Table 11 shows the 
distributions of men and women in the study population by substance group and age. The 
percentage of positive samples from the seriously injured men amounts to 38.20, 
whereas the percentage for women is 16.03.  
 
Both for men and women, the highest total prevalence was found in the age group 25-34, 
and also the highest prevalence of alcohol was found in this age group. Next prevalent for 
men was alcohol in combination with drugs, again with the highest prevalence in the 
group aged 25-34. 
 
Among the illicit drugs, THCCOOH was the most prevalent drug group, with equal 
prevalence in the three age groups of men aged 49 and below. For women, the age 
group of 25-34 had the highest prevalence of both THC and THCCOOH. 
 
Medicinal opioids were quite prevalent (3.17-5.68%) for men aged 35 and above and for 
women aged 25 and above, whereas benzodiazepines and z-drugs were most prevalent 
among men aged 50 and above. 
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Table 11. Distribution of substance groups for men (N=547) and women (N=293) by age 
(percentages) 
Men 
 18-24 
(N=188) 
25-34 
(N=141) 
35-49 
(N=127) 
50+ 
(N=90) 
Unknown 
(N=1) 
All ages 
(N=547) 
Alcohol 20.21 26.24 22.05 14.44 0.85 21.39 
Amphetamines 1.06 3.55 0 0 0 1.28 
Benzoylecgonine 0 0 0 0 0 0 
Cocaine 0 0.71 0 0 0 0.18 
THCCOOH 2.13 2.13 2.36 1.11 0 2.01 
THC 1.60 0 0.79 0 0 0.73 
Illicit opiates 0 0 0.79 0 0 0.18 
Benzodiazepines 1.06 0.71 1.57 3.33 0 1.46 
Z-drugs 0 0 0 2.22 0 0.37 
Medicinal opioids 0.53 0.71 3.15 5.56 0 2.00 
Alcohol-drugs 5.32 9.93 3.94 3.33 0 5.85 
Multiple drugs 2.13 2.84 4.72 1.11 0 2.74 
Total 34.04 46.82 39.37 31.10 0.85 38.20 
Women 
 18-24 
(N=81) 
25-34 
(N=63) 
35-49 
(N=88) 
50+ 
(N=56) 
Unknown 
(N=5) 
All ages 
(N=293) 
Alcohol 1.23 7.94 2.27 7.14 0 4.10 
Amphetamines 2.47 0 0 0 0 0.68 
Benzoylecgonine 0 0 0 0 0 0 
Cocaine 0 0 0 0 0 0 
THCCOOH 1.23 1.59 1.14 0 0 1.02 
THC 0 1.59 0 0 0 0.34 
Illicit opiates 0 0 0 0 0 0 
Benzodiazepines 1.23 1.59 1.14 1.79 20.00 1.70 
Z-drugs 0 1.59 0 1.79 0 0.68 
Medicinal opioids 0 3.17 5.68 3.57 20.00 3.41 
Alcohol-drugs 0 1.59 2.27 1.79 0 1.37 
Multiple drugs 1.23 4.76 2.27 3.57 0 2.73 
Total 7.39 23.82 14.77 19.65 40.00 16.03 
 
The number of accident was equally distributed between single vehicle accidents and 
multiple vehicle accidents.  
 
Table 12 shows that the prevalence of alcohol is more than four times higher in single 
vehicle accidents than in multiple vehicle accidents. However, this trend is not found for 
the other drugs, except for alcohol combined with drugs and multiple drug use.  
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Table 12. Distribution of substance groups by accident type (percentages), N=840 
 Single 
vehicle 
(N=411) 
Multiple 
vehicle 
(N=415) 
Unknown 
 
(N=14) 
In total 
 
(N=840) 
Alcohol 24.33 6.02 28.57 15.36 
Amphetamines 1.22 0.96 0 1.07 
Benzoylecgonine 0 0 0 0 
Cocaine 0.24 0 0 0.12 
THCCOOH 1.46 1.69 7.14 1.67 
THC 0.49 0.72 0 0.60 
Illicit opiates 0.24 0 0 0.12 
Benzodiazepines 1.46 1.69 0 1.55 
Z-drugs 0.49 0.48 0 0.48 
Medicinal opioids 2.19 2.89 0 2.50 
Alcohol-drugs 5.84 2.65 7.14 4.29 
Multiple drugs 3.65 1.93 0 2.74 
Total 41.61 19.03 42.85 30.50 
 
The following table (table 13) shows the number of positive samples for the additional 
substances that were analysed for in Denmark and that were included in the results for 
the core drugs. Table 14 shows the results for the other four extra substances included in 
the toxicological analyses in Denmark.  
 
Table 13. Distribution of additional substances included in the substance groups at or above 
the DRUID cut-off 
Substance Number of samples above the cut-off 
Tramadol 18 
7-amino clonazepam 22 
7-amino flunitrazepam 7 
Total 47 
 
Table 14. Distribution of other additional substances at or above the DRUID cut-off 
Substance Number of samples above the cut-off 
Buprenorphine 2 
Bromazepam 2 
Chlordiazepoxide 7 
Nitrazepam 8 
7-amino nitrazepam 6 
Total 19 
 
Finally, table 15 shows the concentration distribution of the core substances, including 
tramadol, 7-amino clonazepam and 7-amino flunitrazepam and table 16 shows the 
concentration distribution of the other additional substances that were analysed for in 
Denmark.  
 
Compared to the DRUID cut-offs, the medians for all substances are far above this value. 
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Table 15. Concentration distribution of core substances, including three additional 
substances. Only concentrations at and above the DRUID cut-offs 
Concentration range 
(ng/mL) 
Substance Number 
of cases 
Min Max 
Median 
(ng/mL) 
Mean 
(ng/mL) 
Ethanol 165 0.12 g/L 3.18 g/L 1.52 1.50 
Morphine  6 12.30 275.70 57.40 97.45 
Amphetamine  31 22.00 1095.00 99.70 179.63 
MDMA  1 47.60 47.60 47.60 47.60 
MDA  0 n.a. n.a. n.a. n.a. 
Cocaine  5 11.60 28.90 24.60 22.86 
THC  11 1.20 6.65 2.66 3.19 
Diazepam  21 22.10 1747.00 177.00 311.05 
Alprazolam  2 19.50 128.50 74.00 74.00 
Clonazepam  23 11.20 174.00 39.10 46.96 
Benzoylecgonine  11 51.60 1329.00 257.70 459.44 
Codeine  7 10.60 66.90 38.30 42.35 
6-acetylmorphine  1 12.40 12.40 12.40 12.40 
Metamphetamine  8 22.20 227.70 41.40 86.15 
Methadone  9 34.80 581.00 317.40 300.96 
Oxazepam  9 119.20 467.90 228.90 272.42 
Nordiazepam  22 54.30 854.90 258.45 323.30 
Zolpidem  4 50.60 1161.00 104.40 355.10 
MDEA  0 n.a. n.a. n.a. n.a. 
THC-COOH  53 5.50 351.00 40.90 59.70 
Lorazepam  0 n.a. n.a. n.a. n.a. 
Flunitrazepam  3 6.10 12.10 9.92 9.37 
Zopiclone  6 19.60 422.00 74.06 122.82 
7-a-clonazepam  22 14.80 146.80 46.40 53.65 
7-a-flunitrazepam  7 2.60 69.60 8.20 21.39 
Tramadol  18 55.70 4376.00 133.05 489.13 
 
Table 16. Concentration distribution of additional substances. Only concentrations at and 
above the DRUID cut-offs 
Concentration range 
(ng/mL) 
Substance Number 
of cases 
Min Max 
Median 
(ng/mL) 
Mean 
(ng/mL) 
Buprenorphine  2 1.00 1.30 1.15 1.15
Bromazepam  2 30.80 78.30 54.55 54.55
Chlordiazepoxide 7 43.50 3119.00 377.00 1032.63
Nitrazepam 8 14.50 231.30 38.65 60.54
7-amino nitrazepam 6 12.00 116.00 32.45 42.58
 
 
2.5 Discussion of results  
 
2.5.1 Distribution of the study sample 
Compared to the distribution of accidents with seriously injured drivers of passenger cars 
and vans in the accident statistics, the distribution of the study sample by urban and rural 
roads is very close the official accident statistics. In the study sample, 22.8% were 
women, 72.2% were men and for 5% the gender was not known. Based on the mean of 
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the years 2001-2009, 29% of the drivers were seriously injured in accidents on urban 
roads whereas 71% were injured in accidents in rural roads. 
 
As for the distribution of men and women in the study sample this is 65.6% men and 
34.4% women whereas the distribution in the official statistics is 60% men and 40% 
women. The distribution by age is also close the distribution in the official accident 
statistics.  
 
Regarding alcohol the official accidents statistics reveal that 85% of the seriously injured 
drivers of passenger cars or vans with an illegal alcohol limit (>= 0.05% in Denmark) were 
men and 15% were women. This is very close to the situation in the study sample where 
149 men (27.24% of 547) were positive for alcohol alone or in combination with drugs 
(>0.01%) whereas 16 women (5.47% of 293) were positive. This means that 90% of the 
alcohol positive samples were from men and 10% were from women. Taken into account 
that the results from the study population include alcohol concentrations above 0.01%, 
this seems to be comparable with the official accident statistics. 
 
2.5.2 Non-response 
The information on drivers who refused to take part in the study or were not included 
because of time pressure is sparse. However, it is assumed that non-response is 
randomly distributed during the study period.  
 
The only biased non-response period was May 2009 where there was a strike among 
nurses. We got the information that the strike had influenced the data collection in this 
period, but only in one of the hospitals. 
 
2.5.3 Important results 
Time of the week and the day 
Alcohol is the most prevalent drug in the study population (15.36% of the samples were 
positive for alcohol alone and 4.29% for alcohol in combination with other drugs). The 
prevalence is more than twice as high in weekends than during working days. 
Furthermore, the prevalence in the day time is twice as high in weekend days than week 
days whereas the difference is not so big between nighttime of the working days and the 
weekend. 
 
Single medicines and illicit drugs are more prevalent in the study population of seriously 
injured drivers during working days than in weekend days. This is also the case multiple 
drug combinations whereas alcohol in combination with other drugs is found mostly 
during nights of both parts of the week. 
 
Benzoylecgonine was only found in combination with alcohol and other drugs. 
 
THCCOOH was found both alone and in combination with alcohol and other drugs. 
However, only those samples where it was found alone are included in the percentages. 
This is due to the rule of mutually exclusivity which means that a positive sample can only 
be registered in one category and because alcohol in combination with THCCOOH is not 
considered an alcohol-drug combination. Combinations of alcohol and drugs or drug 
combinations were found in 7.03% of the samples. 
 
For some of the single drugs, that is alcohol, amphetamines, cocaine and THCCOOH the 
prevalence is higher during night than during daytime. The opposite is the case for THC, 
illicit opiates, z-drugs and medicinal opioids.  
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Age and gender 
The prevalence of alcohol and alcohol in combination with drugs is more than five times 
as high for men than for women in the study population of seriously injured drivers. 
Regarding illicit drugs, it is also higher for men than for women: Amphetamines, 
THCCOOH and THC for men is about two times the prevalence for women. 
 
But regarding medicinal drugs, the prevalence for women in the study population of 
seriously injured drivers is higher than for men: This is the case for benzodiazepines, z-
drugs and medicinal opioids. 
 
Type of accident  
There is a big difference in the study population regarding prevalence of alcohol for 
drivers in single and multiple vehicle accidents, where the alcohol prevalence is four 
times as high in single vehicle accidents as in multiple vehicle accidents. For medicinal 
and illicit drugs this tendency is only found for amphetamines, alcohol-drug combinations 
and multiple drug combinations. 
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3 Country Report Finland  
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Kivioja2, Lasse Lehtonen2, Pirjo Lillsunde1 
 
1National Institute for Health and Welfare (THL), 2 Hospital District of Helsinki and 
Uusimaa 
 
 
3.1 Description of the hospitalised driver sample 
 
3.1.1 Introduction  
The aim of the survey was to make an estimate of alcohol and drug use among drivers 
injured in traffic accidents and also to evaluate the relative risk for accident involvement 
while impaired by psychoactive substances using data collected in the roadside survey 
(Task 2.3). The samples and survey participant information were collected in southern 
Finland at two hospitals whose catchment areas covered the counties of Uusimaa and 
Itä-Uusimaa. About 28% of the Finnish population lives within this area. According to 
national statistics (1), 8513 people were injured in traffic accidents in 2008 and of these 
injuries 26% occurred within the catchment areas. 
The survey was conducted in accordance with the guidelines for the hospital survey (see 
Annex 1 of the Summary Report). 
 
Sample collection and interviews were carried out at the hospitals by nurses, who then 
sent the samples and interview forms to National Institute for Health and Welfare (THL), 
where the toxicological analyses were performed. 325 drivers were included in the 
survey. A total of 633 samples was collected, consisting of 322 whole blood samples and 
311 oral fluid (OF) samples. Patients included in the study were drivers of a motor vehicle 
or a bicycle. To ensure efficient recruiting of patients and a high inclusion rate, all injured 
drivers over 18 years old, even if only slightly injured, were asked to participate. The 
severity of the injuries was determined afterwards from hospital patient data, which led to 
patients with less severe injuries to also be included in the database. In addition the time 
between the accident and sampling was only determined later by the research team at 
THL, thus cases with a time difference of over three hours between the accident and 
sampling were included as well. 
 
Police traffic accident statistics for all Finland concerning type of vehicle and month of 
accident for injured drivers were available from 2008, so a limited comparison of the 
survey data to national data were possible. 
 
3.1.2 Geographical distribution of hospitalised drivers over the country  
The hospital survey was started at one hospital (Jorvi hospital, Espoo), but it was noticed 
that the patients brought to this hospital had only minor injuries. Therefore a bigger 
hospital (Töölö trauma centre, Helsinki) with more severely injured patients was included 
in the survey and sample collection at Jorvi hospital ceased. The catchment area of the 
two hospitals is shown in Figure 1. 
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Figure 1. Map of Finland. The catchment area of the hospitals is marked in red. 
 
 
3.1.3 Distribution of hospitalised drivers  
The road type at the site of the accident was recorded during the interview as urban or 
rural. The distribution of injured drivers according to road type is shown in table 1. Road 
type information was missing in 15 cases. The study population is quite evenly distributed 
between the two road types. 
 
Table 1. Distribution of injured drivers by road type. 
Road type Fraction of injured drivers (N = 310) 
Urban 0.426
Rural 0.574
Total 1
 
The severity of the injuries was determined afterwards from the patient data by a 
physician. The Maximum Abbreviated Injury Scale (MAIS) was used to measure the 
severity of injuries. The distribution of drivers by MAIS is shown in Table 2. The MAIS 
value was missing in 8 cases. 
 
Table 2. Distribution of injured drivers by injury severity (MAIS). 
MAIS Fraction of injured drivers (N = 317) 
0 0.035
1 0.467
2 0.306
3 0.170
4 0.019
5 0.003
Total 1
 
Injured drivers were recruited between 26 April 2008 and 30 April 2010. The distribution 
of drivers by season (quarter of year) is shown in Table 3. For comparison, the quarterly 
distribution of injured drivers in 2008 in Finland according to national statistics is also 
presented. In both populations the fraction of drivers during the 2nd and 3rd quarters is 
slightly higher than during the 1st and 4th quarters. 
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Table 3. Distribution of injured drivers by season. 
Quarter of the year Fraction of injured drivers 
in the survey 
Fraction of injured drivers 
based on national statistics* 
First (Jan, Feb, Mar) 0.114 0.161 
Second (Apr, May, Jun) 0.348 0.281 
Third (Jul, Aug, Sep) 0.350 0.325 
Fourth (Oct, Nov, Dec) 0.188 0.233 
Total 1 1 
* 2008 Finnish national traffic accident statistics based on accidents reported to the police 
(1)  
 
The exact time of accident was recorded in order to enable the division of the drivers into 
eight DRUID time codes, as proposed in the D 2.1.2 guidelines for hospital surveys. The 
distribution of drivers by day of the week and time of the day is shown in Table 4 The 
fraction of injured drivers is smaller during night time (22:00 to 04:00) than during the day 
for both weekdays and weekends. This is probably due to the volume of traffic flow which 
is also smaller during night (Task 2.2a).According to national statistics (1), in 2008 only 
11.4% of all injuries in traffic accidents occurred during night hours. 
 
Table 4. Distribution of injured drivers by day of the week and time of the day. 
DRUID time code Fraction of injured drivers 
Weekday 4:00 to 10:00 0.160 
Weekday 10:00-16:00 0.200 
Weekday 16:00-22:00 0.154 
Weekday 22:00-4:00 0.077 
Weekend 4:00-10:00 0.074 
Weekend 10:00-16:00 0.095 
Weekend 16:00-22:00 0.145 
Weekend 22:00-4:00 0.095 
Total 1 
 
The total number of cases was 325. Age and gender were recorded for all injured drivers, 
and they were divided into four age groups according to the guidelines for the survey. 
Table 5 shows the distribution of drivers by age group and gender. National statistics 
show that the gender distribution of people injured in traffic accidents in 2008 was 57% 
male and 43% female (1), thus it appears that in our study population males are 
overrepresented (77%). Comparison of age of the study population with national statistics 
was not possible since the age brackets in the two datasets were different. 
 
Table 5. Distribution of injured drivers by age and gender. 
 Fraction of injured drivers 
Age group (years) Male Female In total 
18-24 0.185 0.049 0.234 
25-34 0.206 0.049 0.255 
35-49 0.209 0.062 0.271 
50+ 0.172 0.068 0.240 
Total 0.772 0.228 1 
 
The distribution of drivers according to age and gender is also shown in Figure 2.  
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Figure 2. Age and gender distribution of injured drivers. 
 
The type of the vehicle was also recorded. The distribution of injured drivers by type of 
vehicle is shown in Table 6. Most of the patients were drivers of passenger cars (61.7%) 
but motorcyclists (19.4%) and bicyclists (10.5%) also constituted a large fraction of the 
injured drivers. The ‘other’ vehicles included in the survey were quad bikes and a 
snowmobile. National traffic accident statistics from the year 2008 are also shown in 
Table 6 for comparison. Motorcycles seem to be overrepresented in our survey 
population whereas vans and bicycles are somewhat underrepresented.  
 
Table 6. Distribution of injured drivers by vehicle. 
Type of vehicle Fraction of injured drivers in 
the survey 
Fraction of injured drivers based on 
national statistics* 
Car 0.617 0.620 
Van 0.025 0.054 
Truck/bus 0.028 0.035 
Motorcycle 0.194 0.089 
Bicycle 0.105 0.162 
Moped 0.022 0.025 
Other 0.009 0.015 
Total 1 1 
* 2008 Finnish national traffic accident statistics based on accidents reported to the police 
(1) 
 
The distribution of single and multiple vehicle accidents is shown in table 7. This 
information was missing in 6 cases. 
 
Table 7. Distribution of drivers by type of accident. 
Type of accident Fraction of injured drivers (N = 319) 
Single vehicle 0.533
Multiple vehicle 0.467
Total 1
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3.2 Methods: Data collection and analysis  
 
3.2.1 Ethical approval  
The research survey plan was approved by the coordinating ethical advisory board of the 
Hospital District of Helsinki and Uusimaa. Signed informed consent was necessary for all 
respondents. The identity of the drivers was not recorded. 
 
3.2.2 Specimen collection 
After informed consent was given, the interview was performed by a nurse from the 
hospital who also took the samples. The majority of the cases, 319 out of 325, were 
recruited at Töölö trauma centre and the rest at Jorvi hospital. Sample matrices collected 
were whole blood (N=322) and/or OF (N=311), both matrices were collected from 308 
patients. Altogether 633 samples were collected. OF samples were collected with the 
StatSure SalivaSampler™ device (StatSure Diagnostic Systems, Inc., NY, USA) and the 
samples were stored at -18 ºC. Whole blood samples were collected in 10 ml evacuated 
Venoject® glass tubes (Terumo corp., Japan) containing sodium fluoride and potassium 
oxalate as stabiliser and anticoagulant, respectively. Blood samples were stored at + 4 ºC 
before analysis. In some cases the injured drivers were sampled at the hospital for 
external reasons and if there was sample left after the analysis performed at the hospital, 
the rest of the sample was sent to the THL laboratory in the original tube. The analyses at 
THL were then performed from this sample. All results presented in this report are from 
blood samples. 
 
3.2.3 Toxicological analysis of body fluids 
All samples from injured drivers were analysed at the drug analytics laboratory of THL by 
gas chromatography-mass spectrometry (GC-MS) methods. Analysis methods and 
validation results are presented in (2) and (3). The methods are in continuous routine use 
in the laboratory for prison, hospital and drug driving samples. Analytes were extracted 
from the samples using either solid phase extraction (SPE) or liquid-liquid extraction 
(LLE) and the mass selective detector (MSD) was working in either electron ionisation 
(EI) or negative chemical ionisation (NCI) mode, depending on the method. The cut-offs 
applied for positive results are listed in the Methods section of the Summary Report. 
 
3.2.4 Method of BAC quantification 
Blood alcohol concentration in g(ethanol)/l(blood) (‰) was determined from the whole 
blood samples with a headspace-gas chromatography method (4) at THL. 
 
3.2.5 Other collected data 
The following data were requested in the interview form: 
Gender 
- Birth year 
- Year first motor vehicle licence achieved 
- Is the driver currently in possession of a valid licence? 
- Is the driver a professional driver? 
- Type of vehicle 
- Annual mileage 
- Time of blood sample (if the sample was a hospital diagnostic sample: type of the 
tube) 
- Time of oral fluid sample 
- Ordinary sampling time (i.e. within 5 mins), all deviations recorded 
- Time and place of accident 
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- Road type 
- Single or multiple vehicle accident 
 
3.2.6 Statistical analysis 
The data were processed with PASW (Predictive Analytics SoftWare) Statistics 17.0 by 
SPSS: An IBM® Company. 
 
3.3 Non-response, refusals  
 
3.3.1 Size and nature of non-response 
The overall participation rate was 82.9% (325 injured drivers participated from 392 
potential cases). A number of drivers did not refuse to participate in the survey, but were 
then excluded, e.g. the driver was under 18 or was moved to another hospital before the 
interview could be completed. Therefore, the actual consent rate of eligible participants is 
91.5% (30 non-respondents out of 355 eligible surveyed drivers). 
 
3.3.2 Possible confounding effect of non-response 
Since the consent rate in the survey is more than 90%, it is safe to assume that non-
response does not have any confounding effect on the results.  
 
 
3.4 Results 
From the 325 injured drivers and cyclists included in the survey there were 93 cases 
(28.6%) with positive findings, above LOQ, for DRUID core substances. This increases to 
101 (31.1%) if additional substances analysed in Finland are included. 
 
Nationally, the highest prevalence was for alcohol with 21.5% (70 cases) of alcohol 
positive cases. 15.7% (51 cases) of all participants had blood alcohol concentrations of 
1.3 g/L or more, 3.1% (10 cases) between 0.8 and 1.3 g/L, 1.2% (4 cases) between 0.5 
and 0.8 g/L and 1.5% (5 cases) between 0.1 and 0.5 g/L. 
 
The prevalence of other substance classes was 9.8% for benzodiazepines and Z-drugs 
(32 cases: 28 with benzodiazepines only, 3 with Z-drugs only and 1 with both), 2.5% (8 
cases) for THC, 2.2% (7 cases) for opioids (either illicit or medicinal) and 1.8% (6 cases) 
for amphetamines. 
 
 
3.4.1 Detailed substance group distribution for the area the results are 
applicable to 
Table 8 shows the distribution of cases by substance groups in Uusimaa region where all 
samples were collected. 
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Table 8. Regional distribution of number of cases by substance groups detected. 
Substances present Uusimaa
N (%) 
None 232
Amphetamines and THC-COOH 1 (0.3)
THC* only 1 (0.3)
Benzodiazepines only 7 (2.1)
Amphetamines and benzodiazepines 2 (0.6)
THC-COOH and benzodiazepines 3 (0.9)
THC* and benzodiazepines 1 (0.3)
Amphetamines, THC* and benzodiazepines 1 (0.3)
Z-drugs only 1 (0.3)
Benzodiazepines and Z-drugs 1 (0.3)
Opioids** only 4 (1.2)
Benzodiazepines, opioids** and amphetamines 1 (0.3)
Alcohol only 51 (15.7)
THC* and alcohol 3 (0.9)
Benzodiazepines and alcohol 9 (2.8)
Amphetamines, benzodiazepines and alcohol 1 (0.3)
THC, benzodiazepines and alcohol 2 (0.6)
Z-drugs and alcohol 2 (0.6)
Opioids** and alcohol 1 (0.3)
Benzodiazepines, opioids** and alcohol 1 (0.3)
Total 325 
*with or without THC-COOH**medicinal or illicit 
 
 
 
3.4.2 Distribution of substance groups by DRUID time periods aggregated into 
day vs night, week vs WE  
The distribution of injured drivers according to substance groups and time of the accident 
(whether it happened during day, 4:00 – 22:00, or night, 22:00 – 04:00) is shown in table 
9. 82.8% (269) of the accidents occurred during day and 17.2% (56) during nighttime. 
The percentage of cases that were negative for all DRUID core substances was 77.0% 
during day and 44.6% during night, thus there were more positive cases during the 
nighttime. The distribution of illicit drugs among the positive cases was similar during day 
and night, with 17.7% of all drug positive cases containing illicit drugs during daytime and 
16.1% at night. The percentage of alcohol positive cases was much higher at night 
(50.0%) than at day (15.6%). Benzodiazepines and/or Z-drugs were found in 8.9% of the 
cases during day and in 12.5% of the cases during night.  
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Table 9. Distribution by number of cases according to substance groups detected and time 
of day. 
Substances present Day 
N (%) 
Night 
N (%) 
None 207 (77.0) 25 (44.6) 
Amphetamines and THC-COOH 1 (0.4) 0 (0) 
THC* only 0 (0) 1 (1.8) 
Benzodiazepines only 6 (2.2) 1 (1.8) 
Amphetamines and benzodiazepines 1 (0.4) 1 (1.8) 
THC-COOH and benzodiazepines 3 (1.1) 0 (0) 
THC* and benzodiazepines 1 (0.4) 0 (0) 
Amphetamines, THC* and benzodiazepines 1 (0.4) 0 (0) 
Z-drugs only 1 (0.4) 0 (0) 
Benzodiazepines and Z-drugs 1 (0.4) 0 (0) 
Opioids** only 4 (1.5) 0 (0) 
Benzodiazepines, opioids** and amphetamines 1 (0.4) 0 (0) 
Alcohol only 30 (11.2) 21 (37.5) 
THC* and alcohol 1 (0.4) 2 (3.6) 
Benzodiazepines and alcohol 7 (2.6) 2 (3.6) 
Amphetamines, benzodiazepines and alcohol 1 (0.4) 0 (0) 
THC*, benzodiazepines and alcohol 1 (0.4) 1 (1.8) 
Z-drugs and alcohol 1 (0.4) 1 (1.8) 
Opioids** and alcohol 1 (0.4) 0 (0) 
Benzodiazepines, opioids** and alcohol 0 (0) 1 (1.8) 
Total 269 (100) 56 (100) 
*with or without THC-COOH **medicinal or illicit 
 
Table 10 shows the distribution of cases by substance groups between week and 
weekend. 59.1% (192) of the accidents occurred during weekdays and 40.9% (133) 
during weekends. The proportion of positive cases during weekends (39.1%) was almost 
double that during the week (21.4%). Most of the cases were positive for alcohol with a 
prevalence of 15.1% during the week and 30.8% during the weekend. Illicit drugs were 
found in 8 cases during both week and weekend. This is 19.5% of all positive cases at 
week and 15.4% at weekend. 
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Table 10. Distribution by number of cases according to substance groups detected and time 
of week. 
Substances present Week 
N (%) 
Weekend 
N (%) 
None 151 (78.6) 81 (60.9) 
Amphetamines and THC-COOH 1 (0.5) 0 (0) 
THC* only 1 (0.5) 0 (0) 
Benzodiazepines only 2 (1.0) 5 (3.8) 
Amphetamines and benzodiazepines 0 (0) 2 (1.5) 
THC-COOH and benzodiazepines 2 (1.0) 1 (0.8) 
THC* and benzodiazepines 1 (0.5) 0 (0) 
Amphetamines, THC* and benzodiazepines 1 (0.5) 0 (0) 
Z-drugs only 0 (0) 1 (0.8) 
Benzodiazepines and Z-drugs 0 (0) 1 (0.8) 
Opioids** only 4 (2.1) 0 (0) 
Benzodiazepines, opioids** and amphetamines 0 (0) 1 (0.8) 
Alcohol only 19 (9.9) 32 (24.1) 
THC* and alcohol 1 (0.5) 2 (1.5) 
Benzodiazepines and alcohol 5 (2.6) 4 (3.0) 
Amphetamines, benzodiazepines and alcohol 1 (0.5) 0 (0) 
THC*, benzodiazepines and alcohol 0 (0) 2 (1.5) 
Z-drugs and alcohol 1 (0.5) 1 (0.8) 
Opioids** and alcohol 1 (0.5) 0 (0) 
Benzodiazepines, opioids** and alcohol 1 (0.5) 0 (0) 
Total 192 (100) 133 (100) 
*with or without THC-COOH **medicinal or illicit 
 
 
3.4.3 Distribution of substance groups by gender and age  
Table 11 shows the distribution of cases according to substance groups, age and gender. 
The majority of the drivers included in the survey were men. The number of drug or 
alcohol positive cases among women is low, with only 15 positive cases versus 78 
positive cases among men. The positive cases among women were mainly single 
substance use of alcohol, benzodiazepines or opioids, but there were also two cases with 
combination of alcohol and benzodiazepines. The occurrence of alcohol was higher in 
younger women whereas older women had higher occurrence of benzodiazepines and 
opioids. Among young male drivers (18–24 years) alcohol with no other substances was 
the most common finding. In the 18–24-year-old male group there were three cases 
positive for cannabis (THC and/or THC-COOH) of which two were also positive for 
benzodiazepines. In the age group 25–34 years, a combination of substances was more 
common, especially alcohol combined with illicit drugs and/or medicines. Illicit drugs were 
also detected among 35–49-year-old men, but in this group the number of cases with 
alcohol in combination with other substances was lower than among younger men (i.e. 
below 35 years old). The use of benzodiazepines and Z-drugs was more common among 
older (50+ years) than younger men. 
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Table 11. Distribution by number of cases according to substance groups detected and age 
and gender. 
Age group 
Gender Substances present 
18-24 
N (%) 
25-34 
N (%) 
35-49 
N (%) 
50+ 
N (%) 
Male None 38 47 43 45 
 Amphetamines and THC-COOH 0 (0) 0 (0) 1 (1.5) 0 (0) 
 THC* only 1 (1.7) 0 (0) 0 (0) 0 (0) 
 Benzodiazepines only 0 (0) 2 (3.0) 1 (1.5) 1 (1.8)
 Amphetamines and benzodiazepines 0 (0) 1 (1.5) 1 (1.5) 0 (0) 
 THC-COOH and benzodiazepines 1 (1.7) 1 (1.5) 1 (1.5) 0 (0) 
 THC* and benzodiazepines 1 (1.7) 0 (0) 0 (0) 0 (0) 
 Amphetamines, THC and benzodiazepines 0 (0) 1 (1.5) 0 (0) 0 (0) 
 Z-drugs only 0 (0) 0 (0) 0 (0) 1 (1.8)
 Benzodiazepines and Z-drugs 0 (0) 0 (0) 0 (0) 1 (1.8)
 Opioids** only 0 (0) 1 (1.5) 1 (1.5) 0 (0) 
 Benzodiazepines, opioids** and 0 (0) 0 (0) 1 (1.5) 0 (0) 
 Alcohol only 19 6 (8.9) 15 3 (5.3)
 THC* and alcohol 0 (0) 1 (1.5) 1 (1.5) 1 (1.8)
 Benzodiazepines and alcohol 0 (0) 2 (3.0) 2 (2.9) 3 (5.3)
 Amphetamines, benzodiazepines and 0 (0) 1 (1.5) 0 (0) 0 (0) 
 THC*, benzodiazepines and alcohol 0 (0) 2 (3.0) 0 (0) 0 (0) 
 Z-drugs and alcohol 0 (0) 2 (3.0) 0 (0) 0 (0) 
 Opioids** and alcohol 0 (0) 0 (0) 0 (0) 1 (1.8)
 Benzodiazepines, opioids** and alcohol 0 (0) 0 (0) 1 (1.5) 0 (0) 
Total  60 (100) 67 (100) 68 (100) 56 (100)
None 11 13 17 18
Benzodiazepines only 0 (0) 0 (0) 1 (5.0) 2 (9.1)
Opioids** only 0 (0) 0 (0) 0 (0) 2 (9.1)
Alcohol only 5 (31.2) 2 (12.5) 1 (5.0) 0 (0)
Female 
Benzodiazepines and alcohol 0 (0) 1 (6.2) 1 (5.0) 0 (0) 
Total 16 (100) 16 (100) 20 (100) 22 (100)
*with or without THC-COOH **medicinal or illicit 
 
 
3.4.4 Distribution of substance groups by single-vehicle accidents vs. multiple 
vehicles 
The number of single vehicle accidents in the study was approximately the same as the 
number of multiple vehicle accidents, but as table 12 shows, the number of positive 
findings was much higher in single vehicle accidents. Alcohol was the most prevalent 
substance in both types of accidents. The occurrence of alcohol positive cases (both 
alcohol only and in combination with other substances) was 34.7% in single vehicle 
accidents compared to 6.7% of multiple vehicle accidents. In 27.1% of alcohol positive 
cases involved in single vehicle accidents there was also indication of other substance 
use. 
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Table 12. Distribution by number of cases according to substance groups detected and type 
of accident. 
Substances present Single 
vehicle 
N (%) 
Multiple 
vehicle 
N (%) 
Unknown
N (%) 
None 97 (57.1) 131 (87.9) 4 (66.7) 
Amphetamines and THC-COOH 1 (0.6) 0 (0) - 
THC* only 1 (0.6) 0 (0) - 
Benzodiazepines only 3 (1.8) 4 (2.7) - 
Amphetamines and benzodiazepines 1 (0.6) 0 (0) 1 (16.7) 
THC-COOH and benzodiazepines 1 (0.6) 2 (1.3) - 
THC* and benzodiazepines 1 (0.6) 0 (0) - 
Amphetamines, THC* and 1 (0.6) 0 (0) - 
Z-drugs only 1 (0.6) 0 (0) - 
Benzodiazepines and Z-drugs 1 (0.6) 0 (0) - 
Opioids** only 2 (1.2) 2 (1.3) - 
Benzodiazepines, opioids** and 1 (0.6) 0 (0) - 
Alcohol only 43 (25.3) 8 (5.4) - 
THC* and alcohol 3 (1.8) 0 (0) - 
Benzodiazepines and alcohol 7 (4.1) 1 (0.8) 1 (16.7) 
Amphetamines, benzodiazepines and 1 (0.6) 0 (0) - 
THC*, benzodiazepines and alcohol 2 (1.2) 0 (0) - 
Z-drugs and alcohol 1 (0.6) 1 (0.8) - 
Opioids** and alcohol 1 (0.6) 0 (0) - 
Benzodiazepines, opioids** and alcohol 1 (0.6) 0 (0) - 
Total 170 (100) 149 (100) 6 (100) 
*with or without THC-COOH **medicinal or illicit 
 
 
3.4.5 Distribution of additional substances 
In Finland a number of substances were analysed in addition to the DRUID core 
substance list. There were 31 cases with positive findings of additional substances which 
were buprenorphine, carbamazepine, amitriptylene, citaprolam, fluoxetine, mirtazapine, 
and benzodiazepines temazepam, chlordiazepoxide, alpha-OH-midazolam and alpha-
OH-alprazolam. The distribution of DRUID core substance groups in cases that were 
positive for the additional substances is shown in table 13. None of the DRUID core 
substances were found in 8 of the cases that were positive for additional substances. The 
findings of these ‘negative’ cases are shown in table 14. 
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Table 13. Distribution of cases with additional substance findings according to DRUID 
substance groups. 
DRUID substances present  Additional substances No. of 
cases 
None See Table 14 8 
Benzodiazepines only Benzodiazepines, citalopram 4 
THC-COOH and benzodiazepines Benzodiazepines, buprenorphine, 3 
Amphetamines, THC* and Benzodiazepines 1 
Z-drugs only Fluoxetine 1 
Amphetamines, benzodiazepines and Benzodiazepines 1 
Alcohol only Citalopram 5 
Benzodiazepines and alcohol Amitriptyline, carbamazepine, 4 
Amphetamines, benzodiazepines and Benzodiazepines 1 
THC*, benzodiazepines and alcohol Citalopram 1 
Opioids** and alcohol Benzodiazepines 1 
Benzodiazepines, Z-drugs, opioids** Benzodiazepines, mirtazapine 1 
* with or without THC-COOH **medicinal or illicit 
 
Table 14. Positive findings of additional substances in cases where no DRUID core 
substances were present. 
Substances present  No. of cases 
Chlordiazepoxide 1 
Temazepam and citalopram 1 
Citalopram 3 
Amitriptylene 1 
Carbamazepine 1 
Temazepam 1 
 
The distribution of cases according to time of day and time of week is shown in table 15 
and table 16. The distribution of cases between week and weekend is quite even, but 
majority of these accidents have occurred during daytime (04:00-22:00). 
 
Table 15. Distribution by number of additional substance cases according to time of day. 
 Day Night Total 
N cases (%) 27 (87.1) 4 (12.9) 31 (100) 
 
Table 16. Distribution by number of additional substance cases according to time of week. 
 Weekday Weekend Total 
N cases (%) 16 (51.6) 15 (48.4) 31 (100) 
 
Table 17 shows the distribution of cases by age and gender. These distributions are 
similar to those of DRUID core substances. When the cases are distributed according to 
type of accident (table 18), we can see that 61.3% of them are single vehicle accidents. 
For comparison, the corresponding number for DRUID core substance positive cases is 
80.2%. 
 
Table 17. Distribution by number of additional substance cases according to age and 
gender.  
Age group Gender  
18–24 25–34 35–49 50+ 
Total 
Male N cases (%) 4 (15.4) 8 (30.8) 8 (30.8) 6 (23.0) 26 (100) 
Female N cases (%) 1 (20.0) 1 (20.0) 1 (20.0) 2 (40.0) 5 (100) 
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Table 18. Distribution by number of additional substance cases according to type of 
accident. 
Type of accident  
 Single vehicle Multiple vehicle Unknown 
Total 
N cases (%) 19 (61.3) 11 (35.5) 1 (3.2) 31 
 
 
3.4.6 Distribution of substance concentrations 
The range of concentrations encountered for each drug found and, where applicable, 
median concentration, are shown in table 19 for core DRUID substances and in table 20 
for additional substances. Positive concentrations of medicines administered before the 
sample was taken were also found for morphine (8) and tramadol (4). 
 
Table 19. Distribution of substance concentrations – DRUID core substances. 
Analyte N* Concentration range (ng/mL) Median concentration (ng/mL)
Ethanol 70 0.103 – 3.514 g/L 1.623 g/L 
Amphetamine 6 (2) 140 – 787 342 
THC 8 1.1 – 9.5 2.7 
THCCOOH 11 8.2 – 36 23 
Diazepam 15 28 – 1012 115 
Nordiazepam 16 29 – 1137 118 
Oxazepam 11 26 – 1957 59 
Alprazolam 10 9.6 - 170 29 
Clonazepam 4 (3) 6.1 – 41 18 
Zopiclone 3 (4) 11 – 82 12 
Zolpidem 1 45 - 
Morphine 3 (1) 1.5 – 4.4 3.6 
Codeine 6 (1) 5.3 – 217 16 
Tramadol 3 87 – 430 96 
Methadone 1 51 - 
*Number of positive cases above LOQ, number in parentheses are positive cases 
between LOD and LOQ 
 
Table 20. Distribution of substance concentrations – additional substances in Finland. 
Analyte N* Concentration range (ng/mL) Median concentration (ng/mL)
Temazepam 10 31 - 1079 55 
Buprenorphine 1 1.2 - 
Carbamazepine 2 3285, 7210 - 
Amitriptyline 2 47, 56 - 
Citaprolam 14 9.8 - 175 50 
Fluoxetine 1 55 - 
Mirtazapine 1 54 - 
Alpha-OH-alprazolam 2 2.0, 4.5 - 
Alpha-OH-midazolam 1 5.8 - 
Chlordiazepoxide 4 366 - 1255 845 
* Number of positive cases above LOQ, number in parentheses are positive cases 
between LOD and LOQ 
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3.5 Discussion of results 
 
3.5.1 Representativeness 
All Finnish hospital survey samples were collected in Uusimaa region in southern Finland, 
which was also the main sample collection area in the roadside survey (D 2.2.3). National 
data from 2008 was available on the injured driver distribution by the type of vehicle and 
by the quarter of the year, as presented in Section 1.3. The quarterly distributions of 
injured drivers in both datasets were similar. For the type of vehicle the only appreciable 
differences between the two datasets were that the fraction of motorcycles was higher, 
and the fraction of vans and bicycles was slightly lower, in the survey population than in 
the national data. It should be remembered that the presented hospitalised driver survey 
covers only the Uusimaa region, whereas the national statistics are for the whole country. 
Since the consent rate in the survey was more than 90% it is safe to say that the results 
are representative of at least the Uusimaa region and, in addition, the survey population 
shows quite a lot of similarity to the aforementioned national statistics on injured drivers. 
 
3.5.2 Effects of non-response 
As presented in Section 3.2 there is unlikely to be any confounding effect due to non-
response. 
 
3.5.3 Highlights 
Alcohol was the most prevalent substance among injured drivers in Finland, with an 
occurrence of 21.5%. The second most prevalent substance group was benzodiazepines 
and Z-drugs, with an occurrence of 9.8%. Almost three quarters of alcohol positive cases 
were positive for alcohol only. Alcohol only positive cases were more common among 
young drivers (18-24 years), both male and female, whereas older men had more often 
some combination of alcohol, medicines and/or illicit drugs. Altogether, the use of 
medicines and drugs was more common among older drivers. Most of the positive 
substance findings were from accidents that occurred during nighttime, and the 
prevalence of alcohol positive cases was up to 50% at night, compared to 16% at day. 
Also, there were more positive cases during weekends than during weekdays, and the 
prevalence of alcohol at weekends was double that at weekdays. When comparing the 
accident types, single vehicle accident cases were more often positive for one or more 
substances than multiple vehicle cases. 
 
3.5.4 Comparison to other studies 
There has been one earlier study on drug use among injured drivers in Finland in 1977 
(5). The study was carried out during 16 weeks in spring and autumn. All injured car 
drivers arrived at any of the five public emergency departments in Helsinki within six 
hours of the accident were included. In total 203 patients were included and the inclusion 
rate was estimated to be 90%. Blood serum samples were collected and ethanol (alcohol) 
and around 50 drugs, including psychotropics and analgesics, were determined from the 
samples. The control group consisted of randomly selected car drivers (N=352) who were 
interviewed and breath tested, and a blood sample was collected from 325 drivers. 
Drivers were interviewed on 14 different days in Helsinki at 10 gas stations during the two 
time periods in which the patients were studied. Ethanol above 0.2‰ was found in 15% of 
the accident cases and the most common drug finding was diazepam, in 4.9% of the 
cases. As stated earlier, ethanol was also the most prevalent substance in our study, and 
the most common drug finding was diazepam and its metabolite nordiazepam. The 
prevalence of ethanol was somewhat higher in our study but the prevalence of diazepam 
(4.6%) was at the same level as in the previous study. The percentage of single vehicle 
accidents was lower in the 1977 study (only 30%) than that in our study (53%). 
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4.1 Description of hospitalised driver sample 
According to Annex 1, the specific aim of the hospital survey was to study the prevalence 
of alcohol and various psychoactive substances in drivers who have been injured and/or 
killed in traffic accidents, as well as to provide cases for the risk calculation in the case- 
control study.The hospital study in Italy complied with the general guidelines mentioned in 
Annex 1 of the Summary Report.  
 
4.1.1 Selection of hospitals  
The survey was carried out in close co-operation with the local hospitals. A selection of 
hospitals was made on the basis of willingness to cooperate, geographical distribution 
and influx of injured drivers. 4 out of 5 catchment areas of the roadside survey were 
chosen in the same regions of the selected hospitals in order to have the highest 
statistical power in risk calculation.  
 
4.1.2 Selection of patients 
Only patients that matched a number of well-defined inclusion criteria were selected. The 
list of inclusion criteria contained both obligatory criteria (see Annex 1) and additional 
criteria. 
The obligatory inclusion criteria were: 
− Driver of a motorised vehicle  
− Injured in accident on a public road or in the direct vicinity of a public road  
− Only primary admissions, not patients transferred from other hospitals  
− Admissions because of traumatological reasons  
− Time interval between admission and sampling less than 3 hours  
− Severity of injuries: as to the severity of injuries, since MAIS (Maximum 
Abbreviated Injury Scale) is not implemented in Italian hospitals, the criterion to 
be applied was: prognosis ≥ 20 days. 
 
Additional Italian inclusion criteria were:  
− Age. First, it was decided to collect drivers older than 14 (including motorbike 
drivers) but later it was estabilished to include only drivers older than 18, since 
informed consent was easier to obtain. (On the whole sample, only six drivers 
were aged below 18) 
− Inclusion of foreign drivers.  
− Inclusion of professional drivers  
− Collection of urine when available 
 
4.1.3 Data gathered 
Because of the low accessibility of the patients (e.g. short stay in hospital, 
unconsciousness and practical concerns from the hospital staff), it was decided to collect 
only a limited number of data. 
 
• Patient information:  
o Identification number  
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o Age  
o Gender  
• Toxicological information: 
o Time and date of sampling  
o Medication administered prior to blood sampling  
• Accident data:  
o Time and date  
o Type of vehicle  
o Single vehicle accident: yes/no  
o Driver’s license: yes/yes, but suspended/no  
o Professional use of vehicle: yes/no 
 
4.1.4 Geographical distribution of hospitalised drivers over the region 
The geographical distribution of hospitalised drivers over the region is illustrated in the 
map by encircled provinces. When comparing this distribution with that of the roadside 
survey, 4 out of 5 areas were covered by selected hospital districts. Most of hospitalised 
drivers (55%) were collected in Region 03901 (Padova). 
Figure 1. Geographical distribution of drivers over the country 
 
Table 1. Distribution of injured drivers by region 
Region Code Region Count Fraction 
03901 Padova 377 0.55 
03902 Venezia 135 0.20 
03903 Treviso 101 0.14 
03904 Rovigo 77 0.11 
Total  690 1.00 
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4.1.5 Distribution of hospitalised drivers by season, day of the week and time of 
the day, age and gender. 
  
The distribution of hospitalised drivers by season, illustrated in Table 2, reveals that most 
of samples were collected during spring and summer. 
 
Table 2. Distribution of hospitalised drivers by season 
Season Count Fraction 
1 - month 1-3 (winter) 133 0.19 
2 - month 4-6 (spring) 224 0. 33 
3 - month 7-9 (summer) 232 0.34 
4 - month 10-12 (autumn) 101 0.14 
Total 690 1.00 
 
According to the DRUID definition of time periods (see Figure 1), Table 3 shows the 
distribution of drivers by day of the week and time of the day (8 DRUID Time Period 
categories). Most of injured drivers were hospitalised during weekend days (44 % of total 
sampling occurred on Friday evening, Saturday, Sunday and Monday morning). 
 
Table 3. Distribution of hospitalised drivers by time period 
Time period 
(8 DRUID Time Period categories) 
Count Fraction 
01 47 0.07 
02 103 0.15 
03 123 0.18 
04 71 0.10 
05 37 0.05 
06 57 0.08 
07 123 0.18 
08 90 0.13 
Unknown 39 0.06 
Total 690 1.00 
 
 
 
  Monday Tuesday Wednesday Thursday Friday Saturday Sunday Monday 
04-10 Period 1 Period 5 
  
10-16 Period 2 Period 6 
  
16-22 Period 3 Period 7   
22-24       
00-04   
Period 4 
  
Period 8 
  
 Figure 2. DRUID time periods 
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As presented in Table 4, the large majority of injured drivers were male (77 %); the age 
range between 25 and 49 was the most represented in both the male (59%) and the 
female (65%) groups. 
 
Table 4. Distribution of injured drivers by age and gender. 1= Male, 2 = Female 
Gender – age Count Fraction 
1 – 15-24 107 0.16 
1 - 25-34 164 0.24 
1 - 35-49 152 0.22 
1 - 50+ 110 0.16 
2 - 18-24 26 0.03 
2 - 25-34 47 0.07 
2 - 35-49 55 0.08 
2 - 50+ 29 0.04 
Total 690 1.00 
 
 
1.7 Accident Data  
 
The large majority of vehicles involved were cars, accounting for 85 % of the total. 
 Table 5. Distribution of injured drivers by type of vehicle 
Type of vehicle Count Fraction 
Unknown 62 0.09 
Personal car  589 0.85 
Personal van 39 0.06 
Total 690 1.00 
 
Unfortunately, information on the type of accident, the type of road and the use of safety 
belt could not be collected. 
As to the injury severity, since MAIS was not in use in the selected hospitals, we could 
only ensure that all selected injured drivers had a prognosis of 20 days or more. 
 
As to the time from accident to sampling, for the majority of included subjects it was, 
generally, “< 3 hours“ as requested by the protocol. In that time interval, however, only for 
few subjects more details were available as depicted in the following table 6. The few 
Injured drivers whose time from accident was > 3 h were enrolled but their data were 
excluded from the study. 
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Table 6. Time from accident to sampling 
Time (h) Count 
< 3 685 
0.5 4 
0.75 1 
1 11 
1.2 1 
1.33 1 
1.5 3 
2 3 
2.25 1 
2.5 6 
3 3 
4 1 
5 2 
6 1 
19 1 
 
 
4.2 Methods: sample collection and analysis  
Driver participation in the hospital study was, in principle, voluntary. However, the blood 
sample was taken on arrival during the normal procedure for toxicological screening of 
blood samples (according to Italian legislation on driving under the influence) and sample 
left after the analysis performed was stored in the original tube. The analyses for the 
DRUID protocol at TFA UNPD were then performed using this sample. Written informed 
consent was obtained from each patient. Anonymity was ensured, all necessary efforts 
were made to guarantee the privacy of the patient; non-response in collecting blood was 
thus reduced to zero. 
 
4.2.1 Specimen collection, site of sampling 
For blood specimen collection and site of sampling, the procedures described in the 
summary report were followed. In addition to the common protocol, the Italian HS 
protocol included also collection of urine samples. 555 out of the 690 subjects included in 
the present report gave also a urine sample, that was analyzed for the same group of 
substances as blood. 
 
4.2.2 Toxicological analysis of body fluids  
The list of core substances as well as analytical cut-off values for analyses of blood, 
based on discussions between all DRUID partners, were adopted (see Summary Report). 
The toxicological analysis were performed at the TFA-UNPD laboratory. A GC-HS-FID 
method was used for ethanol determination. Two methods were developed, validated and 
used for the analysis of 30 drugs and metabolites, listed in table 7. The methods are 
described in Annex 1. 
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Table 7. Core substances and *additional substances 
Core substances and *additional substances 
 
Ethanol  
Methamphetamine 
6-acetylmorphine 
Morphine 
Alprazolam 
Nordiazepam 
Amphetamine 
Oxazepam 
Benzoylecgonine 
Delta-9-tetrahydrocannabinol(THC) 
Clonazepam 
11-nor-9-carbooxy-tetrahydrocannabinol (THC-
COOH)   
Cocaine 
Zolpidem 
Codeine 
Buprenorphine* 
Diazepam 
Norbuprenorphine* 
Flunitrazepam 
Ketamine* 
Lorazepam 
Bromazepam* 
Methylendioxyamphetamine (MDA) 
Methylendioxyethylamphetamine (MDEA) 
Fluoxetine* 
Methylendioxymetamphetamine (MDMA) 
Venlafaxine* 
Methadone 
Olanzapine* 
Zopiclone* 
 
Modified versions of the procedures illustrated in Annex 1 were applied for the analysis of 
31 substances and alcohol in urine samples.  
 
4.2.3 Statistical analysis 
Statistical analysis was performed without the application of any correction or weighing 
factor by the standard Excel statistic package. 
 
4.3 Non-response 
Since it was stressed that the questionnaire was anonymous and all necessary efforts 
were made to guarantee the privacy of the patient and the confidentiality of the doctor-
patient relation, non-response in collecting blood was reduced to zero. Collection of 
patient information other than age, gender and medication in the hospital prior to 
sampling was difficult and not achieved in most of cases; accident information from the 
police could not be obtained, probably because the principles of police work are different 
from those of research. 
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4.4 Results  
4.4.1 Substance class and group distributions. 
 The detailed distributions of substance classes and groups (according to agreed group 
definitions, see figure 2) are represented in tables 8 and 9 for the whole region (4 
districts). 
 
Table 8. Substance class distribution 
Substance Class Number of Cases % of total injured drivers 
None 472 68.4% 
Illicit Drugs 47 6.8% 
Medicinal Drugs 11 1.6% 
Illicit + Medicinal Drugs 4 0.6% 
Alcohol only 125 18.1% 
Alcohol + Illicit 17 2.5% 
Alcohol + Medicinal Drugs 11 1.6% 
Alcohol + Illicit + Medicinal Drugs 3 0.4% 
Total 690 100.0% 
 
Table 9. Substance group distribution 
Substance Group Number of Cases % of total injured drivers
BAC group = Ethanol concentration   
0 = < 0.1 g/L 534 77.4 
1 = 0.1-0.5 g/L 17 2.5 
2 = 0.5-0.8 g/L 9 1.3 
3 = 0.8 – 1.3 g/L 26 3.8 
4 = > 1.3 g/L 104 15.0 
Amphetamines 1 0.1 
Benzoylecgonine  19 2.7 
Cocaine or Cocaine + Benzoylecgonine 18 2.6 
Benzodiazepines  5 0.7 
THCCOOH 9 1.3 
THC or THC + THCCOOH 27 3.9 
Medicinal opioids and opioids  21 3.0 
Illicit opiates 19 2.8 
 
31.6% of drivers were found positive for one or more (il)licit substances. The highest 
prevalence was found for alcohol only (18.12%). The sum of injured drivers with ethanol > 
0.1 g/L (ethanol alone or in combination with other substances) account for 22.6 % of the 
total injured drivers; those positive for ethanol at a particularly high concentration (> 
1.3g/L) account for 15 % of the total and 67% of the positive-for-alcohol group. 13.3 % of 
patients had used illicit drugs with the highest prevalence for cocaine (5.4 %) followed by 
cannabis (5.2 %) . Heroin use was detected in 2.6 % of cases while the prevalence of 
amphetamines was extremely low.  
3.7 % of the sampled subjects were positive for medicinal drugs only, benzodiazepines 
(0.7%) and medicinal opioids (3.0%) being the most common drugs detected. 
No subject was positive for Z-drugs or additional substances other than the core 
substances. 
 
In Table 10 the distribution of substance groups and substance classes (alcohol, illicit and 
medicinal drugs) by the 4 districts sampled is presented. 
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Table 10. Substance group distribution by region. BZE = benzoylecgonine; BDZ = 
benzodiazepines.  
SUBSTANCE(S) Padova (03901) 
Venezia 
(03902) 
Treviso 
(03903) 
Rovigo 
(03904) TOTAL 
None 252 (66.8%) 95 (70.4%) 70 (69.3%) 55 (71.4%) 472 (68.4%)
BZE 4 (1.0%) 1 (0.7%) 0 (0.0%) 0 (0.0%) 5 (0.7%) 
Cocaine only 2 (0.5%) 0 (0.0%) 0 (0.0%) 2 (2.6%) 4 (0.6%) 
Amphetamines + Cocaine 1 (0.3%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (0.1%) 
THCCOOH 1 (0.3%) 1 (0.7%) 0 (0.0%) 1 (1.3%) 3 (0.4%) 
THCCOOH + Cocaine 0 (0.0%) 1 (0.7%) 0 (0.0%) 0 (0.0%) 1 (0.1%) 
THC 5 (1.3%) 4 (2.9%) 2 (2.0%) 2 (2.6%) 13 (1.9%) 
THC + BZE 1 (0.3%) 1 (0.7%) 0 (0.0%) 1 (1.3%) 3 (0.4%) 
THC + Cocaine 1 (0.3%) 1 (0.7%) 0 (0.0%) 0 (0.0%) 2 (0.3%) 
Illicit Opiates 6 (1.6%) 2 (1.5%) 1 (1.0%) 0 (0.0%) 9 (1.3%) 
Illicit Opiates + BZE 2 (0.5%) 0 (0.0%) 0 (0.0%) 1 (1.3%) 3 (0.4%) 
Illicit Opiates + Cocaine 1 (0.3%) 0 (0.0%) 1 (1.0%) 0 (0.0%) 2 (0.3%) 
Illicit Opiates + THC 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (1.3%) 1 (0.1%) 
BDZ 2 (0.5%) 0 (0.0%) 0 (0.0%) 1 (1.3%) 3 (0.4%) 
Medicinal opioids 6 (1.6%) 1 (0.7%) 0 (0.0%) 1 (1.3%) 8 (1.2%) 
Medicinal opioids + BZE 0 (0.0%) 0 (0.0%) 1 (1.0%) 0 (0.0%) 1 (0.1%) 
Medicinal opioids + Cocaine 1 (0.3%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (0.1%) 
Medicinal opioids + THCCOOH + 
Cocaine 0 (0.0%) 0 (0.0%) 1 (1.0%) 0 (0.0%) 1 (0.1%) 
Medicinal opioids + THC 1 (0.3%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (0.1%) 
Alcohol only 70 (18.6%) 26 (19.3%) 20 (19.8%) 9 (11.7%) 125 (18.1%)
BZE + Alcohol 5 (1.3%) 0 (0.0%) 1 (1.0%) 0 (0.0%) 6 (0.9%) 
Cocaine + Alcohol 1 (0.3%) 0 (0.0%) 1 (1.0%) 0 (0.0%) 2 (0.3%) 
THCCOOH + Alcohol 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (1.3%) 1 (0.1%) 
Cocaine + THCCOOH + Alcohol 2 (0.5%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 2 (0.3%) 
THC + Alcohol 3 (0.8%) 0 (0.0%) 0 (0.0%) 1 (1.3%) 4 (0.6%) 
Cocaine + THC + Alcohol 2 (0.5%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 2 (0.3%) 
Illicit Opiates + Alcohol 1 (0.1%) 1 (0.7%) 0 (0.0%) 1 (1.3%) 3 (0.4%) 
BDZ + Alcohol 1 (0.3%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (0.1%) 
Medicinal opioids + Alcohol 1 (0.3%) 1 (0.7%) 0 (0.0%) 0 (0.0%) 2 (0.3%) 
Medicinal opioids + BZE + Alcohol 4 (1.0%) 0 (0.0%) 2 (2.0%) 0 (0.0%) 6 (0.9%) 
Medicinal opioids + Cocaine + 
Alcohol 0 (0.0%) 0 (0.0%) 1 (1.0%) 0 (0.0%) 1 (0.1%) 
Medicinal opioids + THC + Alcohol 1 (0.3%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (0.1%) 
TOTAL 377 (100.0%) 135 (100.0%) 101 (100.0%) 77 (100.0%) 690 (100.0%)
 
When examining the prevalence distribution by region, results similar to the total 
prevalence (see last column) are obtained for the category “alcohol only” in 3 out of 4 
regions, For the other substance groups (e.g. Cocaine only, THC plus alcohol or 
substances, medicinal opioids etc), larger variations are onserved among the regions, but 
the scarce absolute numbers of observations may render these differences unworthy. 
It is remarkable that Cocaine, whose circulation is constantly increasing in Italy, has a low 
total prevalence when considering drivers that test positive for Cocaine alone (0.6%); this 
prevalence however sharply rises to 5.3 % when considering the concomitant use of 
Cocaine with alcohol, THC, illicit opiates or medicinal opioids, as witnessed by the sum of 
subjects positive for Cocaine or Benzoylecgonine and alcohol, or amphetamines, or THC, 
or THCCOOH, or illicit opiates or medicinal opioids, or a combinations of drugs. As to the 
use of Cannabis, the prevalence of the active principle THC alone is 1.9%, but it 
increases to 3.9 % when combined with alcohol and/or other drugs; nonetheless, a larger 
use of Cannabis, accounting for a total prevalence of 5.2 %, is witnessed by the presence 
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of the metabolite THCCOOH either alone or combined with alcohol and/or other drugs 
(2.3 %). 
 
4.4.2  Distribution of substance groups by DRUID time periods aggregated into 
day (1-3 and 5-7) vs night (4&8), week (1-4) vs WE (5-8) 
The detailed substance group distribution by DRUID time periods aggregated into day (1-
3 and 5-7) vs night (4&8), week (1-4) vs WE (5-8) is represented in tables 11 and 12 
respectively. 
 
Table 11. Substances by DRUID time periods.Day vs Night. 
Time Period (Day vs. Night) SUBSTANCES 
Unknown Day 
(1-3 & 5-7) 
Night 
(4 & 8) 
TOTAL 
None 30 (76.9%) 367 (74.9%) 75 (46.6%) 472 (68.4%) 
BZE 0 (0.0%) 4 (0.8%) 1 (0.6%) 5 (0.7%) 
Cocaine only 0 (0.0%) 1 (0.2%) 3 (1.9%) 4 (0.6%) 
Amphetamines + Cocaine 0 (0.0%) 1 (0.2%) 0 (0.0%) 1 (0.1%) 
THCCOOH 0 (0.0%) 2 (0.4%) 1 (0.6%) 3 (0.4%) 
THCCOOH + Cocaine 0 (0.0%) 0 (0.0%) 1 (0.6%) 1 (0.1%) 
THC 2 (5.1%) 5 (1.0%) 6 (3.7%) 13 (1.9%) 
THC + BZE 0 (0.0%) 3 (0.6%) 0 (0.0%) 3 (0.4%) 
THC + Cocaine 0 (0.0%) 1 (0.2%) 1 (0.6%) 2 (0.3%) 
Illicit Opiates 0 (0.0%) 8 (1.6%) 1 (0.6%) 9 (1.30%) 
Illicit Opiates + BZE 0 (0.0%) 3 (0.6%) 0 (0.0%) 3 (0.4%) 
Illicit Opiates + Cocaine 0 (0.0%) 2 (0.4%) 0 (0.0%) 2 (0.3%) 
Illicit Opiates + THC 1 (2.5%) 0 (0.0%) 0 (0.0%) 1 (0.1%) 
BDZ 0 (0.0%) 3 (0.6%) 0 (0.0%) 3 (0.3%) 
Medicinal opioids 1 (2.5%) 6 (1.2%) 1 (0.0%) 8 (1.2%) 
Medicinal opioids + BZE 0 (0.0%) 0 (0.0%) 1 (0.0%) 1 (0.1%) 
Medicinal opioids + Cocaine 0 (0.0%) 0 (0.0%) 1 (0.0%) 1 (0.1%) 
Medicinal opioids + THCCOOH + 
Cocaine 
0 (0.0%) 1 (0.2%) 0 (0.0%) 1 (0.1%) 
Medicinal opioids + THC 0 (0.0%) 1 (0.2%) 0 (0.0%) 1 (0.1%) 
Alcohol only 5 (12.8%) 70 (14.3%) 50 (31.0%) 125 (18.1%) 
BZE + Alcohol 0 (0.0%) 1 (0.2%) 5 (3.1%) 6 (0.9%) 
Cocaine + Alcohol 0 (0.0%) 2 (0.4%) 0 (0.0%) 2 (0.3%) 
THCCOOH + Alcohol 0 (0.0%) 1 (0.2%) 0 (0.0%) 1 (0.1%) 
Cocaine + THCCOOH + Alcohol 0 (0.0%) 0 (0.0%) 2 (1.2%) 2 (0.3%) 
THC + Alcohol 0 (0.0%) 1 (0.2%) 3 (0.9%) 4 (0.6%) 
Cocaine + THC + Alcohol 0 (0.0%) 1 (0.2%) 1 (0.6%) 2 (0.3%) 
Illicit Opiates + Alcohol 0 (0.0%) 2 (0.4%) 1 (0.6%) 3 (0.4%) 
BDZ + Alcohol 0 (0.0%) 0 (0.0%) 1 (0.6%) 1 (0.1%) 
Medicinal opioids + Alcohol 0 (0.0%) 2 (0.4%) 0 (0.0%) 2 (0.3%) 
Medicinal opioids + BZE + Alcohol 0 (0.0%) 2 (0.4%) 4 (2.5%) 6 (0.9%) 
Medicinal opioids + Cocaine + Alcohol 0 (0.0%) 0 (0.0%) 1 (0.6%) 1 (0.1%) 
Medicinal opioids + THC + Alcohol 0 (0.0%) 0 (0.0%) 1 (0.6%) 1 (0.1%) 
TOTAL 39 (100.0%) 490 (100.0%) 161 (100.0%) 690 (100%) 
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Table 12. Substances by DRUID time period. Week vs weekend. 
Week vs. Weekend (WE)  
SUBSTANCES Unknown Week (1-4) WE (5-8) TOTAL 
None 30 (76.9%) 248 (72.1%) 194 (63.2%) 472 (68.4%) 
BZE 0 (0.0%) 2 (0.6%) 3 (1.0%) 5 (0.7%) 
Cocaine only 0 (0.0%) 2 (0.6%) 2 (0.6%) 4 (0.6%) 
Amphetamines + Cocaine 0 (0.0%) 1 (0.3%) 0 (0.0%) 1 (0.1%) 
THCCOOH 0 (0.0%) 2 (0.6%) 1 (0.3%) 3 (0.4%) 
THCCOOH + Cocaine 0 (0.0%) 0 (0.0%) 1 (0.3%) 1 (0.1%) 
THC 2 (5.1 %) 5 (1.5%) 6 (2.0%) 13 (1.9%) 
THC + BZE 0 (0.0%) 2 (0.6%) 1 (0.3%) 3 (0.4%) 
THC + Cocaine 0 (0.0%) 2 (0.6%) 0 (0.0%) 2 (0.3%) 
Illicit Opiates 0 (0.0%) 3 (0.9%) 6 (2.0%) 9 (1.3%) 
Illicit Opiates + BZE 0 (0.0%) 2 (0.6%) 1 (0.3%) 3 (0.4%) 
Illicit Opiates + Cocaine 0 (0.0%) 1 (0.3%) 1 (0.3%) 2 (0.3%) 
Illicit Opiates + THC 1 (2.6%) 0 (0.0%) 0 (0.0%) 1 (0.1%) 
BDZ 0 (0.0%) 2 (0.6%) 1 (0.3%) 3 (0.4%) 
Medicinal opioids 1 (2.6%) 4 (1.2%) 3 (1.0%) 8 (1.2%) 
Medicinal opioids + BZE 0 (0.0%) 1 (0.3%) 0 (0.0%) 1 (0.1%) 
Medicinal opioids + Cocaine 0 (0.0 %) 0 (0.0%) 1 (0.3%) 1 (0.1%) 
Medicinal opioids + THCCOOH + 
Cocaine 
0 (0.0%) 1 (0.3%) 0 (0.0%) 1 (0.1%) 
Medicinal opioids + THC 0 (0.0%) 1 (0.3%) 0 (0.0%) 1 (0.1%) 
Alcohol only 5 (12.8%) 47 (13.7%) 73 (23.8%) 125 (18.1%) 
BZE + Alcohol 0 (0.0%) 4 (1.2%) 2 (0.6%) 6 (0.9%) 
Cocaine + Alcohol 0 (0.0%) 1 (0.3%) 1 (0.3%) 2 (0.3%) 
THCCOOH + Alcohol 0 (0.0%) 1 (0.3%) 0 (0.0%) 1 (0.1%) 
Cocaine + THCCOOH + Alcohol 0 (0.0%) 1 (0.3%) 1 (0.3%) 2 (0.3%) 
THC + Alcohol 0 (0.0%) 2 (0.6%) 2 (0.6%) 4 (0.6%) 
Cocaine + THC + Alcohol 0 (0.0%) 0 (0.0%) 2 (0.6%) 2 (0.3%) 
Illicit Opiates + Alcohol 0 (0.0%) 1 (0.3%) 2 (0.6%) 3 (0.4%) 
BDZ + Alcohol 0 (0.0%) 1 (0.3%) 0 (0.0%) 1 (0.1%) 
Medicinal opioids + Alcohol 0 (0.0%) 2 (0.6%) 0 (0.0%) 2 (0.3%) 
Medicinal opioids + BZE + Alcohol 0 (0.0%) 3 (0.9%) 3 (1.0%) 6 (0.9%) 
Medicinal opioids + Cocaine + Alcohol 0 (0.0%) 1 (0.3%) 0 (0.0%) 1 (0.1%) 
Medicinal opioids + THC + Alcohol 0 (0.0%) 1 (0.3%) 0 (0.0%) 1 (0.1%) 
TOTAL 39 (100%) 344 (100%) 307 (100%) 690 (100%) 
 
In general, the higher percentage of positives for alcohol and/or substances (Cocaine, 
BZE, THC, THC-COOH) were found in drivers injured in accidents during night time; the 
percentage of subjects positive for alcohol alone is noticeably higher during night time 
(31.0 vs 14.3 % of sampled drivers). However, the % of positives for illicit or medicinal 
opioids is higher during day time. 
 
As to week vs weekend distribution, the proportion of injured drivers found positive for 
one or more substances were higher in the weekend (36.8 % of sampled drivers) than in 
the week time period (20.8% of sampled drivers); this difference is particularly remarkable 
for those positive for alcohol only ( 23.8 % in WE vs 13,. % in week). In Figure 2 the 
distribution of substance groups according to DRUID time periods aggregated into 
weekday (1-3), weeknight (4), weekend day (5-7) and weekend night (8) is presented.  
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Figure 3. Distribution of substance groups by weekday, weeknight, weekend day and 
weekend night 
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4.4.3 Distribution of substance groups by gender and age 
The detailed substance group distribution by gender and age is represented in tables 13A 
and 13B. 
 
Table 13A. Distribution of substances in the Female group by age 
 Female 
Substance 15-24 25-34 35-49 50+ Total F 
None 21 (80.8%) 31 
(66.0%) 
45 
(81.8%) 
23 
(79.3%) 
120 (76.4%) 
BZE 0 (0.0%) 1 (2.1%) 0 (0.0%) 0 (0.0%) 1 (0.6%) 
Cocaine only 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 
Amphetamines + Cocaine 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 
THCCOOH 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 
THCCOOH + Cocaine 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 
THC 0 (0.0%) 1 (2.1%) 0 (0.0%) 0 (0.0%) 1 (0.6%) 
THC + BZE 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 
THC + Cocaine 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 
Illicit Opiates 0 (0.0%) 3 (6.4%) 1 (1.8%) 0 (0.0%) 4 (2.5%) 
Illicit Opiates + BZE 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 
Illicit Opiates + Cocaine 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 
Illicit Opiates + THC 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 
BDZ 0 (0.0%) 1 (2.1%) 0 (0.0%) 2 (6.9%) 3 (1.9%) 
Medicinal opioids 0 (0.0%) 1 (2.1%) 1 (1.8%) 0 (0.0%) 2 (1.3%) 
Medicinal opioids + BZE 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 
Medicinal opioids + Cocaine 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 
Medicinal opioids + THCCOOH + 
Cocaine 
0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 
Medicinal opioids + THC 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 
Alcohol only 5 (19.2%) 7 (14.9%) 7 (12.7%) 3 (10.3%) 22 (14.0%) 
BZE + Alcohol 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 
Cocaine + Alcohol 0 (0.0%) 1 (2.1%) 0 (0.0%) 0 (0.0%) 1 (0.6%) 
THCCOOH + Alcohol 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 
Cocaine + THCCOOH + Alcohol 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 
THC + Alcohol 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 
Cocaine + THC + Alcohol 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 
Illicit Opiates + Alcohol 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 
BDZ + Alcohol 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 
Medicinal opioids + Alcohol 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (3.4%) 1 (0.6%) 
Medicinal opioids + BZE + Alcohol 0 (0.0%) 1 (2.1%) 0 (0.0%) 0 (0.0%) 1 (0.6%) 
Medicinal opioids + Cocaine + 
Alcohol 
0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 
Medicinal opioids + THC + Alcohol 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (0.6%) 
TOTAL Female Substances 26 (100%) 47 
(100%) 
55 (100%) 29 (100%) 157 (100%) 
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Table 13B. Distribution of substances in the Male group by age 
 Male 
Substances 15-24 25-34 35-49 50+ Total M 
None 67 (62.6%) 96 (58.5%) 100 
(65.8%) 
89 (80.9%) 352 (66.0%) 
BZE 1 (0.9%) 1 (0.6%) 2 (1.3%) 0 (0.0%) 4 (0.8%) 
Cocaine only 0 (0.0%) 1 (0.6%) 3 (2.0%) 0 (0.0%) 4 (0.8%) 
Amphetamines + Cocaine 0 (0.0%) 0 (0.0%) 1 (0.7%) 0 (0.0%) 1 (0.2%) 
THCCOOH 2 (1.9%) 1 (0.6%) 0 (0.0%) 0 (0.0%) 3 (0.6%) 
THCCOOH + Cocaine 0 (0.0%) 1 (0.6%) 0 (0.0%) 0 (0.0%) 1 (0.2%) 
THC 6 (5.6%) 5 (3.0%) 1 (0.7%) 0 (0.0%) 12 (2.3%) 
THC + BZE 2 (1.9%) 1 (0.6%) 0 (0.0%) 0 (0.0%) 3 (0.6%) 
THC + Cocaine 0 (0.0%) 1 (0.6%) 1 (0.7%) 0 (0.0%) 2 (0.4%) 
Illicit Opiates 1 (0.9%) 2 (1.2%) 2 (1.3%) 0 (0.0%) 5 (0.9%) 
Illicit Opiates + BZE 1 (0.9%) 1 (0.6%) 1 (0.7%) 0 (0.0%) 3 (0.6%) 
Illicit Opiates + Cocaine 1 (0.9%) 0 (0.0%) 1 (0.7%) 0 (0.0%) 2 (0.2%) 
Illicit Opiates + THC 1 (0.9%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (0.2%) 
BDZ 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 
Medicinal opioids 0 (0.0%) 2 (1.2%) 3 (2.0%) 1 (0.9%) 6 (1.1%) 
Medicinal opioids + BZE 0 (0.0%) 1 (1.2%) 0 (0.0%) 0 (0.0%) 1 (0.2%) 
Medicinal opioids + Cocaine 1 (0.9%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (0.2%) 
Medicinal opioids + THCCOOH + 
Cocaine 
0 (0.0%) 0 (0.0%) 1 (0.7%) 0 (0.0%) 1 (0.2%) 
Medicinal opioids + THC 0 (0.0%) 1 (0.6%) 0 (0.0%) 0 (0.0%) 1 (0.2%) 
Alcohol only 21 (19.6%) 37 (22.6%) 26 (17.1%) 19 (17.3%) 103 (19.7%) 
BZE + Alcohol 1 (0.9%) 3 (1.8%) 2 (1.3%) 0 (0.0%) 6 (1.1%) 
Cocaine + Alcohol 0 (0.0%) 0 (0.0%) 1 (0.7%) 0 (0.0%) 1 (0.2%) 
THCCOOH + Alcohol 0 (0.0%) 0 (0.0%) 1 (0.7%) 0 (0.0%) 1 (0.2%) 
Cocaine + THCCOOH + Alcohol 0 (0.0%) 2 (1.2%) 0 (0.0%) 0 (0.0%) 2 (0.4%) 
THC + Alcohol 0 (0.0%) 3 (1.2%) 1 (0.7%) 0 (0.0%) 4 (0.8%) 
Cocaine + THC + Alcohol 1 (0.9%) 0 (0.0%) 1 (0.7%) 0 (0.0%) 2 (0.4%) 
Illicit Opiates + Alcohol 1 (0.9%) 2 (1.2%) 0 (0.0%) 0 (0.0%) 3 (0.6%) 
BDZ + Alcohol 0 (0.0%) 1 (0.6 %) 0 (0.0%) 0 (0.0%) 1 (0.2%) 
Medicinal opioids + Alcohol 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (0.9%) 1 (0.2%) 
Medicinal opioids + BZE + Alcohol 0 (0.0%) 1 (0.6%) 3 (2.0%) 0 (0.0%) 5 (1.0%) 
Medicinal opioids + Cocaine + 
Alcohol 
0 (0.0%) 0 (0.0%) 1 (0.7%) 0 (0.0%) 1 (0.2%) 
Medicinal opioids + THC + Alcohol 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 
TOTAL Male Substances 107 (100%) 164 (100%) 152 (100%) 110 (100%) 533 (100%) 
 
The proportion of injured drivers positive for one or more substances is higher in men 
(34.0 % ) than in women (23.6 %). For both male and female drivers, the highest 
prevalence was found in the age group 25 – 34. Alcohol was the most used substance by 
both male and female subjects, but the prevalence in the male group was significantly 
higher (range 17.6 – 22.6 % and total 19.3 % in men vs range 10.3 – 19.2 % and total 
14.0 % in women) the highest frequency being in the age group 25 – 34 for the male and 
15 -24 for the female group. Whereas Cocaine and THC (alone or in combination with 
alcohol) were the most prevalent illicit drugs in the male groups, especially below 50, in 
female subjects only few cases of THC, Cocaine and illicit opiates are present, and in 2 
cases only there is a combination with alcohol. Benzodiazepines are used essentially by 
female subjects. 
 
Unfortunately, the substance group distribution by single-vehicle accidents vs. multiple 
vehicles could not be calculated due to the lack of data 
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4.4.4 Distribution of substance concentrations 
In Table 14 the range of concentrations measured for the core substances are listed. As 
expected from cocaine pharmacokinetics, benzoylecgonine exhibited the highest 
concentrations, both as a maximum and as mean value in blood. 
 
Table 14. Range of substance concentrations. A = alfa-amino 
Concentration range (ng/mL) 
SUBSTANCE Number 
of Cases 
Min Max Median 
value 
Mean value 
Alcohol 156 0.1 4.2 1.6 1.65 
Morphine 39 1.2 134 17 26.8 
Amphetamine 0     
MDMA 1 8.9 8.9 8.9 8.9 
MDA 1 6 6 6 6 
Cocaine 28 1 127 15.5 51.6 
THC 29 0.2 80 1.3 4.5 
Diazepam 4 2 120 56.15 63.1 
Alprazolam 1 18.5 18.5 18.5 18.5 
Clonazepam 0 0 0   
Benzoylecgonine 43 3 420 165 192.95 
Codeine 14 3 22 10.5 10.83 
6-Acetylmorphine 4 2 5.8 3.15 3.525 
Metamphetamine 1 143 143 143 143 
Methadone 14 13 190 68.5 79.07 
Oxazepam 1 102 102 102 102 
Nordiazepam 2 31 38.5 34.75 34.75 
Zolpidem 0     
MDEA 0     
THC-COOH 48 1 120 6.5 12.5 
Lorazepam 0     
Flunitrazepam 0     
Zopiclone 0     
7-A-Clonazepam 0     
7-A-Flunitrazepam 0     
Tramadol 0     
 
A short summary of analytical results obtained for the 555 urine samples is reported in 
Table 15. 
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Table 15. Substances and concentrations found in 555 urine samples 
SUBSTANCES (urine) Number of 
Cases 
Min Max Mean value 
Alcohol 90 0.1 4.4 1.8 
Morphine 41 10.2 800 285.2 
Amphetamine 0    
MDMA 1 800 800 800 
MDA 1 279 279 279 
Cocaine 31 6 1000 332.1 
THC 3 20 160 79.3 
Diazepam 2 500 600 550 
Alprazolam 0    
Clonazepam 0    
Benzoylecgonine 37 30 1000 431.8 
Codeine 28 4. 800 192.5 
6-Acetylmorphine 22 11 800 267.5 
Metamphetamine 0 0 0  
Methadone 22 102 650 338.8 
Oxazepam 2 350 500 425 
Nordiazepam 3 100 600 326.7 
Zolpidem 0    
MDEA 0    
THCCOOH 42 8.5 194.0 59.6 
Lorazepam 0    
Flunitrazepam 0    
Zopiclone 0    
7-A-Clonazepam 0    
7-A-Flunitrazepam 0    
Tramadol 0    
 
16 % of urine samples were found positive for alcohol, 7.4 % for morphine and 3.5 % for 
6-acetylmorphine, whereas those positive for THCCOOH represented 7.6 % of the total 
samples. In 3 cases only was THC found, as reasonably expected. As to the Cocaine 
class, 31 out of 555 samples (5.6 %) were positive for Cocaine and 37 out of 555 for BZE 
(6.7 %). 7 out of 555 cases (1.3%) were positive for benzodiazepines. 
 
4.5 Discussion of results 
 
4.5.1 Representativeness 
The Veneto region was chosen due to the vast number of rural, urban, provincial and 
state roads within the country. Veneto is a large region of Italy that covers a total area of 
18,398.9 km2 that can be divided into four areas: the northern Alpine zone, the hill zone, 
the lower plain, and the coastal territory. In total there are 7397 kilometres of state 
regional and provincial roads. The following specific districts were included in our road 
side survey: Padova, Rovigo, Treviso, Venice, and Vicenza, accounting for more than 8% 
of the entire population in Italy and in 4 out of 5 districts could a hospital be selected for 
the hospital survey (see also Table 1).  
 
4.5.2 Non response 
No confounding effect due to non-responses in sampling injured drivers was observed.  
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4.5.3 Highlights 
Alcohol was the most prevalent substance among injured drivers in Italy, with a total 
prevalence of 22.6 % (18.1 % for alcohol only and 4.6 % for combination with an illicit 
and/or a medicinal drug). The cases positive for alcohol only were more common in male 
drivers, with prevalence values nearly stable as age increases. Conversely, in the female 
group, the prevalence for alcohol decreases with increasing age. Positives for “illicit drugs 
only” represented the second most prevalent group (7.4 %) followed by “medicinal drugs 
only” (2.9 %) and the combination of illicit and medicinal drugs. The male group in the 
age range 25 – 34 exhibit the highest prevalence for both alcohol and illicit drugs. The 
total prevalence of Cocaine (Cocaine alone, Cocaine plus Benzoylecgonine and their 
combination with alcohol and/or other drugs) accounts for 5.3 % of the total injured driver 
population. Analogously, the total prevalence of Cannabis is 5.2 %. The use of iIlicit 
opiates is documented by an occurrence of 2.8 %, whereas the most of medicinal drugs 
are represented by medicinal opioids (including methadone). The combinations alcohol-
illicit drug were rarely found in the female population.  
In general the number of positive drivers was higher during night-time and during 
weekend with an occurrence of alcohol that was almost double during weekends 
compared to weekdays, and more than 3 times during night vs daytime.  
 
It must be emphasised that the collection of urine samples proved to be useful in defining 
the use of illicit opiates in 18 of 39 cases, where 6-acetylmorphine (6-AM) in blood was < 
10 ng/mL (DRUID cut off). 
A single case of blood containing less than 10 ng/mL of 6-AM (3.1 ng/mL), and for which 
urine sample was not collected, could also be attributed to illicit opiates use after 
verification that no opiate medicinal drug was administered to the injured driver prior to 
sampling.  
These results suggest once more that the use of both biological fluids, blood and urine, 
would facilitate the interpretation of toxicological results in DUI of opiates, and that a cut 
off of 10 ng/mL can be too high for evidencing 6-AM in blood. 
In total, 19 out of 40 cases were attributed to illicit opiates, whereas the other 
opioids/opiates cases were interpreted as medicinal. 
 
4.5.4 Comparison with other studies 
To the best of our knowledge, only a similar study has been conducted in Italy so far: in a 
town of northern Italy (Modena) and its surrounding territory a total of 115 crash-
responsible injured drivers (90 males and 25 females) were enrolled [3]. A urine sample 
was obtained and different screening and confirmation procedures were employed to 
detect the presence of drugs and/or alcohol. Among the 115 enrolled drivers, 46 (40%) 
were positive for at least one drug and/or alcohol. Of these 46 drivers, 66% were positive 
for a single drug, 25% for two drugs, 9% for three or more drugs. The use of marjuana 
was found most frequently (19% out of the total 115 enrolled drivers), surpassing alcohol 
(10%), amphetamines (7%) and cocaine (6%); about 10% tested positive for 
benzodiazepines. Most drivers positive for alcohol or other drugs were 21-40 years old 
while the majority of drivers positive for benzodiazepines were 41-70 years old. Thirty-
nine (85%) of the positive injured drivers were males and seven (15%) were female. The 
lower prevalence of total positive samples in the present study (31.6 vs 40 %) can be 
ascribed to the different biological fluids (blood vs urine) and selection procedures 
(general population of injured drivers vs culpable injured drivers) that have been 
employed. Both studies confirm that the use of alcohol and/or drugs is more prevalent in 
the youngest driving population, and in the male group. 
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4.8 ANNEX 1: Methods of analysis 
Sample collection. See 2.1. For the preparation of blanks, calibrators and quality control 
samples, a pool of drug-free blood was prepared from samples from 6 healthy volunteers. 
 
Liquid chromatography/tandem mass spectrometry for the analysis of illicit drugs and 
medicines (excluded THC and THC-COOH) 
 
Chemicals.Stock solutions of analytes and internal standards (benzoylecgonine D3, 
buprenorphine D4, cocaine D3, nordiazepam D5 and methylendioxypropylamphetamine) 
in methanol or acetonitrile at 1 g/L or 100 mg/L were supplied by Cerilliant (Round Rock, 
TX, USA) and Lipomed (Arlesheim, Switzerland).  
 
Standard solutions. From individual stock solutions mixed working solutions in methanol 
at 12.5 mg/L, 2.5 mg/L, 0.5 mg/L and 0.05 mg/L were prepared with the exception of 
zopiclone. The IS stock solutions were diluted in methanol to give a mixed working 
solution of 4 mg/L. Zopiclone working solution in acetonitrile at 10 mg/L, 1 mg/L, 0.1 mg/L 
and 0.01mg/L were prepared weekly and not mixed with the other substances. 
 
Sample preparation. The samples were extracted by solid phase extraction (SPE) using 
Bond Elut Certify SPE (130 mg - 10 mL; Varian Inc, Palo Alto, CA, USA) columns. 1 ml 
blood samples were diluted with 6 ml of phosphate buffer, spiked with 20 ⎧L of IS working 
solution, centrifuged and introduced into the SPE columns conditioned with methanol and 
phosphate buffer (0.1 M, pH 6). The calibrators and quality control samples were 
prepared from 1 mL blank blood samples spiked with working solutions of standards and 
IS and diluted with buffer to the same final volume of samples. The columns were 
washed with purified water, HCl 0.1 N, and methanol. The elution was carried out with 1 
mL of dichloromethane/isopropanol 90:10 (v/v) containing 2% of NH4OH aqueous 
solution. Eluates were evaporated at room temperature under a stream of nitrogen and 
re-dissolved in 50 ⎧L of 5 mM ammonium acetate buffer pH 5.0/acetonitrile (vol/vol, 
10:90). 
 
HPLC Chromatographic conditions. An Agilent 1200 HPLC system (Agilent, Santa Clara, 
CA, USA) was used. The chromatographic separation was performed by a Waters 
Atlantis T3 (100 x 2.1 mm, 3 µm particle size) column at 40 °C using gradient elution with 
5 mM ammonium acetate buffer pH 5.0 (phase A) and acetonitrile (phase B) at a flow rate 
of 0.3 mL/min. A gradient was programmed by increasing % B as follows: from 10% B to 
25 % B in 4 min, hold for 3 min, to 40 % B in 5 min, to 60% in 4 min, to 90 % B in 2 min, 
hold for 2 min. An injection volume of 5 μL was used. 
 
Mass spectrometry. The HPLC system was combined with an Agilent MSD ion trap mass 
spectrometer (Agilent, Santa Clara, CA, USA) fitted with an Electrospray (ESI) ionisation 
source. The mass spectrometer was operated in positive ion mode and in the multiple 
reaction monitoring (MRM) mode. For collisionally induced dissociations helium was used 
as a target gas and appropriate tickle voltage, tickle time and qz values were determined 
for each substance. The MRM transitions with the corresponding collision voltage and 
retention time of the analytes and internal standards are presented in Table 16. 
 
Validation results. The method was validated in terms of specificity/selectivity, linearity, 
limits of quantitation (LOQ), intra-assay precision, inter-assay precision and accuracy 
(bias). No interferences were detected by analysing 20 drug-free blood samples. The 
calibration curves, prepared with six points ranging from 1 to 200 µg/L in spiked blood, 
yielded r2 ≥0.9889. The LOQs, expressed as the lowest analyte concentration which 
could be determined with an acceptable level of precision and bias (≤ 20 %), were 0.5 
ng/mL for all compounds. The intra- and inter-assay precision and accuracy were 
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determined by measuring four replicates at two concentration levels (low and high) on 
four different days (n=16). Precision was expressed as the CV% of the measured values 
and was always < 15%, with the exception of zopiclone. The accuracy, expressed as 
bias, was always in the range ± 15 % at the two levels. 
 
Gas chromatography- mass spectrometry for the determination of THC and THC-COOH 
 
Chemicals. Delta-9-tetrahydrocannabinol(THC),11-nor-9-carbooxy-tetrahydrocannabinol 
(THC-COOH) and the internal standards THC-d3 and THC-COOH-d3 in methanol at 100 
mg/L were obtained from Cerilliant (Round Rock, TX, USA).  
 
Standard solutions. From individual stock solutions at 100 mg/L, mixed working solutions 
in methanol at 5 mg/L, 1 mg/L, 0.500 mg/L, 0.250 mg/L and 0.025 mg/L were prepared. 
The internal standard (THC-d3 and THC-COOH-d3) stock solutions at 100 mg/L were 
diluted in methanol to give a mixed working solution of 0.5 mg/L.  
 
Sample preparation. The samples were prepared by liquid-liquid extraction. To 2 ml 
blood. 5 mL of hexane/ethyl acetate (vol/vol, 90:10) containing 0.4% of glacial acetic acid 
and 40 ⎧L of IS working solution were added. The calibrators and quality control samples 
were prepared by spiking 2 mL blank blood with working solutions. The samples were 
mixed by inversion for 15 min. After centrifugation, the organic phase was transferred to 
conical tubes and evaporated to dryness at 40 °C under a stream of nitrogen. To the 
dried extracts 50 µL of trimethylsilyl-trifluoro acetamide containing 1% of 
trimethylchlorosilane were added as derivatising agent. Derivatisation was achieved by 
heating at 75 °C for 20 min. 
 
Gas chromatography conditions. An Agilent 6890N gas chromatography (GC) system 
(Agilent, Santa Clara, CA, USA). The chromatographic separation was performed with an 
HP Ultra 1 Methyl Siloxane column (12 m x 200 µm o.d., 0.33 µm film thickness). Helium 
at a constant flow of 0.8 mL/min was used as a carrier gas. 1 μL of derivatised extracts 
was injected by splitless injection at 250°C. The initial oven temperature of 80 °C was 
held for 1 min, followed by an increase to 300°C at 25°C/min with 2 min hold. 
 
Mass Spectrometry. All mass spectrometric measurements were performed on an Agilent 
5973 MS single quadrupole mass spectrometer (Agilent, Santa Clara, CA, USA). The 
single quadrupole was operated in Electron Ionisation (EI) conditions (70 eV, 200 μA) and 
in single ion monitoring mode. The following ions were monitored: for THC ions at m/z 
303, 371 and 386; for THC-COOH ions at m/z 371, 473 and 488; for the IS THC-d3 ions 
at m/z 306, 374 and 389; for the IS THC-COOH-d3 ions at m/z 374, 476 and 491. 
 
Validation results. No interferences were detected by analysing 20 drug-free blood 
samples. The calibration curves, prepared with six points ranging from 0.2 to 20.0 µg/L 
THC and THC-COOH in spiked blood yielded r2 ≥0.999. The LOQs resulted to be 0.2 
µg/L for THC and THC-COOH. The intra- and inter-assay precision and accuracy were 
determined by measuring four replicates at two concentration levels (1 µg/L and 5 µg/L) 
on four different days (n=16). The intra-assay precision was found to be 3.2 and 1.9 % 
and the inter-assay precision 3.5 and 2.3 % for the lower and higher concentration levels, 
respectively. The accuracy (bias) was found to be +1.2 and +0.8% for the lower and 
higher concentration levels, respectively. 
 
BAC quantification by Headspace Gas Chromatography 
 
Chemicals. Absolute 200 proof ethanol, LC grade iso-propanol, sodium chloride, and 
sodium fluoride were obtained from Sigma Aldrich (Milan, Italy). Acetaldehyde, LC grade 
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methanol, acetone, n-propanol, methyl,ethyl ketone and toluene were purchased from 
Merck Chemicals (Milan, Italy). Purified water was obtained with a Milli-Q system 
(Millipore).  
 
Standard solutions. Ethanol working solutions in purified water at 1, 2 and 5 g/L were 
prepared and used for the validation and preparation of calibration curves. Iso-propanol 
(IS) working solution was prepared in purified water at 0.5 g/L. Ethanol Standards 
(0.05%, 0.08%, 0.10%, 0.20% and 0.30% w/v) NIST traceable were purchased from 
Cerilliant (Round Rock, TX, USA) and used as quality controls. 
 
Sample preparation. 750 mg sodium chloride, 40 mg sodium fluoride, 0.5 mL of IS 
working solution and water to a final volume of 1.5 mL were added to 0.5 mL blood in a 
20 mL glass headspace vial. The calibrators and quality control samples were prepared 
by adding to 0.5 mL blank blood samples or to water the appropriate working solution 
volumes. Headspace-Gas Chromatography (HS-GC) conditions. An Agilent 7694 gas 
chromatograph (GC) with flame ionisation detector and a headspace autosampler was 
used. The chromatographic separation was performed on J&W DB-ALC1 (30 m x 0.534 
µm x 3.00 µm) column. The GC operational parameters were: oven 50º C isothermal, 
injector 250 ºC, detector (FID) 250 ºC, hydrogen flow 35 mL/min, Air flow 450 mL/min, 
Make-up gas (nitrogen) flow 22.6 ml/min. The injection was in split mode with a split ratio 
1:50. The HS sampler parameters were: sample oven 75 ºC, sample equilibration 10 min, 
sample inject 1.00 min.  
 
Validation results. Volatiles were identified based on relative retention times compared to 
calibrators. Linearity was evaluated by the preparation of calibration curves with 5 points 
ranging from 0.01 to 0.05 % w/v. The r2 value for the linear regression curve was always 
0.997 or greater. A study was run to evaluate the interferences of other volatile 
substances (acetaldehyde, methanol, acetone, n-propanol, toluene and methyl ethyl 
ketone). The peaks were resolved with a resolution better than 1 and a peak-to-valley 
ratio better than 90%. The precision, accuracy, and limit of quantitation (LOQ) were 
determined by ten replicate measurements of ethanol at different concentrations; 
precision was defined as the coefficient of variation (CV%); accuracy was defined as the 
deviations from the actual concentration. The LOQ was determined to be 0.010% w/v. .At 
concentrations of 0.010, 0.050, 0.100, 0.200 and 0.300 % precisions were 1.8%, 0.4%, 
0.2%, 0.5%, 0.2% respectively and accuracies were +13.0%, +8.5%, -1.8%, +0.6%, -
1.6%. 
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Table 16. Validation parameters of the LC-MS/MS method 
Compound Rt 
(min) 
Fragment
ation 
amplitud
e (V) 
Transitions  
(m/z) 
IS R2 
 
Intra-assay  
% CV 
Low High  
Inter-
assay 
%CV 
Low High 
6-Acetylmorphine (6-MAM) 6.4 1.10 328 → 268 cocaine D3 0.9961 6.2 4.5 10,0 9,8 
7-aminoclonazepam 9.9 1.00 286 → 250 nordiazepam D5 0.9940 7.2 5.4 9.5 5.0 
7-aminoflunitrazepam 11.7 1.00 284 → 135 nordiazepam D5 0.9920 4.3 4.2 13.8 9.1 
alprazolam 17.2 1.20 309 → 281 nordiazepam D5 0.9889 8.5 9.8 14.8 13.0
amitriptyline 17.0 1.10 278 → 233 cocaine D3 0.9940 5.4 2.2 9.3 8.5 
amphetamine 5.9 1.10 136 → 119 MDPA 0.9928 4.3 3.6 11.9 7.0 
benzoylecgonine 7.7 1.20 290 → 168 benzoylecgonineD3 0.9942 4.1 4.3 13.5 12.8
bromazepam 14.7 1.00 316 → 182 nordiazepam D5 0.9918 3.7 3.2 14.1 10.5
buprenorphine 15.4 1.00 468 → 414 buprenorphine D4 0.9958 2.9 1.8 7.9 6.5 
clonazepam 17.5 0.90 316 → 270 nordiazepam D5 0.9989 3.8 2.6 14.1 12.5
cocaine 9.9 1.00 304 → 182 cocaine D3 0.9928 4.6 5.4 10.7 5.9 
codeine 4.9 1.00 300 → 215 cocaine D3 0.9972 3.8 2.5 11.1 14.3
diazepam 19.9 0.90 285 → 193 nordiazepam D5 0.9958 5.5 4.2 16.3 9.7 
flunitrazepam 18.3 1.10 314 → 268 nordiazepam D5 0.9930 6.1 5.3 11.5 9.8 
fluoxetine 17.3 1.20 310 → 148 cocaine D3 0.9990 3.5 2.9 12.4 8.7 
ketamine 8.1 0.90 238 → 220 MDPA 0.9978 4.5 4.0 14.3 10.3
lorazepam 17.3 1.10 322 → 305 nordiazepam D5 0.9880 9.8 8.0 14.7 10.5
metamphetamine 6.6 1.10 150 → 119 MDPA 0.9928 6.0 4.5 12.3 8.8 
methadone 17.2 1.20 310 → 265 cocaine D3 0.9989 3.1 2.8 8.5 6.5 
methylendioxyamphetamin
e (MDA) 
6.4 1.00 180 → 163 MDPA 0.9937 5.5 6.5 10.9 10.5
methylendioxyethylamphet
amine (MDEA) 
7.7 1.00 208 → 163 MDPA 0.9962 4.8 4.1 9.9 8.5 
methylendioxymetampheta
mine (MDMA) 
6.9 0.90 194 → 163 MDPA 0.9948 5.9 4.2 8.0 6.6 
morphine 2.2 1.10 286 → 201 cocaine D3 0.9989 5.0 3.2 7.7 6.6 
norbuprenorphine 11.4 1.30 414 → 396 buprenorphine D4 0.9995 3.9 2.4 7.0 5.4 
nordiazepam 18.5 0.90 271 → 208 nordiazepam D5 0.9943 5.5 4.9 9.1 8.7 
olanzapine 8.2 1.20 313 → 256 MDPA 0.9961 4.0 3.5 5.8 6.0 
oxazepam 16.9 0.80 288 → 241 nordiazepam D5 0.9921 3.7 2.9 8.1 7.2 
venlafaxine 11.5 1.10 278 → 260 cocaine D3 0.9989 3.5 1.9 6.0 5.3 
zolpidem 11.1 1.10 308 → 263 cocaine D3 0.9925 3.0 2.0 5.5 5.3 
zopiclone 8.8 0.80 389 → 345 MDPA 0.9918 10.
5 
9.3 16.2 14.8
benzoylecgonine D3(IS) 7.6 1.00 293 → 171 -      
buprenorphine D4 (IS) 15.4 1.00 472 → 415 -      
cocaine D3 (IS) 9.9 1.00 307 → 185 -      
methylendioxypropylamfeta
mine (MDPA) (IS) 
9.0 0.90 222 → 163 -      
nordiazepam D5 18.4 0.90 276 → 213 -      
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5 Country Report Lithuania 
 
Authors 
Marija Caplinskiene, Alvydas Pauliukevicius, Romas Raudys, Zita Minkuviene, Vaida 
Stankute (TMI – Institute of Forensic Medicine Mykolas Romeris University, Lithuania) 
 
5.1 Description of the hospitalised drive sample  
 
The hospital survey (HS) in Lithuania have been carried out from 1stof April 2008 until 20th 
of March 2010 to assess the situation in country regarding the prevalence of alcohol and 
other psychoactive substances in accident involved drivers. The hospital survey design 
was set up following the recommendations of DRUID project protocols. The research 
areas of Lithuania (see Figure 1) were based on the geographical distribution of 
population over the country, accounting for 3,350 mln. inhabitants in total. All studies and 
study protocols were approved by Lithuanian Bioethics Commission according to the 
code of ethics on human experimentation established by the declaration of Helsinki 
(1964) and amended in Edinburgh (2000).  
 
4 (four) main 
Hospitals in LT: 
Vilnius, Kaunas, 
Klaipėda, Alytus
Hospital in Vilnius
Hospital in Klaipėda
Hospital in Kaunas
Hospital in Alytus
 
 Figure 1. The research areas of Lithuania: Vilnius, Kaunas, Klaipeda, and Alytus  
 
Figure 1 shows the geographical distribution of the hospital survey areas in Lithuania and 
the four main hospitals involved in the HS. 
The uniform protocol on the hospital survey and all procedures were prepared and 
adapted by the working paper "Uniform design and protocols for carrying out hospital 
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survey" (revision date: 29/06/2007) of DRUID. Information and the design on the uniform 
hospital survey were sent to the administration departments of four hospitals in Vilnius, 
Kaunas, Klaipeda and Alytus. The uniform questionnaire form in Lithuanian language for 
the hospital survey was prepared following the DRUID project recommendations. The 
administration and hospital staff was informed on study requirements and procedures. 
The questionnaire form collects data information on injured drivers such as age, gender, 
time of accident, vehicle type, driver’s licence, the use of any infusions or medicines by 
ambulance staff.  
The blood samples were collected from injured drives (from MAIS 2 and >) and sent to 
the TMI Toxicology laboratory with the filled questionnaire. During the hospital survey 424 
samples were collected. 
 
Table 1 presents the distribution of injured drivers by region and hospital: the highest 
percentage of injured drivers was from Kaunas research region - 83.96% which is in 
urban area of Lithuania in cross connection with main urban roads, from Vilnius research 
region (capital of Lithuania) - 14.62% (see Table 1). 
 
Table 1. Distribution of injured drivers by region and hospital 
Region and Hospital Distribution of injured drivers 
Vilnius 37001 62 (14.62%) 
Kaunas 37002 356 (83.96%) 
Klaipeda 37003 4 (0.94%) 
Alytus 37004 2 (0.47%) 
Total 424 
 
Table 2 presents the distribution of injured drivers by road type: the highest percentage of 
injured drivers was from urban road type - 98.10% and rest of drivers - 1.9% were from 
rural roads (see Table 2). 
Table 2. Distribution of injured drivers by road type 
Road type Distribution of injured drivers 
Urban road 414 (98.10%) 
Rural road 8 (1.90%) 
Total 422 (100%) 
Frequency Missing = 2  
 
Table 3 presents the distribution of injured drivers by day of the week and time of the day: 
the highest percentage of injured drivers was in the weekday period - 65,23 %, the rest of 
drivers: 25.38% - in weekend day, 6.35% - in weekend night and 3.05% – in weeknight. 
The high percentage of injured drives during the daytime hours was caused by the much 
higher traffic volumes during daytime hours than during night time hours (see Table 3). 
Table 3. Distribution of injured drivers by day of the week and time of the day 
Time period  Distribution of injured drivers 
Weekday 257 (65.23%)
Weeknight 12 (3.05%)
Weekend day 100 (25.38%)
Weekend night 25 (6.35%)
Total 394 (100%)
Frequency Missing = 30  
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Table 4 presents the distribution of injured drivers by season (quarter): no big difference 
on injured drivers was found by the seasons of the year (see Table 4).  
 
Table 4. Distribution of injured drivers by season (quarter) 
Quarter Distribution of injured drivers 
1st quarter 116 (27.36%)
2nd quarter 106 (25.00%)
3rd quarter 81 (19.10%)
4th quarter 121 (28.54%)
Total 424 (100%)
 
Table 5 presents the distribution of injured drivers by severity: the highest percentage of 
injured drivers was in MAIS2 group (86.55%) followed by MAIS 3 (7.6%) and MAIS 4 
(3.51%). Both MAIS 1 and 6 were observed in only one case. In 253 cases the MAIS was 
not indicated (see Table 5). 
Table 5. Distribution of injured drivers by severity 
MAIS Distribution of injured drivers 
MAIS 1 1 (0.58%)
MAIS 2 148 (86.55%)
MAIS 3 13 (7.60%)
MAIS 4 6 (3.51%)
MAIS 5 2 (1.17%)
MAIS 6 1 (0.58%)
Total 171 (100%)
Frequency Missing = 253  
 
Table 6 presents the distribution of injured drivers by age and gender: no big significant 
difference found in distribution by age groups both in males and females from age 18 till 
age 50. In male group the number of injured drivers was higher than in a female group 
(see Table 6). 
Table 6. Distribution of drivers by age and gender  
Table of age by gender    
Age gender  Total 
 male female  
18-25 years 77 (30.20%) 38 (27.94%) 115 (29.41)
25-35 years 65 (25.49%) 42 (30.88%) 107 (27.37)
35-50 years 70 (27.45%) 41 (30.15%) 111 (28.39%)
50 years and older 43 (16.86%) 15 (11.03%) 58 (14.83%)
Total 255 (100%) 136 (100%) 391 (100%)
Frequency Missing = 33    
 
Table 7 presents the distribution of injured drivers by type of vehicle: the highest 
percentage of injured drivers was in personal car drivers group - 84.88% (see Table 7). 
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Table 7. Distribution of drivers by type of vehicle 
Vehicle type Distribution injured drivers 
personal cars 348 (84.88%)
vans 27 (6.59%)
motorcycle 31 (7.56%)
bicycle 1 (0.24%)
bus/truck >3500kg 3 (0.73%)
Total 410 (100%)
Frequency Missing = 14  
 
Table 8 presents the distribution of injured drivers by accident type: the highest 
percentage of injured drivers was in the multi-part accident type group - 68.22% (see 
Table 8). 
Table 8. Distribution of drivers by accident type 
Accident type Distribution injured drivers 
single-vehicle accident 130 (31.78%)
multi-part accident 279 (68.22%)
Total 409 (100%)
Frequency Missing = 15  
 
5.2 Methods: Data collection and analysis  
5.2.1 Ethical approval 
TMI submitted all the documents required for receiving the permission for implementation 
of the DRUID project in Lithuania to the Lithuanian Bioethical Committee in November, 
2007. The documents were prepared following the Committee's previous 
recommendations and remarks. The written consent (including some remarks) from the 
Committee was received at TMI on November 21, 2007 (Lithuania's Bioethical 
Committee's official letter No.6B-07-386 (Code 07-11-01). 
 
5.2.2 Data collection procedure:  
Data and sample collection in Task 2.2a, 2.2b, 2.3 has been started following the relative 
protocols, procedures and other requirements. The blood samples were collected from 
severe injured drives at the moment of arrival to the hospital. Time between accident and 
sampling time was not longer than 3 hours. The questionnaire form was filled by hospital 
staff and sent together with a blood sample to TMI Toxicology laboratory.  
 
5.2.3 The transportation and storage of blood samples:  
The blood samples were collected in 6 ml vacuum blood tubes, made by „Vacuette“ firm 
containing sodium fluoride and potassium oxalate, the blood samples were transported at 
4°C to the TMI Toxicology Laboratory for analyses. The blood samples were storage at -
20°C.  
 
5.2.4 Toxicological analysis:  
The toxicological methods regarding the blood sample analyses in the above tasks have 
been set up in the TMI Toxicology laboratory in Vilnius, Lithuania. During the joint 
workshop at LMU (Muenchen, February 18-22, 2008) TMI experts-toxicologists have 
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undergone inter-lab quality control. The TMI Toxicology laboratory has undergone the 
Round Robin test - the proficiency testing.  
 
The methods used for toxicological analysis in TMI Toxicology Laboratory for: 
 
AMPHETAMINES:  
LLE 
1ml whole blood + 1ml H2O + 50μl IS + 200μl 8N NaOH + 5ml 1-chlorobutane. Vortex 1 
min. Organic layer + 1ml 0,2N H2SO4. Vortex 2 min.  
Aqueous layer + 100μl 8N NaOH + 1,2ml 1-chlorbutane. Vortex 2 min.  
Organic layer +100μl tartaric acid in ethylacetate. Evaporate at 40°C, N2 Equipment: 
Caliper Turbo Vap LV 
 
Derivatisation 
+ 50µL ethylacetate + 50μg HFBA. 20min. at 70°C. Equipment: Pierce Reacti-Therm III 
+100μl tartaric acid in ethylacetateat. Evaporate at 40°C, N2 Equipment: Caliper Turbo 
Vap LV  
 Reconstitution:50µL ethylacetate. 
 
IS: 
Amphetamine-D5 Cerilliant, 1mg/mL 1000 ng/mL 
Metamphetamine-D5 Cerilliant, 1mg/mL 1000 ng/mL 
MDA-D5 Cerilliant, 1mg/mL 1000 ng/mL 
MDMA-D5 Cerilliant, 1mg/mL 1000 ng/mL 
MDEA-D5 Cerilliant, 1mg/mL 1000 ng/mL 
 
Chromatographic conditions: 
Chromatographic system: Agilent technologies 7890A 
Column: DB-5ms ( Agilent technologies, ID -0,25 mm, length – 30 m, 5% Phenyl Arylene 
polymer, non-polar) 
Carrier gas: Helium 
Temperature gradient: 100°C(1,0)→20°C/min→200°C→30°C/min→300°C(7) 
Injection: 2μl  
Mass Spec conditions: 
MS system: Agilent technologies 5975C inert XL MSD with Triple Axis Detector; EI 70 V 
 
Compound Rt TIon (m/z) QIon (m/z) 
Amphetamine-D5 (IS) 5.11 244 123 
Amphetamine 5.13 240 91; 118 
Methamphetamine-
D5(IS) 
6.03 258 213 
Methamphetamine 6.06 254 118; 210 
MDA-D5(IS) 7.67 167 268 
MDA 7.69 162 240; 375 
MDMA-D5(IS) 8.25 258 213 
MDMA 8.27 254 162; 210 
MDEA-D5(IS) 8.43 273 408 
MDEA 8.45 268 240; 403 
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COCAINE and OPIATES 
SPE 
 
Columns: mixed mode, Grace 3 ml/200mg Drug-Clean, Alltech Associates 
 
Sample: 
1 ml whole blood + 4 ml H2O + 50 μl IS 
+ 2 ml phosphate buffer pH-6,2 (K2HPO4 x 3H2O) 
 
Column 
conditioning 
3 ml Methanol 
3 ml H2O 
1 ml phosphate buffer pH-6,2 
 
Washing:  2 ml H2O 
2 ml 0,1 N HCl 
3 ml Methanol 
 
Elution: 1 x 3 ml CH2 Cl2/IPA/NH4OH (78:20:2) 
40 ml 2-propanol + 4 ml NH4OH. Mix + 156 ml dichlormethane  
 Evaporate at 40°C, N2 Equipment: Pierce Reacti-Therm III  
 
Derivatisation 
+ 50 μl Ethyl acetate + 40 μl BSTFA. 20min. at 100°C. Equipment: Pierce Reacti-Therm 
III  
 
IS: 
ME-D3 Cerilliant, 0,1mg/mL 1000 ng/mL 
Cocaine-D3 Cerilliant, 1mg/mL 1000 ng/mL 
BE-D Cerilliant, 1mg/mL 10 000 ng/mL 
Codeine-D3 Cerilliant, 1mg/mL 2000 ng/mL 
Morphine-D3 Cerilliant, 1mg/mL 2000 ng/mL 
6MAM-D3 Cerilliant, 1mg/mL 2000 ng/mL 
 
Chromatographic conditions: 
Chromatographic system: Agilent technologies 7890A 
Column: DB-5ms ( Agilent technologies, ID -0,25 mm, length – 30 m, 5% Phenyl Arylene 
polymer, non-polar) 
Carrier gas: Helium 
Temperature gradient (opiates): 150C (3,0) → 10C/min. → 280C (0,0) → 40C/min. → 
300C (8,0) 
Temperature gradient (cocaine): 80C (4,0) → 40C/min. → 240C (6,0) → 30C/min. → 
290C (0,0) 
Injection: 2μl  
 
Mass Spec conditions: 
MS system: Agilent technologies 5975C inert XL MSD with Triple Axis Detector; EI 70 V 
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Compound Rt TIon (m/z) QIon (m/z) 
ME-D3(IS) 6.98 85 185; 274 
ME 6.99 82 182; 271 
Cocaine-D3(IS) 8.87 185 201; 306 
Cocaine 8.88 182 198; 303 
BE-D3(IS) 9.07 243 364 
BE 9.08 240 256; 361 
Codeine-D3(IS) 15.09 374 346 
Diphenhydramine 9.62 58 152; 165 
Tramadol 10.52 58 245; 335 
Methadone 12.37 72 165; 178 
Codeine 15.12 371 234; 343 
Morphine-D3(IS) 15.47 432 417 
Morphine 15.49 429 401; 414 
6-MAM-D3(IS) 16.02 402 343 
6-MAM 16.04 399 287; 340 
Zolpidem 17.9 235 219; 307 
Buprenorphine 23.44 450 482 
 
CANNABINOIDS 
SPE 
Columns: non-polar, Chromabond C8 1 ml/100 mg, Macherey-Nagel Gmbh & Co.  
 
Sample: 
1 ml whole blood + 1 ml IS + 2 ml H2O 
 
Column 
conditioning 
2x1ml Methanol 
2x1ml H2O 
 
Washing:  1ml H2O 
1ml 0.25M acetic acid 
1ml H2O 
 
Elution: 2x1ml Acetone  
 
 Evaporate at 40°C, N2 Equipment: Caliper Turbo Vap LV 
Derivatisation 
+ 150 μl DMSO/TBAH (1ml: 980 μl DMSO/ 20 μl TBAH)  
+ 50 μl Jodmethane, 25-30 min room temperature 
+ 350 μl 0,1 M HCl + 1 ml Isooctane 
Organic layer evaporate at 40°C, N2 Equipment: Caliper Turbo Vap LV 
Reconstitute in 40 μl Ethylacetate  
 
IS: 
THC-D3 Cerilliant, 0,1mg/mL 30 ng/mL 
THC-OH-D3 Cerilliant, 0,1mg/mL 20 ng/mL 
THC-COOH-D3 Cerilliant, 0,1mg/mL 30 ng/mL 
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Chromatographic conditions: 
Chromatographic system: Agilent technologies 7890A 
Column: DB-5ms (Agilent technologies, ID -0,25 mm, length – 30 m, 5% Phenyl Arylene 
polymer, non-polar) 
Carrier gas: Helium 
Temperature gradient: 150C (0,0) → 25C/min. → 280C (9,8) 
Injection: 2μl  
 
Mass Spec conditions: 
MS system: Agilent technologies 5975C inert XL MSD with Triple Axis Detector; EI 70 V 
 
Compound Rt TIon (m/z) QIon (m/z) 
THC-D3(IS) 6.03 316 248; 331 
THC 6.04 328 245; 285 
THC-OH-D3(IS) 6.69 316 260; 361 
THC-OH 6.7 313 257; 358 
THC-COOH-D3(IS) 7.35 316 360; 375 
THC-COOH 7.36 313 357; 372 
 
 
BENZODIAZEPINES 
LLE 
200μl whole blood + 100μl K2HPO4 (PBS pH-9,2) + 300μl organic mix from (n-
Butylacetate and IS Flurazepam 200 ng/mL), 
Vortex 1 min.  
 
Derivatisation 
50μl Upper organic layer transfer to chromatography vials + 10μl (MTBSTFA)Vortex 0,1 
min., 20min. at 90°C. Equipment: Pierce Reacti-Therm III 
IS: 
 Flurazepam  Lipomed 200 ng/mL 
 
Chromatographic conditions: 
GC/NICI-MS system, Agilent 5975C inert XL el/cl MSD GC System  
 Column: Agilent 123-5731 DB-5HT, max. 400 ºC, 30 m, 0,320 mm, 0,1 μm particle size.  
Carrier gas: Helium 
Chemical ionisation gas – methan (purity 5,5) 
Temperature gradient: 180C (0) → 50ºC/min. → 325ºC → (2,0) Run Time- 4,9 min 
Injection: 2μl  
 
Mass Spec conditions: 
Compound  Retention time (min) TIon (m/z) QIon (m/z) 
Flurazepam (IS) 2.57 387 389 
Diazepam 2.05 284 286 
Flunitrazepam 2.32 313 314 
Oxazepam 2.49 268 270 
Lorazepam 2.70 302 304 
Alprazolam 2.84 308 310 
Zopiclone 3.03 143 246 
Nordazepam 2.11 234 384 
7-amino-clonazepam 2.62 249 363 
Clonazepam 2.73 429 431 
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ETHANOL 
IS: 0,1 % 1-propanol 
Chromatographic conditions: 
Chromatographic system: Perkin Elmer Clarus 500 TurboMatrix110 
Column 1: Elite BAC1 ( PE: 0,18x10x1,0) 
Column 1: Elite BAC2 ( PE: 0,18x10x0,63) 
Carrier gas: Helium 
Temperature: 35C  
Injection: 2μl  
 
Controls for: 
Benzodiazepines – Medidrug Benzodiazepine S, level 1 (serum cotrol). Remark: used 
serum control as not produsing the controls in blood. 
 
Other – Medidrug BTMF 2/---B, drugs of abuse, whole blood control with reference 
values.  
Alkohol – Medidrug Ethanol VB-plus, Blood alcohol- Whole blood control (human). C%: 
0,5 g/L; 0,8 g/L ir 1,1 g/L. Folowing concentrations produced: 0,2 g/L ir 4,0 g/L 
 
Validation data see in Annex 1. 
 
5.3 Results 
5.3.1 Substance group distribution 
 
Table 9 presents the general distribution of substance groups. The toxicology results on 
the injured drivers show that 307 (72.41%) drivers were negative for the investigated core 
substances. Only one driver was positive for amphetamines, two for cocaine, one for 
THC and 11 for benzodiazepines. Drug-drug combinations were found in 4 drivers, the 
medicinal opioids and opiodes were found in 24 drivers. 63 (14.86%) injured drivers were 
found positive for alcohol only and 11 (2.59%) drivers for the combination alcohol and 
drugs (see Table 9). 
Table 9. Substance group distribution  
Substances Distribution of injured drivers 
Negative 307 (72.41%) 
Amphetamines 1 (0.24%) 
Cocaine 2 (0.47%) 
THC 1 (0.24%) 
Benzodiazepines 11 (2.59%) 
Drugs-drugs combination 4 (0.94%) 
Medicinal opioids 24 (5.66%) 
Alcohol 63 (14.86%) 
Alcohol+drugs 11 (2.59%) 
Total 424 (100%) 
 
 
5.3.2 Distribution of substance groups by DRUID time periods aggregated into 
day (1-3 & 5-7) vs. night (4&8), week (1-4) vs WE (5-8) 
Table 10 presents the distribution of substance groups by DRUID time periods. The 
lowest percentage of subjects tested negative was found in weekend nights. Alcohol 
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(alone or in combination) was most prevalent in all time periods, there was no large 
difference in prevalence between weekdays (15.5%), weeknights (16.6%) and weekend 
days (18%), while a higher percentage of positive findings for alcohol only was found on 
weekend nights (32%) (see Table 10). No alcohol-drug combination was found in week 
nights. Benzodiazepines and drug-drug combinations were only found during week- and 
weekendday. 
 
Table 10. Distribution of substance groups by druid time periods  
 Weekday Weeknight Weekend day Weekend 
night 
Negative 190 (73.93%) 10 (83.33%) 73 (73%) 13 (52%) 
Amphetamines 1 (0.39%) 0 0 0 
Cocaine 1 (0.39%) 0 0 1 (4%) 
THC 0 (0%) 0 0 1 (4%) 
Benzodiazepines 8 (3.11%) 0 3 (3.0%) 0 
Drugs-drugs combi 3 (1.17%) 0 1 (1%) 0 
Medicinal opioids  14 (5.45%) 0 5 (5%) 2 (8%) 
Alcohol 34(13.2%) 2 (16.6%) 15 (15%) 7 (28%) 
Alcohol+drugs  6 (2.33%) 0 3 (3%) 1 (4%) 
Total 257 (100%) 12 (100%) 100 (100%) 25 (100%) 
 
 
5.3.3 Distribution of substance groups by gender and age 
The distribution of substance groups by gender and age was shown in Table 11(Male) 
and Table 12 (Female).  
In the male subpopulation the highest percentage of drivers tested positive for alcohol 
was found in the age group 18-24 (22.08%). The combination alcohol-drug was found 
most in the age group 35-49 (4.29% and 7.32% for resp male and female).   
In male drivers the medicinal opioids were most prevalent in the age group 50+ (13.95%) 
followed by the group 18-24 ( 10.4%), while in female drivers medicinal opioids were only 
found in the age groups 25-34 (2.38%) and 35-49 (4.88%).  
In the male subpopulation the highest percentage of positive findings for benzodiazepines 
was observed in the age group 50+ (6.98%), in female group the highest percentage was 
found in  the age group 25-34 (4.76%). For the other illicit substances only male subjects 
had tested positive. (see Tables 11 and 12).  
 
Table 11. Distribution of substance groups by gender and age (Male) 
 18-24 25-34 35-49 50+ 
Negative 50 (64.94%) 46 (70.77%) 49 (70.0%) 28 (65.12%) 
Amphetamines 0 0 1 (1.43%) 0 
Cocaine 0 1 (1.54%) 0 1 (2.33%) 
THC 0 0 1 (1.43%) 0 
Benzodiazepines 1 (1.30%) 2 (3.08%) 1 (1.43%) 3 (6.98%) 
Drugs-drugs combi 0 2 (3.08%) 1 (1.43%) 0 
Medicinal opioids  8 (10.40%) 3 (4.62%) 3 (4.29%) 6 (13.95%) 
Alcohol 17 (22.08%) 9 (13.85%) 11 (15.71%) 5 (11.63%) 
Alcohol+drugs  1 (1.30%) 2 (3.08%) 3 (4.29%) 0 
Total 77 (100%) 65 (100%) 70 (100%) 43 (100%) 
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Table 12. Distribution of substance groups by gender and age (Female) 
 18-24 25-34 35-49 50+ 
Negative 29 (76.32%) 34 (80.95%) 29 (70.73%) 15 (100%) 
Amphetamines 0 0 0 0 
Cocaine 0 0 0 0 
THC 0 0 0 0 
Benzodiazepines 1 (2.63%) 2 (4.76%) 0 0 
Drugs-drugs combi 0 0 0 0 
Medicinal opioids and 
opioids 
0 1 (2.38%) 2 (4.88%) 0 
Alcohol 8 (21.05%) 4 (9.52%) 7 (17.07%) 0 
Alcohol+drugs  0 1 (2.38%) 3 (7.32%) 0 
Total 38 (100%) 42 (100%) 41 (100%) 15 (100%) 
 
 
5.3.4 Distribution of substance groups by accident type 
Table 13 presents the distribution of substance groups by single-vehicle and multi-part 
accidents. No significant diference was found in prevalence of benzodiazepines, 
medicinal opioids and alcohol-drug combination. More positive findings for alcohol were 
observed in drivers involved in single-vehicle accidents. Amphetamines and cocaine were 
only found in drivers involved in multi-part collisions, while cocaine only in single-vehicle 
accidents. It has to be noted that these last three substances were each found positive in 
only one case. (see Table 13).  
 
Table 13. Distribution of substance groups by single-vehicle accidents vs multipart 
accidents 
 Single-vehicle Multi-part 
Negative 87 (66.92%) 209 (74.91%) 
Amphetamines 0  1 (0.36%) 
Cocaine 1 (0.77%) 0 
THC 0 1 (0.36%) 
Benzodiazepines 4 (3.08%) 7 (2.51%) 
Drugs-drugs combi 0 4 (1.43%) 
Medicinal opioids and opioids 6 (4.62%) 17 (6.09%) 
Alcohol 28 (21.54%) 33 (11.83%) 
Alcohol+drugs  4 (3.08%) 7 (2.51%) 
Total 130 (100%) 279 (100%) 
 
 
5.3.5 Results for additional substances: 
In Lithuania, the following additional substances were detected in the collected blood 
samples: Tramadol – 13, Metamizol (NSAID) – 3, Midazolam (BZD) – 1, 
Diphenhydramine (AHD) – 1, Ketolgan (NSAID) – 1. 
Table 14. Additional substances in injured drivers 
Substances present  No. of cases 
Tramadol 13 
Metamizol (NSAID) 3 
Midazolam (BZD) 1 
Diphenhydramine (AHD) 1 
Ketolgan (NSAID) 1 
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5.3.6 Distribution of substance concentrations 
The range of concentration level for core DRUID substances found during the hospital 
survey in Lithuania are shown in table 15. The range level of ethanol was from 0.11 till 
3.26 g/L (see Table 15). 
 
Table 15. Distribution of substance concentrations  
Substance  Whole blood 
analytical cut-off 
(ng/mL) 
Number of 
cases 
Range of level 
(ng/mL) 
Ethanol  0.1 g/L 74 0.11-3.26 
6-acetylmorphine  10 0 - 
Alprazolam  10 1 0-54 
Amphetamine  20 2 20-42 
Benzoylecgonine  50 2 570-882 
Clonazepam  10 6 26-145 
Cocaine  10 1 0-20 
Codeine  10 1 0-24 
Diazepam  20 16 11-547 
Flunitrazepam  2 0 - 
Lorazepam  10 1 0-23 
MDA  20 0 - 
MDEA  20 0 - 
MDMA  20 0 - 
Methadone  10 1 0-152 
Methamphetamine  20 2 160-240 
Morphine  10 20 11-898 
Nordiazepam  20 8 18-144 
Oxazepam  50 0 - 
THC  1 2 1.92-2.26 
THCCOOH  5 4 6.5-72 
Zolpidem  20 0 - 
Zopiclone  10 1 0-29 
 
 
5.4 Discussion of results 
All Lithuanian hospital survey samples were collected in Vilnius, Kaunas, Klaipeda and 
Alytus research regions, which were the main sample collection research areas in the 
roadside survey. National data were collected from 1stof April 2008 until 20th of March 
2010 to assess the situation in the country regarding the prevalence of alcohol and other 
psychoactive substances in accident involved drivers. The research areas of Lithuania 
were based on the geographical distribution of population over the country, accounting for 
3,350 mln. inhabitants in total. The data were available on the injured drivers distribution 
by the type of vehicle, the quarter of the year, gender, age. The hospital survey area 
covers the whole of Lithuania and the representativeness of the sample is good since all 
injured drivers were included. During the survey period the total number of injured drivers 
involved in the hospital study was 424 drivers. The total number of collected blood 
samples and investigated in TMI Toxicology laboratory were 424. All data collected from 
the injured drivers and the toxicology analyses data were filled in a database and the 
database was sent to DTU and UGent on the 10th of May 2010. During the hospital study 
there was no one non-response or refuse. The response rate (RR) was 100%. 
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During the hospital survey in Lithuania most of the injured drivers were from urban road 
type – 98% and from Kaunas research region – 84 % which is in urban area of Lithuania 
in cross connection with main urban roads. The larger number of injured drivers was in 
the daytime hours which caused by the much higher traffic volumes during day time 
hours than during the night time. No big difference was found in the distribution of injured 
drivers by quarters. The majority of the injured drivers – 94 % had a MAIS 3. In the male 
group the number of injured drivers was higher than in the female group, no big 
significant difference found in distribution by age groups both in males and females from 
age 18 till age 50. The higher percentage of injured drivers was in personal car drivers 
group – 85 %, most of the injured drivers had a multi-part accident. 
 
The toxicology results of the injured drivers show that 307 (72.41%) drivers were negative 
for investigated DRUID core substances. Only one driver was positive for amphetamine, 
two drivers were positive for cocaine, one driver was positive for THC, 11 drivers were 
positive for benzodiazepines. The drugs-drugs combination was found in 4 drivers, the 
medicinal opioids and opiodes was found in 24 drivers.  
 
At last 63 (14.86%) injured drivers were positive for alcohol and 11 (2.59%) drivers for the 
combination alcohol and drugs. The highest substance prevalence in injured drivers was 
found in weekend night period. Alcohol was prevalent in all time periods. the highest 
percentage of drivers tested positive for alcohol was found in the male age group 18-24. 
The combination alcohol-drug was found most in the age group 35-49 for both gender. 
The range level of ethanol was from 0.11 till 3.26 ng/mL. In male drivers the medicinal 
opioids were most prevalent in the age group 50+ followed by the group 18-24 while in 
female drivers this substance group was only found in the age groups 25-34 and 35-49. 
In the male subpopulation the highest percentage of positive findings for benzodiazepines 
was observed in the age group 50+, in the female group this percentage was found in  
the age group 25-34. Only injured male drivers were positive for other illicit drugs. No 
significant diference was found in prevalence of benzodiazepines, medicinal opioids and 
alcohol-drug combination. More positive findings for alcohol were observed in drivers 
involved in single-vehicle accidents. 
 
5.5 Acknowledgements 
The hospital study in Lithuania was carried out in close cooperation with the 
administration and medical staff of the main hospitals in the following research areas of 
Lithuania – in Vilnius, Kaunas, Klaipeda and Alytus. The authors are grateful to the 
hospital staff and executive personnel for their dedication to make the survey a success. 
Besides we want to express our gratitude for the TMI Toxicology Laboratory staff was the 
collected blood samples were analysed. 
 
5.6 References 
1. Mass Spectral and GC Data of Drugs, Poisons, Pesticides, Pollutants and Their 
Metabolites, K.Pfleger, H.H.Maurer, A.Weber, Second revised and enlarged 
edition, part 1, 1992. 
2. Recommended methods for the detection and assay of heroin, cannabinoids, 
cocaine, amphetamine, methamphetamine and ring-substituted amphetamine 
derivatives in biological specimens (United Nations, 1995). 
3. „No Vacuum“ Gravity Series GV-65 Method for the Analysis of Amphetamine, 
Methamphetamine, 3,4-Methylenedioxyamphetamine (MDA), 3,4-
Methylenedioxymethamphetamine (MDMA), 3,4-
Methylenedioxyethylamphetamine (MDEA) in oral fluid, serum or urine by 
GC/MS. Biochemical Diagnostics, Inc., revised: April 2004 . 
 DRUID 6th Framework Programme Deliverable D.2.2.5  
Part 2 – Country Reports from hospital studies - Country Report Lithuania 
Prevalence of alcohol and other psychoactive substances in injured and killed drivers. 
 
 Page 285 of 349 
4. Extraction Methods Guide for Mixed-Mode Drug-CleanTM SPE, Alltech 
Associates, Inc., 2003. 
5. Solid Phase Extraction Application Guide, Macherey-Nagel. 
6. Fast gas chromatography–negative-ion chemical ionisation mass spectrometry 
with microscale volume sample preparation for the determination of 
benzodiazepines and a-hydroxy metabolites, zaleplon and zopiclone in whole 
blood, Teemu Gunnar, Kari Ariniemi and Pirjo Lillsunde, Journal of Mass 
Spectrometry, J. Mass Spectrom. 2006; 41: 741–754, Published online 27 April 
2006 in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/jms.1030 
 
 DRUID 6th Framework Programme Deliverable D.2.2.5  
Part 2 – Country Reports from hospital studies - Country Report Lithuania 
Prevalence of alcohol and other psychoactive substances in injured and killed drivers. 
 
 Page 286 of 349 
 
5.7 Annex 1 
Validation data 
 (reproducibility) 
Compound Calibration points, ng/mL Avg. ng/mL RSD, % Bias, % LOD, 
ng/mL 
LOQ, 
ng/mL 
Diazepam 0;10;20;30;50;70;100;120 10.34 /49.7/ 101.11 10.83 /4.67/ 
4.48 
3.4 /-0.6/ 
1.11 
1.4 4.2 
Flunitrazepam 0;10;20;30;50;70;100;120 11.8 /49.26/ 103.4 9.92 /10.90/ 
4.46 
18 /-1.5/ 
3.4 
1.2 3.6 
Oxazepam 0;10;20;30;50;70;100;120 10.93 /51.3/ 102.22 14.36 /5.54/ 
7.15 
9.3 /2.6/ 
2.22 
3.2 9.8 
Lorazepam 0;10;20;30;50;70;100;120 11.73 /50.4/ 102.91 14.66 /7.90/ 
9.37 
17.3 /0.8/ 
2.91 
2.3 7.0 
Alprazolam 0;10;20;30;50;70;100;120 12.38 /51.64/ 102.67 5.25 /4.45/ 5.07 23.8 /3.3/ 
2.67 
2.6 7.9 
Zopiclone 0;10;20;30;50;70;100;120 - /49.16/ 104.19 - /16.97/ 18.47 - /-1.7/ 
4.19 
6.1 18.4 
Nordazepam 0;10;20;30;50;70;100;120 9.32 /49.65/ 103.31 13.63 /9.73/ 
10.75 
-6.8 /-0.7/ 
3.31 
1.8 5.5 
7-amino-
clonazepam 
0;10;20;30;50;70;100;120 12.85 /51.8/ 95.43 22.18 /8.55/ 
8.79 
28.5 /3.6/ -
4.57 
3.8 11.4 
Clonazepam 0;10;20;30;50;70;100;120 11.87 /52.89/ 101.52 15.25 /7.83/ 
11.14 
18.7 /5.8/ 
1.52 
1.7 5.0 
Amphetamine 0;20;50;100;150;200;250;300 23.60/143.07/288.13 14.58/2.40/1.92 18/-5/-4 4.2 12.7 
Methamphetamine 0;20;50;100;150;200;250;300 21.93/139.26/289.14 7.48/4.72/4.05 10/-7/-4 5.24 15.9 
MDA 0;20;50;100;150;200;250;300 20.44/141.32/285.23 10.71/2.05/6.25 2/-6/-5 2.65 8.02 
MDMA 0;20;50;100;150;200;250;300 21.63/133.58/277.62 3.24/1.91/1.61 8/-11/-7 2.33 7.1 
MDEA 0;20;50;100;150;200;250;300 22.68/136.7/280.33 1.59/2.44/1.5 13/-9/-7 1.78 5.39 
THC 0;2;4;6;8;10;12;14 -/9.58/14.58 -/3.44/2.47 19.75/4.1 0.84 2.54 
THC-OH 0;2;4;6;8;10;12;14 2.08/8.61/13.70 4.33/3.14/14.45 4/7.63/-
2.14 
0.52 1.56 
THC-COOH 0;10;20;30;40;50;60;70 11.04/46.06/63.55 5.34/3.34/10.95 10.4/15.5/-
9.21 
2.39 7.15 
ME 0;10;20;30;40;50;60;70 -/35.93/59.18 -/6.74/14.26 -/-10.17/-
15.46 
4.56 13.82 
Cocaine 0;10;20;30;40;50;60;70 10.42/39.2/69.92 9.69/4.69/3.7 4.2/-2/-
0.11 
3.71 11.25 
BE 0;50;100;150;200;250;300;350 50.24/184.46/326.3 4.48/6.3/3.85 0.48/-
7.77/-6.77 
7.95 24.08 
Diphenhydramine 0;10;25;50;100;150;200;250 112.87/221.77 11.32/21.31 12.87/-
11.29 
7.11 21.55 
Tramadol 0;10;25;50;100;150;200;250 94.92/193.81 9.17/6.28 -5.08/-
22.48 
3.95 11.98 
Methadone 0;10;25;50;100;150;200;250 8.94/96.86/198.04 14.32/2.97/8.12 -10.6/-
3.14/-
20.78 
3.21 9.72 
Codeine 0;10;25;50;100;150;200;250 10.79/99.36/251/83 1.76/2.21/3.37 7.9/-
0.64/0.73 
1.8 5.44 
Morphine 0;10;25;50;100;150;200;250 -/104.9/217.17 -/12.4/3.58 -/4.9/-
13.13 
5.01 15.18 
6MAM 0;10;25;50;100;150;200;250 10.94/95.14/248.02 4.94/1.32/3.12 9.4/-
4.86/0.79 
2.78 8.42 
Buprenorphine 0;10;25;50;100;150;200;250 87/7/266.05 13.61/5.59 -12.3/6.42 5.22 15.82 
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6 Country Report the Netherlands  
 
Authors 
Sjoerd Houwing, Maura Houtenbos , René Mathijssen, Beitske Smink² the Netherlands 
(SWOV Institute for Road Safety Research, ²Netherlands Forensic Institute (NFI) - the 
Netherlands) 
 
6.1 Introduction 
The hospital survey in the Netherlands was performed according to the DRUID 
"Guidelines for Hospital surveys" (see Annex 1 of the Summary Report), with some minor 
deviations which will be highlighted in the following paragraphs.  
 
The first objective of the hospital survey was to gain insight into the prevalence of 
psychoactive substances among injured drivers in the Netherlands. A second objective 
was to collect case data for a case-control study aimed at assessing the risk of driving 
under the influence of psychoactive substances. 
 
 
6.2 Geographical distribution 
Hospitals in the cities of Enschede, Nijmegen and Tilburg participated in the DRUID case-
control study and collected accident and demographic data plus blood samples from 
seriously injured drivers who were admitted to the hospitals' Emergency Departments.  
 
Figure 1 presents the geographical location of the three hospitals that participated. 
 
Figure 1. Participating hospitals and surrounding research areas of the roadside survey in 
the Netherlands 
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6.3 Distribution of the injured drivers 
6.3.1 Distribution by time period 
Approximately 60% of all included patients were injured during daytime hours (4 AM-
10PM). The high proportion of injured drivers during daytime hours can be explained by 
the traffic volumes that are much higher during daytime hours than during night time 
hours. 
 
Table 1. Distribution injured drivers by time period (n=186). 
Time period  
Weekday 04:00-22:00 48.4% 
Weeknight 22:00-04:00 24.7% 
Weekend day 04:00-22:00 11.8% 
Weekend night 22:00-04:00 15.1% 
 
6.3.2 Distribution by quarter of the year 
During the 3rd quarter of the year the proportion of injured drivers is lower (although not 
significant, p = 0.30) than during the other three quarters. This lower proportion coincides 
with the summer holiday period, when traffic volumes are significantly reduced.  
Table 2. Distribution of injured drivers by quarter of the year (n=186). 
Quarter of the year  
1st quarter (Jan-Mar) 28.0% 
2nd quarter (Apr-Jun) 24.7% 
3rd quarter (Jul-Sep) 19.3% 
4th quarter (Okt-Dec) 28.0% 
 
6.3.3 Distribution by road type 
In the Netherlands, the road type where accidents happened could not reliably be 
recorded. 
 
6.3.4 Distribution by injury severity 
The Maximum Abbreviated Injury Scale (MAIS) was used to classify the severity of injury. 
Injured drivers with a MAIS of 2 or higher were included. 
 
Almost half of the included drivers had a MAIS 2 injury score. The percentage of drivers 
decreased with increasing MAIS: 35.7% of the injured drivers had MAIS 3; 8.7% had 
MAIS 4; and finally, 7.0% had MAIS 5. Killed drivers were not included in this study.   
Table 3. Distribution of injured drivers by MAIS scale (n=185); missing data for 1 driver. 
MAIS  
MAIS 2 48.6% 
MAIS 3 35.7% 
MAIS 4 8.7% 
MAIS 5 7.0% 
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6.3.5 Distribution by gender and age 
80% of the injured drivers were males. The percentage of males was the highest among 
the age group 18-24 years (89.6%). Among the other age groups the percentage of 
males varied between 75% and 77%. The number of injured drivers was higher in the age 
groups 18-24 and 25-34, which account for 56.6% of the sample. In the older age groups 
the percentage decreased to 24.5% and 18.9%, respectively.  
 
Table 4. Distribution of injured drivers by gender and age (n=186). 
 Male Female Total 
18-24 years old 90.9% 9.1% 29.6% 
25-34 years old 76.5% 23.5% 27.4% 
35-49 years old 75.6% 24.4% 24.2% 
50 years and older 74.3% 25.7% 18.8% 
Total ages 80.1% 19.9% 100% 
 
6.3.6 Distribution by seatbelt use 
Seatbelt use was not recorded in 44 cases. Among the remaining 142 injured drivers 
more than a quarter did not wear a seatbelt.  
 
Table 5. Distribution of injured drivers by seatbelt use (n=142); missing data for 44 drivers. 
Seatbelt use  
Seatbelt used 73.9% 
Seatbelt not used 26.1% 
 
6.3.7 Distribution by hospital region 
Most of the drivers included in this study were sampled at Tilburg St. Elizabeth hospital. 
This could be expected since in this hospital the inclusion period had been longer than in 
the other two hospitals. Almost a third were from Enschede Medisch Spectrum hospital, 
and a quarter from Nijmegen University hospital.  
 
Table 6. Distribution of injured drivers by hospital region (n=186). 
Hospital  
Tilburg 42.5% 
Enschede 33.3% 
Nijmegen 24.2% 
 
6.3.8 Distribution by type of crash 
Information on type of crash was available for 168 injured drivers. Of these, almost 
twothird were involved in a single-vehicle crash.  
Table 7. Distribution of injured drivers by type of crash (n=160); missing data for 26 drivers. 
Type of crash  
Single-vehicle crash 63.1% 
Multi-vehicle crash 36.9% 
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6.4 Methods 
6.4.1 Ethical approval 
Before the hospital survey started, the study protocol was submitted for approval to the 
ethical commissions of six hospitals that were invited to participate in the DRUID case-
control study. Approval was granted in only three hospitals. Due to the long process for 
approval, the inclusion of cases could only start at the end of 2007.  
 
6.4.2 Toxicological analysis of body fluids 
Chemicals 
Drugs of abuse and deuterated analogues were purchased from Cerilliant Corporation 
(Texas). Methanol, acetonitrile, water and formic acid (99%) were obtained in ULC/MS 
grade from Biosolve. Ammonium hydrogen carbonate and ammonia (25 %) were 
obtained in analytical grade from Merck. Acetone was obtained in picograde from 
Promochem.  
 
Blood and plasma samples 
 
Two venous blood samples were collected from each injured car driver, using glass tubes 
containing 20 mg sodium fluoride and 143 IU heparin sodium (BD Plymouth, UK). From 
one out of each pair of blood samples plasma was prepared by means of a centrifuge.  
 
During the hospital survey, blood samples were stored in solid carbon dioxide at about -
80˚C (dry ice). After transportation to the Netherlands Forensic Institute (NFI) in The 
Hague, blood samples were stored at -20˚C until analysis. 
 
Sample preparation 
 
Protein precipitation was performed after addition of deuterated analogs of the target 
compounds, by addition of acetone (0.75 ml) to the blood sample (0.25 ml), followed by 
centrifugation.  
 
Analytical conditions 
 
LCMS analysis was performed on a Water Acquity UPLC®-system with a Waters Quatro 
premier XE triple quadrupole mass spectrometer. Chromatography employed a reversed-
phase UPLC ® column (BEH C-18, 100 x 2.1-mm i.d., 1.7 µm particle diameter) and a 
17-min gradient elution (methanol / 10 mM ammonium bicarbonate pH 10.0, 5/95 to 
95/5). The UPLC® injector was modified for on-line dilution of the injected sample to 
allow large injection volumes of acetone. The eluent was introduced to the electrospray 
source of the triple quadrupole MS instrument at a flow-rate of 500 μL/min. Molecular ions 
were fragmented using optimised collision-induced dissociation voltages for each 
compound (9 to 50 eV, positive ion mode). For each target-compound two MRM were 
monitored and for each deuterated internal standard one MRM was monitored. 
 
Quality Control 
The following Quality Control measures were taken: 
− Internal standards (deuterated analogues of most target compounds) were used 
to correct for analytical variations. 
− Calibration of all compounds in blood was performed every 2 months.  
− Blank blood samples and control samples (spiked blood samples, prepared at the 
NFI as well as externally) were analysed daily. 
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− Shewhart cards were used for a selected number of compounds to monitor the 
daily performance.  
− Regular participation took place in Round Robin tests. 
 
Validation 
The analytical method was fully validated for all compounds in blood. Validation included 
determination of linearity, accuracy, reproducibility, limit of detection (LOD) and stability. 
Validation of the analytical method was performed on blood samples obtained during a 
roadside survey (50 %) as well as on postmortem blood obtained during autopsies at the 
NFI (50 %), and obtained results were averaged. 
 
Internal standards and analytical data are shown in Annex 1. Validation results are 
summarised in Annex 2. 
 
Selectivity  
The majority of compounds were separated chromatographically from each other during 
the LC run. Selectivity was assured by utilising a triple quadrupole system in MS/MS 
mode, in which single chromatographic peaks were observed for all SRM (Selective Ion 
Monitoring) transitions. Analytical data are collected in annex Table 1. No interfering 
compounds were present in blank blood.  
 
Calibration 
Calibration curves were prepared on eight concentration levels, numbered A to H. The 
calibration ranges are shown in Annex 2. The highest concentration level (A) was chosen 
on the basis of therapeutic and toxic concentrations in blood. The other concentrations 
were 50, 20, 10, 5, 2.5, 1 and 0.5 % of the highest concentration level for B to H, 
respectively.  
 
Curves were created by plotting the peak area ratio of the drug to the internal standard 
versus the drug concentration. Most compounds were fitted linearly (weighing factor 1/x2), 
whereas six compounds were fitted quadratic as indicated in Annex 2. Correlation 
coefficients were > 0.99 for most compounds.  
 
Recovery 
The recovery was determined for each compound in blood on four concentration levels by 
comparing the response to that of standards in methanol. For most compounds, the 
recovery was around 100 % (data not shown).  
 
Precision 
The within-day precision was determined on concentration levels B and F by repeated 
analysis (n=8). All compounds showed a within-day precision of < 20 %.  
 
Reproducibility 
The between-day reproducibility was determined on concentration levels B and F by 
analysis on different days. In annex Table 2 results are shown on concentration level F 
for blood (n=8). Most compounds showed a reproducibility of < 20 %. The exception was 
aminonitrazepam in blood (25 %).  
 
Accuracy  
The accuracy for blood was determined using the average values obtained during the 
within-day precision experiments (n=8). For all compounds, the accuracy was in the 
range of 80-120 % on level B and F (see annex, Table 2 for results on level F), 
desmethylclobazam (74%) and flurazepam (78%) on level F excepted.  
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Limit of Detection and Limit of Quantification  
The limit of detection (LOD) was defined as the lowest concentration for which the signal-
to-noise ratio (S/N) was three for the main SRM. For this purpose, the lowest calibration 
sample (H) was diluted up to 1000 times and analysed. The results are shown in Annex 
2. It should be taken in consideration that various factors may affect the LOD values, 
such as the recovery after precipitation, matrix suppression and LCMS system 
performance which may vary per analysis or series. Therefore, the reported LOD values 
should be regarded as indicative. 
The lowest concentration of the calibration curves was considered as the limit of 
quantification (LOQ). Almost without exception the limit of quantitation (LOQ) for each 
analyte was equal to, or below, the DRUID cut offs. The only exception was codeine, 
however the limit of detection was still lower than the DRUID cut off. 
 
Stability 
The stability of all compounds was studied in methanol, precipitates (of blood), blood and 
oral fluid at different temperatures up to 8 weeks A compound was considered unstable if 
the concentration deviated more than 30 % from the initial concentration.  
 
In methanol, all compounds were stable at -20 °C during 8 weeks on all concentration 
levels. However, chlordiazepoxide, desmethylchlordiazepoxide and demoxepam degrade 
after regular use. This is probably due to repeated exposure to light and room 
temperature.  
 
The stability of precipitates of blood was determined during 8 weeks on two concentration 
levels (B and F) to investigate if samples could be re-run in case of failed analysis. For 
this purpose, precipitates were analysed on 7 days (day 0, 2, 4, 9, 16, 28 and 56). 
Samples were kept in the auto-sampler during 24 h at 10 °C and then stored at -20 °C. A 
control sample was stored at -20 °C on day 0 and analysed on day 56. 
 
All compounds were stable during re-analyses during 4 weeks and most compounds up 
to 8 weeks. After 8 weeks, zoplicone was degraded (30 % left), whereas 
benzoylecgonine and aminonitrazepam showed an increase in signal. This may be 
explained by evaporation, which is insufficiently corrected for by the internal standard.  
Stability results are summarised in Annex 3. The stability of spiked blood samples was 
studied on two concentration levels (B and F) during 8 weeks at -20 °C, during 1 month at 
4-8 °C and during 1 week at 20 °C.  
 
At -20 °C, all compounds were stable in blood during 8 weeks. At higher temperature, 
some compounds were unstable and started to degrade. It should be kept in mind during 
data interpretation that concentrations of the unstable compounds THC, THC-OH, 
zopiclone and desmethylchlordiazepoxide may have been higher at the moment of blood 
sampling than at the moment of analysis. 
 
 
6.4.3 Method of BAC-quantification 
Blood alcohol concentrations were determined by the NFI by using the enzymatic "alcohol 
dehydrogenase" method, after vapour micro-diffusion (Neuteboom et al., 1980). 
 
6.4.4 Other collected data 
Apart from the blood sampling, additional information was gathered for each subject on: 
gender, age, self-reported drug use, type of vehicle, crash type, injury severity, time of 
the accident, and administered medicinal drugs. 
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6.4.5 Statistical analysis 
Descriptive statistics were used to calculate prevalence figures of psychoactive 
substances for the injured drivers. 
 
 
6.5 Non-response 
In the Netherlands, the ethical commissions did not require informed consent by the 
patients, since blood specimens had to be collected anonymously and no extra medical 
acts were needed for it. Consequently, the risk of selection bias caused by refusing 
patients was non-existent. It is possible, however, that drug and alcohol intoxicated 
patients were less likely to be blood sampled than sober patients, e.g., because of 
aggressive behaviour or because of their entrance in the Emergency Departments during 
peak hours. Unfortunately, no information on this kind of non-response could be retrieved 
by the medical staff of the Emergency Departments. 
 
 
6.6 Results 
6.6.1 Substance group distribution + substance classes (alcohol, illicit and 
medicinal drugs) 
 
Tables 8 and 9 show the overall substance class and substance group distribution. 
Approximately one third of the drivers were positive for one or more substances. Alcohol 
alone is the most prevalent having been detected in 25 per cent of the drivers and 4.3% 
of the samples was positive for alcohol in combination with other psychoactive 
substances. Only one drug-drug combination was detected among the injured drivers. 
Cocaine, illicit opiates and benzodiazepines have not been detected among the 186 
included drivers, although the benzoylecgonine (a metabolite of cocaine) was detected 
three times: twice as a single drug and one time in combination with THC-COOH, which 
is a metabolite of THC. One driver among the excluded samples was positive for 
benzodiazepines. However, this record was excluded since the time between accident 
and blood sampling was 3 hours. 
 
Table 8. Distribution of substance classes (n=186).  
Substance class Number of drivers Proportion of drivers 
Negative 123 66.1% 
Alcohol 47 25.3% 
Illicit drugs 5 2.7% 
Medicinal drugs 2 1.1% 
Drug-alcohol combination 8 4.3% 
Drug-drug combination 1 0.5% 
Total 186 100.00% 
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Table 9. Distribution of substance groups. 
Type Substance group Number of 
drivers 
Proportion of drivers
 Negative 123 66.1% 
Alcohol Alcohol 47 25.3% 
Illicit drugs Amphetamines 2 1.1% 
 Benzoylegonine  2 1.1% 
 Cocaine -- -- 
 THC 1 0.5% 
 Illicit opiates -- -- 
Medicinal drugs Benzodiazepines -- -- 
 Z-drugs 1 0.5% 
 Opiates and opioids 1 0.5% 
Combinations Drug-alcohol combination 8 4.3% 
 Drug-drug combination 1 0.5% 
Total  186 100.00% 
 
6.6.2 Distribution of substance groups by DRUID time periods aggregated into 
day (1-3 & 5-7) vs night (4&8), week (1-4) vs WE (5-8) 
The distribution of substance classes by time period shows that substance prevalence in 
injured drivers was lowest on weekdays during daytime hours (04 AM -10 PM) with 
around 20% positive drivers. For the other time periods the prevalence of alcohol and 
drugs was double during weeknights and weekend days. In weekend nights the 
prevalence was even triple (62%) as compared to weekdays.  
Alcohol was most prevalent in all time periods, but there was no large difference in 
prevalence between weekdays (34.8%), weekend days (40.9%) and weekend nights 
(39.3%) (p = 0.97).  
Single drug prevalence was highest in weekend nights. Cocaine was most prevalent 
among injured drivers in the weekend both during daytime and night time hours. The 
number of samples is very low though. Therefore, these results should be taken very 
cautiously.   
Table 10. Distribution of substance classes by time period. 
Type Substance class Weekday 
(n=90) 
Weeknight
(n=46) 
Weekend 
day 
(n=22) 
Weekend 
night 
(n=28) 
 Negative 81.1% 58.7% 54.6% 39.3% 
Alcohol Alcohol 12.2% 34.8% 40.9% 39.3% 
Illicit drugs Amphetamines 1.1% -- -- 3.6% 
 Benzoylegonine  1.1% -- 4.6% -- 
 Cocaine -- -- -- -- 
 THC -- -- -- 3.6% 
 Illicit Opiates -- -- -- -- 
Medicinal drugs Benzodiazepines -- -- -- -- 
 Z-drugs 1.1% -- -- -- 
 Opiates and opioids 1.1% -- -- -- 
Combinations Drug-alcohol combi 2.2% 6.5% -- 10.7% 
 Drug-drug combi -- -- -- 3.6% 
Total  100.00% 100.00% 100.00% 100.00% 
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6.6.3 Distribution of substance groups by gender and age 
The prevalence of psychoactive substances in total differs significantly over the four age 
classes among male drivers (p = 0.03). Alcohol and illicit drugs were most prevalent 
among seriously injured male drivers between 25 and 35 years old. The combination of 
drugs and alcohol was most prevalent among seriously injured drivers younger than 35.  
Medicinal drugs was only detected among male injured drivers aged 35 and older. The 
number of samples is very low and any disaggregated results should be dealed with care.   
 
Table 11. Distribution of substance classes by age for male drivers. 
Type Substance class 18-24 
years 
(n=50) 
25-34 
years 
(n=39) 
35-49 
years 
(n=34) 
≥50 
years 
(n=26) 
 Negative 68.0% 41.0% 64.7% 73.1% 
Alcohol Alcohol 26.0% 41.0% 26.5% 23.1% 
Illicit drugs Amphetamines -- 2.6% -- -- 
 Benzoylegonine  -- 2.6% 5.9% -- 
 Cocaine -- -- -- -- 
 THC -- 2.6% -- -- 
 Illicit Opiates -- -- -- -- 
Medicinal drugs Benzodiazepines -- -- -- -- 
 Z-drugs -- -- -- 3.9% 
 Opiates and opioids -- -- 2.9% -- 
Combinations Drug-alcohol combi 6.0% 10.3% -- -- 
 Drug-drug combi -- 2.6% -- -- 
Total  100.00% 100.00% 100.00% 100.00% 
 
For female injured drivers alcohol was only present from 25 years and over. Among the 
five young female injured drivers (18-24 years) no psychoactive substances were 
detected. Only women in the age group 25-34 were positive for illicit drugs. One woman 
was positive for amphetamines and one was positive for the combination cocaine-alcohol. 
The number of injured females per age group was very low, so none of the findings were 
significant. 
 
Table 12. Distribution of substance classes by age for female drivers. 
Type Substance class 18-24 
years 
(n=5) 
25-34 
years 
(n=12) 
35-49 
years 
(n=11) 
≥50 
years 
(n=9) 
 Negative 100.0% 75.0% 90.9% 88.9% 
Alcohol Alcohol -- 8.33% 9.1% 11.1% 
Illicit drugs Amphetamines -- 8.33% -- -- 
 Benzoylegonine  -- -- -- -- 
 Cocaine -- -- -- -- 
 THC -- -- -- -- 
 Illicit Opiates -- -- -- -- 
Medicinal drugs Benzodiazepines -- -- -- -- 
 Z-drugs -- -- -- -- 
 Opiates and opioids -- -- -- -- 
Combinations Drug-alcohol combi -- 8.33% -- -- 
 Drug-drug combi -- -- -- -- 
Total  100.00% 100.00% 100.00% 100.00% 
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6.6.4 Distribution of substance groups by accident type 
Table 13 shows the distribution of substance classes by accident type. Psychoactive 
substances were significantly (p = 0.003) more prevalent in single-vehicle accidents than 
in multi-vehicle accidents.  This is in line with other findings in literature (Gjerde et al., 
1993; Hasselberg & Laflamme, 2009) 
  
Table 13. Distribution of substance classes by accident type (missing data for 26 drivers). 
Type Substance class Single-vehicle 
accident 
(n=101) 
Multi-vehicle 
accident 
(n=59) 
 Negative 62.4% 84.8% 
Alcohol Alcohol 29.7% 8.5% 
Illicit drugs Amphetamines -- 1.7% 
 Benzoylegonine  1.0% 1.7% 
 Cocaine -- -- 
 THC 1.0% -- 
 Illicit Opiates -- -- 
Medicinal drugs Benzodiazepines -- -- 
 Z-drugs -- 1.7% 
 Opiates and opioids -- 1.7% 
Combinations Drug-alcohol combination 5.0% -- 
 Drug-drug combination 1.0% -- 
Total  100.00% 100.00% 
 
6.6.5 Distribution of substance concentrations 
 
Substance concentrations are shown for all positive results from the 186 drivers. 
Minimum, maximum and median concentrations are shown for all single substances. 
Table 14. Substance concentrations for substances. Minimum, maximum and median 
concentrations are shown. 
Substance Number of 
observations 
Min Max Median 
Alcohol 59 0.06 g/L 2.82 g/L 1.42 g/L 
Benzoylecgonine 9 109.1 ng/mL 1500 ng/mL 763.4 ng/mL 
Cocaine 5 8.9 ng/mL 208.9 ng/mL 68.3 ng/mL 
MDMA 2 29.3 ng/mL 93.9 ng/mL 61.6 ng/mL 
Amphetamine 2 48 ng/mL 208.7 ng/mL 128.4 ng/mL 
THC 1 19.7 ng/mL 19.7 ng/mL 19.7 ng/mL 
Zolpidem 1 41.6 ng/mL 41.6 ng/mL 41.6 ng/mL 
MDA 1 12.6 ng/mL 12.6 ng/mL 12.6 ng/mL 
Morphine 1 77.9 ng/mL 77.9 ng/mL 77.9 ng/mL 
 
Most substances were present in only one or two injured drivers. Only alcohol, cocaine 
and benzoylecgonine were found in 5 or more injured drivers. The median of alcohol is 
quite high. 95% of the injured drivers who were positive for alcohol (BAC 0.1 g/L or 
higher) had a BAC above the legal limit (0.5 g/L). 57% of the injured alcohol positive 
drivers even had a BAC above the 1.3 g/L. 
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6.6.6 6.6.6 Distribution of additional substances 
In the Netherlands Gamma Hudroxy Butyrate (GHB) was analysed in addition to the 
DRUID core substances. In total 180 serum samples have been analysed by the 
laboratory of the department of Clinical chmistry, microbiology and immunology of Ghent 
university. In this subset five samples (2.8%) were positive for GHB with concentrations 
ranging from 42 to 424 ng/ml. One of these samples was positive as well for 
amphetamines. 
 
6.7 Discussion 
The study area covers only the South and Eastern part of the Netherlands, but not the 
North and Western part. A recently conducted roadside survey (Houwing et al., 2011) 
showed no large differences between the prevalence of psychoactive substances in the 
four parts of the Netherlands. Based on this distribution, the expected bias from the 
covered area was small.  
 
No informed consent was needed to collect a blood sample from injured drivers in the 
Netherlands. Therefore, the risk of selection bias caused by refusing patients was non-
existent. It is possible, however, that drug and alcohol intoxicated patients were less likely 
to be blood sampled than sober patients, e.g., because of aggressive behaviour or 
because of their entrance in the Emergency Departments during peak hours. 
Unfortunately, no general information on this kind of non-response could be retrieved by 
the medical staff of the Emergency Departments. 
The results show that alcohol is by far the most prevalent substance among seriously 
injured drivers, followed by the combination of alcohol and drugs. 58% of all alcohol 
positive injured drivers (BAC 0.1 g/L or higher) had a very high BAC of more than 1.3 g/L. 
Only one drug-drug combination and no benzodiazepines were found among the injured 
drivers which was a bit surprising since these were detected more frequently than single 
drugs in a previous hospital study which was counducted between 2000 and 2004 in the 
Tilburg Saint Elisabeth Hospital (Mathijssen & Houwing, 2005). This study was conducted 
in the framework of the European research project IMMORTAL.  
When compared to the hospital data of the IMMORTAL study, the percentage of drugs is 
much lower in the DRUID study, whilst the percentage of alcohol is higher. It is difficult to 
draw conclusions on the difference in prevalence between both studies, since chance 
might be an important explanatory factor, due to the low number of injured drivers in both 
hospital studies (respectively 184 injured drivers in the IMMORTAL study and 186 in this 
DRUID study). Furthermore, in the IMMORTAL study both urine and blood samples were 
taken, whereas in this hospital study only blood samples were used. The use of different 
body fluid samples makes it hard to compare the prevalence rates of both studies. 
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6.10 Annex 1 
Internal standards, protonated molecules [M+H]+, monitored fragments, retention times 
(RT), and collision energies (CE) of the drugs of abuse in the order of retention time 
RT [M+H]
+ 
CV Fragm
. 1  
Fragm. 2  Analyte Internal standaard 
min m/z (V) m/z 
CE 1 
(eV) 
m/z 
CE 2 
(eV) 
Benzoylecgonine Methylecgonine-d3  3.3 290.2 25 168.1 20 105  30 
Methylecgonine Methylecgonine-d3 3.4 200.2 25 182.2 20 81.9 25 
7-Aminonitrazepam 7-aminoclonazepam-d4 3.5 252.1 35 121.1 25 93.9 40 
Aminoclonazepam 7-aminoclonazepam-d4 3.6 286.1 30 121.1 30 222.3 25 
7-Acetamidonitrazepam 7-aminoflunitrazepam-d7 3.7 294.2 30 207.2 25 121 35 
Aminoflunitrazepam 7-aminoflunitrazepam-d7 3.8 284.2 35 135.2 25 240.2 30 
Acetamidoclonazepam 7-aminoflunitrazepam-d7 3.8 328.1 35 121.1 35 205.2 35 
Morphine Morfine-d3 3.9 286.2 36 165.1 40 153.1 30 
MDA MDA-d5 4.4 180.2 10 163 10 105 20 
Amphetamine Amfetamine-d8 4.6 135.9 10 119 10 90.9 15 
6-MAM 6-monoacetylmorfine-d6 4.8 328.2 35 165.1 35 211.2 25 
MDMA MDMA-d5 5.1 194.2 15 163.1 15 105 25 
Desmethylflunitrazepam Desmethylflunitrazepam-d4 5.2 300.2 35 254.2 25 198.2 40 
Demoxepam Desmethylflunitrazepam-d4 5.4 287.2 35 180 20 105 20 
Codeine Codeine-d3 5.4 300.3 35 215.3 25 165.1 30 
Bromazepam Desmethylflunitrazepam-d4 5.4 316.1 30 182.2 35 209.2 25 
Metamphetamine Methylamfetamine-d8 5.5 150 15 91 15 119.1 10 
Nitrazepam Nitrazepam-d5 5.6 282.1 25 236.2 25 180.2 35 
Zopiclone Nitrazepam-d5 5.7 389 15 245.2 20 217.2 35 
Clonazepam Nitrazepam-d5 5.8 316.1 35 270.2 25 214.2 35 
Desmethylclobazam Nitrazepam-d5 6.1 287.2 25 245.2 20 210.2 35 
MDEA MDEA-d5 6.1 208.3 15 163.1 15 105 25 
Flunitrazepam Flunitrazepam-d7 6.2 314.2 30 268.3 25 239.2 35 
Alpha-hydroxytriazolam Alpha-hydroxytriazolam-d4 6.7 359 35 176.1 25 250.2 25 
Alpha-hydroxy-alprazolam Alpha-hydroxyalprazolam-d5 6.9 325.1 30 243.3 35 279.2 20 
Clobazam Oxazepam-d5 7.3 301.2 25 259.2 20 224.2 35 
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Desmethylchlorodiazepoxide Oxazepam-d5 7.4 286.2 25 227.2 25 192.2 35 
Oxazepam Oxazepam-d5 7.5 287.2 25 241.2 25 104 35 
Lorazepam Lorazepam-d4 7.8 321.1 25 275.2 25 229.2 35 
Hydroxy-ethyl-flurazepam Hydroxy-ethyl-flurazepam-d4 8 333.1 30 109 25 211.2 35 
Alprazolam Alprazolam-d5 8.4 309.3 35 281.3 25 274.2 25 
Zolpidem Zolpidem-d6 8.4 308.3 35 235.3 35 263.2 25 
Triazolam Triazolam-d4 8.7 343 35 239.2 40 111.1 50 
Desalkylflurazepam Desalkylflurazepam-d4 8.8 289.2 35 140 30 226.2 30 
Temazepam Temazepam-d5 8.9 301.2 20 255.2 20 177.1 35 
Alpha-hydroxymidazolam Desmethyldiazepam-d5 9.9 342.1 30 203.3 25 168.1 40 
Chlordiazepoxide Desmethyldiazepam-d5 9.9 300.2 20 227.2 25 165.1 45 
Brotizolam Desmethyldiazepam-d5 10 394.8 35 314.1 25 316.2 25 
Lormetazepam Desmethyldiazepam-d5 10.1 335 20 289.2 20 177.1 40 
Desmethyldiazepam Desmethyldiazepam-d5 10.8 271.2 35 140 25 165 25 
Cocaine Cocaine-d3 11.4 304.2 25 182.2 20 105 35 
Diazepam Desmethyldiazepam-d5 11.6 285.2 30 154 25 193.2 30 
Midazolam Desmethyldiazepam-d5 11.8 326.2 35 244.2 25 291.3 25 
THC-COOH 11-nor-9-carboxy-delta9-THC-d9 12.1 345.2 25 299.4 20 327.3 15 
Flurazepam Desalkylflurazepam-d4  12.6 388.1 25 315.2 25 288.3 25 
Methadone Methadone-d9 13.1 310.3 20 265.3 15 105 25 
11-OH-THC 11-hydroxy-delta 9-THC-d3 13.2 331.3 20 193.4 25 313.3 15 
THC Delta 9-THC-d3 15.3 315.3 25 193.2 20 259.5 30 
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6.11 Annex 2 
Validation results of drugs of abuse in blood. Analytes are shown in the order of retention 
time. 
Analyte Calibration 
range  
(mg/L) * 
Correlation 
coefficient 
(R2) ** 
Reproducibility  
(%) *** 
Accuracy 
(%) *** 
LOD 
(µg/L) 
LOQ 
(µg/L) 
Benzoylecgonine 0.015-3.0 1.000 (2nd ) 6 117 0.1 15 
Methylecgonine 0.005-1.0 0.999 5 101 0.02 5 
7-Aminonitrazepam 0.001-0.2 0.999 25 110 0.2 1 
Aminoclonazepam 0.001-0.2 0.999 11 110 0.02 1 
7-Acetamidonitrazepam 0.001-0.2 0.999 8 91 0.03 1 
Aminoflunitrazepam 0.001-0.2 0.999 10 94 0.1 1 
Acetamidoclonazepam 0.001-0.2 0.999 8 95 0.02 2 
Morphine 0.005-1.0 0.999 6 96 0.1 5 
MDA 0.01-2.0 0.999 5 101 0.1 10 
Amphetamine 0.01-2.0 0.999 16 95 0.1 10 
6-MAM 0.002-0.4 0.999 7 92 0.02 2 
MDMA 0.01-2.0 1.000 (2nd) 4 102 0.1 10 
Desmethylflunitrazepam 0.001-0.2 0.999 13 93 0.02 1 
Demoxepam 0.01-2.0 0.999 (2nd) 18 118 0.1 20 
Codeine 0.02-4.0 0.999 (2nd) 6 103 0.2 20 
Bromazepam 0.002-0.4 0.999 12 89 0.1 2 
Metamphetamine 0.005-1.0 0.999 10 91 0.1 5 
Nitrazepam 0.002-0.4 0.999 17 87 0.01 2 
Zopiclone 0.004-0.8 0.999 10 100 0.03 4 
Clonazepam 0.001-0.2 0.999 11 96 0.04 1 
Desmethylclobazam 0.005-1.0 0.995 10 74 0.04 5 
MDEA 0.005-1.0 0.999 5 91 0.03 5 
Flunitrazepam 0.001-0.2 0.999 15 99 0.02 1 
Alpha-hydroxytriazolam 0.001-0.2 0.999 10 97 0.01 1 
Alpha-hydroxy-alprazolam 0.001-0.2 0.999 19 96 0.05 5 
Clobazam 0.005-1.0 0.999 5 106 0.02 5 
Desmethylchlorodiazepoxide 0.008-1.6 0.999 9 102 0.3 8 
Oxazepam 0.01-2.0 0.999 5 96 0.1 10 
Lorazepam 0.002-0.4 1.000 (2nd) 7 112 0.1 4 
Hydroxy-ethyl-flurazepam 0.002-0.4 0.999 6 90 0.1 2 
Alprazolam 0.001-0.2 0.999 6 93 0.01 1 
Zolpidem 0.003-0.6 0.999 4 96 0.02 3 
Triazolam 0.001-0.2 0.999 7 107 0.03 1 
Desalkylflurazepam 0.002-0.4 0.999 7 95 0.01 2 
Temazepam 0.01-2.0 0.999 5 94 0.04 10 
Alpha-hydroxymidazolam 0.001-0.2 0.999 4 99 0.03 1 
Chlorediazepoxide 0.01-2.0 0.999 5 93 0.1 10 
Brotizolam 0.001-0.2 0.999 6 107 0.01 1 
Lormetazepam 0.001-0.2 0.995 6 94 0.02 1 
Desmethyldiazepam 0.005-1.0 0.999 7 104 0.1 5 
Cocaine 0.005-1.0 0.999 5 106 0.04 5 
Diazepam 0.005-1.0 0.999 7 92 0.4 5 
Midazolam 0.002-0.4 0.999 8 86 0.03 2 
9-COOH-THC 0.001-0.2 0.991 9 96 0.5 1 
Flurazepam 0.001-0.2 0.999 15 78 0.01 1 
Methadon 0.005-1.0 0.999 11 116 0.03 5 
11-OH-THC 0.001-0.2 0.999 9 98 0.4 1 
THC 0.001-0.2 0.999 13 103 0.02 1 
*) The LOQ is defined as the lowest concentration of the linear range.  
**) Linear fit except when labeled 2nd: quadratic fit; ***) Shown results obtained using 
concentration level F; ND: Not determined 
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6.12  Annex 3 
Stability (in days) of compounds in blood and oral fluid on concentration levels B and F at 
different temperatures. 
 
 Blood 
 20 °C  20 °C  10 °C 10 °C -20 °C -20 °C 
   B F   B F   B F  
benzoylecgonine >7 >7 >28 >28 >57 >57 
methylecgonine >2 >2 >7 >7 >57 >57 
aminonitrazepam >7 >7 >28 >28 >57 >57 
aminoclonazepam >7 >7 >28 >28 >57 >57 
Acetamidonitrazepam >7 >7 >28 >28 >57 >57 
aminoflunitrazepam >7 >7 >28 >28 >57 >57 
acetamidoclonazepam >7 >7 >28 >28 >57 >57 
morphine >7 >7 >28 >28 >57 >57 
MDA >7 >7 >28 >28 >57 >57 
amphetamine >7 >7 >28 >28 >57 >57 
6-M.A.M >2 >2 >7 >28 >57 >57 
MDMA >7 >7 >28 >28 >57 >57 
desm.flunitrazepam >7 >7 >28 >28 >57 >57 
demoxepam >7 >7 >28 >28 >57 >57 
codeine >7 >7 >28 >28 >57 >57 
bromazepam >7 >7 >28 >28 >57 >57 
metamphetamine >7 >7 >28 >28 >57 >57 
nitrazepam >7 >7 >28 >28 >57 >57 
zopiclone <2 <2 <2 <2 >57 >57 
clonazepam >7 >7 >28 >28 >57 >57 
desm.clobazam >7 >7 >28 >28 >57 >57 
MDEA >7 >7 >28 >28 >57 >57 
flunitrazepam >7 >7 >28 >28 >57 >57 
OH-triazolam >7 >7 >28 >28 >57 >57 
OH-alprazolam >7 >7 >28 >28 >57 >57 
clobazam >7 >7 >28 >28 >57 >57 
desm.chloordiazepoxide >2 >2 >7 >2 >57 >57 
oxazepam >7 >7 >28 >28 >57 >57 
lorazepam >7 >7 >28 >28 >57 >57 
OH-ethylflurazepam >7 >7 >28 >28 >57 >57 
alprazolam >7 >7 >28 >28 >57 >57 
zolpidem >7 >7 >28 >28 >57 >57 
triazolam >7 >7 >28 >28 >57 >57 
desalk.flurazepam >7 >7 >28 >28 >57 >57 
temazepam >7 >7 >28 >28 >57 >57 
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OH-midazolam >7 >7 >28 >28 >57 >57 
chloordiazepoxide >7 >7 >28 >28 >57 >57 
brotizolam >7 >7 >28 >28 >57 >57 
lormetazepam >7 >7 >28 >28 >57 >57 
nordiazepam >7 >7 >28 >28 >57 >57 
cocaine >2 >2 >7 >7 >57 >57 
diazepam >7 >7 >28 >28 >57 >57 
midazolam >7 >7 >28 >28 >57 >57 
COOH-THC >7 >2 >28 >28 >57 >57 
flurazepam ND ND ND ND ND ND 
methadon <2 >7 >28 >28 >57 >57 
OH-THC >2 <2 >2 >2 >57 >57 
THC <2 <2 >2 >2 >57 >57 
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Part 3 - Country reports from the studies on killed 
drivers 
 
 
1 Country Report Finland  
 
 
Authors: Tom Blencowe1, Kaarina Langel1, Charlotta Engblom1, Anna Pehrsson1, Erkki 
Vuori2, Lasse Lehtonen3 and Pirjo Lillsunde1 
 
1National Institute for Health and Welfare (THL), 2Department of Forensic Medicine of 
Helsinki University, 3Hospital District of Helsinki and Uusimaa 
 
1.1 Description of the killed driver sample 
 
1.1.1 Introduction. 
The aim of the survey was to form an estimate of alcohol and drug use among killed 
drivers in Finland. Retrospective data of all killed drivers throughout Finland for the period 
2006 - 2008 were collated. 
 
The survey data were collated in accordance with the inclusion criteria set out in the 
guidelines for the hospital survey (D 2.1.2). 
 
Data concerning the accidents was collected from the Finnish Motor Insurers´ Centre 
(VALT). VALT is the agency that collects and holds information gathered by accident 
investigation teams in Finland. When toxicological analytical information for killed drivers 
could not be retrieved from the VALT archives the autopsy reports were requested from 
the Department of Forensic Medicine, Helsinki University, which performs forensic 
autopsies for the whole of Finland. In these instances the information for respective cases 
was then matched and collated to one database. 
 
Information for all killed drivers during the survey period was available: the inclusion 
criteria for the survey were that all drivers were age 18 years old or over and died within 
24 hours of the accident. Vehicles included were cars, vans, motorcycles, mopeds, 
bicycles, buses, trucks and others (e.g., quad bikes, tractors and snowmobiles). A total of 
652 killed drivers and cyclists were included in the survey. 
 
1.1.2 Geographical distribution of killed drivers over the country 
Drivers killed throughout the whole of Finland (Figure 1) were included in the survey. The 
fraction of drivers killed in each of the roadside survey regions of Uusimaa (southern 
Finland) and Pohjois-Savo (central Finland) and the rest of the country are presented in  
Table 1. 
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Figure 1. Finland (Uusimaa and Pohjois-Savo regions highlighted red) 
 
Table 1. Distribution of killed drivers 
Region Fraction of killed drivers 
Uusimaa 0.141 
Pohjois-Savo 0.067 
Rest of Finland 0.791 
Total 1 
 
 
1.1.3 Distributions of killed drivers 
Information presented is fully comprehensive for all 652 cases included in the database 
unless otherwise stated. 
Information on whether the fatal accident site was urban or rural was recorded in the 
database at VALT. The distribution of killed drivers according to road type is shown in 
table 2. Road type information for 109 of the killed drivers was recorded at VALT as 
‘neighbouring densely populated area’; these cases were interpreted as rural accidents. 
Road type information was missing for 11 cases. 
 
Table 2. Distribution of killed drivers by road type 
Road type Fraction of killed drivers (n=641) 
Urban 0.178 
Rural 0.822 
Total 1 
 
The retrospective survey period covered three whole complete years, from the beginning 
of 2006 to the end of 2008. The distribution of killed drivers by season is shown in table 3. 
Table 3. Distribution of killed drivers by quarter of the year 
Quarter of the year Fraction of killed drivers 
First (Jan, Feb, Mar) 0.179 
Second (Apr, May, Jun) 0.259 
Third (Jul, Aug, Sep) 0.314 
Fourth (Oct, Nov, Dec) 0.247 
Total 1 
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The distribution of time of accident for the killed drivers in the survey according to DRUID 
time periods, as defined in the survey guidelines, is presented in table 4. 
 
Table 4. Distribution of killed drivers by day of the week and time of the day 
DRUID time code Fraction of killed drivers 
Weekday 4:00 to 10:00 0.156 
Weekday 10:00-16:00 0.247 
Weekday 16:00-22:00 0.156 
Weekday 22:00-4:00 0.072 
Weekend 4:00-10:00 0.064 
Weekend 10:00-16:00 0.069 
Weekend 16:00-22:00 0.132 
Weekend 22:00-4:00 0.103 
Total 1 
 
The age and gender distribution of all killed drivers in the survey is shown in table 5. The 
age group classifications are as defined in the survey guidelines. 
 
Table 5. Distribution of killed drivers by age and gender 
 Killed drivers 
Age group (years) Male Female In total 
18-24 0.199 0.029 0.229 
25-34 0.133 0.015 0.149 
35-49 0.166 0.055 0.221 
50+ 0.328 0.074 0.402 
Total 0.827 0.173 1 
 
A more detailed histogram of the age-gender distribution of the survey population is 
presented in Figure 2.  
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Figure 2. Age and gender distribution of killed drivers 
 
Information on the distribution of vehicle type of the killed drivers is presented in table 6. 
The vehicle type for 27 killed drivers was classified as ‘other’, these vehicles included 
tractors, snowmobiles and other 3 or 4 wheel vehicles requiring a licence (e.g. quad 
bikes). 
 
Table 6. Distribution of killed drivers by vehicle 
Type of vehicle Fraction of killed drivers 
car 0.709 
van 0.032 
truck/bus 0.104 
motorcycle 0.017 
bicycle 0.066 
moped 0.031 
other 0.041 
Total 1 
 
The distribution of killed drivers according to whether the accident involved only one or 
multiple vehicles is shown in table 7. For multiple vehicle accidents, including those 
involving cyclists, 288 killed drivers out of 375 were listed as the primary or main cause of 
the accident. 7 of the single vehicle fatal accidents were caused by hitting an animal. 
 
Table 7. Distribution of killed drivers by accident type 
Type of accident Fraction of killed drivers 
Single vehicle 0.425 
Multiple vehicle 0.575 
Total 1 
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For 107 of the killed drivers in the survey information regarding the use of a safety belt 
was recorded as unknown. The distribution of the other 545 killed drivers, according to 
whether a safety belt was used or not, is seen in table 8. 
 
Table 8. Distribution of killed drivers according to safety belt use 
Safety belt used Fraction of killed drivers (n =545 ) 
Yes 0.481 
No 0.519 
Total 1 
 
 
1.2 Methods: Data collection and analysis  
1.2.1 Ethical approval 
The research plan for this survey was approved by the coordinating ethical advisory 
board of the Hospital District of Helsinki and Uusimaa. The identities of the killed drivers 
were not recorded. 
 
1.2.2 Specimen collection, time between death and sampling, site of sampling 
Only drivers who died within 24 hours of the accident were included in the survey. For 
those cases where the date of sampling was available (n=301), the time between death 
and sampling varied between 0 and 288 hrs. Only analytical toxicology results for blood 
samples were used in this survey. Blood autopsy samples were collected from the 
femoral vein to a tube containing 0.1g of sodium fluoride. The final concentration of 
fluoride was at least 1%. 
 
1.2.3 Toxicological analysis of body fluids  
Toxicological analysis of the autopsy samples was carried out at the Department of 
Forensic Medicine, Helsinki University. Comprehensive screening and quantification was 
carried out by precise gas chromatography with retention time locking as described in (1). 
The DRUID cut-offs applied for positive results in this survey are listed in the Methods 
section of the Summary Report. 
 
1.2.4 Other collected data 
Extensive information concerning the killed drivers and place of accident was available 
from VALT and this information was almost fully comprehensive for all cases. The 
relevant variables selected for the DRUID survey are listed here:  
 
- Gender 
- Age at death 
- Type(s) of motor vehicle licence held at time of death 
- Year first motor vehicle licence achieved 
- Type of vehicle 
- Time and place of accident 
- Death was instant, dead on arrival, within 6 hours or 6-24 hours of accident 
- Road type 
- Single or multiple vehicle accident 
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For 301 cases the sampling date was also obtained. The number of days from the death 
date to the sampling date was then multiplied by 24 to provide an estimate of the time 
between death and sampling in hours. 
 
1.2.5 Statistical analysis 
The data were processed with PASW (Predictive Analytics SoftWare) Statistics 17.0 by 
SPSS: An IBM® Company. 
 
 
1.3 Non-response, refusals  
 
1.3.1 Size and nature of non-response 
The analytical toxicology results for the blood autopsy samples of 20 killed drivers were 
not found, although a blood alcohol result was obtained. In a further 12 cases only the 
blood alcohol results were not retrieved. In five cases no analytical toxicology results 
were retrieved for either drugs or alcohol.  
 
1.3.2 Possible confounding effect of non-response 
The percentage of cases for which toxicological analysis results are unknown or 
incomplete is only 5.7% and it is unlikely that there is any confounding effect from this 
since the reason they are missing, i.e. the autopsy reports could not be found from the 
Department of Forensic Medicine with the available case information, is independent of 
any factors involved in the fatal accidents.  
 
 
1.4 Results  
From the 652 killed drivers and cyclists included in the survey there were 253 cases 
(38.8%) with positive findings, above DRUID cut-offs, for the DRUID core substances. 
This increases to 272 (41.7%) if additional substances analysed in Finland are included. 
 
Regarding the core substances, nationally the highest prevalence was for alcohol with 
29.1% (190 cases) of alcohol positive cases - 23.8% (155 cases) at blood alcohol 
concentrations of 1.3 g/L or more, 2.9% (19 cases) between 0.8 – 1.3 g/L, 0.5% (3 cases) 
between 0.5 – 0.8 g/L and 2.0% (13 cases) between 0.1 – 0.5 g/L. 
 
The prevalence of other substance classes was 12.9% for benzodiazepines and Z-drugs 
(84 cases: 68 with benzodiazepines only, 9 with Z-drugs only and 7 with both), 1.8% (12 
cases) for both amphetamines and opioids (either illicit or medicinal) and 1.1% (7 cases) 
for THC. 
 
1.4.1 Detailed substance group distribution for the area the results are 
applicable to  
Table 9 shows the regional distribution of cases according to the types of substances 
detected, or combinations thereof. A relatively large proportion of cases positive for 
substances other than alcohol, benzodiazepines and Z-drugs can be seen for the 
Uusimaa region (8 cases) in comparison to Pohjois-Savo (1 case) and the rest of the 
country (17 cases). Alcohol and sedative type drugs appear to be more evenly distributed 
among the survey cases throughout Finland.  
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Table 9. Regional distribution of cases by substance groups detected 
Region Substances present  
Uu
sim
aa 
Pohjois-
Savo 
Rest of 
Finland 
Total 
None 62 22 315 399 
Amphetamines only 2 0 3 5 
Benzodiazepines only 2 1 30 33 
Amphetamines and benzodiazepines 2 0 0 2 
Amphetamines, cannabis and 0 1 2 3 
Z-drugs only 0 2 6 8 
Benzodiazepines and Z-drugs 0 0 3 3 
Opioids* only 3 0 6 9 
Benzodiazepines and opioids* 0 0 1 1 
Alcohol only 13 14 124 151 
Amphetamines and alcohol 0 0 1 1 
Cannabis and alcohol 1 0 2 3 
Benzodiazepines and alcohol 7 4 16 27 
Cannabis, benzodiazepines and alcohol 0 0 1 1 
Z-drugs and alcohol 0 0 1 1 
Benzodiazepines, Z-drugs and alcohol 0 0 3 3 
Amphetamines, benzodiazepines, opioids* 0 0 1 1 
Benzodiazepines, Z-drugs, opioids* and 
alcohol 
0 0 1 1 
*medicinal or illicit 
 
 
1.4.2 Distribution of substance groups by DRUID time periods aggregated into 
day vs night, week vs WE 
Table 10 shows the distribution of killed drivers according to whether the fatal accident 
occurred during the day or night. As can be seen, procentually the occurrence of 
accidents with no findings during the day is over double of that during the night. Most 
substance-positive cases occurred during day time, except for cases involving alcohol or 
alcohol and benzodiazepines which are more equally spread. Results are similar for the 
distribution over weekdays and the weekend (Table 11), although the proportion of cases 
occurring at the weekend is greater than for nighttime. Again alcohol and alcohol with 
benzodiazepines findings are more evenly distributed over weekday and weekend 
periods. 
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Table 10. Distribution by number of cases according to substance groups detected and time 
of day 
Time Substances present  
Day (%) Night (%) 
None 365 (67.8) 34 (29.4) 
Amphetamines only 4 (0.7) 1 (0.9) 
Benzodiazepines only 31 (5.8) 2 (1.8) 
Amphetamines and benzodiazepines 2 (0.4) 0 (0) 
Amphetamines, cannabis and benzodiazepines 2 (0.4) 1 (0.9) 
Z-drugs only 7 (1.3) 1 (0.9) 
Benzodiazepines and Z-drugs 3 (0.6) 0 (0) 
Opioids* only 9 (1.7) 0 (0) 
Benzodiazepines and opioids* 1 (0.2) 0 (0) 
Alcohol only 92 (17.1) 59 (51.8) 
Amphetamines and alcohol 1 (0.2) 0 (0) 
Cannabis and alcohol 2 (0.4) 1 (0.9) 
Benzodiazepines and alcohol 15 (2.8) 12 (10.5) 
Cannabis, benzodiazepines and alcohol 0 (0) 1 (0.9) 
Z-drugs and alcohol 1 (0.2) 0 (0) 
Benzodiazepines, Z-drugs and alcohol 2 (0.4) 1 (0.9) 
Amphetamines, benzodiazepines, opioids* and alcohol 0 (0) 1 (0.9) 
Benzodiazepines, Z-drugs, opioids* and alcohol 1 (0.2) 0 (0) 
Total 538 (100) 114 (100)
*medicinal or illicit 
 
Table 11. Distribution by number of cases according to substance groups detected and time 
of week 
Time Substances present  
Weekday 
(%) 
Weekend 
(%) 
None 280 (68.0) 119 (49.6) 
Amphetamines only 3 (0.7) 2 (0.8) 
Benzodiazepines only 23 (5.6) 10 (4.2) 
Amphetamines and benzodiazepines 1 (0.2) 1 (0.4) 
Amphetamines, cannabis and benzodiazepines 2 (0.5) 1 (0.4) 
Z-drugs only 7 (1.7) 1 (0.4) 
Benzodiazepines and Z-drugs 3 (0.7) 0 (0) 
Opioids* only 5 (1.2) 4 (1.7) 
Benzodiazepines and opioids* 1 (0.2) 0 (0) 
Alcohol only 69 (16.7) 82 (34.2) 
Amphetamines and alcohol 0 (0) 1 (0.4) 
Cannabis and alcohol 1 (0.2) 2 (0.8) 
Benzodiazepines and alcohol 13 (3.2) 14 (5.8) 
Cannabis, benzodiazepines and alcohol 0 (0) 1 (0.4) 
Z-drugs and alcohol 1 (0.2) 0 (0) 
Benzodiazepines, Z-drugs and alcohol 2 (0.5) 1 (0.4) 
Amphetamines, benzodiazepines, opioids* and alcohol 0 (0) 1 (0.4) 
Benzodiazepines, Z-drugs, opioids* and alcohol 1 (0.2) 0 (0) 
Total 412 (100) 240 (100) 
*medicinal or illicit 
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1.4.3 Distribution of substance groups by gender and age  
Table 12 shows the distribution of survey cases according to substances detected and 
age and gender. 83% of drivers included in the survey were male and correspondingly 
the occurrence of drugs in women drivers was low, furthermore only one of these cases 
involved a substance other than alcohol or benzodiazepines (1 opioids detection, age 
group 50+ years). Among males occurrence of amphetamines and cannabis was more 
frequent among younger drivers (18 – 34 years), whereas opioids and sedative type 
drugs, particularly Z-drugs, were more frequent among the older drivers (35 – 50+ years). 
The occurrence of alcohol in male killed drivers aged 24 and under was noticeably high in 
comparison to the other age groups, contrastingly the corresponding ‘risk’ group for 
alcohol among women appears to be those aged between 35-49 years. Use of 
benzodiazepines with alcohol in fatal accidents appears to be more common for males 
between 25-49 years rather than the younger or older age groups. 
 
Table 12. Distribution by number of cases according to substance groups detected and age 
and gender 
Age group 
Gender Substances present 
18-24 
(%) 
25-34 
(%) 
35-49 
(%) 
50+ 
(%) 
Male None 57 52 57 149 
 Amphetamines only 2 (1.7) 2 (2.1) 0 (0) 1 (0.5)
 Benzodiazepines only 1 (0.8) 6 (6.2) 4 (3.7) 12 (5.6)
 Amphetamines and benzodiazepines 0 (0) 0 (0) 2 (1.9) 0 (0) 
 Amphetamines, cannabis and 1 (0.8) 1 (1.0) 1 (0.9) 0 (0) 
 Z-drugs only 1 (0.8) 0 (0) 0 (0) 7 (3.3)
 Benzodiazepines and Z-drugs 0 (0) 0 (0) 0 (0) 3 (1.4)
 Opioids* only 1 (0.8) 0 (0) 1 (0.9) 7 (3.3)
 Alcohol only 54 25 29 29 
 Amphetamines and alcohol 1 (0.8) 0 (0) 0 (0) 0 (0) 
 Cannabis and alcohol 0 (0) 1 (1.0) 2 (1.9) 0 (0) 
 Benzodiazepines and alcohol 2 (1.7) 9 (9.3) 9 (8.3) 3 (1.4)
 Cannabis, benzodiazepines and alcohol 0 (0) 0 (0) 1 (0.9) 0 (0) 
 Z-drugs and alcohol 0 (0) 0 (0) 0 (0) 1 (0.5)
 Benzodiazepines, Z-drugs and alcohol 0 (0) 1 (1.0) 0 (0) 2 (0.9)
 Amphetamines, benzodiazepines, opioids* 0 (0) 0 (0) 1 (0.9) 0 (0) 
 Benzodiazepines, Z-drugs, opioids* and 0 (0) 0 (0) 1 (0.9) 0 (0) 
 Total 120 97 (100) 108 214 
None 13 9 (75.0) 22 40
Benzodiazepines only 2 (11.8) 0 (0) 3 (8.3) 5 (10.4)
Benzodiazepines and opioids* 0 (0) 0 (0) 0 (0) 1 (2.1)
Alcohol only 1 (5.9) 3 (25.0) 9 (25.0) 1 (2.1)
Female 
Benzodiazepines and alcohol 1 (5.9) 0 (0) 2 (5.6) 1 (2.1)
 Total 17 (100) 12 (100) 36 (100) 48 (100)
*medicinal or illicit 
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1.4.4 Distribution of substance groups by single-vehicle accidents vs. multiple 
vehicles 
The occurrences of single and multiple vehicle accidents included in the survey was 
approximately 40% and 60%. In contrast the overall occurrence of positive findings in the 
fatal accidents (Table 13) studied was approximately 60% for single vehicle accidents 
and 40% for multiple vehicle accidents.  
 
Table 13. Distribution by number of cases according to substance groups detected 
according to type of accident 
Type of accident Substances present  
Single 
vehicle (%) 
Multiple 
vehicle 
(%) 
None 130 (46.9) 269 (71.7)
Amphetamines only 3 (1.1) 2 (0.5) 
Benzodiazepines only 12 (4.3) 21 (5.6) 
Amphetamines and benzodiazepines 0 (0) 2 (0.5) 
Amphetamines, cannabis and benzodiazepines 0 (0) 3 (0.8) 
Z-drugs only 2 (0.7) 6 (1.6) 
Benzodiazepines and Z-drugs 0 (0) 3 (0.8) 
Opioids* only 5 (1.8) 4 (1.1) 
Benzodiazepines and opioids* 0 (0) 1 (0.3) 
Alcohol only 101 (36.5) 50 (13.3) 
Amphetamines and alcohol 1 (0.4) 0 (0) 
Cannabis and alcohol 3 (1.1) 0 (0) 
Benzodiazepines and alcohol 17 (6.1) 10 (2.7) 
Cannabis, benzodiazepines and alcohol 1 (0.4) 0 (0) 
Z-drugs and alcohol 0 (0) 1 (0.3) 
Benzodiazepines, Z-drugs and alcohol 1 (0.4) 2 (0.5) 
Amphetamines, benzodiazepines, opioids* and alcohol 0 (0) 1 (0.3) 
Benzodiazepines, Z-drugs, opioids* and alcohol 1 (0.4) 0 (0) 
Total 277 (100) 375 (100)
*medicinal or illicit 
 
 
1.4.5 Distribution of additional substances 
In addition to the core substances analysed by all countries for DRUID there were 
substance findings (above the LOQ) for either temazepam, buprenorphine, 
carbamazepine, midazolam, amitriptyline, citaprolam, fluoxetine or mirtazapine in 65 
cases. The distribution of these findings within the cases, according to positive detections 
for core DRUID substances is shown in table 14. Additional substances were also 
detected below the LOQ in a further 13 cases, of which seven cases were positive for 
core DRUID substances. There were no positive cases for carisoprodol or nitrazepam 
within the survey.  
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Table 14. Distribution of positive detections of additional substances within cases as 
according to core DRUID substance groups detected 
Substances present  No. of cases 
None 18 
Amphetamines only 1 
Benzodiazepines only 12 
Amphetamines and benzodiazepines 1 
Amphetamines, cannabis and benzodiazepines 1 
Z-drugs only 1 
Benzodiazepines and Z-drugs 1 
Opioids* only 1 
Alcohol only 11 
Benzodiazepines and alcohol 13 
Cannabis, benzodiazepines and alcohol 1 
Z-drugs and alcohol 1 
Benzodiazepines, Z-drugs and alcohol 1 
Amphetamines, benzodiazepines, opioids* and alcohol 1 
Benzodiazepines, Z-drugs, opioids* and alcohol 1 
*medicinal or illicit 
 
Tables 15 – 19 show the distributions of these additional substance findings according to 
region, time of day, time of week, age and gender and type of vehicle accident. 
Compared to, for example, amphetamines and cannabis, the additional substances are 
more evenly spread by region (table 15). 
 
Table 15. Distribution by number of cases of additional substances by region 
Region 
Uusimaa (%) Pohjois-Savo (%) Rest of Finland (%) Total (%) 
11 (16.9) 5 (7.7) 49 (75.4) 65 (100) 
 
Distribution by time of day (table 16) and time of week (table 17) for additional 
substances are similar to those of the DRUID core substances, excepting alcohol and 
benzodiazepines combined with alcohol. 
 
Table 16. Distribution by number of cases of additional substances by time of day 
Time 
Day (%) Night (%) 
53 (81.5) 12 (18.5)
 
Table 17. Distribution by number of cases of additional substances by time of week 
Time 
Weekday (%) Weekend (%) 
40 (61.5) 25 (38.5)
 
Distribution of additional substances by age and gender (table 18) suggests these drugs 
are found more commonly among older drivers (35-50+ years) for both sexes. 
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Table 18. Distribution by number of cases of additional substances by age and gender 
Age group Gender 
18-24 (%) 25-34 (%) 35-49 (%) 50+ (%) Total (%) 
Male 7 (13.5) 10 (19.2) 17 (32.7) 18 (34.6) 52 (100) 
Female 0 (0) 0 (0) 5 (38.5) 8 (61.5) 13 (100) 
 
The distribution of additional substances among killed drivers (table 19) was quite equal, 
in fact slightly more were encountered in single vehicle accidents, which did not reflect 
the fact that the majority of accidents were involving multiple vehicles. 
 
Table 19. Distribution by number of cases of additional substances by type of accident 
Type of accident 
Single vehicle (%) Multiple vehicle (%) 
33 (50.8) 32 (49.2)
 
 
1.4.6 Distribution of substance concentrations 
The range of concentrations encountered for each drug found and, where applicable, 
median concentration, are shown in table 20 for core DRUID substances and table 21 for 
additional substances. For substances other than those listed only concentrations 
between the LOD & LOQ were found; these were the core DRUID substances 
clonazepam (2 cases) and MDA (1 case). 
 
Table 20. Distribution of substance concentrations for core DRUID substances 
Analyte N* Concentration range (ng/mL) Median concentration (ng/mL)
Ethanol 189 0.1 – 3.7 g/L 1.9 g/L 
Amphetamine 10 40 - 120000 2400 
Methamphetaminee 2 40, 2100 - 
MDMA 3 60 - 320 300 
THC 7 2.0 – 4.5 3.1 
Diazepam 47 20 - 1200 100 
Nordiazepam 45 20 - 1600 100 
Oxazepam 29 20 - 2400 90 
Alprazolam 10 20 - 100 40 
Lorazepam 4 10 - 20 20 
Zopiclone 11 40 - 800 100 
Zolpidem 5 30 - 300 100 
Morphine 2 30, 70 - 
Codeine 4 20 - 70 40 
Tramadol 7 200 - 800 400 
* Number of positive cases above LOQ, number in parentheses are positive cases 
between LOD and LOQ 
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Table 21. Distribution of concentrations for additional substances  
Analyte N* Concentration range (ng/mL) Median concentration (ng/mL)
Temazepam 29 20 - 3600 70 
Buprenorphine 5 0.4 - 4500 4.8 
Carbamazepine 2 5800, 8000 - 
Midazolam 2 30, 70 - 
Amitriptyline 3 100 - 700 100 
Citaprolam 20 100 - 1000 300 
Fluoxetine 7 100 - 900 300 
Mirtazapine 10 60 - 300 100 
* Number of positive cases above LOQ, number in parentheses are positive cases 
between LOD and LOQ 
 
 
1.5 Discussion of results 
1.5.1 Representativeness 
The data presented here is almost fully comprehensive for the three years 2006 to 2008. 
Therefore it can be assumed that these results are representative of the situation 
regarding killed drivers of motorised vehicles and bicycles in Finland. 
 
1.5.2 Effects of non-response 
There was no ‘non-response’ group and analytical toxicology results were either partially 
or completely missing for only a relatively small number of cases (37). For the reason 
stated in section 3.2 it is reasonable to assume there is no confounding effect due to any 
missing sample analysis data. 
 
1.5.3 Highlights 
About 28% of the Finnish population lives within the Uusimaa area, this contains the 
capital city Helsinki – a high proportion of fatal accidents involving illicit drugs within the 
survey are located in this region. Conversely, alcohol and benzodiazepines, particularly in 
combination with the former, are more commonly encountered throughout the rest of the 
country. The more even regional distribution of such cases is probably explainable by the 
easier availability of these substances. The distribution of these cases in terms of time 
(day vs. night and weekday vs. weekend) is also atypical of the distributions of cases 
encountered in this survey, involving other types or combinations of substances. It is 
notable that alcohol-only positive cases are much more common among males aged 18-
24 years. In all the male age groups, and also for females aged 34-49 years, alcohol-only 
cases are predominant. Nonetheless, the number of these cases in the males aged 18-24 
years group, which comprised almost 20% of the survey population, was almost double 
that in the next highest groups: males aged 30-49 years (17% of survey population) and 
aged 50+ years (33% of survey population). Fatal accident cases involving no detected 
substances were most common in the oldest age group (50+ years) for both sexes. 
These two groups comprised the largest proportions of the survey populations. 
 
1.5.4 Comparison to other studies 
Similarly to previous studies, male drivers are predominantly represented in this survey at 
a level of approximately 80% of killed drivers. Unsurprisingly, where differentiated, the 
majority of drivers in these studies were also of passenger cars. Alcohol was found to be 
a significant factor in all these studies, commonly occurring in approximately 30% of 
cases and frequently at relatively high BAC levels whilst the proportion of killed drivers 
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with no substance detections were also similar at 45-50% of cases (2-5). Both of these 
are findings that are comparable to the results in this survey. In the earlier studies by 
Seymour and Oliver (1999) and Carsten Hansen et al. (1995) alcohol was deemed to be 
a major causative factor in road traffic accidents while the contribution of medical drugs 
and narcotics was deemed to be a much lower causative factor (2, 5), again results which 
appear to tally with this survey. The later studies by Drummer et al. (2003) and Elliot et al. 
(2009) both demonstrated that, aside from alcohol, cannabinoids were the most 
commonly encountered drugs which contrasts markedly with this survey (3, 4). Drummer 
et al. also reviewed a number of fatal accident studies from different countries for which 
cannabis prevalence varied between 1.4-37%. Other substance groups noted in the 
review were cocaine 0.2-20%, benzodiazepines (or specifically diazepam) 1.4-6.3%, 
opioids 2.1-4.9% and amphetamines ~2% These results vary a lot depending on the 
country and probably also on the study design (i.e. specific driver groups included to the 
studies and grouping of substances). Regarding prevalence of chemical substances in 
single and multiple vehicle crashes, Drummer et al. also found a higher incidence of 
alcohol in single vehicle accidents (44.1% vs 13.7%), as seen in this survey (3). 
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2 Country Report Norway  
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2.1 Description of the killed driver sample 
The study was performed as described in Annex 1 of the Summary Report. 
 
Data on persons injured or killed in road traffic accidents in Norway are submitted by the 
police to Statistics Norway on a regular basis. These data are entered into the Norwegian 
Road Accident Registry. The recorded data include the national identification number of 
the subject in addition to information about the accident. Data on biological samples 
submitted for forensic analysis of alcohol and drugs at the Norwegian Institute of Public 
Health (NIPH) are recorded in the Forensic Toxicology Database at NIPH. This database 
contains the national identification number together with analytical results for each blood 
sample taken in police investigations from the whole country. In addition, analytical data 
from samples taken from legal autopsies from all regions of the country except Trøndelag 
in central Norway (which comprises two counties and 8.7% of the total population in 
Norway) are included in this database. A new dataset was generated by Statistics 
Norway by coupling these two databases, selecting drivers of cars and vans who had 
been killed in road traffic accidents in Norway from January 2006 to December 2008. 
Cases with time lapse between accident and death of more than one day were excluded. 
 
In the period 2006-2008, a total of 328 drivers of cars and vans at the age of 18 years or 
older were killed in road traffic accidents in Norway. Blood samples were submitted to 
NIPH for analysis of alcohol and drugs in 193 of those cases (59%); the data presented in 
this report are based on those cases only. Blood samples were taken shortly after the 
accident from 100 drivers and during legal autopsy of 93 drivers. 
 
The country was divided into three regions as shown in Figure 1. About 53% of the cases 
were from south-east, 25% from south-west, and 22% from middle/north. As comparison, 
in December 2008 about 54% of all cars and vans were owned by drivers in south-east, 
23% in south-west, and 23% in middle/north according to Statistics Norway 
(www.ssb.no). 
 
Of the samples analysed, 42% were from drivers killed in single-vehicle accidents, and 
58% from collisions with another vehicle. The vast majority of the accidents occurred on 
rural roads (Table 1).  
 
Table 1. Distribution of the included killed drivers (%) in relation to road type from the three 
regions of Norway. 
Road type South-east South-west Middle/north Total 
Urban 16.5 8.5 11.6 13.5 
Rural 83.5 91.5 88.4 86.5 
Total 100.0 100.0 100.0 100.0 
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Figure 1. Map showing the study regions. 1: South-east, 2: South-west, and 3: Middle/north. 
 
The distribution of included killed drivers for each season is presented in Table 2 which 
shows that about 50% more drivers were killed in the 4th quarter compared to the 1st 
quarter.  
 
Table 2. Distribution of included killed drivers (%) by season 
January - March April – June July - September October - December 
21.2 22.8 25.4 30.6 
 
The distribution of included killed drivers for each time period is presented in Table 3 
together with data on normal traffic obtained from the Norwegian Public Roads 
Administration. A higher proportion of the fatal accidents occurred during weekend nights 
and mornings (15.0%) compared to normal traffic at this time (6.1%), and a somewhat 
lower proportion of the fatal accidents occurred during weekday afternoons (17.6%) 
compared to normal traffic (23.1%). For other time periods there was no marked 
difference between killed drivers and normal traffic. 
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Table 3. Distribution of included drivers (%) by the eight time periods compared with normal 
traffic 
Time period 
no. 
Day and time Normal traffic Killed drivers 
1 Mon-Fri, 04-9.59 15.0 15.5 
2 Mon-Fri , 10-15.59 26.6 24.9 
3 Mon-Thu, 16-21.59 23.1 17.6 
4 Mon-Thu, 22-23.59 
Tue-Fri, 00-03.59 
5.9 5.2 
5 Sat-Sun, 04-9.59 1.5 5.2 
6 Sat-Sun, 10-15.59 8.0 4.7 
7 Fri-Sun, 16-21.59 15.3 17.1 
8 Fri-Sun, 22-23.59 
Sat-Mon, 00-03.59 
4.6 9.8 
 
The distribution by age and gender is presented in Table 4 (please note that the age 
intervals for the groups are different). Only about 21% of the killed drivers were women, 
although females contribute to about 34% of the traffic volume (1). About 29% of the 
killed drivers were aged 18-24 years; this age group contributes to only about 8% of the 
traffic volume (1). 
 
Table 4. Distribution of included killed drivers (%) by age (years) and gender 
Gender 18-24 y 25-34 y 35-49 y 50+ y Total 
Female 4.1 4.1 6.7 6.2 21.2 
Male 24.9 15.0 15.0 23.8 78.8 
Total 29.0 19.2 21.8 30.1 100.0 
 
 
2.2 Methods 
If blood sampling was done shortly after the accident, venous blood was taken using 5 ml 
Vacutainer® tubes containing sodium fluoride and heparin (BD Vacutainer Systems, 
Belliver Industrial Estate, Plymouth, UK). In these cases, the average time between 
accident and blood sampling was 5.5 h (range 0.7-22.7h). The patient was alive at the 
time of accident in 8 of these cases, for those the average time between accident and 
sampling was 4.2h (range 1.3-7.3h). 
 
For legal autopsy samples, blood was transferred to Sterilin tubes (Bibby Sterilin, 
Staffordshire, UK) containing potassium fluoride. Samples were preferably taken from the 
femoral vein; if this was impossible, blood was taken from the heart. The average time 
between accident and autopsy was 2.5 days (range 1-18 days). 
 
Blood samples were kept at 2-8°C from the arrival at NIPH until the analyses had been 
performed, normally within 4 weeks, and thereafter frozen at about -20°C. The blood 
samples were handled using normal routine procedures for forensic toxicology analysis. 
 
Blood samples from all cases were screened for alcohol using an enzymatic method (2), 
and if alcohol was found, the concentration was quantified using gas chromatography (3). 
 
Samples of blood were also initially screened for amphetamines, cannabinoids, cocaine 
metabolites, and opiates by an immunological method (4). Screening for other drugs (see 
Table 6) was performed using high-performance liquid chromatography with mass 
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spectroscopy detection (LC-MS) (5). Drug findings were confirmed and quantified using 
gas chromatography with mass spectroscopy detection (GC-MS) or LC-MS (5-8).  
 
All samples which had more than 3.0 mL blood left after the routine forensic toxicology 
testing programme (n=162) were re-analysed using UPLC-MS-MS (9) in order to comply 
with the drugs and cut-off concentrations listed in the Summary Report. Analytical results 
from the initial testing were complemented with results from re-testing. 
 
The laboratory was accredited according to ISO 17025 for performing the confirmation 
and quantification methods for forensic toxicology purposes by the Norwegian body for 
accreditation of laboratories (Norsk Akkreditering, Kjeller, Norway). 
 
Statistical analysis was carried out using SPSS 14.0 (SPSS Inc., Chicago, IL, USA). 
 
 
2.3 Missing cases 
Out of the whole population of killed drivers, toxicological analyses were performed for 
61% of the killed drivers in south-eastern Norway, 68% of those in south-western 
Norway, and 47% of those in middle/northern Norway. Of those from middle/north, 
samples were received from 32% of killed drivers in Trøndelag (middle region); thus, 
samples from this area were particularly under-represented since most autopsy samples 
from that region were analysed by a regional laboratory and not by NIPH. Analytical data 
from that laboratory were not available for this study. 
 
Toxicological analyses were performed for 68% and 55% of drivers killed during 
weekends and working days, respectively, for 62% and 57% of those killed in single 
vehicle accidents and in collisions, respectively, and for 60% and 56% of killed male and 
female drivers, respectively. The frequencies of toxicological analysis were 56.1%, 60.4% 
and 60.2% for drivers killed in 2006, 2007 and 2008, respectively, and 54.7%, 62.0%, 
60.5% and 58.4% for drivers killed during the first to the fourth quarter of the year, 
respectively. 
 
The blood samples submitted for analysis in relation to age are presented in Table 5. 
Drivers below 35 years of age were more frequently investigated for alcohol and drug use 
than older drivers. 
 
It is likely that some sampling bias occurred when the police decided whether or not a 
blood sample should be taken from the killed driver, and whether or not a legal autopsy 
should be performed. The magnitude of the possible bias effect is not known. 
Confounders like age, gender and time period of the week may affect the overall findings, 
but those factors were taken into account when presenting analytical results. 
 
Table 5. Frequency of toxicological analysis in relation to age group 
 18-24 y 25-34 y 35-49 y 50+ y Total 
Toxicological analyses performed (%) 67.9 66.7 57.7 50.0 58.8 
 
 
2.4 Results 
An overview of the substances found in our study is presented in Tables 6-7, and details 
on analytical findings in relation to geographical region, road type, day or night, weekday 
or weekend, accident type, age and gender are presented in Tables 8-9. 
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Alcohol and/or drugs were found in samples from 38.9% of the drivers; from 64.2% of 
drivers killed in single vehicle accidents and 20.5% of drivers killed in multiple vehicle 
accidents. Alcohol was detected in samples from 25.4% of the drivers. Of these ones, 
94% had blood alcohol concentrations above 0.5 g/L and 59% above 1.5 g/L.  
 
The most commonly found group of medicinal drugs was the benzodiazepines, and the 
most commonly found illicit drug group was amphetamines. THC was also frequently 
detected, while the use of cocaine was confirmed in only one case by finding the 
degradation product benzoylecgonine. 
 
Drug concentration in autopsy samples may not reflect the concentrations at time of 
death because of possible post-mortal changes (10, 11). Therefore, the interpretations of 
drug concentrations may be unreliable. 
 
Amphetamines were found in blood samples from 13 drivers (6.7%); 9 drivers (4.7%) 
were positive for amphetamine, 9 (4.7%) for methamphetamine, and 2 (1.0%) for MDMA. 
Amphetamine is a metabolite of methamphetamine and also found in preparations of 
methamphetamine on the illegal market, so most of the amphetamine detections were not 
related to the use of pure amphetamine. Amphetamine and/or methamphetamine were 
found in 11 cases (5.7%), and the concentration of amphetamine was higher than the 
concentration of methamphetamine in only three of these cases. In 10 of these cases the 
concentration of amphetamine plus methamphetamine was more than 200 ng/mL, which 
is higher than concentrations found after therapeutic use of amphetamines (10).  
 
THC was found in samples from 11 drivers (5.6%); 9 and 5 drivers had concentrations 
above 2 and 5ng/mL, respectively. It has previously been suggested that blood drug 
concentrations of THC above 2-5 ng/mL (or twice as high in serum) are associated with 
impairment (12, 13). 
 
Benzodiazepines were found in samples from 21 drivers (10.9%); benzodiazepines on 
the core drugs list in 17 cases (8.8%), and on the additional drugs list in 4 cases. The 
most frequently found compounds were diazepam and/or the pharmacologically active 
metabolite nordiazepam in 8 cases (4.1%); nordiazepam is not marketed as a drug in 
Norway. The concentration of diazepam exceeded 200 ng/mL in three cases (1.6%); this 
can be regarded as high therapeutic or supra-therapeutic use (14). Oxazepam was found 
in 5 cases (2.6%), exceeding 500 ng/mL in one case.  
 
Hypnotics or their degradation products were found in samples from 14 drivers (7.3%); 
hypnotics on the core drugs list in 8 cases and on the additional drugs list in 7 cases. 
Zopiclone was the most frequently found hypnotic drug (7 cases). Hypnotics may affect 
driving skills for several hours after use, also when having normal therapeutic drug 
concentrations in blood. It has previously been found that plasma concentrations of 
zopiclone were above 25 ng/mL for about four hours after taking a therapeutic dose of 7.5 
mg (15). Based on a plasma/blood ratio of 1.0 (16), this therapeutic dose corresponds to 
a blood concentration of 25 ng/mL. Four of the drivers had blood zopiclone 
concentrations above 25 ng/mL. 
 
A total of 28 drivers (14.5%) were positive for more than one substance (including core 
drugs and additional drugs). The combination of two or more psychoactive substances 
may affect driving safety even if the concentration of each substance would not affect 
driving performance significantly if taken alone. 
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Table 6. Analytical results for core substances 
Substance No. analysed No. 
positive 
%* 
Alcohol 193 49 25.4 
Illicit drugs    
 Amphetamines 180 13 6.7 
 Amphetamine 180 9 4.7 
 Methamphetamine 180 9 4.7 
 MDMA 180 2 1.0 
 MDEA 143 0 0.0 
 MDA 174 1 0.5 
 Cocaine/benzoylecgonine 179 1 0.5 
 Cocaine 179 0 0.0 
 Benzoylecgonine 171 1 0.5 
 Cannabis 179 11 5.6 
 THC 179 11 5.6 
 THCCOOH 0 n/a n/a 
 Illicit opiates 179 0 0.0 
 Monoacetylmorphine 169 0 0.0 
 Morphine + codeine (< morphine) 179 0 0.0 
Medicinal drugs    
 Benzodiazepines 182 17 8.8 
 Diazepam/nordiazepam 182 8 4.1 
 Diazepam 182 6 3.1 
 Nordiazepam 182 8 4.1 
 Oxazepam 182 5 2.6 
 Lorazepam 157 0 0.0 
 Alprazolam 182 3 1.6 
 Flunitrazepam 182 0 0.0 
 Clonazepam 165 4 2.1 
 Z-drugs 182 8 4.1 
 Zolpidem 182 1 0.5 
 Zopiclone 182 7 3.6 
 Opiates and opioids 179 3 1.6 
 Morphine 179 2 1.0 
 Codeine 179 1 0.5 
 Methadone 182 0 0.0 
Combinations    
 Alcohol-drugs 182 13 6.7 
 Multiple drugs 180 13 6.7 
* % of all samples received for analysis (n=193). 
 
Table 7. Analytical results for additional substances 
Substance No. analysed No. 
positive 
%* 
7-aminoflunitrazepam 165 2 1.0 
7-aminoclonazepam 182 4 2.1 
Nitrazepam 182 2 1.0 
7-aminonitrazepam 165 6 3.1 
Carisoprodol 182 0 0.0 
Meprobamate 182 0 0.0 
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Table 8. Prevalence (%) of alcohol and drugs in relation to gender and age 
Females (n=41) 18-24 y 25-34 y 35-49 y 50+ y Total 
Core substances 
Alcohol ≥ 0.1 g/L 12.5 12.5 23.1 0.0 12.2 
Amphetamines 0.0 0.0 7.7 0.0 2.4 
Benzoylecgonine 0.0 0.0 0.0 0.0 0.0 
Cocaine 0.0 0.0 0.0 0.0 0.0 
THC 0.0 0.0 0.0 0.0 0.0 
Illicit opiates 0.0 0.0 0.0 0.0 0.0 
Benzodiazepines 12.5 0.0 0.0 16.7 7.3 
Z-drugs 12.5 0.0 0.0 16.7 7.3 
Medicinal opioid/opiates 12.5 0.0 7.7 0.0 4.9 
Drug-Alcohol 12.5 0.0 0.0 0.0 2.4 
Drug-Drug 12.5 0.0 7.7 8.3 7.3 
 
Additional substances 0.0 0.0 0.0 0.0 0.0 
 
Core and/or additional substances 
Illicit drugs 0.0 0.0 7.7 0.0 2.4 
Medicinal drugs 37.5 0.0 7.7 25.0 17.1 
Presence of any substance 37.5 12.5 30.8 25.0 26.8 
 
Males (n=152) 18-24 y 25-34 y 35-49 y 50+ y Total 
Core substances 
Alcohol ≥ 0.1 g/L 37.5 34.5 34.5 13.0 28.9 
Amphetamines 8.3 13.8 13.8 0.0 7.9 
Benzoylecgonine 0.0 3.4 0.0 0.0 0.7 
Cocaine 0.0 0.0 0.0 0.0 0.0 
THC 10.4 13.8 6.9 0.0 7.2 
Illicit opiates 0.0 0.0 0.0 0.0 0.0 
Benzodiazepines 4.2 20.7 17.2 2.2 9.2 
Z-drugs 0.0 0.0 6.9 6.5 3.3 
Medicinal opioids/opiates 0.0 0.0 0.0 2.2 0.7 
Drug-Alcohol 14.6 13.8 0.0 2.2 7.9 
Drug-Drug 0.0 13.8 17.2 2.2 6.6 
 
Additional substances 2.1 10.3 10.3 4.3 5.9 
 
Core and/or additional substances 
Illicit drugs 16.7 31.0 17.2 0.0 14.5 
Medicinal drugs 6.3 20.7 24.1 13.0 14.5 
Presence of any substance 41.7 55.2 58.6 23.9 42.1 
 
A higher proportion of the samples from middle and northern Norway was positive for 
alcohol or illicit drugs than of the samples from other parts of the country. A higher 
proportion was positive for alcohol or drugs if the accident happened in urban areas. The 
speed limit in urban areas is lower than in rural areas, so it is likely that many of these 
drivers were speeding or driving aggressively as the outcome of the accident was fatal. 
This may often have been related to the use of alcohol or drugs. 
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Table 9. Prevalence (%) of alcohol, illicit drugs and medicinal drugs among killed drivers 
(core and additional substances)  
 Alcohol Illicit 
drugs 
Medicinal 
drugs 
Presence of 
any 
substance 
Norway in total (n=193) 25.4 11.9 15.0 38.9 
South-east (n=103) 21.4 10.7 16.5 35.0 
South-west (n=47) 25.5 12.8 14.9 40.4 
Middle/north (n=43) 34.9 14.0 11.6 46.5 
     
Urban roads (n=26) 38.5 19.2 23.1 57.7 
Rural roads (n=167) 23.4 10.8 13.8 35.9 
     
Day (n=164) 16.5 10.4 14.0 31.1 
Night (n=29) 75.9 20.7 20.7 82.8 
     
Week (n=122) 13.1 9.8 18.9 32.0 
Weekend (n=71) 46.5 16.9 8.5 50.7 
     
Single vehicle accidents (n=81) 50.6 19.8 19.8 64.2 
Multiple vehicle accidents (n=112) 7.1 6.3 11.6 20.5 
  
Alcohol and illicit drugs were particularly often found in samples from drivers killed at 
night-time and during weekends, while medicinal drugs were more frequently found in 
samples from those killed during weekdays than during the weekend. Alcohol and illicit 
drugs were more frequently found in samples from male drivers than female drivers, and 
more frequently in samples from young drivers than older ones. Medicinal drugs were 
more frequently found in samples from older drivers; there was no difference between 
males and females. 
 
A higher proportion of samples from drivers killed in single vehicle accidents were 
positive for alcohol or drugs than in samples from drivers killed in collisions. This is 
expected because in collisions the killed driver cannot always be blamed for the accident; 
the surviving driver might in many cases be responsible. 
 
 
2.5 Discussion 
We received blood samples for analysis of alcohol and drugs from 59% of all drivers of 
cars and vans killed in Norway during the study period. We expect that sampling was not 
performed if the police considered that the probability of finding alcohol or drugs was low, 
but other practical matters as economy and transportation over long distances to obtain 
an autopsy might also have contributed to a somewhat low frequency of toxicological 
testing.  
 
The prevalence of alcohol and/or drugs in blood samples from drivers killed in Norway 
was 37% in 1989-90 and 42% in 2001-2 (17, 18), which is similar to the finding presented 
in this report. There seems thus not to have been any marked change over the last 
decades. 
 
The most frequently found drugs in samples from killed drivers during 2006-8 were the 
same as those found in blood samples from suspected drugged drivers. In 2007, the 
most frequently detected drug in blood samples from suspected drugged drivers were 
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diazepam (found in 29% of the samples), THC (27%), amphetamine (27%), and 
methamphetamine (21%) (19). During the last years there has been a shift from 
amphetamine to methamphetamine on the Norwegian illicit drug market. The ratio 
between methamphetamine and amphetamine detections increased from about 1:4 in 
2001 to 4:3 in 2009 (20). Our study of killed drivers from 2006-8 reflects this trend. 
 
When comparing with drugs found in the roadside survey (See D2.2.3 Summary Report), 
a marked difference in the prevalence of alcohol and drugs can be observed. The 
prevalence of alcohol in samples of oral fluid from random drivers in Norway was very 
low; only about 0.3% had alcohol concentrations equal to or above 0.1 g/L. Marked 
differences were also found for most drugs, and particularly for the use of two or more 
psychoactive substances. It is thus evident that the use of alcohol or a combined use of 
two or more psychoactive substances may cause particularly high risks for involvement in 
a fatal road traffic accident. 
 
2.6 Acknowledgements 
Thanks to the staff at the Division of Forensic Toxicology and Drug Abuse for analysis of 
alcohol and drugs in blood samples. Thanks to Bartho van der Linden for database 
management. 
 
 
2.7 References 
1. Vågane L. Den norske reisevaneundersøkelsen [The Norwegian Travel Survey]. Oslo: 
Institute of Transport Economics; 2005. 
 
2. Kristoffersen L, Smith-Kielland A. An automated alcohol dehydrogenase method for 
ethanol quantification in urine and whole blood. J Anal Toxicol 2005;29:387-9. 
 
3. Kristoffersen L, Stormyhr LE, Smith-Kielland A. Headspace gas chromatographic 
determination of ethanol: the use of factorial design to study effects of blood storage and 
headspace conditions on ethanol stability and acetaldehyde formation in whole blood and 
plasma. Forensic Sci Int 2006;161:151-7. 
 
4. Gjerde H, Christophersen AS, Skuterud B, Klemetsen K, Mørland J. Screening for 
drugs in forensic blood samples using EMIT urine assays. Forensic Sci Int 1990;44:179-
85. 
 
5. Christophersen AS, Gulliksen M, Hasvold I, Johansen U, Karinen R, Ripel A, et al. 
Screening, confirmation and quantification of drugs of abuse in whole blood by LC-MS 
(ESI). In: Abstracts of The 39th Meeting of The International Association of Forensic 
Toxicologists (TIAFT). Prague: 2001. 
 
6. Christophersen AS. Tetrahydrocannabinol stability in whole blood: plastic versus glass 
containers. J Anal Toxicol 1986;10:129-31. 
 
7. Gjerde H, Fongen U, Gundersen H, Christophersen AS. Evaluation of a method for 
simultaneous quantification of codeine, ethylmorphine and morphine in blood. Forensic 
Sci Int 1991;51:105-10. 
 
8. Gjerde H, Hasvold I, Pettersen G, Christophersen AS. Determination of amphetamine 
and methamphetamine in blood by derivatisation with perfluorooctanoyl chloride and gas 
chromatography/mass spectrometry. J Anal Toxicol 1993;17:65-8. 
 DRUID 6th Framework Programme Deliverable D.2.2.5  
Part 3 - Country reports from the studies on killed drivers- Country Report 
Norway 
 Prevalence of alcohol and other psychoactive substances in injured and killed drivers. 
 
 Page 326 of 349 
 
9. Øiestad EL, Øiestad ÅML, Johansen U, Christophersen AS. Drug screening in whole 
blood with ultra performance liquid chromatography tandem mass spectrometry. Abstract, 
47th International Meeting The International Association of Forensic Toxicologists, 
Geneva, Switzerland, August 23-27, 2009. Ann Toxicol Anal 2009;21:15. 
 
10. Drummer OH. Postmortem toxicology of drugs of abuse. Forensic Sci Int 
2004;142:101-13. 
 
11. Hilberg T, Rogde S, Mørland J. Postmortem drug redistribution - human cases related 
to results in experimental animals. J Forensic Sci 1999;44:3-9. 
 
12. Ramaekers JG, Moeller MR, van Ruitenbeek P, Theunissen EL, Schneider E, Kauert 
G. Cognition and motor control as a function of Delta9-THC concentration in serum and 
oral fluid: limits of impairment. Drug Alcohol Depend 2006;85:114-22. 
 
13. Grotenhermen F, Leson G, Berghaus G, Drummer OH, Kruger HP, Longo M, et al. 
Developing limits for driving under cannabis. Addiction 2007;102:1910-7. 
 
14. Welzen M, Uges DR. TIAFT reference blood level list of therapeutic and toxic 
substances. 2004. 
 
15. Tornio A, Neuvonen PJ, Backman JT. The CYP2C8 inhibitor gemfibrozil does not 
increase the plasma concentrations of zopiclone. European Journal of Clinical 
Pharmacology 2006;62:645-51. 
 
16. Skopp G. Preanalytic aspects in postmortem toxicology. Forensic Sci Int 
2004;142:75-100. 
 
17. Gjerde H, Beylich KM, Mørland J. Incidence of alcohol and drugs in fatally injured car 
drivers in Norway. Accid Anal Prev 1993;25:479-83. 
  
18. Christophersen AS. Commentary on the risks posed by drugs in traffic. Transportation 
Research Circular; Washington DC: Transportation Research Board; 2005 p. 41-6. 
Available online at http://onlinepubs.trb.org/onlinepubs/circulars/ec096.pdf.  
  
19. Nasjonalt Folkehelseinstitutt. Rusmiddelstatistikk for 2007 - funn i blodprøver fra 
pågrepne bilførere. Oslo: Nasjonalt Folkehelseinstitutt; 2008. Available online at 
http://www.fhi.no/artikler/?id=77359.  
  
20. Nasjonalt Folkehelseinstitutt. Rusmiddelstatistikk. Funn i blodprøver hos bilførere 
mistenkt for påvirket kjøring i 2009. Oslo: Nasjonalt folkehelseinstitutt; 2010. Available 
online at http://www.fhi.no/artikler/?id=84851.  
 
 DRUID 6th Framework Programme Deliverable D.2.2.5  
Part 3 - Country reports from the studies on killed drivers - Country Report 
Portugal 
 Prevalence of alcohol and other psychoactive substances in injured and killed drivers. 
 
 Page 327 of 349 
3  Country Report Portugal  
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3.1 Description of the killed driver sample 
 
According to the Portuguese Road Traffic Law, a test for alcohol and drugs (narcotic and 
psychotropic substances) must be performed on all drivers and pedestrians killed in road 
accidents. 
 
The Penal Code stipulates also that the Court may request the screening for other 
substances that affect the ability to drive, other than those included in routine 
enforcement activities carried out by the police. 
 
As established by the Law 45/2004, the National Institute of Legal Medicine (from now 
designated INML, IP) is responsible for the medico-legal autopsies, which are mandatory 
in the cases of drivers killed in immediate fatal accidents. For the toxicological analysis, 
the biological samples are collected in accordance with technical recommendations 
defined to ensure the integrity and identity of the samples and therefore the medico-legal 
value of the results. The postmortem samples collected for analysis of alcohol, illicit and 
medicinal drugs are usually the cardiac and peripheral blood. The analyses are 
performed by the Departments of Forensic Toxicology of the INML, IP. 
 
The cases selected for the present study were that ones with information of road accident 
in which the driver was the victim and the toxicological analysis previously requested 
included alcohol, illicit drugs and medicinal drugs (benzodiazepines). 
 
To the toxicological results obtained previously, additional information was obtained such 
as: age and gender of the driver, month, day and time of the accident and time from 
accident to death. 
All analyses were performed in the Departments of Forensic Toxicology of the INML, IP 
using the routine validated methods with limits of detection (LOD) and quantification 
(LOQ) for the core substances, provided in Deliverable D 2.1.2 (Uniform design and 
protocols for carrying out case-control studies).  
 
3.1.1 Geographical distribution 
According to the Portuguese law, autopsies of victims of fatal road accidents were 
performed by Court order in one of the three Branches or in one of the Medico-Legal 
Offices (Gabinetes Médico Legais, GML) of the INML, IP (Fig. 1). 
 
 DRUID 6th Framework Programme Deliverable D.2.2.5  
Part 3 - Country reports from the studies on killed drivers - Country Report 
Portugal 
 Prevalence of alcohol and other psychoactive substances in injured and killed drivers. 
 
 Page 328 of 349 
S1
S6
S5
S4S3
S2
C8
C7
C6
C
C5
C4
C3
C2
C1
S8
S7
S
N6
N5
N4
N2N
N1
N3
N7
N8
S ‐ South Branch of INML,IP  (Lisboa)
S1 ‐ GML Faro
S2 ‐ GML Portimão
S3 ‐ GML Santiago do  Cacém
S4 ‐ GML Beja
S5 ‐ GML  Évora
S6 ‐ GML Vila Franca de Xira
S7 ‐ GML Torres Vedras
S8 ‐ GML Portalegre
C ‐ Centre Branch of INML,IP (Coimbra)
C1  – GML Tomar 
C2  ‐ GML Leiria
C3  ‐ GML Castelo Branco
C4  ‐ GML Covilhã
C5  ‐ GML  Guarda
C6  ‐ GML Figueira da Foz
C7  ‐ GML Viseu
C8 ‐ GML Aveiro
C9  ‐ GML  Angra do Heroísmo  (Açores )
C10  ‐ GML  Ponta Delgada (Açores)
C11  ‐ GML  Funchal  (Madeira )
N ‐ North Branch of INML,IP  (Porto)
N1 – GML  Santa Maria da Feira 
N2 ‐ GML Penafiel
N3 ‐ GML  Guimarães
N4 ‐ GML  Vila real
N5 ‐ GML  Bragança
N6 ‐ GML  Chaves
N7 ‐ GML  Braga
N8 ‐ GML Viana do Castelo
Lisboa
Coimbra
Porto
C11
C9
C10
 
 
Figure 1 . Distribution of Branches and Medico-Legal Offices of the INML, IP  
3.1.2 Road Type 
Information about road type, use of seatbelt or other aspects related to the circumstances 
of the accident are part of the police investigation process to which the INML, IP has no 
access. 
 
3.1.3 Region 
The cases included in this study (n=290) correspond to drivers, victims of fatal road 
accidents occurred in 2009 and on which postmortem analyzes were carried out in 
Centre and South Branches of the INML, IP (Table 1). The data presented include 79% of 
the total killed drivers autopsied in INML during the year 2009.The sampling distribution is 
different from the one obtained in the Road Side Survey because covers all Municipalities 
of the Centre and South regions, an area where lives about 71% of Portuguese 
population.  
 
Table 1. Distribution of killed drivers by region. 
Region Inhabitants (1) Killed drivers 
Centre  2385891 123 (42.4 %) 
South  4754736 167 (57.5%) 
 (1) Year 2006 (Source: Instituto Nacional de Estatística) 
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3.1.4 Season, day and time period 
Under the criteria established in Deliverable D 2.1.2, the cases were distributed by season, 
day and time period (Tables 2, 3 and 4). 
 
Table 2. Distribution of killed drivers by season. 
Season Killed drivers 
Winter (month 1-3) 63 (21.7%) 
Spring (month 4-6) 70 (24.1%) 
Summer (month 7-9) 88 (30.3%) 
Autumn (month 10-12) 69 (23.8%) 
 
Table 3. Distribution of killed drivers by day. 
Day Killed drivers 
Sunday 47 (16.2%) 
Monday 35 (12.1%) 
Tuesday 36 (12.4%) 
Wednesday 24 (8.3%) 
Thursday 34 (11.7%) 
Friday 31 (10.7%) 
Saturday 38 (13.1%) 
Unknown 45 (15.5%) 
 
Table 4. Distribution of killed drivers by time period.(1) 
Time period Killed Drivers 
1 37 (12.8%) 
2 45 (15.5%) 
3 34 (11.7%) 
4 24 (8.3%) 
5 19 (6.6%) 
6 15 (5.2%) 
7 36 (12.4%) 
8 25 (8.6%) 
Unknown 55 (19.0%) 
 
Weekday:  
1- Monday to Friday 04:00 to 10:00  
2- Monday to Friday 10:00 to 16:00  
3 - Monday to Thursday 16:00 to 22:00 4 
- Monday to Thursday 22:00 to 04:00 
 
 
Weekend:  
5 – Saturday and Sunday 04:00 to 10:00 
6 – Saturday and Sunday 10:00 to 16:00 
7 – Friday to Sunday 16:00 to 22:00  
8 – Friday to Sunday 22:00 to 04:00 
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3.1.5 Gender and Age  
 
Table 5 represents the distribution of killed drivers by gender and age group. 
 
Table 5. Distribution of killed drivers by gender and age group. 
Gender Age group 
male female Total 
15-24 45 (17.2%) 4 (20%) 49 (17.4%) 
25-34 65 (24.8%) 6 (30%) 71 (25.2%) 
35-49 69 (26.3%) 8 (40%) 77 (27.3%) 
>=50 83 (31.7%) 2 (10%) 85 (30.1%) 
Total  262 20 282* 
*Note: Information about age (7 cases) and gender (1 case) was unknown 
 
 
3.2 Data collection and analysis 
 
3.2.1 Ethical approval 
Following the approval by the Ethics Committee of the Faculty of Medicine of the 
University of Coimbra, this survey was performed without any information about identities 
of the killed drivers. 
 
3.2.2 Biological samples and storage 
Blood samples were collected during the autopsy by the forensic pathologist in 
polyethylene tubes containing sodium fluoride (2%) and preserved at -15 °C until 
toxicological analysis. 
 
3.2.3 Analytical methods 
All the core substances were screened by methods fully validated, including specificity 
and capacity of identification, limit of detection (LOD), limit of quantification (LOQ), 
recovery, carryover, linearity, intra-assay precision and inter-assay accuracy. The results 
of the validation for each group of substances are: 
 
Alcohol* 
 
Substance LOD (g/L) 
LOQ 
(g/L) 
Intermediate 
Precision  
(CV %) 
Linearity 
 
Intra-
assay 
precision 
(%) 
Inter-
assay 
accuracy 
(%) 
Ethanol 0.02 0.06 5.7 
(0.1 – 5.1 g/L) 
Y=0.4462x+0.0044 
R2=0.9999 
4.7 102.2 
* Extraction: HS  Method: HS-GC-FID 
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Illicit Drugs*: Cannabis; Amphetamines; Cocaine  
 
Substance LOD (ng/mL) 
LOQ 
(ng/mL) 
Recovery 
(%) 
Linearity 
 
Intra-
assay 
precision 
(%) 
Inter-
assay 
accuracy 
(%) 
THC 2 5 51.7 
(5-500 ng/mL) 
Y=0.004x+0.0146 
R2=0.995 
3 94.9 
THCCOOH 2 5 44.1 
(5-500 ng/mL) 
Y=0.0048x-
0.0003 
R2=0.9989 
3 89.8 
Amphetamine 8 23 88 
(25-1000 ng/mL) 
Y=0.0019x-
0.0001 
R2=0.996 
4 99.7 
MDA 3 9 95 
(25-1000 ng/mL) 
Y=0.0025x-
0.0353 
R2=0.998 
4 99.7 
MDEA 3 8 93 
(25-1000 ng/mL) 
Y=0.0034x-
0.0724 
R2=0.998 
4 99.9 
Methamphetamine 4 13 94 
(25-1000 ng/mL) 
Y=0.0027x-
0.0342 
R2=0.994 
4 100.3 
MDMA 7 20 96 
(25-1000 ng/mL) 
Y=0.0012x-
0.0155 
R2=0.9982 
2 103.6 
Benzoylecgonine 2.8 8.4 90.3 
(25-1000 ng/mL) 
Y=0.0029x-
0.0247 
R2=0.9982 
3 99.5 
Cocaine 2.7 8.3 84.5 
(25-1000 ng/mL) 
Y=0.0046x-
0.0151 
R2=0.999 
3 102 
* Extraction: SPE  Method: GC-MS 
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Medicinal Drugs*: Benzodiazepines; Opiates 
 
Substance LOD (ng/mL) 
LOQ 
(ng/mL) 
Recovery 
(%) 
Linearity 
 
Intra-
assay 
precision 
(%) 
Inter-
assay 
accuracy 
(%) 
Diazepam 0.21 0.65 99 (1-400 ng/mL) 
Y=0.0166x+0.0685 
R2=0.9954 
6.2 97.7 
Nordiazepam 0.37 1.12 91 (1-400 ng/mL) 
Y=0.0068x+0.0536 
R2=0.9968 
6.7 96.1 
Alprazolam 0.26 0.79 94 (1-400 ng/mL) 
Y=0.0054x+0.0175 
R2=0.9956 
7.9 96.2 
Clonazepam 0.52 1.58 97 (1-400 ng/mL) 
Y=0.0048x+0.0421 
R2=0.9940 
4.5 100.9 
Oxazepam 0.38 1.16 95 (1-400 ng/mL) 
Y=0.0111x+0.0141 
R2=0.9954 
5.3 97.2 
Lorazepam 0.38 1.14 95 (1-400 ng/mL) 
Y=0.0048x+0.041 
R2=0.9969 
8.6 99.1 
Flunitrazepam 0.31 0.94 97 (1-400 ng/mL) 
Y=0.0112x-0.0035 
R2=0.9932 
5.7 97.1 
Morphine 4.8 14.5 78.8 (25-1000 ng/mL) 
Y=0.0019x+0.007 
R2=0.9964 
4 100.8 
Codeine 1.4 4.2 85.3 (25-1000 ng/mL) 
Y=0.0021x-0.0161 
R2=0.9978 
3 96.7 
* Extraction: SPE  Method: GC-MS (Opiates); LC-MS/MS (Benzodiazepines) 
 
3.2.4 Other collected data 
Aditional information such as: age and gender of the driver; month, day and time of the 
accident, time from accident to death, was obtained from pathologist process. 
Informations about road type, use of seatbelt or other informations related to the 
circunstances of the accident were not available. 
 
3.2.5 Statistical analysis 
Statistical analysis was performed with standard Excel software without application of any 
correction or weighing factor. 
 
3.3 Non-response (Representativeness) 
To permit a comparative analysis of the results obtained in other countries, the cases of 
drivers killed in immediate fatal accidents in which analysis was performed only for 
alcohol or only for alcohol and illicit drugs were excluded from this study. Although the 
number of fatal road accidents occurred in 2009 in Portugal is higher than the number of 
cases included in this study; the data presented include 79% of the total killed drivers 
autopsied in INML during the year 2009. 
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A comparative analysis of the results at National level is not possible as there are no 
previous studies available with aggregated data in accordance to the criteria used in this 
study. 
 
3.4 Results  
The cases selected for the present study were that ones with information of road 
accidents in which the driver was the victim and the toxicological analysis previously 
requested included alcohol, illicit drugs and medicinal drugs (benzodiazepines). The 
screening analyses included all the core substances and the positive results were 
aggregated according to the substance classes established in the project.  
 
3.4.1 Distribution of cases by substance group and region 
The results presented in Table 6 include a total of 290 drivers killed in an immediate fatal 
accident occurred in all the Municipalities of Centre and South Regions of Portugal in 
2009. In 54.5% of the accidents in the Centre Region and 43% of the accidents in the 
South Region, at least one psychoactive substance with influence on the ability to drive 
was detected.  
Among drivers victims of fatal accident in Central and South Regions 44.5% revealed the 
presence of alcohol in blood. The presence of drugs was observed in 9.9% while the 
consumption of alcohol in association with, at least, one drug, was observed in 5.9% of 
drivers tested. 
Table 6. Distribution of cases by substance group and region. 
 Centre Region 
South 
Region Total 
Number of cases  123 167 290 
Number of Positive Cases 67 (54.5%) 72 (43%) 139 (47.9%) 
Alcohol 51.2% 39.5% 44.5% 
THCCOOH 3.3 5.4% 4.5% 
Benzoylecgonine --- 1.2% 0.7% 
Illicit Drugs 
Cocaine/Benzoylecgonine 0.8% 0.6% 0.7% 
Benzodiazepines 1.6% 2.4% 2% Medicinal 
Drugs Morphine/Codeine 2.4% 1.8% 2% 
Drugs-Alcohol 4.9% 6.6% 5.9% Various 
Combinations Drug-Drug --- 1.2% 0.7% 
 
3.4.2 Distribution of positive cases by substance group and time period 
The social and cultural aspects of alcohol and drugs consumption are important factors to 
be considered when assessing driving under the influence (DUI). For this reason, 
measures to prevent DUI should be linked with other policies in the context of public 
health that aim to prevent the consumption of alcohol and drugs among the general 
population.  
The prevalence of psychoactive substances used by drivers may vary considerably by 
time (month, day of the week and time of the day).  
 
The results obtained show that the prevalence of drivers that tested positive for 
psychoactive substances as cannabis and alcohol, alone or in association with drugs, 
was much higher in the accidents occurred at night (22:00 – 04:00) and weekend (Friday 
- Sunday) (Tables 7 and 8). 
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Alcohol was detected in 36% of drivers killed in accidents that occurred in the day period. 
The prevalence observed in accidents that occurred at night (75.5%) is more than twice 
that was observed in the day period. In accidents that occurred during the weekend 
56.8% of drivers were found positive for alcohol, a prevalence higher than that observed 
during the week (35.8%). 
 
As with alcohol, also the prevalence of drugs is higher in accidents that occurred at night 
(14.2%) and during the weekend (9.6%) when compared with the day period of the 
weekdays, 8% and 9.2%, respectively. In accidents that occurred during the night, 8.2% 
of drivers was positive for cannabis and 2% for cocaine. The results showed also an 
association of alcohol and drugs in 16.3% of the drivers involved in fatal accidents 
occurred during the night period. 
 
Table 7. Distribution of positive cases by substance group and time period aggregated into 
day (time period 1 to 3 and 5 to 7) vs night (time period 4 and 8). 
Time period Substance Group(1) Day Night 
Alcohol 36% 75.5% 
THCCOOH 3.2% 8.2% 
Benzoylecgonine 0.5% 2% 
Illicit Drugs 
Cocaine/benzoylecgonine 1.1% --- 
Benzodiazepines 2.1% 2% Medicinal Drugs 
Morphine/Codeine 1.1% 2% 
Drugs-Alcohol 3.2% 16.3% Various Combinations 
Drug-Drug --- 2% 
 
(1) 25 cases of alcohol; 1 case of Benzoylecgonine; 2 cases of THCCOOH; 1 case of 
benzodiazepines were not included because information about time period was 
unknown. 
 
Table 8. Distribution of positive cases by substance group and time period aggregated into 
week (time period 1 to 4) vs weekend (time period 5 to 8). 
Time period Substance Group (1) Week Weekend 
Alcohol 35.8% 56.8% 
THCCOOH 3.6% 5.3% 
Benzoylecgonine 0.7% 1.1% 
Illicit Drugs 
Cocaine/Benzoylecgonine 1.4% --- 
Benzodiazepines 2.1% 2.1% Medicinal Drugs 
Morphine/Codeine 1.4% 1.1.% 
Drugs-Alcohol 5% 7.4% Various Combinations 
Drug-Drug --- 1.1% 
 
(1) 25 cases of alcohol; 1 case of benzoylecgonine; 2 cases of THCCOOH; 1 case of 
benzodiazepines was not included because information about time period was 
unknown. 
 
3.4.3 Distribution of positive cases by substance group and age group 
Table 9 shows the distribution of male drivers positive cases by age group. Only 20 
female drivers (7%) were included in this study and only 3 of them were found positive for 
alcohol alone. 
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The mean value of blood alcohol concentration (BAC) on drivers who tested positive for 
alcohol alone was 1.4 g/L (Table 10) while the mean value of BAC on drivers with a 
combination of alcohol and drugs was 1.2 g/L. 
 
Over 50% of male drivers in the age group of 25-34 and 35-49 years were found positive 
for alcohol in blood with the BAC ≥ 1.2 g/L in 69.6% and 57.8%, respectively (Table 10). 
In these age groups, the mean values of BAC were 1.4 and 1.5 g/L, respectively. 
 
The prevalence of alcohol in young drivers (15-24 years) is also high (36.5%) with 42.1% 
of them with BAC values ≥ 1.2 g/L and an average BAC of 1.1 g/L. In 8.9% of this group 
of drivers the presence of alcohol was in combination with other drugs. 
 
All age groups showed drivers who tested positive for drugs. The higher prevalence of 
cannabis was found in the group aged 15-24 (11.1%) while cocaine was more prevalent 
in the group 25-34 (3%). This last group also presents a higher prevalence of drivers with 
cannabis (6.2%), benzodiazepines (3%), opiates (6.2%) and consumption of alcohol in 
association with drugs (10.8%). 
 
Table 9. Distribution of male drivers positive cases by substance group and age group  
Age group Substance Group* 15-24 25-34 35-49 ≥ 50 
Alcohol 36.5% 58.5% 63.8% 28.9%
THCCOOH 11.1% 6.2% 2.3% 1.2% 
Benzoylecgonine --- 1.5% 1.4% --- 
Illicit Drugs 
Cocaine/ Benzoylecgonine  2.2% 1.5% --- --- 
Benzodiazepines --- 3% 2.9% 2.4% Medicinal Drugs 
Morphine/Codeine ---- 6.2% 1.4% 1.2% 
Drugs-Alcohol 8.9% 10.8% 7.4% 1.2% Various 
Combinations Drug-Drug --- 1.5% --- --- 
 
*One case of alcohol was not included because information about age was unknown. 
 
 
Table 10. Distribution of negative and positive cases by BAC and age group. 
 
Age Group* BAC (g/L) 15-24 25-34 35-49 ≥ 50 
Negative1   
< 0.1  11.0% 11.3% 11.3% 21.2% 
Positive2  
> 0.1  6.7% 13.8% 15.9% 8.8% 
BAC group  
0.1-0.49 31.6% 17.9% 15.6% 36.0% 
0.5-0.79 10.5% 10.3% 17.8% 8.0% 
0.8-1.19 15.8% 2.6% 8.9% 4.0% 
≥ 1.2 42.1% 69.6% 57.8% 52.0% 
1.1 g/L 1.4 g/L 1.5 g/L 1.4 g/L BAC (Mean) 
1.4 g/L 
 
(1) Six cases were not included because information about age was unknown. 
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(2) One case was not included because information about age was unknown. 
 
Table 11. Distribution of substance concentration in Alcohol-Drug and Drug-Drug positive 
cases. 
Case Substances 
1 Alcohol: 2.40 g/L; Morphine1: <14.5 ng/mL; Cocaine: 68 ng/mL; 
Benzoylecgonine: 650 ng/mL 
2 Alcohol: 1.33 g/L; ; THCCOOH 12 ng/mL 
3 Alcohol: 1.76 g/L; Morphine1: 56 ng/mL; 
4 Alcohol: 1.55 g/L; Morphine1: 151 ng/mL; 
5 Alcohol : 0.57 g/L; THCCOOH 6ng/mL 
6 Alcohol : 0.94 g/L; THCCOOH 10ng/mL 
7 Alcohol : 2.40 g/L; THCCOOH 18 ng/mL 
8 Alcohol: 0.12 g/L; Diazepam 169 ng/mL; Nordiazepam 157 ng/mL 
9 Alcohol: 1.54 g/L; THCCOOH 8 ng/mL 
10 Alcohol: 1.43 g/L; Diazepam 33 ng/mL; Oxazepam 1.5 ng/mL; Nordiazepam 69 
ng/mL; THCCOOH 24 ng/mL 
11 Alcohol: 1.31 g/L; Morphine1: 345 ng/mL 
12 Alcohol: 1.56 g/L; Cocaine: <8.3 ng/mL; Benzoylecgonine: 277 ng/mL 
13 Morphine1 34 ng/mL; Diazepam: 4.4 ng/mL; Oxazepam: <1.6 ng/mL; 
Nordiazepam: 23.2 ng/mL; 5.6 ng/mL; 7 amino clonazepam 
14 Alcohol: 0.65 g/L; THCCOOH: 6 ng/mL 
15 Alcohol: 1.17 g/L; Benzoylecgonine: 89 ng/mL 
16 Alcohol: 0.14 g/L; THCCOOH: 95 ng/mL 
17 Alcohol: 0.70 g/L; THCCOOH: 6 ng/mL 
18 Alcohol: 0.29 g/L; Cocaine: 35 ng/mL; Benzoylecgonine: 73 ng/mL 
(1) Free morphine 
 
 
3.5 Discussion 
Data presented in this study include 79% of killed drivers autopsied in INML. These 
drivers have been victims of accidents occurred in municipalities of the Centre and South 
Regions of Portugal, where 71% of the Portuguese population lives. So, it can be 
assumed that these results are representative of the situation regarding killed drivers in 
Portugal.  
 
The cases which were not included in this study (21%) show a gender and age 
distribution similar to the one observed in the cases included. So, it is reasonable to 
assume that there are no confounding effects due to the missing cases. 
 
Alcohol was the most common psychoactive substance, detected in 44.5% of drivers. A 
concentration above the legal limit (≥0.5 g/L) was found in 34.5% of drivers. 
 
The high mean value of BAC (1.1 to 1.5 g/L) in all age groups reflects the high 
prevalence of drivers with BAC exceeding 1.2 g/L (42.1% to 69.6%). Although the 
possibility of postmortem production cannot be completely excluded, these values may 
suggest that many of those drivers were probably heavy drinkers. Although the effects 
caused by alcohol depend on age, health status, type and frequency of consumption, 
tolerance and association with other drugs, these concentrations are clearly associated 
with situations of impairment to drive. 
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Drivers who tested positive for drugs and alcohol (5.9%) showed also a high mean value 
of BAC (1.2 g/L). Although the concentrations found for some drugs are not high, 
combination with alcohol may result in additive impairing effects on psychomotor 
performance and greater relative risk of accident. (Table 11) 
 
A high prevalence of alcohol was found especially at night and during the weekend 
(75.5% and 56.8%, respectively). This was also observed in equivalent studies with 
serious injured drivers in road accidents [1]. 
 
Illicit drugs were detected in 5.9% of the drivers. The most common illicit drugs found 
were cannabis (4.5%) and cocaine (1.4%).The presence of Δ9-tetrahydrocannabinol 
(THC) was not detected in any of the positive cases for cannabis. Although the LOD of 
the method (2 ng/mL) is higher than that stated in the DRUID project (1 ng/mL), the 
absence of positive cases for THC could also be related to the stability of this substance 
during storage of samples and the time elapsed between sampling and analysis. 
 
The prevalence of illegal drugs was similar to that described in studies conducted in other 
countries [2]. Any comparison must take into account the reality of each country 
regarding the type of substances and consumption habits. In 2009, cannabis and cocaine 
were also the substances with greater prevalence among Portuguese drivers involved in 
accidents with injured victims submitted for drug analysis by the Police.[3]. The higher 
prevalence of positive cases observed in the south region may be justified because it 
includes the sub-regions of Lisbon and the Algarve who, according to official statistics, 
show the highest (above the national average) prevalence of drug use. In this sub-
regions cannabis is the most consumed substance followed by cocaine [10].  
 
The prevalence of medicinal drugs was 2% for opiates and 2% for benzodiazepines, a 
prevalence similar to the frequencies found in different countries. None of the positive 
cases for morphine showed the presence of 6-acetylmorphine so we should admit the 
possibility in some cases that the presence of morphine could be related with the medical 
assistance to the injured victims of the accident. 
 
In conclusion, the prevalence for drugs and alcohol found in this study is consistent with 
literature. [2,4-9]. However, prevalence figures could be hard to compare due to different 
condition criteria (selections of cases, time trends and local differences in alcohol and 
drug use habits, patterns and legislation). Studies with the same design and protocol 
must be carried out periodically in future to enable a comparative analyze about the 
prevalence of drivers driving under the influence of alcohol and psychotropic substances 
in Portugal. 
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4 Country Report Sweden 
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4.1 Description of the killed driver sample 
The Swedish sample includes drivers of personal cars and vans that were killed during 
the year 2008 and died within 24 hours after the accident. In total, the sample includes 
157 drivers from which we have toxicological results, this corresponds to about 94 per 
cent of all drivers. 
 
Guidelines for the survey design are found in Annex 1 of the Summary report. The 
guidelines that are applicable to killed drivers have been followed to a large extent. The 
main deviation is that we collected data from drivers killed in the whole country and did 
not restrict collection to the catchment area of the road side survey. The reason for this 
was to increase the number of cases. In this report we will show results from the whole 
country. For the risk calculations that will be presented in a forthcoming report we will 
restrict the area somewhat.  
 
The distribution of the sample by road type, accident type, vehicle type, quarter of the 
year, time period, age and gender, are shown in table 1- 6. 
 
Most drivers are killed on rural roads (table1). The reason for this is partly because the 
traffic volume is larger on rural roads and partly because there is a higher death risk on 
rural roads due to higher speeds. 
 
Table 1. Distribution of killed drivers by road type. (n = 157). 
Road type Distribution of sample 
Rural 85.4% 
Urban 14.6% 
 
The distribution of killed drivers by accident type is shown in table 2. Most drivers are 
killed in multi-vehicle accidents.  
 
Table 2. Distribution of killed drivers by accident type. (n = 156). 
Accident type Distribution of sample 
Single-vehicle accident 41.7% 
Multi-vehicle accident 58.3% 
 
Almost all of the killed drivers in the sample were driving a personal car, as shown in 
table 3. 
 
Table 3. Distribution of killed drivers by vehicle type. (n = 157). 
Vehicle type Distribution of sample 
Personal car 93.6% 
Van 6.4% 
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The number of killed drivers is relatively stable between quarters of the year. The highest 
number is found during the third quarter and the lowest during the fourth quarter (table 4). 
 
Table 4. Distribution of killed drivers by quarter. (n = 157). 
Season Distribution of sample 
Quarter 1 (Jan-Mar)  26.1% 
Quarter 2 (Apr-Jun) 24.2% 
Quarter 3 (Jul-Sep) 28.7% 
Quarter 4 (Oct-Dec) 21.0% 
 
In comparison with the distribution of traffic volume, the number of killed drivers is 
strongly overrepresented during weekend nights (period 8). The risk is also substantially 
increased during weekday nights (period 4).  
 
Table 5. Distribution of killed drivers by time period. (n = 157). 
Time period Distribution of sample 
1: Weekday 04-10 12.7% 
2: Weekday 10-16 28.0% 
3: Weekday 16-22 20.4% 
4: Weekday 22-04 4.5% 
5: Weekend 04-10 5.1% 
6: Weekend 10-16 8.9% 
7: Weekend 16-22 9.6% 
8: Weekend 22-04 10.8% 
 
The distribution by age category and gender is shown in table 6. Only one driver (male) 
was under the age of 18. Overall, about 76 per cent of the killed drivers are male. When 
comparing these data to the distribution of total mileage, where about 70 per cent is 
carried out by male drivers, no overall large difference can be seen. However, the 
distribution between males and females varies greatly for different age categories. There 
is for example a strong over representation of male drivers in the age category 18-24. 
 
Table 6. Distribution of killed drivers by age category and gender (n = 157). 
Age category Males Females All 
<18 years 0.6% 0.0% 0.6% 
18-24 years 19.1% 2.5% 21.6% 
25-34 years 8.9% 2.5% 11.4% 
35-49 years 14.6% 7.6% 22.2% 
50- years 33.1% 10.8% 43.9% 
All ages 76.3% 23.4% 99.7% 
 
 
4.2 Methods: Data collection and analysis 
Before the study started, we were in contact with the Regional Ethical Review Board in 
Linköping. However, since the study only included samples from deceased drivers we did 
not have to apply for ethical approval. 
 
All people killed in road traffic accidents in Sweden should undergo a post-mortem 
examination. In practice, about 90 per cent are examined. The examination is carried out 
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at the National Board of Forensic Medicine and, if possible, samples of blood, urine and 
sometimes other material are collected and sent to the department of Forensic 
Toxicology, which performs a toxicological analysis. The list of substances tested for is 
not standardised and may differ between drivers. Additional analyses were therefore 
carried out in order to cover the DRUID substances. This was possible in most cases but 
since the additional analyses were made afterwards, there were no blood samples left for 
a few drivers. Thus, there are missing values for some substances and drivers. Apart 
from the core substances listed in the method part of the summary report, the following 
additional substances were included: tramadol, 7-a-clonazepam, 7-a-flunitrazepam, 
nitrazepam, 7-a-nitrazepam, carisoprodol, and meprobamate. The first three of these 
drugs have been included in the international comparisons and are therefore incorporated 
in the substance groups and classes described below. The results for the last four 
substances are reported at the end of the results section. 
 
Drivers who died more than 24 hours after the accident were excluded from the sample. 
Finally, 157 drivers were included in the study. 
 
Blood samples were used for the analyses in most cases. These samples were collected 
during the post-mortem examination according to a standardised procedure; femoral 
blood is collected if possible. In some cases, negative screening results from urine have 
been reported. This was done only when there was no blood left to do complementary 
analysis. Results from analyses on muscle tissue have also been reported in a few cases 
when there was not enough blood to conduct the analyses. Since we mainly are 
interested in whether a drug is present or absent in a driver and not in its actual 
concentration, inclusion of results from urine and muscle tissue should be acceptable. 
 
The time between death and sampling varies between 1 and about 20 days. In about 80 
per cent of the cases, sampling was conducted within a week from the death.  
 
 
4.2.1 Toxicological analysis of body fluids 
The toxicological analysis was performed at the National Board of Forensic Medicine in 
Linköping, Sweden. The routines for toxicological analysis included a broad analysis for 
prescription drugs in blood and a screening for drugs of abuse in blood (or in some cases 
in urine) as well as determination of alcohols and other volatiles. 
 
Immunoassays were used to screen for opiates, amphetamines, cocaine metabolites, 
and cannabis. Positive results from the screening were confirmed and quantitated in 
blood by more specific methods using gas chromatography–mass spectrometry with 
deuterium labeled internal standards. Limit of quantitation (LOQ) was 0.3 ng/mL for 
tetrahydrocannabinol, the corresponding LOQ for amphetamine and methamphetamine 
was 20 ng/mL and 5 ng/mL for morphine, codeine and 6-acetyl morphine (1). LOQ for 
cocaine and benzoylecgonine was 20 ng/mL. 
 
Prescription drugs were determined in blood by capillary column gas chromatography 
and a nitrogen–phosphorous detection, a method described in more detail elsewhere (2). 
With this analytical method, quantitative analysis of approximately 200 different 
pharmaceutical substances is possible. The LOQs differed for different drugs, and were 
100 ng/mL for methadone, 50 ng/mL for diazepam, nordazepam, zolpidem, and 7-
aminoclonazepam, and 20 ng/mL for zopiclone, alprazolam, and for 7-amino-
flunitrazepam. Since some of the thresholds recommended by DRUID could not be met 
by the routine methods, chromatograms were re-evaluated for peaks corresponding to 
the DRUID core drugs. Additional analyses in blood were also performed using an LC-
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MS-MS method including all DRUID core drugs except THC, at or lower than the 
recommended thresholds (3). 
 
Volatiles in blood, primarily ethanol, were determined by headspace gas chromatography 
with a flame ionisation detector as described in more detail elsewhere (4). Each blood 
specimen (0.1 mL) was diluted 1 + 10 with tert-butanol as the internal standard, 
transferred into glass vials and immediately made airtight with crimped aluminum cap. All 
determinations of ethanol were done in duplicate on two chromatographic systems that 
result in different retention times for ethanol. The mean of duplicate determinations was 
reported and all concentrations of ethanol in blood less than 0.1 g/L were reported as 
negative. 
 
The results in this report are based on the DRUID cut-offs (see list of applied cut-offs in 
the Summary report), even when the LOQ is lower. 
 
4.2.2 Other data 
For each subject, we also collected data on age, gender, date and time of accident, 
vehicle type (personal car or van), accident type (single-vehicle accident or multi-vehicle 
accident) and road type (rural or urban road). 
 
The time of accident is divided into four groups: 
− Weekday: Monday-Thursday: 04.00 – 22.00, Friday 04.00 - 16.00 
− Weeknight: Monday-Thursday: 22.00 – 04.00 
− Weekend day: Friday: 16.00-22.00, Saturday and Sunday: 04.00 – 22.00 
− Weekend night: Friday – Sunday: 22.00 – 04.00 
 
4.2.3 Classification of substances and missing values 
The substances are divided in types, groups and classes according to a classification 
scheme (see the method part of the summary report). This is done in three steps: 
 
1. Substances of the same type are combined into: alcohol, amphetamines, 
cocaine, cannabis1, cannabis2, illicit opiates, benzodiazepines, Z-drugs, and 
medicinal opioids and opiates. 
2. Substance groups are formed by adding two categories: drug-alcohol and drug-
drug combination. Thus, if a subject is positive for two different drug types he or 
she will be classified as a drug-drug combination. 
3. Substance groups are aggregated into the following substance classes: alcohol, 
illicit drugs, medicinal drugs, drug-alcohol combination and drug-drug 
combination. 
 
The substance type cocaine1 means that only benzoylecgonine is found but not cocaine. 
Cocaine2 means that cocaine or a combination of cocaine and benzoylecgonine is found. 
However, in this country report, we have combined the two groups to one group, called 
cocaine. 
 
The substance type cannabis1 means that only THC-COOH is found and not THC. This 
is here regarded as a negative result and therefore not included in the tables. Thus, this 
differs from the summary report. This difference only has a small effect on the results 
since all results regarding THC-COOH were negative. However, it does affect the number 
of drivers included in the results since there were a few missing values of THC-COOH. 
This was ignored here in the country report (it was regarded as negative) but was 
considered as missing in the summary report. 
 
 DRUID 6th Framework Programme Deliverable D.2.2.5  
Part 3 - Country reports from the studies on killed drivers - Country Report 
Sweden 
 Prevalence of alcohol and other psychoactive substances in injured and killed drivers. 
 
 Page 343 of 349 
 
The data from the toxicological analysis is incomplete for some of the drivers in the sense 
that data are missing for one or several substances. One reason for this partial non-
response is that there was no blood left to do the complementary analyses. Moreover, if a 
driver survived a while after the accident and was given morphine during treatment it is 
not possible to know if morphine was present before the accident. This is also considered 
as a missing value. 
 
Due to missing values, it is sometimes not possible to decide the status of a specific 
substance type (amphetamines, illicit opiates, Z-drugs, etc). For example, if the results for 
zopiclone is missing and results for zoldipem is negative, the result for the type Z-drug is 
also missing. However, if zoldipem is positive then Z-drugs are also positive even though 
we do not know the results of zopiclone. A missing value may thus be handled differently 
depending on the results for the other substances of the same type. 
 
If it is possible to determine the substance group or substance class belonging, even 
though one or more substance types are missing, then the driver is kept in the data set. 
Otherwise the driver is removed. Consider the following situations as examples: the driver 
is positive for alcohol and negative for all other drug types except for illicit opiates where 
the data is missing. In this case we do not know if the driver belongs to the group alcohol 
only or drug-alcohol combination and he or she is removed. If, instead, the driver is 
positive for alcohol and amphetamines but missing on other illicit drugs, then he or she is 
classified as alcohol-drug combination. 
 
4.2.4  Statistical analysis 
The data were processed by the statistical software SAS 9.1.3. 
 
4.3 Non-response 
The non-response in this study consists of killed drivers who did not undergo post-
mortem examination or where no toxicological analyses were requested.  
 
All people killed in road traffic accidents in Sweden should undergo a post-mortem 
examination and in general this is done in about 90 per cent of the cases. It is formally 
the police that request the examination. A reason for not requesting an examination may 
be that a person was treated in a hospital long after the accident before he or she died. 
There may also be circumstances of the accident that explain why the police do not 
request a post-mortem examination. However, we have no knowledge of the specific 
reasons for not requesting an examination of the drivers in our study. 
 
During the study period, year 2008, 178 drivers of personal cars or vans were killed in 
road traffic accidents in Sweden and 170 (96%) of these did undergo a post-mortem 
examination. In 2 of the 170 cases, no toxicological analyses were performed 
(toxicological results were thus available from 94% of the drivers). Because of the low 
number of missing drivers it is unlikely that the non-response affects the results of this 
study more than marginally. Finally, 11 cases were excluded because they died more 
than 24 hours after the accident, leaving 157 cases for the study.  
 
 
4.4 Results 
Table 7 and table 8 show the overall substance group and substance class distribution. 
Slightly less than 70 per cent of the drivers are negative for all substances. Alcohol alone 
is found in 16 per cent of the drivers, which makes it the most common group by far. It 
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can also be noted that drugs are relatively often taken in combination with other drugs or 
alcohol. 
 
Table 7. Substance group distribution. Missing data for 12 drivers. 
Type Substance group Number of 
drivers 
Proportion of 
drivers (%) 
 Negative 100 69.0 
Alcohol Alcohol 23 15.9 
Illicit drugs Amphetamines 4 2.8 
 Cocaine 0 0.0 
 THC 1 0.7 
 Illicit Opiates 0 0.0 
Medicinal drugs Benzodiazepines 0 0.0 
 Z-drugs 4 2.8 
 Opiates and opioids 1 0.7 
Combinations Drug-alcohol 
combination 
6 4.1 
 Drug-drug combination 6 4.1 
Total  145 100.1 
 
Table 8. Substance class distribution. Missing data for 12 drivers. 
Substance class Number of drivers Proportion of drivers (%) 
Negative 100 69.0 
Alcohol 23 15.9 
Illicit drugs 5 3.4 
Medicinal drugs 5 3.4 
Drug-alcohol combination 6 4.1 
Drug-drug combination 6 4.1 
Total 145 99.9 
 
In the first two tables, 12 drivers are excluded because of missing values. However, they 
may only have missing values for one substance group and can be positive for other 
groups. Complementary information is provided in table 9 where results are shown for 
one substance type at a time. The number and proportion of positive drivers for each 
substance type as well as the number of missing values are presented.  
 
The results show that amphetamines are the most prevalent substance type after alcohol, 
while cocaine and cannabis are relatively rare. The three types of medicinal drugs are 
used at more or less the same extent. However, Z-drugs are more often used alone and 
not in combination with other drugs or alcohol. 
 
Note that one driver may be included in several classes. The total number of drivers is 
157, the number of missing values for each substance type is presented in the table. 
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Table 9. Proportion of killed drivers positive for a substance in a specific substance type.  
Type Substance type Number of 
positive 
drivers 
Proportion of 
drivers (%) 
Missing 
values 
Alcohol Alcohol 29 18.8 3 
Illicit drugs Amphetamines 10 6.5 4 
 Cocaine 2 1.3 4 
 THC 2 1.3 4 
 Illicit Opiates 0 0.0 4 
Medicinal 
drugs 
Benzodiazepines 6 3.9 2 
 Z-drugs 5 3.2 2 
 Opiates and 
opioids 
6 4.1 10* 
* Includes 6 drivers who were given morphine after the accident. 
 
Table 10 shows the substance group distribution for different time periods. The number of 
drivers in each group is low, especially for week and weekend nights, so the results must 
be interpreted with caution. Nevertheless, it can be seen that the proportion of negative 
drivers is much lower during the nights than during the days. The main reason for the 
difference is due to alcohol which is much more prevalent during the night. 
 
Table 10. Distribution of substance group by time period. Missing data for 12 drivers. 
Type Substance 
class 
Weekday 
(n=87) 
Weeknight
(n=7) 
Weekend 
day 
(n=35) 
Weekend 
night 
(n=16) 
 Negative 75.9% 14.3% 77.1% 37.5% 
Alcohol Alcohol 10.3% 42.9% 11.4% 43.8% 
Illicit drugs Amphetamines 3.5% 0.0% 2.9% 0.0% 
 Cocaine 0.0% 0.0% 0.0% 0.0% 
 THC 0.0% 0.0% 2.9% 0.0% 
 Illicit Opiates 0.0% 0.0% 0.0% 0.0% 
Medicinal 
drugs 
Benzodiazepines 0.0% 0.0% 0.0% 0.0% 
 Z-drugs 2.3% 14.3% 0.0% 6.3% 
 Opiates and 
opioids 
0.0% 0.0% 2.9% 0.0% 
Combinations Drug-alcohol 
combination 
3.5% 14.3% 2.9% 6.3% 
 Drug-drug 
combination 
4.6% 14.3% 0.0% 6.3% 
Total  100.1% 100.1% 100.1% 100.2% 
 
 
The substance group distribution by age category is shown in table 11 (male drivers) and 
table 12 (female drivers). The age category “< 18 years” only included one driver and is 
therefore not shown. This driver was male and was found negative for all substances. 
The proportion of negative drivers is relatively stable for male drivers, except for the 
category 25-34 years old. This category have a much lower proportion of negative drivers 
but the difference only depend on a few drivers and no strong conclusions can be drawn 
from this result. 
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The prevalence of alcohol and drugs is very low among the female drivers. For example, 
all but one driver over 35 years old are negative for all substances. However, the total 
number of killed female drivers is very low and it is not possible to interpret any age 
differences. 
 
Table 11. Distribution of substance group by age, male drivers. Missing data for 9 drivers. 
Type Substance class 18-24 
years 
(n=29) 
25-34 
years 
(n=14) 
35-49 
years 
(n=21) 
≥50 years 
(n=46) 
 Negative 65.5% 42.9% 61.9% 69.6% 
Alcohol Alcohol 24.1% 21.4% 19.1% 13.0% 
Illicit drugs Amphetamines 3.4% 7.1% 4.8% 2.2% 
 Cocaine 0.0% 0.0% 0.0% 0.0% 
 THC 3.4% 0.0% 0.0% 0.0% 
 Illicit Opiates 0.0% 0.0% 0.0% 0.0% 
Medicinal 
drugs 
Benzodiazepines 0.0% 0.0% 0.0% 0.0% 
 Z-drugs 0.0% 0.0% 4.8% 4.3% 
 Opiates and 
opioids 
0.0% 0.0% 0.0% 2.2% 
Combinations Drug-alcohol 
combination 
3.4% 14.3% 4.8% 2.2% 
 Drug-drug 
combination 
0.0% 14.3% 4.8% 6.5% 
Total  99.8% 100.0% 100.2% 100.0% 
 
Table 12. Distribution of substance group by age, female drivers. Missing data for 3 drivers. 
Type Substance class 18-24 
years 
(n=4) 
25-34 
years 
(n=4) 
35-49 
years 
(n=10) 
≥50 years 
(n=16) 
 Negative 25.0% 75.0% 90.0% 100.0% 
Alcohol Alcohol 75.0% 0.0% 0.0% 0.0% 
Illicit drugs Amphetamines 0.0% 0.0% 0.0% 0.0% 
 Cocaine 0.0% 0.0% 0.0% 0.0% 
 THC 0.0% 0.0% 0.0% 0.0% 
 Illicit Opiates 0.0% 0.0% 0.0% 0.0% 
Medicinal 
drugs 
Benzodiazepines 0.0% 0.0% 0.0% 0.0% 
 Z-drugs 0.0% 0.0% 10.0% 0.0% 
 Opiates and 
opioids 
0.0% 0.0% 0.0% 0.0% 
Combinations Drug-alcohol 
combination 
0.0% 25.0% 0.0% 0.0% 
 Drug-drug 
combination 
0.0% 0.0% 0.0% 0.0% 
Total  100.0% 100.0% 100.0% 100.0% 
 
The prevalence of alcohol and drugs are much higher in single-vehicle accidents than in 
multi-vehicle accidents, see table 13. The difference is most evident for alcohol, drug-
alcohol combination and drug-drug combination. 
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Table 13. Distribution of substance group by accident type. Missing data for 12 drivers. 
Type Substance class Single-vehicle 
accident 
(n=62) 
Multi-vehicle 
accident 
(n=82) 
 Negative 51.6% 81.7% 
Alcohol Alcohol 21.0% 12.2% 
Illicit drugs Amphetamines 4.8% 1.2% 
 Cocaine 0.0% 0.0% 
 THC 0.0% 1.2% 
 Illicit Opiates 0.0% 0.0% 
Medicinal drugs Benzodiazepines 0.0% 0.0% 
 Z-drugs 4.8% 1.2% 
 Opiates and opioids 0.0% 1.2% 
Combinations Drug-alcohol 
combination 
9.7% 0.0% 
 Drug-drug combination 8.1% 1.2% 
Total  100.0% 99.9% 
 
 
4.4.1 Results for additional substances 
In Sweden, the following additional analyses were included: carisoprodol, nitrazepam, 7-
amino-nitrazepam, and meprobamate. The results show that one driver (out of 155) was 
positive for Carisoprodol and one (out of 155) for Nitrazepam and 7-amino-nitrazepam. 
All results were negative for meprobamate. 
 
4.4.2 Concentrations 
Substance concentrations are shown for all positive results from the 157 drivers. 
Minimum, maximum and median concentrations are shown for the substances with at 
least 5 positive observations, see table 14. Concentrations for the rest of the substances 
are shown in figure 1 and figure 2. All single concentration values are shown and 
represented by bars in the diagram. No positive cases were found for: MDMA, MDA, 
MDEA, clonazepam, lorazepam, flunitrazepam, 7-a-flunitrazepam, and 6-acetylmorphine. 
 
Table 14. Substance concentrations for substances with at least 5 positive observations. 
Minimum, maximum and median concentrations are shown. 
Substance Number of 
observations 
Min Max Median 
Alcohol 29 0.13 g/L 3.23 g/L 1.5 g/L 
Amphetamine 10 35 ng/mL 4931 ng/mL 445 ng/mL 
Zopiclone 5 20 ng/mL 419 ng/mL 60 ng/mL 
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Figure 1. Substance concentrations for substances with less than five positive observations. 
Each positive observation is represented by one bar in the diagram. 
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Figure 2. Substance concentrations for substances with less than five positive observations. 
Each positive observation is represented by one bar in the diagram. 
 
4.5 Discussion of results 
 
The study area covers the whole of Sweden and the representativeness of the sample is 
very good since almost all killed drivers were included (about 94%). We have no 
information about the missing drivers, but because of the low number it is unlikely that the 
non-response affects the results of this study more than marginally. 
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The results show that slightly more than 30 per cent of all killed drivers were positive for 
at least one substance. The highest prevalence was found for alcohol, which was found 
in 20.0 per cent of all drivers (15.9% alcohol alone and 4.1% in combination with one or 
more drugs). The most prevalent substance type among the illicit drugs was 
amphetamines. None of the killed drivers were positive for illicit opiates. 
 
Due to the low number of killed drivers, it is difficult to draw any conclusions regarding 
subgroups of the data. However, the results indicate higher prevalence among male 
drivers than female drivers, with respect to both alcohol and drugs. Moreover, alcohol and 
drugs were prevalent in all age categories among male drivers while in the female groups 
over 35 years, only one subject had positive toxicological findings. The results also show 
a high prevalence of both drugs and alcohol in single-vehicle accidents. 
 
The high prevalence of alcohol among killed drivers is in agreement with results from 
previous studies in Sweden. A study of killed drivers during the period 2003-2007 showed 
that alcohol (over 0.2 g/L) was prevalent in about 22 per cent of the drivers (1). This study 
also confirms that amphetamines are the most prevalent of the illicit substance types. 
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